
<html lang="en"     class="pb-page"  data-request-id="fe5611f8-1148-4020-8b0d-bddca474b150"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.9b00952;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents" /></meta><meta name="dc.Creator" content="Adeniyi Michael  Adebesin" /></meta><meta name="dc.Creator" content="Tim  Wesser" /></meta><meta name="dc.Creator" content="Jonnalagadda  Vijaykumar" /></meta><meta name="dc.Creator" content="Anne  Konkel" /></meta><meta name="dc.Creator" content="Mahesh P.  Paudyal" /></meta><meta name="dc.Creator" content="Janine  Lossie" /></meta><meta name="dc.Creator" content="Chen  Zhu" /></meta><meta name="dc.Creator" content="Christina  Westphal" /></meta><meta name="dc.Creator" content="Narender  Puli" /></meta><meta name="dc.Creator" content="Robert  Fischer" /></meta><meta name="dc.Creator" content="Wolf-Hagen  Schunck" /></meta><meta name="dc.Creator" content="John R.  Falck" /></meta><meta name="dc.Description" content="17(R),18(S)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA) and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiom..." /></meta><meta name="Description" content="17(R),18(S)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA) and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiom..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 6, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00952" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00952" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00952" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00952" /></link>
        
    
    

<title>Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00952" /></meta><meta property="og:title" content="Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0015.jpeg" /></meta><meta property="og:description" content="17(R),18(S)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA) and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiomyocyte (NRCM) arrhythmia model. Prior studies identified oxamide 2b as a soluble epoxide hydrolase (sEH) stable replacement but unsuitable for in vivo applications due to limited oral bioavailability and metabolic stability. These ADME limitations have been addressed in an improved generation of negative chronotropes, e.g., 4 and 16, which were evaluated as potential clinical candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00952"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00952">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00952&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00952&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00952&amp;href=/doi/10.1021/acs.jmedchem.9b00952" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10124-10143</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00722" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00988" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Robust 17(<i>R</i>),18(<i>S</i>)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Adeniyi Michael Adebesin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adeniyi Michael Adebesin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adeniyi+Michael++Adebesin">Adeniyi Michael Adebesin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2865-2532" title="Orcid link">http://orcid.org/0000-0002-2865-2532</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tim Wesser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tim Wesser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OMEICOS Therapeutics GmbH, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Wesser">Tim Wesser</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5076-7603" title="Orcid link">http://orcid.org/0000-0001-5076-7603</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonnalagadda Vijaykumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonnalagadda Vijaykumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonnalagadda++Vijaykumar">Jonnalagadda Vijaykumar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3570-2307" title="Orcid link">http://orcid.org/0000-0002-3570-2307</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne Konkel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne Konkel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OMEICOS Therapeutics GmbH, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Konkel">Anne Konkel</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4875-2204" title="Orcid link">http://orcid.org/0000-0003-4875-2204</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mahesh P. Paudyal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mahesh P. Paudyal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mahesh+P.++Paudyal">Mahesh P. Paudyal</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1025-395X" title="Orcid link">http://orcid.org/0000-0003-1025-395X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janine Lossie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janine Lossie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OMEICOS Therapeutics GmbH, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janine++Lossie">Janine Lossie</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1210-4520" title="Orcid link">http://orcid.org/0000-0003-1210-4520</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chen Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chen Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chen++Zhu">Chen Zhu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4548-047X" title="Orcid link">http://orcid.org/0000-0002-4548-047X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christina Westphal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Westphal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Westphal">Christina Westphal</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1480-2448" title="Orcid link">http://orcid.org/0000-0002-1480-2448</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Narender Puli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Narender Puli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Narender++Puli">Narender Puli</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8104-6008" title="Orcid link">http://orcid.org/0000-0001-8104-6008</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Fischer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Fischer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">OMEICOS Therapeutics GmbH, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Fischer">Robert Fischer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4828-2882" title="Orcid link">http://orcid.org/0000-0002-4828-2882</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wolf-Hagen Schunck</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wolf-Hagen Schunck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#b3e0d0dbc6ddd0d8f3ded7d09ed1d6c1dfdadd9dd7d6"><span class="__cf_email__" data-cfemail="5e0d3d362b303d351e333a3d733c3b2c323730703a3b">[email protected]</span></a>. Phone: +49-30 9406 3750.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wolf-Hagen++Schunck">Wolf-Hagen Schunck</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7965-7731" title="Orcid link">http://orcid.org/0000-0001-7965-7731</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">John R. Falck</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John R. Falck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#13593d55727f7078534647407c66677b6476606776617d3d767766"><span class="__cf_email__" data-cfemail="3c76127a5d505f577c69686f534948544b594f48594e5212595849">[email protected]</span></a>. Phone: (214) 648-2406.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Falck">John R. Falck</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9219-7845" title="Orcid link">http://orcid.org/0000-0002-9219-7845</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00952&amp;href=/doi/10.1021%2Facs.jmedchem.9b00952" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10124–10143</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 6, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 June 2019</li><li><span class="item_label"><b>Published</b> online</span>6 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00952" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00952</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10124%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAdeniyi%2BMichael%2BAdebesin%252C%2BTim%2BWesser%252C%2BJonnalagadda%2BVijaykumar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D22%26contentID%3Dacs.jmedchem.9b00952%26title%3DDevelopment%2Bof%2BRobust%2B17%2528R%2529%252C18%2528S%2529-Epoxyeicosatetraenoic%2BAcid%2B%252817%252C18-EEQ%2529%2BAnalogues%2Bas%2BPotential%2BClinical%2BAntiarrhythmic%2BAgents%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10143%26publicationDate%3DNovember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00952"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">659</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00952" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Adeniyi&quot;,&quot;last_name&quot;:&quot;Michael Adebesin&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Wesser&quot;},{&quot;first_name&quot;:&quot;Jonnalagadda&quot;,&quot;last_name&quot;:&quot;Vijaykumar&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Konkel&quot;},{&quot;first_name&quot;:&quot;Mahesh&quot;,&quot;last_name&quot;:&quot;P. Paudyal&quot;},{&quot;first_name&quot;:&quot;Janine&quot;,&quot;last_name&quot;:&quot;Lossie&quot;},{&quot;first_name&quot;:&quot;Chen&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Westphal&quot;},{&quot;first_name&quot;:&quot;Narender&quot;,&quot;last_name&quot;:&quot;Puli&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Fischer&quot;},{&quot;first_name&quot;:&quot;Wolf-Hagen&quot;,&quot;last_name&quot;:&quot;Schunck&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Falck&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10124-10143&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00952&quot;},&quot;abstract&quot;:&quot;17(R),18(S)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA) and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiomyocyte (NRCM) arrhythmia model. Prior studies identified oxamide 2b as a soluble epoxide hydrolase (sEH) stable replacement but unsuitable for in vivo applications due to limited oral bioavailability and metabolic stability. These ADME limitations have been addressed in an improved generation of negative chronotropes, e.g., 4 and 16, which were evaluated as potential clinical candidates.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00952&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00952" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00952&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00952" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00952&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00952" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00952&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00952&amp;href=/doi/10.1021/acs.jmedchem.9b00952" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00952" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00952" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00952%26sid%3Dliteratum%253Aachs%26pmid%3D31693857%26genre%3Darticle%26aulast%3DAdebesin%26date%3D2019%26atitle%3DDevelopment%2Bof%2BRobust%2B17%2528R%2529%252C18%2528S%2529-Epoxyeicosatetraenoic%2BAcid%2B%252817%252C18-EEQ%2529%2BAnalogues%2Bas%2BPotential%2BClinical%2BAntiarrhythmic%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D22%26spage%3D10124%26epage%3D10143%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/jmcmar.2019.62.issue-22/20191127/jmcmar.2019.62.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">17(<i>R</i>),18(<i>S</i>)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA) and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiomyocyte (NRCM) arrhythmia model. Prior studies identified oxamide <b>2b</b> as a soluble epoxide hydrolase (sEH) stable replacement but unsuitable for <i>in vivo</i> applications due to limited oral bioavailability and metabolic stability. These ADME limitations have been addressed in an improved generation of negative chronotropes, e.g., <b>4</b> and <b>16</b>, which were evaluated as potential clinical candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cardiac arrhythmias often progress into serious cardiovascular complications<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> such as cardiac arrest or stroke and, thus, are important contributors to morbidity and mortality worldwide.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Current treatment options<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> include potentially risky and invasive procedures, e.g., electric shock therapy (cardioversion) and catheter ablation, and usually long-term medication.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Unfortunately, extant antiarrhythmic drugs, when used prophylactically or therapeutically, are often poorly tolerated because of their side effects<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and have a disconcerting propensity toward inducing future arrhythmias.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Due to the various etiologies of arrhythmias, the development of safer and more effective antiarrhythmic drugs is very challenging and requires the discovery of pleiotropic agents effective at various stages of an arrhythmic episode.</div><div class="NLM_p">In recent decades, a large body of evidence has been garnered from epidemiological, animal, and clinical studies that purport polyunsaturated ω-3 fatty acids (ω-3 PUFAs), primarily the eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids commonly found in fish oils, have rhythm stabilizing effects and are beneficial for the prevention and/or amelioration of arrhythmias arising from diverse origins.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> Specifically, EPA prevents and/or terminates arrhythmias caused by β-adrenergic agonists and calcium overload,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which suggests EPA offers multimodal benefits in prophylactic and therapeutic applications for the management of arrhythmias.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> It is also reassuring that the above referenced clinical studies concluded ω-3 PUFA supplementation is well tolerated, safe, and synergistic with existing therapies. On the other hand, some clinical studies of dietary fish oil or EPA ester dietary supplementation have proven inconclusive<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> or proposed narrowly defined utility.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Pioneering studies<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> by Schunck and colleagues into the mechanisms of action and molecular species responsible for the antiarrhythmic and cardioprotective effects of EPA and its congeners implicated the cytochrome P450 (CYP) branch of the eicosanoid cascade as an important participant.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Noteworthy observations include the following: (i) dietary EPA/DHA ester supplementation reduced arrhythmia as well as sudden cardiac death in an angiotensin (Ang) II-induced hypertension study using rats;<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (ii) EPA is equal or preferred over arachidonic acid (AA) as a substrate by most CYP epoxygenases;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (iii) CYP-epoxyeicosanoid reservoirs are present at the <i>sn</i>-2 position of phospholipids and readily released by phospholipase (PL) A2;<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (iv) the principal CYP epoxygenase isoforms preferentially metabolize EPA to the 17,18-epoxide (17,18-EEQ), including most relevantly the major cardiac isoform, CYP2J;<a onclick="showRef(event, 'ref18 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref21 ref22">(18,20−22)</a> (v) transgenic overexpression of human CYP2J2 protects against arrhythmia susceptibility in mouse models of cardiac hypertrophy;<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (vi) 17,18-EEQ is the main fatty acid epoxide in the heart and other organs of rats fed an ω-3 PUFA rich diet but not when ingesting an ω-6 PUFA diet;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (vii) EPA epoxides and/or their hydrolysis products have been detected in humans <i>in vivo</i>, and their levels were found to increase in the plasma and urine of human volunteers ingesting daily multigram amounts of ω-3 PUFA esters;<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> and (viii) EPA and 17,18-EEQ are non-angiogenic unlike some AA metabolites.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The effects of EPA (3–10 μM) in a neonatal rat cardiomyocyte (NRCM) arrhythmia model,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> e.g., restoration to basal beating rate and termination of Ca<sup>2+</sup>-induced fibrillation, could be reproduced by 17,18-EEQ but at a 1000-fold lower concentration and with almost an immediate effect as compared with the 10–30 min delay needed for EPA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref18 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref28">(18,28)</a> Reflective of the dominant stereoselectivity in the biosynthesis of 17,18-EEQ (<i>vide supra</i>), the <i>R</i>,<i>S</i>-enantiomer dose-dependently reduces the spontaneous beating rate of neonatal cardiomyocytes with an EC<sub>50</sub> of 1–2 nM, whereas its antipode has the opposite, albeit far less potent, effect.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and properties of eicosapentaenoic acid (EPA), 17,18-EEQ, and analogues. Negative chronotropic effects on NRCM beating rate at 30 nM.<a onclick="showRef(event, 'ref18 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref28">(18,28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In common with other CYP PUFA autacoids,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> 17,18-EEQ is chemically and metabolically labile which constrains its study <i>in vivo</i> as well as its therapeutic utility. Prominent degradative/catabolic processes for epoxyeicosanoids include (i) autoxidation, (ii) β-oxidation, (iii) esterification, and (iv) metabolism by other pathways of the eicosanoid cascade, viz., cytochromes P450 (CYPs), cyclooxygenases (COXs), lipoxygenases (LOXs), and soluble epoxide hydrolase (sEH).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The latter converts 17,18-EEQ to the corresponding <i>vic</i>-17,18-diol and nullifies the ability to regulate NRCM beating rates.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">A systematic program to elucidate the pharmacophore responsible for the chronotropic activity of 17,18-EEQ identified the carboxylic acid, <i>cis</i>-Δ<sup>11,12</sup>-olefin, and 17(<i>R</i>),18(<i>S</i>)-epoxide as key structural elements.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Consequently, 17,18-EEQ could be simplified to <b>1</b> which was more accessible synthetically and precluded autoxidation as well as metabolism by COXs and LOXs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The second generation of analogues, illustrated by <b>2</b>, imparted more drug-like properties and witnessed the introduction of epoxide bioisosteres including ureas and oxamides. These epoxide mimetics were conveniently often solids, dispensed with the two stereocenters without loss of efficacy, modestly improved hydrophilicity, and, most importantly, obviated sEH inactivation. In the present study, we address the remaining β-oxidation and esterification liabilities in preparation for pharmacokinetic (PK) studies, <i>in vivo</i> evaluation in animal arrhythmia models, and to expedite progress toward the clinical introduction of a first-in-class therapeutic.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The third generation analogues shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were screened initially for their chronotropic effects in our NRCM assay and for inhibition of recombinant sEH at 1 and 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Since replacement of the β-carbon of PUFAs with oxygen abolishes<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> β-oxidation and profoundly limits esterification into phospholipids and glycerides,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the 3-oxa versions of <b>2a</b> and <b>b</b>, i.e., <b>3</b> and <b>4</b>, respectively, were prepared. In addition to improving water solubility by 2–3 orders of magnitude (<i>vide infra</i>), this simple atomic substitution boosted the negative chronotropic impact of urea <b>3</b> by ca. 40%, whereas that of oxamide <b>4</b> remained essentially unchanged. As expected based upon earlier studies,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>4</b> was also the weaker sEH inhibitor of the two analogues. The aqueous solubilities of triethylene glycol (TEG) esters <b>5</b> and <b>6</b> as well as glycine amide <b>7</b> improved compared with their parent carboxylates, but later studies revealed they were quickly hydrolyzed in biologic milieu. The more hindered <i>N</i>-methylglycine amide <b>8</b> and alanine amide <b>9</b> proved less proficient than <b>7</b> at suppressing the beating rate of the NRCMs. This can be attributed to the reduced rate of amidase hydrolysis of <b>8</b> and <b>9</b> to the free carboxylic acid which is necessary for biological activity. With its ionizable proton that mimics the carboxylate in <b>1</b> and <b>2</b> at physiologic pH, <i>N</i>-phenylsulphonimide <b>10</b> restored the activity to an acceptable level, as did sulfonate <b>11</b> and phosphonate <b>13</b>. Since the latter is dibasic, it was of interest to probe the influence of charge on biologic activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We anticipated phosphodiesterases would rapidly cleave <b>12</b> into dianion <b>13</b>, whereas the mixed methyl/pivaloyloxymethyldiester analogue <b>14</b> would in the short term furnish a monoanion, and the dipivaloyloxymethyldiester <b>15</b> might survive intact long enough to penetrate the cellular membrane and undergo intracellular cleavage. In the event, there was no clear advantage from any of the three compared with disodium salt <b>13</b>. Of several traditional carboxylate bioisosteres,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> tetrazole <b>16</b> was the most potent in the NRCM assay followed by oxathiadiazole <b>17</b>, while the structurally related oxadiazol-5-one <b>18</b> proved disappointing, likely due to the much reduced acidity of oxadiazol-5-ones compared with tetrazoles and oxathiadiazoles. Despite the utilization of an oxamide epoxide bioisostere, <b>19</b> was second only to urea <b>6</b> for inhibition of sEH; this would appear to be an unrecognized property of the benzothiazolylacetamide moiety. The poor performance of phenol <b>20</b> is consistent with the earlier SAR study<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> that identified a carboxylic acid or comparably acidic functional group as essential for full biological activity of CYP epoxyeicosanoids. Departing from the linear aliphatic template utilized thus far, analogues <b>21</b> and <b>22</b> demonstrate the Δ<sup>11,12</sup>-olefin can be replaced with an arene without loss of efficacy, thus suggesting wider options for future development.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Negative Chronotropic Effects of 17,18-EEQ Analogues on NRCMs and Inhibition of Soluble Epoxide Hydrolase (sEH)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#tbl1-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0014.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Analogues tested at 30 nM final concentration using <i>n</i> = 18–24 clusters originating from at least three independent NRCM preparations. Data presented as means ± SE.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">sEH = soluble epoxide hydrolase. The assay used recombinant human sEH with 14,15-EET as substrate. Data represent means ± SD (<i>n</i> = 4). AUDA, a potent sEH inhibitor, produced 98.4 ± 0.1% inhibition at 1 μM.</p></div><div class="footnote" id="tbl1-fn1"><sup><sup>c</sup></sup><p class="last">Asterisks indicate statistically significant differences (<i>t</i> test versus vehicle control) were observed (<i>p</i> < 0.05). Piv = pivaloyl.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">sEHi = soluble epoxide hydrolase inhibition. sEH inhibition by <b>2a</b> is 4.7 ± 1.7%* and 23.4 ± 2.9%* at 1 and 10 μM, respectively.</p></div><div class="footnote" id="t1fn4"><sup><sup>e</sup></sup><p class="last">sEH inhibition by <b>2b</b> is −4.1 ± 2.9 and −8.3 ± 6.3% at 1 and 10 μM, respectively.</p></div></div><div></div></div><div class="NLM_p">Oxamides <b>4</b> and <b>16</b> were selected for the next tier of evaluations based upon potency and their minimal sEH inhibition which <i>in toto</i> more closely represent the pharmacological profile of 17,18-EEQ. The potential advantages and disadvantages of sEH inhibitors versus epoxyeicosanoid mimetics as therapeutics have been thoroughly discussed recently.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Chief among the many strategic considerations of sEH inhibition by the analogues was the unpredictable consequences of the accumulation of endogenous epoxy-PUFAs [e.g., leukotoxins (EpOMEs) and epoxyeicosatrienoic acids (EETs)] which can vary depending among other things on tissue, disease state, and nutritional intake of PUFAs.</div><div class="NLM_p">Inspection of the dose response curves for 17,18-EEQ, <b>2b</b>, <b>4</b>, and <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) reveals a progressive generational improvement in potency in the order of 17,18-EEQ < <b>2b</b> < <b>4</b> ≈ <b>16</b>. The <i>E</i><sub>max</sub> for negative chronotropic activity, on the other hand, was about the same for all of the synthetic analogues (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–response curves for (±)-17,18-EEQ, <b>2b</b>, <b>4</b>, and <b>16</b> using NRCMs. Data points are means ± SEM (<i>n</i> = 24, each concentration). Curves were fitted using the standard slope model in GraphPad Prism. The basal beating rates of the spontaneously contracting cardiomyocyte clusters ranged between 120 and 150 beats/min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>2b</b>, <b>4</b>, and <b>16</b> displayed similarly high human plasma stability and percent plasma protein binding (PPB), but the <i>in vitro</i> clearance rate of <b>2b</b> using human hepatocytes was ∼6.6 and ∼3.5 times faster than <b>4</b> and <b>16</b>, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). However, it was the latter’s significant inhibition of CYP2C9, CYP2C19, and CYP3A4 that relegated this analogue to a lower priority.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> ADME Profile of <b>2b</b>, <b>4</b>, and <b>16</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">ADME parameter</th><th class="colsep0 rowsep0" align="center"><b>2b</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility</td><td class="colsep0 rowsep0" align="left">phosphate buffer, pH 7.4</td><td class="colsep0 rowsep0" align="left">mg/mL</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.96 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogD</td><td class="colsep0 rowsep0" align="left">Tris buffer, pH 7.4</td><td class="colsep0 rowsep0" align="left"><i>n</i>-octanol/aqueous phase ratio</td><td class="colsep0 rowsep0" align="left">2.01</td><td class="colsep0 rowsep0" align="left">–0.03</td><td class="colsep0 rowsep0" align="left">2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">calculated</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.95</td><td class="colsep0 rowsep0" align="left">4.23</td><td class="colsep0 rowsep0" align="left">5.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma stability</td><td class="colsep0 rowsep0" align="left">human plasma, half-life</td><td class="colsep0 rowsep0" align="left">min</td><td class="colsep0 rowsep0" align="left">no degradation</td><td class="colsep0 rowsep0" align="left">no degradation</td><td class="colsep0 rowsep0" align="left">no degradation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB</td><td class="colsep0 rowsep0" align="left">human plasma</td><td class="colsep0 rowsep0" align="left">% binding</td><td class="colsep0 rowsep0" align="left">99.91</td><td class="colsep0 rowsep0" align="left">99.37</td><td class="colsep0 rowsep0" align="left">99.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolic stability in human hepatocytes</td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub></td><td class="colsep0 rowsep0" align="left">μL/min/million cells</td><td class="colsep0 rowsep0" align="left">16.53</td><td class="colsep0 rowsep0" align="left">2.48</td><td class="colsep0 rowsep0" align="left">4.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">half-life</td><td class="colsep0 rowsep0" align="left">min</td><td class="colsep0 rowsep0" align="left">52.43</td><td class="colsep0 rowsep0" align="left">349.72</td><td class="colsep0 rowsep0" align="left">181.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition</td><td class="colsep0 rowsep0" align="left">1A2</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2B6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">5.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">46.20</td><td class="colsep0 rowsep0" align="left">0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">43.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">4.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2</td><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> a-b and b-a</td><td class="colsep0 rowsep0" align="left">×10<sup>–6</sup> cm/s</td><td class="colsep0 rowsep0" align="left">5.3/2.3</td><td class="colsep0 rowsep0" align="left">28.2/15.8</td><td class="colsep0 rowsep0" align="left">10.0/8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">efflux ratio</td><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> (b-a)/<i>P</i><sub>app</sub> (a-b)</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">0.80</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">PPB = plasma protein binding; Cl<sub>int</sub> = intrinsic clearance; <i>P</i><sub>app</sub> = apparent permeation coefficient; a = apical; b = basolateral.</p></div></div></div><div class="NLM_p">In contrast to <b>2b</b> and <b>4</b>, analogue <b>16</b> also inhibited the biosynthesis of EEQs from EPA by CYP2J2, the major CYP epoxygenase in human heart (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Analogue <b>16</b> shared this property with the currently used antiarrhythmic drugs amiodarone and dronedarone as well as with the antihistamine terfenadine (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As discussed recently, drug-mediated inhibition of CYP2J2-catalyzed formation of endogenous cardioprotective epoxyeicosanoids might induce adverse cardiac effects.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>2b</b>, <b>4</b>, <b>16</b>, amiodarone, dronedarone, and terfenadine on CYP2J2-catalyzed EPA epoxidation. Epoxygenase activities were calculated from the sum of EEQs and <i>vic</i>-dihydoxyeicosatetraenoic acids (DiHETEs) formed by the recombinant enzyme in incubations containing 10 μM EPA as substrate and 1 mM NADPH as electron donor. All reactions were performed in triplicate, as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The inhibitory effects of amiodarone, dronedarone, and terfenadine on CYP2J2-catalyzed EPA epoxidation were analyzed in parallel incubations. Data are means ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Studies with human liver microsomes indicate that analogue <b>16</b> is not only a potent inhibitor but also an effective substrate for CYP enzymes. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <b>16</b> was rapidly metabolized to [+O] and [+O + H<sub>2</sub>O] metabolites. The reaction sequence presumably consisted of CYP-catalyzed epoxidation of the double bond, followed by hydration to a diol through the action of microsomal and/or soluble epoxide hydrolases, which are present in human liver microsomes.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In contrast to <b>16</b>, analogues <b>2b</b> and <b>4</b> remained comparatively stable (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). After 60 min of incubation, about 40% of <b>16</b>, 3.9% of <b>2b</b>, and 1.5% of <b>4</b> were converted to the corresponding oxygenated metabolites (sum of [+O] and [+O + H<sub>2</sub>O] metabolites), as calculated from the relative peak areas in LC-MS analysis.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NADPH-dependent metabolism of oleic acid (reference compound) and analogues <b>2b</b>, <b>4</b>, and <b>16</b> by human liver microsomes. The incubations contained 0.5 mg/mL of human liver microsomes and the test compound at a final concentration of 1 μM, as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. LC-MS in single ion monitoring mode was used to follow the time-dependent loss of the respective parental compound and the formation of primary metabolites resulting from monooxygenation (hydroxylation or epoxidation; [+O] metabolites) as well as secondary metabolites originating from epoxidation and addition of the elements of water, presumably from epoxide hydrolysis; ([+O + H<sub>2</sub>O] metabolites). Data are mean values from reactions run in duplicate for each time point and represent the peak areas of the molecular ions as detected by LC-MS. No product formation occurred when NADPH was omitted from the incubations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The influences of the 3-oxa and tetrazole bioisostere on PK are evident in the 24 h plasma concentration–time curves of <b>4</b> and <b>16</b> vs <b>2b</b> in rat (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Maximum plasma levels were reached about 1.6 (<b>2b</b> and <b>4</b>) and 2 h (<b>16</b>) after oral administration, indicating rapid absorption of all three analogues. However, the maximum plasma levels for <b>4</b> and <b>16</b> were approximately 2 orders of magnitude higher and remained elevated far longer than for <b>2b</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel A). Oral bioavailabilities were almost 100% with <b>4</b> and 35% with <b>16</b>, as calculated from the dose-corrected areas under the curve after oral (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel A) versus intravenous (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, panel B) administration. Factors contributing to the higher oral bioavailability of <b>4</b> compared to <b>16</b> are so far unknown but may include differences in their physicochemical properties (for p<i>K</i><sub>a</sub> and logD values; see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) as well as gastrointestinal absorption sites. In the elimination phase, <b>4</b> showed a considerably higher half-life than <b>16</b> (9.6 vs 3.6 h after oral administration), in line with the different <i>in vitro</i> stabilities of these analogues in liver microsomes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) and hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma concentration–time curves of <b>2b</b>, <b>4</b>, and <b>16</b> in rats. (A) Time course of uptake, distribution, and elimination after a single oral dose of 3 mg/kg. (B) Time course of distribution and elimination after a single intravenous dose of 1 mg/kg. Data are means ± SEM; <i>n</i> = 4 per group; n.d. = not detectable (below LOQ).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based upon the foregoing results, <b>4</b> was selected for allometric scaling in three mammalian species using a linear regression model with the log of animal mass as the <i>X</i> variable and log of half-life as the <i>Y</i> variable (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Based on this allometric scaling, a <i>t</i><sub>1/2</sub> of 37.9 h is predicted in humans with a standard weight of 75 kg (<i>Y</i> = 0.2742*<i>X</i> + 1.064).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma half-life of <b>4</b> in different animal species and predicted value for human. Data are based on PK studies following single dose oral administration of <b>4</b> to mouse (<i>n</i> = 3, 8 mg/kg bw), rat (<i>n</i> = 4, 3 mg/kg bw), and dog (<i>n</i> = 4, 3 mg/kg bw).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To obtain a first <i>in vivo</i> proof of concept regarding the antiarrhythmic properties of synthetic 17,18-EEQ analogues, compound <b>5</b> was tested in a rat model of acute myocardial infarction. In this model, coronary artery ligation is used to induce the development of spontaneous ventricular tachycardia. Continuous ECG recording showed that pretreating the animals with compound <b>5</b> significantly reduced the total time in arrhythmia as well as the severity of the arrhythmic episodes compared with the vehicle control (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>5</b>, the triethylene glycol (TEG)-prodrug of <b>4</b>, on the development of ventricular tachycardia in a rat model of acute myocardial infarction. The animals received single i.v. bolus injections of <b>5</b> (<i>n</i> = 10) or vehicle (<i>n</i> = 9) 10 min before inducing ventricular arrhythmia by coronary artery ligation. Continuous ECG monitoring was performed over the whole observational period of 45 min. The severity score was calculated as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Data are means ± SD; *(<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Syntheses of analogues <b>11</b>, <b>19</b>, and <b>20</b> are summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Alkylation of silyl protected 5-hexyn-1-ol<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>23</b> with 2-(9-bromononaloxy)tetrahydro-2<i>H</i>-pyran<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> in THF/HMPA gave <b>24</b> in good yield. Removal of the silyl protecting group, followed by semihydrogenation of the alkyne over catalytic P2-nickel, and substitution of the hydroxyl group for an azide under Mitsunobu conditions provided <b>25</b>. Staudinger reduction of the azide and subsequent substitutive amidation of the crude amine with ethyl 2-(methylamino)-2-oxoacetate<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> gave <b>26</b> (71% over two steps). The tetrahydropyranyl group was uneventfully removed under acidic conditions, and the resulting alcohol was converted to either iodide <b>27</b> or bromide <b>28</b> under Appel-type conditions.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Substitution of the iodide in <b>27</b> with sodium sulfite, phenol <b>29</b>,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> or <i>o</i>-thiophenol gave <b>11</b>, <b>19</b>, and <b>20</b>, respectively.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>11</b>, <b>19</b>, and <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi (1.1 equiv), THF/HMPA (5:1), −78 to −20 °C, 1 h; Br(CH<sub>2</sub>)<sub>9</sub>OTHP, −78 °C to rt, 14 h, 88%. (b) <i>n</i>-Bu<sub>4</sub>NF, THF, rt, 12 h, 80%. (c) P-2 Ni/(H<sub>2</sub>NCH<sub>2</sub>)<sub>2</sub>, H<sub>2</sub> (1 atm), EtOH, rt, 98%. (d) DIAD, Ph<sub>3</sub>P, THF, −20 °C, 30 min; (PhO)<sub>2</sub>P(O)N<sub>3</sub>, 0 °C to rt, 10 h, 86%. (e) Ph<sub>3</sub>P, THF/H<sub>2</sub>O, rt, 14 h. (f) EtO(CO)(CO)NHCH<sub>3</sub>, EtOH, 85 °C, 10 h, 71% (over two steps). (g) 10 mol % <i>p</i>-TSA, MeOH, rt, 10 h, 98%. (h) Ph<sub>3</sub>P, imidazole, I<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 70%. (i) Ph<sub>3</sub>P, CBr<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 67%. (j) Na<sub>2</sub>SO<sub>3</sub>, cyclohexene, rt, 27%. (k) <b>29</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h, 29%. (l) KHCO<sub>3</sub>, <i>o</i>-thiophenol, DMF, rt, 79%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> outlines the syntheses of analogues <b>12</b>–<b>15</b> and is representative of the approach utilized for <b>21</b> and <b>22</b>. Briefly, bromide <b>28</b> was transformed into dimethylphosphonate <b>12</b> via a Michaelis–Arbuzov reaction. Demethylation of the phosphonate esters using trimethylsilyl bromide afforded <b>13</b> after basification with aqueous sodium carbonate and SM-2 Bio-Bead (Bio-Rad) extraction. The mixed methyl/pivaloyloxymethyl (POM) ester <b>14</b> and di-POM ester <b>15</b> were obtained from <b>12</b> by substitution with POM iodide.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of <b>12</b>, <b>13</b>, <b>14</b>, and <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (MeO)<sub>3</sub>P, reflux, 48 h, 54%. (b) TMSBr, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; Na<sub>2</sub>CO<sub>3</sub>, 1 h, SM-2 Biobeads, 30%. (c) POM-I (5 equiv), MeCN/CH<sub>2</sub>Cl<sub>2</sub> (5:1), rt, 48 h: <b>14</b> (3.8%) and <b>15</b> (3.3%).</p></p></figure><div class="NLM_p">Heterocyclic analogues <b>16</b>, <b>17</b>, and <b>18</b> were obtained from the common precursor, <b>30</b>, that in turn was secured from bromide <b>28</b> via S<sub>N</sub>2 cyanation (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Following literature precedent,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> 1,3-dipolar cycloaddition of <b>30</b> with hydrazoic acid, generated <i>in situ</i> from sodium azide and triethylamine hydrochloride, in dioxane provided <b>16</b> in moderate yield. Addition of hydroxylamine to <b>30</b> provided amidoxime <b>31</b>, which was reacted with either thionyl chloride or 1,1′-carbonyldiimidazole to furnish <b>17</b> and <b>18</b>, respectively.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of <b>16</b>, <b>17</b>, and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KCN, DMSO, rt, 20 h, 99%. (b) NaN<sub>3</sub>, Et<sub>3</sub>N·HCl, dioxane, 120 °C, 24 h, 37%. (c) NH<sub>2</sub>OH·HCl, Na<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 10 h, 69%. (d) SOCl<sub>2</sub>, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 63%. (e) (Imidazole)<sub>2</sub>CO, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h, 18%.</p></p></figure><div class="NLM_p">The syntheses of <b>3</b> and <b>4</b> were accomplished using a more convergent synthetic strategy involving Suzuki–Miyaura coupling between vinyl iodide <b>35</b> or <b>36</b> and borane <b>39</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The latter was generated in two steps via chemoselective In(OTf)<sub>3</sub> mediated diazo O–H insertion<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> using commercial 6-hepten-1-ol (<b>37</b>) and ethyl diazoacetate followed by hydroboration of the resultant ether <b>38</b> with 9-BBN. Urea <b>35</b> and oxamide <b>36</b> were synthesized from the known alkyne <b>32</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> in four routine steps involving silver-mediated alkyne iodination to give <b>33</b>, disiamylborane reduction, phthalimide deprotection affording vinyl iodide <b>34</b>, and subsequent addition to ethyl isocyanate or acylation with ethyl (methylamino) (oxo) acetate, respectively. Pd-catalyzed cross-coupling led to <b>40</b> and <b>41</b>. Final ester hydrolysis and acidification delivered <b>3</b> and <b>4</b>, respectively.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Iodosuccinimide, AgNO<sub>3</sub>, THF, rt, 14 h, 97%. (b) Disiamylborane, THF, 0 °C to rt, 4 h. (c) 40% aq. MeNH<sub>2</sub>, EtOH, rt, 35% (two steps). (d) EtNCO, THF, rt, 20 h, 94%. (e) EtO(CO)(CO)NHCH<sub>3</sub>, EtOH, 85 °C, 10 h, 60%. (f) 20 mol % In(OTf)<sub>3</sub>, ethyl diazoacetate, toluene, rt, 3 h, 70%. (g) 9-BBN, THF, 0 °C to rt, 2 h. (h) <b>35</b>, 10 mol % Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, THF, 50 °C, 14–16 h, <b>40</b> (70%); <b>36</b>, same conditions, <b>41</b> (90%). (i) LiOH, THF, H<sub>2</sub>O, 0 °C to rt, 18–20 h; 1 M oxalic acid, <b>3</b> (82%) and <b>4</b> (67%).</p></p></figure><div class="NLM_p">Finally, esters <b>5</b> and <b>6</b> as well as amides <b>7</b>–<b>10</b> were obtained from <b>2a</b>, <b>2b</b>, and <b>4</b>, as described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Routine EDCI/DCC couplings and ester hydrolysis under basic conditions provided the desired compounds.</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of <b>5</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Triethylene glycol (TEG), EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 53%. (b) TEG, EDCI, DMF, rt, 14 h, 85%. (c) Methyl glycinate, EDCI, MeCN/CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 18 h, 71%. (d) NaOH, THF/MeOH/H<sub>2</sub>O, 0 °C to rt, 48 h; SM-2 Bio-Beads, 79%. (e) Methyl sarcosinate, EDCI, MeCN/CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 74%. (f) NaOH, THF/H<sub>2</sub>O, 0 °C to rt, 48 h; SM-2 Bio-Beads, 84%. (g) NHS, DCC, cat. DMAP, EtOAc, 40 °C, 24 h. (h) <span class="smallcaps smallerCapital"><i>L</i></span>-Alanine, DMAP, MeCN/DMF/H<sub>2</sub>O, 48 h; 1 N HCl; NaHCO<sub>3</sub>, 37% (two steps). (i) Benzenesulfonamide, EDCI, cat. DMAP, DMF, rt, 24 h, 84%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The identification of 17(<i>R</i>),18(<i>S</i>)-epoxyeicosatetraenoic acid (EEQ) as the primary cytochrome P450 metabolite of EPA and the recognition of EEQ’s powerful biological activities provided a cogent mechanistic foundation to help rationalize many of the cardiovascular benefits attributed to diets rich in fish oils. SAR studies in these laboratories elucidated the pharmacophore responsible for EEQ’s antiarrhythmic effects and supported significant progress toward more drug-like analogues; however, these were still unsuitable for <i>in vivo</i> applications due to limited oral bioavailability and metabolic stability. Subsequent investigations as described herein of prodrug modifications, carboxylate bioisosteres, and carbon backbone substitutions identified the 3-oxa analogue <b>4</b> whose <i>in vivo</i> ADME/PK properties make it a potential candidate for further preclinical and clinical development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemical Syntheses</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Information</h4><div class="NLM_p">Nuclear magnetic resonance (NMR) spectra were recorded in CDCl<sub>3</sub> with TMS as internal standard, unless otherwise stated. <sup>1</sup>H NMR data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = quartet, app q = apparent quartet, qn = quintet, app qn = apparent quintet, m = multiplet), and coupling constant (Hz). Melting points were measured using an automated melting point apparatus and are uncorrected. Analytical thin layer chromatography (TLC) used EMD Chemicals TLC silica gel 60 F<sub>254</sub> plates (0.040–0.063 mm) with visualization by UV light and/or KMnO<sub>4</sub> or phosphomolybdic acid (PMA) solution followed by heating. All oxygen and/or moisture sensitive reactions were performed under an argon atmosphere using oven-dried glassware and anhydrous solvents. Extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered prior to removal of all volatiles under reduced pressure. Chromatographic purifications utilized preparative TLC or flash chromatography using commercial prepacked SiO<sub>2</sub> columns on a CombiFlash <i>R</i><sub><i>f</i></sub> 200 chromatograph (Teledyne Isco). Unless otherwise noted, yields refer to isolated, purified material with spectral data consistent with assigned structures or, if known, were concordant with published data. Reagents were the highest commercial quality available and used without further purification, unless otherwise noted. POM-I was purchased from Enamine LLC, Monmouth Jct., NJ 08852 USA. Reaction solvents, except anhydrous CH<sub>3</sub>CN, were dried via passage under argon through activated, neutral alumina columns immediately prior to use. The purity of all test compounds was determined to be ≥95% by a combination of high-field <sup>13</sup>C/<sup>1</sup>H NMR and LC-MS using a Luna C18(2) (3 μm), 100 × 2 mm, and/or an Agilent ZORBAX Eclipse XDB-C18 (3.5 μm), 50 × 2.1 mm, using a gradient of aq. ammonium acetate (50 mM) and CH<sub>3</sub>CN or MeOH.</div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Synthesis of 2-((13-(3-Ethylureido)tridec-8(<i>Z</i>)-en-1-yl)oxy)acetic Acid (<b>3</b>)</h5><div class="NLM_p last">To a rt solution of <b>40</b> (60 mg, 0.161 mmol) in THF (0.5 mL) and MeOH (0.5 mL) was added LiOH·H<sub>2</sub>O (20.38 mg, 0.485 mmol, 3.0 equiv) in H<sub>2</sub>O (0.25 mL). After 20 h, the reaction was cooled to 4 °C and acidified to pH 4 using aq. 2 N HCl. The mixture was diluted with H<sub>2</sub>O (10 mL) and extracted with EtOAc (20 mL × 3). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. Flash chromatography of the crude material (4 g SiO<sub>2</sub> column eluted with CH<sub>2</sub>Cl<sub>2</sub>, 3 min; 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 12 min; 10%, 10 min; 10–20%, 5 min; 20%, 5 min) gave <b>3</b> (46 mg, 82.0%) as a white solid, mp 56.5–57.5 °C. TLC: 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub><i>f</i></sub> ∼ 0.20. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.50–5.35 (m, 1H), 5.35–5.21 (m, 1H), 4.05 (s, 2H), 3.54 (t, <i>J</i> = 6.2 Hz, 2H), 3.24 (q, <i>J</i> = 7.2 Hz, 2H), 3.03 (t, <i>J</i> = 7.3 Hz, 2H), 2.17–1.96 (m, 4H), 1.68–1.50 (m, 4H), 1.50–1.28 (m, 10H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 174.18, 159.66, 130.79, 129.23, 71.66, 68.10, 41.20, 35.55, 29.53, 29.31, 29.15, 29.01, 28.67, 27.19, 26.99, 26.87, 25.84, 15.41. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>34</sub>N<sub>2</sub>O<sub>4</sub> 343.2591; Found 343.2597.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Synthesis of 2-[(13-(2-(Methylamino)-2-oxoacetamido)tridec-8(<i>Z</i>)-en-1-yl)oxy]acetic Acid (<b>4</b>)</h5><div class="NLM_p last">To a rt solution of <b>41</b> (1.08 g, 2.80 mmol) in THF (60 mL) was added LiOH (90 mg, 3.76 mmol, 1.3 equiv) in H<sub>2</sub>O (20 mL). After 48 h, the reaction was cooled to 4 °C and acidified to pH 4 using aq. 2 N HCl. The mixture was diluted with H<sub>2</sub>O (10 mL) and extracted with EtOAc (20 mL × 3). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. Flash chromatography of the crude material (24 g SiO<sub>2</sub> column eluted with 0–30% EtOAc/hexanes, 5 min; 30%, 5 min; CH<sub>2</sub>Cl<sub>2</sub>, 3 min; 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 10 min; 10%, 10 min; 10–20%, 5 min; 20%, 5 min) gave <b>4</b> (676 mg, 67%) as a white solid, mp 94.6–94.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.90 (s, 1H), 7.66 (s, 1H), 5.48–5.22 (m, 2H), 4.10 (s, 2H), 3.58 (t, <i>J</i> = 6.5 Hz, 2H), 3.32 (app q, <i>J</i> = 6.9 Hz, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.16–1.90 (m, 4H), 1.71–1.48 (m, 4H), 1.45–1.18 (m, 10H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 172.98, 160.86, 159.82, 130.65, 129.22, 72.12, 67.91, 39.85, 29.50, 29.46, 29.05, 28.96, 28.81, 27.14, 26.98, 26.80, 26.40, 25.91. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>32</sub>N<sub>2</sub>O<sub>5</sub> 357.2384; Found 357.2376.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Synthesis of 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 2-((13-(2-(Methylamino)-2-oxoacetamido)tridec-8(<i>Z</i>)-en-1-yl)oxy)acetate (<b>5</b>)</h5><div class="NLM_p last">A mixture of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI·HCl, 275 mg, 1.43 mmol, 1.30 equiv) and triethyleneglycol (1.5 mL, 11 mmol, 10 equiv) was dried under high vacuum for 90 min. The reaction flask was flushed with argon, and 4-dimethylaminopyridine (DMAP, 175 mg, 1.43 mmol, 1.30 equiv), acid <b>4</b> (395 mg, 1.10 mmol), and anhydrous CH<sub>2</sub>Cl<sub>2</sub> (55 mL) were added. After 2 days, the reaction mixture was diluted with brine (20 mL) and 1 N aq. HCl (10 mL). The organic phase was separated, and the aqueous phase was re-extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL × 2). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. Flash chromatographic purification of the residue (12 g SiO<sub>2</sub> column eluted with 0–100% EtOAc/hexanes, 15 min; EtOAc, 15 min; 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 5 min) gave <b>5</b> (286 mg, 53%) as a white solid, mp 65.3–65.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (br s, 2H), 5.40–5.21 (m, 2H), 4.32–4.27 (m, 2H), 4.08 (s, 2H), 3.73–3.67 (m, 4H), 3.66–3.60 (m, 4H), 3.60–3.55 (m, 2H), 3.49 (t, <i>J</i> = 6.7 Hz, 1H), 3.28 (app q, <i>J</i> = 7.2 Hz, 2H), 2.87 (d, <i>J</i> = 5.2 Hz, 3H), 2.55 (br s, 1H), 2.08–1.90 (m, 4H), 1.65–1.48 (m, 4H), 1.42–1.17 (m, 10H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.68, 160.68, 159.80, 130.63, 128.97, 72.59, 72.05, 70.63, 70.39, 69.04, 68.20, 63.67, 61.79, 39.63, 29.68, 29.57, 29.37, 29.26, 28.87, 27.27, 26.93, 26.76, 26.23, 25.99. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>24</sub>H<sub>44</sub>N<sub>2</sub>O<sub>8</sub>Na 511.2990; Found 511.3010.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Synthesis of 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 16-(3-Ethylureido)hexadec-11(<i>Z</i>)-enoate (<b>6</b>)</h5><div class="NLM_p last">A mixture of EDCI·HCl (6.40 mg, 0.034 mmol, 1.10 equiv) and triethyleneglycol (42.0 mg, 0.277 mmol, 10 equiv) was dried under high vacuum for 90 min. After flushing the flask with argon, DMAP (4.20 mg, 0.034 mmol, 1.2 equiv), 16-(3-ethylureido)hexadec-11(<i>Z</i>)-enoic acid<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<b>2a</b>, 10.0 mg, 0.028 mmol), and anhydrous DMF (3 mL) were added. After 14 h, the reaction mixture was diluted with EtOAc (10 mL) and washed with water (5 mL). The organic phase was concentrated <i>in vacuo</i>, and the residue was purified by column chromatography (SiO<sub>2</sub> column, eluted with 0–100% EtOAc/hexanes) to give <b>6</b> (11.1 mg, 85%) as a low melting white solid. TLC: 100% EtOAc, <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.42–5.27 (m, 2H), 4.34 (br s, 1H), 4.23 (t, <i>J</i> = 5.8 Hz, 2H), 3.74–3.59 (m, 10H), 3.24–3.12 (m, 4H), 2.46 (br s, 1H), 2.33 (t, <i>J</i> = 7.3 Hz, 2H), 2.07–1.96 (m, 4H), 1.62–1.25 (m, 18H), 1.13 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.21, 158.42, 130.66, 129.44, 72.70, 70.79, 70.57, 69.44, 63.46, 61.98, 40.74, 35.59, 34.40, 30.11, 29.88, 29.63, 29.60, 29.44, 29.42, 29.31, 27.41, 27.22, 27.08, 25.10, 15.73. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>25</sub>H<sub>48</sub>N<sub>2</sub>O<sub>6</sub> 473.3585; Found 473.3585.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Synthesis of Sodium (16-(3-ethylureido)Hexadec-11(<i>Z</i>)-enoyl)glycinate (<b>7</b>)</h5><div class="NLM_p">To a mixture of <b>2a</b> (80 mg, 0.234 mmol), glycine methyl ester hydrochloride (38.3 mg, 0.305 mmol, 1.30 equiv), and EDCI·HCl (62.8 mg, 0.327 mmol, 1.40 equiv) in MeCN/CH<sub>2</sub>Cl<sub>2</sub> (1.5/1.5 mL) was added DMAP (80.0 mg, 0.655 mmol, 2.80 equiv) at 0 °C. After stirring for 18 h at 40 °C, the reaction mixture was diluted with water (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with 1 N aq. HCl (2 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, and the residue was purified via flash chromatography (4 g SiO<sub>2</sub> column eluted with 0–80% EtOAc/hexanes) to give methyl (16-(3-ethylureido)hexadec-11(<i>Z</i>)-enoyl)glycinate (75 mg, 71%) as a white solid, mp 92.4–93.6 °C. TLC: EtOAc, <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.13 (br s, 1H), 5.43–5.24 (m, 2H), 4.32 (br s, 2H), 4.05 (d, <i>J</i> = 5.2 Hz, 2H), 3.76 (s, 3H), 3.26–3.07 (m, 4H), 2.24 (t, <i>J</i> = 7.6 Hz, 2H), 2.11–1.93 (m, 4H), 1.70–1.59 (m, 2H), 1.55–1.44 (m, 2H), 1.44–1.21 (m, 14H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.77, 170.72, 158.66, 130.47, 129.40, 52.46, 41.28, 40.50, 36.46, 35.31, 30.11, 29.63, 29.43, 29.37, 29.35, 29.31, 29.12, 27.18, 27.16, 27.01, 25.69, 15.66. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>22</sub>H<sub>41</sub>N<sub>3</sub>O<sub>4</sub> 412.3170; Found 412.3201.</div><div class="NLM_p last">To a 0 °C solution of the above amide (70 mg, 0.156 mmol) in THF/MeOH/H<sub>2</sub>O (0.500 mL each) was added 2 M NaOH solution (0.200 mmol, 1.30 equiv, 100 μL). The mixture was stirred at rt for 48 h and then concentrated <i>in vacuo</i>. The residue was dissolved in H<sub>2</sub>O (2 mL), and prewashed (alternate washes with EtOH and H<sub>2</sub>O, 3 times) Bio-Beads SM-2 absorbent (Bio-Rad, 20–50 mesh, 3 g) was added to the solution. The mixture was allowed to stand at rt for 4 h, and then, the beads were collected on a Buchner funnel. The beads were washed with cold H<sub>2</sub>O (2 mL), and the product was stripped from the beads with EtOH. Concentration of the EtOH filtrate gave <b>7</b> (52 mg, 79%) as a white solid, mp 163.8–169.8 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.44–5.27 (m, 2H), 3.74 (s, 2H), 3.19–3.03 (m, 4H), 2.24 (t, <i>J</i> = 7.8 Hz, 2H), 2.11–1.98 (m, 4H), 1.69–1.55 (m, 2H), 1.55–1.42 (m, 2H), 1.43–1.23 (m, 14H), 1.09 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 176.59, 175.80, 161.24, 131.14, 130.48, 44.54, 40.88, 37.17, 35.75, 31.01, 30.83, 30.59, 30.48, 30.46, 30.39, 30.32, 28.14, 28.10, 27.91, 26.87, 15.85. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 2H – Na]<sup>+</sup> Calcd for C<sub>21</sub>H<sub>38</sub>N<sub>3</sub>O<sub>4</sub>Na 398.3013; Found 398.3013.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Synthesis of Sodium <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(16-(2-(methylamino)-2-oxoacetamido)hexadec-11(<i>Z</i>)-enoyl)glycinate (<b>8</b>)</h5><div class="NLM_p">To a mixture of 16-(2-(methylamino)-2-oxoacetamido)hexadec-11(<i>Z</i>)-enoic acid<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<b>2b</b>, 50 mg, 0.141 mmol), sarcosine methyl ester hydrochloride (23.6 mg, 0.169 mmol, 1.20 equiv), and EDCI·HCl (40.5 mg, 0.212 mmol, 1.50 equiv) in MeCN/CH<sub>2</sub>Cl<sub>2</sub> (3:1, 4 mL) was added DMAP (48.2 mg, 0.395 mmol, 2.80 equiv). After stirring for 48 h at rt, the reaction mixture was diluted with water (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, and the residue was purified by TLC (55% EtOAc/hexanes, 4 times) to give methyl <i>N</i><sup>1</sup>-methyl-<i>N</i><sup>2</sup>-(16-(2-(methylamino)-2-oxoacetamido)hexadec-11(<i>Z</i>)-enoyl)glycinate (46 mg, 74%) as a white solid, mp 79.4 °C. TLC: 65% EtOAc, <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>; 4.5:1 mixture of amide rotamers) δ 7.59 (br s, 1H), 7.54 (br s, 1H), 5.43–5.20 (m, 2H), 4.10 (s, 1.59H), 4.03 (s, 0.34H), 3.75 (s, 0.6H), 3.70 (s, 2.2H), 3.34–3.24 (m, 2H), 3.05 (s, 2.3H), 2.95 (s, 0.5H), 2.88 (d, <i>J</i> = 5.2 Hz, 3H), 2.35 (t, <i>J</i> = 7.7 Hz, 1.66H), 2.19 (t, <i>J</i> = 7.6 Hz, 0.31H), 2.08–1.89 (m, 4H), 1.67–1.48 (m, 4H), 1.41–1.14 (m, 14H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.98, 173.53, 170.06, 169.70, 160.66, 159.79, 130.70, 128.91, 52.49, 52.12, 51.57, 49.33, 39.63, 36.62, 36.41, 34.89, 33.21, 33.01, 29.76, 29.55, 29.53, 29.50, 29.44, 29.35, 28.87, 27.30, 26.93, 26.76, 26.24, 25.12, 24.94. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>23</sub>H<sub>41</sub>N<sub>3</sub>O<sub>5</sub> 440.3119; Found 440.3123.</div><div class="NLM_p last">To a 0 °C solution of the above amide (34 mg, 0.077 mmol) in THF/H<sub>2</sub>O (0.900/0.250 mL) was added 2 M aq. NaOH solution (0.100 mmol, 1.30 equiv, 50 μL). The solution was stirred at rt for 48 h and then concentrated <i>in vacuo</i>. The residue was dissolved in H<sub>2</sub>O (2 mL), and prewashed (alternate washes with EtOH and H<sub>2</sub>O, 3 times) Bio-Beads SM-2 absorbent (Bio-Rad, 20–50 mesh, 3 g) was added. The mixture was allowed to stand at 2–4 °C for 14 h, and then, the beads were collected on a Buchner funnel. The beads were washed with cold H<sub>2</sub>O (2 × 2 mL), and the product was stripped from the beads with EtOH. Concentration of the EtOH filtrate gave <b>8</b> (29 mg, 84%) as a white solid, mp 145.6–163.4 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD; 1:1 mixture of amide rotamers) δ 5.43–5.26 (m, 2H), 3.93 (s, 1H), 3.87 (s, 1H), 3.30–3.18 (m, 2H), 3.05 (s, 1.4H), 2.94 (s, 1.6H), 2.82 (s, 3H), 2.46–2.36 (m, 1H), 2.35–2.25 (m, 1H), 2.12–1.97 (m, 4H), 1.67–1.50 (m, 4H), 1.44–1.23 (m, 14H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 176.63, 176.29, 175.93, 175.71, 166.55, 166.16, 162.39, 161.53, 131.29, 131.21, 130.34, 130.27, 55.19, 52.63, 40.37, 37.02, 35.47, 34.25, 34.10, 30.82, 30.64, 30.61, 30.59, 30.57, 30.53, 30.33, 30.06, 29.87, 28.14, 28.05, 27.84, 27.78, 26.38, 26.30, 26.16. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 2H – Na]<sup>+</sup> Calcd for C<sub>22</sub>H<sub>38</sub>N<sub>3</sub>O<sub>5</sub>Na 426.2962; Found 426.2961.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Synthesis of Sodium (16-(2-(Methylamino)-2-oxoacetamido)hexadec-11(<i>Z</i>)-enoyl)-<span class="smallcaps smallerCapital">l</span>-alaninate (<b>9</b>)</h5><div class="NLM_p">To a mixture of <b>2b</b> (55 mg, 0.155 mmol), <i>N</i>-hydroxysuccinimide (NHS, 21.4 mg, 0.186 mmol, 1.20 equiv), and dicyclohexylcarbodiimide (DCC, 35.2 mg, 0.171 mmol, 1.10 equiv) in dry EtOAc (2.55 mL) was added DMAP (1.89 mg, 0.016 mmol, 0.1 equiv). After stirring for 24 h at 40 °C, the reaction mixture was cooled to rt and filtered through a pad of Celite with EtOAc, and the filtrate was concentrated to give the crude NHS ester.</div><div class="NLM_p last">To a mixture of the above crude NHS ester and <span class="smallcaps smallerCapital">l</span>-alanine (18 mg, 0.202 mmol, 1.30 equiv) in MeCN/H<sub>2</sub>O/DMF (3/0.5/0.5 mL) was added DMAP (28 mg, 0.233 mmol, 1.50 equiv). After 2 days, the reaction mixture was diluted with EtOAc (12 mL) and H<sub>2</sub>O (6 mL), cooled to 0 °C, and acidified to pH 2.0 with 2 N aq. HCl. The organic phase was separated, and the aqueous phase was re-extracted with EtOAc (12 mL × 2). The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. Flash chromatography of the residue (4 g SiO<sub>2</sub> column eluted with CH<sub>2</sub>Cl<sub>2</sub>, 5 min; 0–5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 40 min; 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 50 min) gave the adduct (25 mg, 37%; TLC: 10% MeOH/CHCl<sub>3</sub>, <i>R</i><sub><i>f</i></sub> ∼ 0.13) as a white solid. The crude product (15 mg, 0.035 mmol) was dissolved in MeOH (4 mL), and NaHCO<sub>3</sub> (3.85 mg, 0.046 mmol, 1.30 equiv) was added. After stirring for 6 h, the product was filtered through a syringe filter (Millex-FH, 0.45 μM, PTFE) and concentrated to give <b>9</b> (15 mg) as a white solid, mp 129.3–129.4 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.42–5.29 (m, 2H), 4.28 (q, <i>J</i> = 7.1 Hz, 1H), 3.25 (t, <i>J</i> = 7.1 Hz, 2H), 2.82 (s, 3H), 2.22 (t, <i>J</i> = 7.6 Hz, 2H), 2.11–1.98 (m, 4H), 1.66–1.52 (m, 4H), 1.43–1.24 (m, 17H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 178.56, 175.44, 162.42, 161.56, 131.31, 130.28, 50.98, 40.38, 37.12, 30.82, 30.60, 30.58, 30.47, 30.31, 29.87, 28.13, 28.05, 27.77, 26.94, 26.29, 18.85. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 2H – Na]<sup>+</sup> Calcd for C<sub>22</sub>H<sub>39</sub>N<sub>3</sub>O<sub>5</sub>Na 426.2963; Found 426.2962.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Synthesis of <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(16-oxo-16-(phenylsulfonamido)hexadec-5(<i>Z</i>)-en-1-yl)oxalamide (<b>10</b>)</h5><div class="NLM_p last">To a mixture of <b>2b</b> (30 mg, 0.091 mmol) and benzenesulfonamide (13 mg, 0.091 mmol) in anhydrous DMF (5 mL) were added DMAP (13 mg, 0.120 mmol, 1.30 equiv) and EDCI·HCl (16 mg, 0.120 mmol, 1.30 equiv). After stirring for 24 h at rt, the reaction mixture was diluted with water (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, and the residue was purified by TLC using 70% EtOAc as eluent to give <b>10</b> (35 mg, 84%) as a white solid, mp 71.6 °C. TLC: 50% EtOAc, <i>R</i><sub><i>f</i></sub> ∼ 0.28. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.75 (s, 1H), 8.08–8.01 (m, 2H), 7.89 (br s, 1H), 7.72 (br s, 1H), 7.67–7.60 (m, 1H), 7.57–7.50 (m, 2H), 5.39–5.27 (m, 2H), 3.31 (app q, <i>J</i> = 7.0, 2H), 2.92 (d, <i>J</i> = 5.2 Hz, 3H), 2.27 (t, <i>J</i> = 8.0, 2H), 2.09–1.94 (m, 4H), 1.63–1.51 (m, 4H), 1.44–1.35 (m, 2H), 1.35–1.27 (m, 2H), 1.20 (s, 10H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.38, 160.63, 160.00, 138.91, 133.93, 130.76, 129.08, 129.04, 128.38, 39.83, 36.43, 29.27, 28.97, 28.94, 28.88, 28.67, 27.06, 26.86, 26.82, 26.44, 24.41. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>25</sub>H<sub>39</sub>N<sub>3</sub>O<sub>5</sub>S 494.2683; Found 494.2690.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Synthesis of Sodium 15-(2-(Methylamino)-2-oxoacetamido)pentadec-10(<i>Z</i>)-en-1-sulfonate (<b>11</b>)</h5><div class="NLM_p last">A mixture of <b>27</b> (0.2 g, 0.460 mmol), Na<sub>2</sub>SO<sub>3</sub> (0.231 g, 1.83 mmol, 4 equiv), EtOH (3 mL), cyclohexene (0.932 mL, 9.20 mmol, 20 equiv), and water (1.5 mL) was heated at 85 °C in a sealed tube for 4 days. The reaction was cooled to rt and concentrated <i>in vacuo</i>. Analogue <b>11</b> (51.0 mg, 27%) was isolated via Bio-Beads SM-2 absorbent (Bio-Rad, 20–50 mesh) extraction as a solid, mp 202–210 °C (dec). <sup>1</sup>H NMR (500 MHz, [CD<sub>3</sub>]<sub>2</sub>SO) δ 8.79–8.63 (m, 2H), 5.39–5.26 (m, 2H), 3.11 (app q, <i>J</i> = 6.8 Hz, 2H), 2.65 (d, <i>J</i> = 4.9 Hz, 3H), 2.40–2.33 (m, 2H), 2.05–1.90 (m, 4H), 1.59–1.49 (m, 2H), 1.49–1.39 (m, 2H), 1.34–1.16 (m, 14H); <sup>13</sup>C NMR (101 MHz, [CD<sub>3</sub>]<sub>2</sub>SO) δ 160.61, 159.86, 129.87, 129.39, 51.57, 38.58, 29.17, 28.95, 28.92, 28.67, 28.47, 28.33, 26.63, 26.42, 26.29, 25.82, 25.15. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 2H – Na]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>33</sub>N<sub>2</sub>O<sub>5</sub>SNa 391.2261; Found 391.2269.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Synthesis of Dimethyl 15-(2-(Methylamino)-2-oxoacetamido)pentadec-10(<i>Z</i>)-enylphosphonate (<b>12</b>)</h5><div class="NLM_p last">Excess trimethyl phosphite (16 mL) was added to a solution of <b>28</b> (0.375 g, 1.1 mmol) in THF (16 mL). The reaction was refluxed (120 °C) in a sealed tube and monitored by TLC every day over 3 days. After complete reaction as judged by TLC analysis, the excess P(OMe)<sub>3</sub> was distilled off and the crude material (white paste) was subjected to the next reaction without further purification (0.250 g, ∼54% crude). An analytical sample was purified by TLC to give <b>12</b> as a low melting solid. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.48 (br s, 2H), 5.39–5.26 (m, 2H), 3.72 (d, <i>J</i><sub>H–P</sub> = 10.7 Hz, 6H), 3.30 (app q, <i>J</i> = 7.0 Hz, 2H), 2.90 (d, <i>J</i> = 5.0 Hz, 3H), 2.04 (app q, <i>J</i> = 7.5 Hz, 2H), 1.98 (app q, <i>J</i> = 7.5 Hz, 2H), 1.81–1.67 (m, 2H), 1.63–1.51(m, 4H), 1.43–1.21 (m, 14H); <sup>31</sup>P NMR (202 MHz, CDCl<sub>3</sub>, H<sub>3</sub>PO<sub>4</sub> external standard) δ 36.86–36.16 (m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.63, 159.76, 130.53, 128.86, 52.21 (d, <sup>2</sup><i>J</i><sub>C–O–P</sub> = 6.6 Hz), 39.52, 30.54 (d, <sup>2</sup><i>J</i><sub>C–C–P</sub> = 16.8 Hz), 29.64, 29.40, 29.27, 29.20, 29.03, 28.76, 27.18, 26.85, 26.67, 26.14, 24.62 (d, <sup>1</sup><i>J</i><sub>C–P</sub> = 140.1 Hz), 22.26 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 5.3 Hz). HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>39</sub>N<sub>2</sub>O<sub>5</sub>P 419.2669; Found 419.2673.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Synthesis of Disodium 15-(2-(Methylamino)-2-oxoacetamido)pentadec-10(<i>Z</i>)-enylphosphonate (<b>13</b>)</h5><div class="NLM_p last">TMSBr (10 equiv, 0.5 mL) was added dropwise to a 0 °C solution of <b>12</b> (0.155 g, 0.371 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). After 75 min, the reaction was quenched with methanol and concentrated <i>in vacuo</i>. The crude product was triturated with CH<sub>2</sub>Cl<sub>2</sub> and decanted. The residue (mp 130.6–130.7 °C) was dissolved in 1 M aq. Na<sub>2</sub>CO<sub>3</sub> (20 mL). Bio-Beads SM-2 absorbent (Bio-Rad, 20–50 mesh) was added to the solution and gently stirred for 30 min. The Bio-Beads/compound mixture was collected on a fritted glass Buchner funnel and washed with water (3 × 20 mL). The product was eluted from the beads with methanol, and the eluent was concentrated to give <b>13</b> (48.4 mg, 30%) as a white solid, mp 240 °C (dec). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 5.42–5.29 (m, 2H), 3.26 (t, <i>J</i> = 7.0 Hz, 2H), 2.82 (s, 3H), 2.13–1.97 (m, 4H), 1.87–1.75 (m, 2H), 1.69–1.43 (m, 4H), 1.42–1.23 (m, 14H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.45, 161.58, 131.36, 130.24, 40.39, 33.29 (d, <sup>2</sup><i>J</i><sub>C–P</sub> = 17.6 Hz), 31.74 (d, <sup>1</sup><i>J</i><sub>C–P</sub> = 130.6 Hz), 30.89, 30.84, 30.76, 30.74 (d, <sup>4</sup><i>J</i><sub>C–P</sub> = 1.0 Hz), 30.40, 29.88, 28.19, 28.07, 27.78, 26.28, 26.05 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 3.9 Hz). HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 3H – 2Na]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>33</sub>N<sub>2</sub>O<sub>5</sub>PNa<sub>2</sub> 391.2356; Found 391.2355.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Synthesis of ((Methoxy(15-(2-(methylamino)-2-oxoacetamido)pentadec-10(<i>Z</i>)-en-1-yl)phosphoryl)oxy)methyl Pivalate (<b>14</b>) and (((15-(2-(Methylamino)-2-oxoacetamido)pentadec-10(<i>Z</i>)-en-1-yl)phosphoryl)bis(oxy))bis(methylene) Bis(2,2-dimethylpropanoate) (<b>15</b>)</h5><div class="NLM_p">To a stirring solution of <b>12</b> (1.00 mmol, 0.418 g) in a mixture of dry CH<sub>3</sub>CN (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added dropwise pivaloyloxymethyl iodide (POM-I, 5.00 mmol, 0.76 mL, 5 equiv). After 2 days, the volatiles were evaporated and the crude product was purified by flash chromatography (40 g SiO<sub>2</sub> column eluted with 0–2% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give pure <b>14</b> (20 mg, 3.8%) and <b>15</b> (21 mg, 3.3%). TLC: 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, <b>14</b> and <b>15</b>, <i>R</i><sub><i>f</i></sub> ∼ 0.4 and ∼0.5, respectively.</div><div class="NLM_p">Analogue <b>14</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.51 (br s, 2H), 5.65 (d, <i>J</i><sub>H–P</sub> = 13.0 Hz, 2H), 5.41–5.22 (m, 2H), 3.72 (d, <i>J</i><sub>H–P</sub> = 11.1, 3H), 3.29 (app q, <i>J</i> = 6.8 Hz, 2H), 2.89 (d, <i>J</i> = 5.2, 3H), 2.08–1.92 (m, 4H), 1.83–1.70 (m, 2H), 1.63–1.48 (m, 4H), 1.43–1.23 (m, 14H), 1.22 (s, 9H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.13, 160.69, 159.80, 130.72, 128.98, 81.80 (d, <sup>2</sup><i>J</i><sub>C–O–P</sub> = 6.1 Hz), 51.94 (d, <sup>2</sup><i>J</i><sub>C–O–P</sub> = 7.2 Hz), 39.67, 38.85, 30.63 (d, <sup>2</sup><i>J</i><sub>C–C–P</sub> = 17.5 Hz), 29.79, 29.55, 29.42, 29.35, 29.17 (d, <sup>4</sup><i>J</i><sub>C–P</sub> = 1.3 Hz), 28.92, 27.34, 27.03, 26.97, 26.80, 26.66, 26.28, 25.27, 22.26, 22.23 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 5.4 Hz). HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>25</sub>H<sub>47</sub>N<sub>2</sub>O<sub>7</sub>P 519.3194; Found 519.3190.</div><div class="NLM_p last">Analogue <b>15</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48 (br s, 2H), 5.67 (d, <i>J</i><sub>H–P</sub> = 13.2 Hz, 2H), 5.42–5.25 (m, 2H), 3.30 (app q, <i>J</i> = 7.2 Hz, 2H), 2.90 (d, <i>J</i> = 5.2 Hz, 3H), 2.09–1.93 (m, 4H), 1.87–1.75 (m, 2H), 1.64–1.49 (m, 4H), 1.44–1.24 (m, 14H), 1.23 (s, 18H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.03, 160.69, 159.81, 130.74, 128.99, 81.41 (d, <sup>2</sup><i>J</i><sub>C–O–P</sub> = 6.3 Hz), 39.69, 38.86, 30.57 (d, <sup>2</sup><i>J</i><sub>C–C–P</sub> = 18.1 Hz), 29.81, 29.57, 29.44, 29.37, 29.19 (d, <sup>4</sup><i>J</i><sub>C–P</sub> = 1.4 Hz), 28.95, 27.36, 27.00, 26.98, 26.82, 26.29, 25.98, 22.08 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 5.3 Hz). HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>30</sub>H<sub>55</sub>N<sub>2</sub>O<sub>9</sub>P 619.3718; Found 619.3712.</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Synthesis of <i>N</i><sup>1</sup>-(15-(1<i>H</i>-Tetrazol-5-yl)pentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>16</b>)</h5><div class="NLM_p last">NaN<sub>3</sub> (350 mg, 5.40 mmol, 3.90 equiv) and Et<sub>3</sub>N·HCl (860 mg, 4.60 equiv) were added to a solution of <b>30</b> (440 mg, 1.37 mmol) in dry dioxane (8 mL). The reaction was refluxed in a sealed tube for 3 days. The reaction was cooled to rt and acidified with 10% aq. HCl to pH 1. The reaction was diluted with H<sub>2</sub>O (10 mL) and extracted with EtOAc (4 × 10 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 0–3% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to give <b>16</b> (195 mg, 37%) as a white solid, mp 127.3 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.42–5.25 (m, 2H), 3.23 (t, <i>J</i> = 7.2 Hz, 2H), 2.90 (t, <i>J</i> = 7.6 Hz, 2H), 2.80 (s, 3H), 2.09–1.95 (m, 4H), 1.81–1.69 (m, 2H), 1.60–1.47 (m, 2H), 1.41–1.22 (m, 12H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.43, 161.57, 158.39, 131.30, 130.30, 40.38, 30.81, 30.53, 30.51, 30.28, 30.21, 30.04, 29.87, 28.76, 28.12, 28.04, 27.77, 26.27, 24.25. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>19</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub> 379.2816; Found 379.2822.</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Synthesis of <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(15-(2-oxido-3<i>H</i>-1,2,3,5-oxathiadiazol-4-yl)pentadec-5(<i>Z</i>)-en-1-yl)oxalamide (<b>17</b>)</h5><div class="NLM_p last">Thionyl chloride (20 μL, 0.273 mmol, 1.3 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added slowly to a solution of crude <b>31</b> (74 mg, 0.210 mmol) and pyridine (43.6 μL, 0.546 mmol, 2.6 equiv) in THF (4 mL) at 0 °C. The reaction was continued at 0 °C for 1 h 40 min and then concentrated <i>in vacuo</i>. The concentrate was diluted with water (5 mL) and extracted with EtOAc (5 × 5 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated <i>in vacuo</i>. The crude product was purified by TLC to give <b>17</b> (54.8 mg, 63%) as a white solid, mp 92.7–92.9 °C. TLC: 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub><i>f</i></sub> ∼ 0.6. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 7.50 (s, 2H), 5.41–5.28 (m, 2H), 3.41–3.21 (m, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.62 (t, <i>J</i> = 7.7 Hz, 2H), 2.06 (app q, <i>J</i> = 7.0 Hz, 2H), 2.01 (app q, <i>J</i> = 6.8 Hz, 2H), 1.69 (p, <i>J</i> = 7.7 Hz, 2H), 1.63–1.55 (m, 4H), 1.46–1.24 (m, 12H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.65, 159.84, 152.82, 130.82, 129.12, 39.88, 29.36, 29.25, 29.13, 29.04, 28.97, 28.90, 28.81, 27.01, 26.81, 26.51, 26.46, 23.88. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M – H]<sup>−</sup> Calcd for C<sub>19</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub>S 413.2228; Found 413.2236.</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Synthesis of <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(15-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)pentadec-5(<i>Z</i>)-en-1-yl)oxalamide (<b>18</b>)</h5><div class="NLM_p last">1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU, 51 μL, 0.340 mmol, 1.2 equiv) was added via syringe to a mixture of crude <b>31</b> (100 mg, 0.280 mmol) and 1,1′-carbonyldiimidazole (55 mg, 0.340 mmol, 1.2 equiv) in anhydrous dioxane (1 mL). The reaction was stirred at rt for 30 min and at 100 °C for 10 min. The reaction mixture was cooled to rt and concentrated <i>in vacuo</i>. The concentrate was purified by TLC to give <b>18</b> (19.8 mg, 18%) as a white solid, mp 125.6 °C. TLC: 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub><i>f</i></sub> ∼ 0.65. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 7.68 (s, 1H), 5.47–5.26 (m, 2H), 3.33 (q, <i>J</i> = 7.0 Hz, 2H), 2.93 (d, <i>J</i> = 5.1 Hz, 3H), 2.57 (app t, <i>J</i> = 7.8 Hz, 2H), 2.14–1.97 (m, 4H), 1.76–1.50 (m, 4H), 1.46–1.16 (m, 14H); <sup>13</sup>C NMR [101 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD (2:1)] δ 161.23, 160.97, 160.05, 130.74, 129.12, 39.75, 29.82, 29.58, 29.52, 29.38, 29.23, 29.03, 28.87, 27.36, 27.07, 26.89, 26.15, 25.79, 25.23. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub> 417.2472; Found 417.2470.</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Synthesis of <i>N</i><sup>1</sup>-(15-(2-Acetamidobenzo[<i>d</i>]thiazol-7-yloxy)pentadec-5(<i>Z</i>)-en-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>19</b>)</h5><div class="NLM_p last">A mixture of <b>27</b> (0.200 g, 0.458 mmol), <i>N</i>-(4-hydroxybenzo[<i>d</i>]thiazol-2-yl)acetamide<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (<b>29</b>, 0.122 g, 0.458 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.095 g, 0.687 mmol, 1.5 equiv) in DMF (3 mL) was heated in a sealed tube at 85 °C for 6 h. The reaction was cooled to rt, diluted with H<sub>2</sub>O (20 mL), and extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 50–60% EtOAc/hexanes to give <b>19</b> (68.6 mg, 29%). TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 11.34 (br s, 1H), 7.85 (br s, 1H), 7.59 (br s, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (t, <i>J</i> = 8.0 Hz, 1H), 6.90 (d, <i>J</i> = 8.0 Hz, 1H), 5.40–5.26 (m, 2H), 4.13 (t, <i>J</i> = 6.5 Hz, 2H), 3.32 (q, <i>J</i> = 7.0 Hz, 2H), 2.89 (d, <i>J</i> = 5.0 Hz, 3H), 2.24 (s, 3H), 2.05 (app q, <i>J</i> = 7.2 Hz, 2H), 1.96 (app q, <i>J</i> = 7.0 Hz, 2H), 1.89–1.80 (m, 2H), 1.77 (br s, 1H), 1.62–1.51 (m, 2H), 1.50–1.35 (m, 4H), 1.34–1.17 (m, 10H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 169.08, 160.75, 160.03, 158.12, 151.46, 138.21, 133.61, 130.84, 128.96, 124.88, 113.51, 108.12, 68.88, 39.74, 29.71, 29.68, 29.58, 29.53, 29.38, 29.36, 28.90, 27.32, 26.95, 26.78, 26.41, 26.23, 23.47. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>27</sub>H<sub>40</sub>N<sub>4</sub>O<sub>4</sub>S 517.2843; Found 517.2862.</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Synthesis of <i>N</i><sup>1</sup>-(15-((2-Hydroxyphenyl)thio)pentadec-5(<i>Z</i>)-en-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>20</b>)</h5><div class="NLM_p last">To a suspension of <b>27</b> (400 mg, 0.920 mmol) and KHCO<sub>3</sub> (111 mg, 1.10 mmol, 1.2 equiv) in anhydrous DMF (3.50 mL) was added 2-mercaptophenol (116 mg, 1 equiv) dropwise. The reaction was stirred overnight at rt during when the reaction went from a white suspension to a clear solution. The reaction was quenched with water, extracted with EtOAc (3 × 30 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated under vacuum. The crude product was purified via flash chromatography (12 g SiO<sub>2</sub> column eluted with 15–20% EtOAc/hexane) to give <b>20</b> (317 mg, 79%) as a pale yellow solid, mp 62.4–62.7 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.65. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.46 (dd, <i>J</i> = 7.5, 1.5 Hz, 2H), 7.43 (br s, 1H), 7.29–7.23 (m, 1H), 6.98 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 6.87 (td, <i>J</i> = 7.5, 1.3 Hz, 1H), 6.78 (s, 1H), 5.42–5.26 (m, 2H), 3.31 (app q, <i>J</i> = 6.9 Hz, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.68 (app t, <i>J</i> = 7.5 Hz, 2H), 2.05 (app q, <i>J</i> = 7.2 Hz, 2H), 1.99 (app q, <i>J</i> = 6.8 Hz, 2H), 1.62–1.49 (m, 4H), 1.44–1.23 (m, 14H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) δ 160.68, 159.81, 156.98, 135.93, 130.95, 130.72, 128.96, 120.74, 119.36, 114.77, 44.86, 39.68, 36.85, 29.77, 29.73, 29.52, 29.51, 29.34, 29.19, 28.90, 28.67, 27.32, 26.96, 26.79, 26.28. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>24</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub>S 435.2676; Found 435.2680.</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Synthesis of Disodium (6-(2-(3-(2-(Methylamino)-2-oxoacetamido)propyl)phenyl)hexyl)phosphonate (<b>21</b>)</h5><div class="NLM_p last">TMSBr (2 mmol, 260 uL) was added dropwise to a solution of crude dimethyl (6-(2-(3-(2-(methylamino)-2-oxoacetamido)propyl)phenyl)hexyl)phosphonate (80 mg, 0.19 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (3 mL) under an argon atmosphere. After 3 h, the reaction was quenched with MeOH (2 mL). After stirring for another 1 h, all volatiles were removed <i>in vacuo</i> and aq. Na<sub>2</sub>CO<sub>3</sub> solution (0.5 M) was added to reach pH ∼ 10. Bio-Rad SM-2 Bio-Beads (20–50 mesh, 5 g) were added to the solution. After gently stirring for 30 min, the beads were collected on a fritted funnel and washed with water (20 mL). Methanol and EtOAc were then used to strip the compound from the Bio-Beads. Evaporation of the organic washes gave <b>21</b> (37 mg, 45%) as an off-white solid, mp >300 °C (dec). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.02–7.12 (m, 4H), 2.81 (s, 3H), 3.26–3.34 (m, 2H), 2.63 (dd, <i>J</i> = 8.0, 8.0 Hz, 2H), 2.58 (dd, <i>J</i> = 8.0, 8.0 Hz, 2H), 1.74–1.84 (m, 2H), 1.34–1.66 (m, 10H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.43, 161.70, 141.75, 140.36, 130.42, 130.14, 127.08, 126.86, 40.50, 33.80, 33.00 (d, <sup>2</sup><i>J</i><sub>C–P</sub> = 17.4 Hz), 32.73, 32.05, 32.02, 30.95, 30.73, 26.32, 25.81 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 4.0 Hz); <sup>31</sup>P NMR (162 MHz, CD<sub>3</sub>OD; ext. ref 85% H<sub>3</sub>PO<sub>4</sub>) δ 24.4. HRMS (LC-API) <i>m</i>/<i>z</i>: [M – 2Na + 2NH<sub>4</sub>]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>35</sub>N<sub>4</sub>O<sub>5</sub>P 418.2345; Found 418.2360.</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Synthesis of Disodium (9-(2-(4-(2-(Methylamino)-2-oxoacetamido)butyl)phenyl)nonyl)phosphonate (<b>22</b>)</h5><div class="NLM_p last">Following the procedure used to prepare <b>21</b>, dimethyl (9-(2-(4-(2-(methylamino)-2-oxoacetamido)butyl)phenyl)nonyl)phosphonate was converted into disodium salt <b>22</b>, obtained as a white solid, mp >300 °C (dec). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.02–7.12 (m, 4H), 3.25–3.30 (m, 2H), 2.80 (s, 3H), 2.56–2.66 (m, 4H), 1.45–1.65 (m, 10H), 1.25–1.40 (m, 10H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.44, 161.62, 141.58, 140.96, 130.30, 130.26, 126.95, 126.82, 40.35, 33.68, 33.28, 32.96, 32.78, 32.74, 30.88 (d, <sup>1</sup><i>J</i><sub>C–P</sub> = 133.3 Hz), 30.81, 30.76, 30.62, 30.28, 29.82, 26.29, 25.53 (d, <sup>3</sup><i>J</i><sub>C–P</sub> = 5.3 Hz); <sup>31</sup>P NMR (162 MHz, CD<sub>3</sub>OD) δ 24.6. HRMS (LC-API) <i>m</i>/<i>z</i>: [M – 2Na + 2NH<sub>4</sub>]<sup>+</sup> Calcd for C<sub>22</sub>H<sub>43</sub>N<sub>4</sub>O<sub>5</sub>P 474.2971; Found 474.2966.</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Synthesis of <i>tert</i>-Butyldiphenyl[15-(tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5-yn-1-yloxy]silane (<b>24</b>)</h5><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M in hexanes, 3.89 mL, 9.72 mmol, 1.2 equiv) was added dropwise to a −78 °C solution of <i>tert</i>-butyl(hex-5-yn-1-yloxy)diphenylsilane<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (<b>23</b>, 2.70 g, 8.10 mmol, 1 equiv) in THF (20 mL) and anhydrous hexamethylphosphoramide (HMPA, 10 mL). The reaction (blood red color) was stirred at −78 °C for 30 min and at 0 °C for 2 h. The reaction was recooled to −78 °C, and 2-(9-bromononyloxy)tetrahydro-2<i>H</i>-pyran<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (2.50 g, 8.10 mmol, 1 equiv) in THF (16.2 mL) was added slowly to the reaction via cannula. The reaction was stirred at −78 °C for 40 min and then allowed to gradually warm to rt overnight (18 h). The reaction was quenched with sat. NH<sub>4</sub>Cl solution, diluted with water, and extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 2% EtOAc/hexanes to give <b>24</b> (4.04 g, 88% yield) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.71–7.63 (m, 4H), 7.45–7.34 (m, 6H), 4.57 (dd, <i>J</i> = 4.5, 2.7 Hz, 1H), 3.87 (ddd, <i>J</i> = 11.0, 7.6, 3.1 Hz, 1H), 3.72 (dt, <i>J</i> = 9.6, 6.9 Hz, 1H), 3.67 (t, <i>J</i> = 6.2 Hz, 2H), 3.55–3.45 (m, 1H), 3.37 (dt, <i>J</i> = 9.6, 6.7 Hz, 1H), 2.22–2.07 (m, 2H), 1.89–1.41 (m, 16H), 1.39–1.21 (m, 12H), 1.04 (s, 9H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 135.63, 134.09, 129.59, 127.67, 98.93, 98.90, 80.50, 80.05, 67.75, 67.72, 63.56, 62.42, 62.39, 32.72, 31.82, 30.88, 29.85, 29.83, 29.56, 29.49, 29.46, 29.25, 29.22, 28.96, 28.92, 26.95, 26.33, 26.30, 25.65, 25.61, 19.81, 19.79, 19.31, 18.85, 18.64. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + 1]<sup>+</sup> Calcd for C<sub>21</sub>H<sub>37</sub>O<sub>5</sub> 369.2641; Found 369.2649.</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Synthesis of 15-(Tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5-yn-1-ol</h5><div class="NLM_p last">A solution of <b>24</b> (6 g, 10.42 mmol, 1 equiv) and tetra-<i>n</i>-butylammonium fluoride (3.14 g, 12.5 mL of a 1 M solution in THF, 12.5 mmol, 1.2 equiv) in THF (150 mL) was stirred at rt under an argon atmosphere. After 5 h, the reaction mixture was quenched with saturated aqueous NH<sub>4</sub>Cl (5 mL) and washed with water (100 mL) and brine (75 mL). The aqueous layer was back-extracted with ether (2 × 75 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure, and the residue was purified by SiO<sub>2</sub> column chromatography, using 5–10% EtOAc/hexanes as eluent to give the title compound (3.17 g, 80%) as a colorless oil. TLC: 40% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.4. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 4.57 (dd, <i>J</i> = 4.5, 2.8 Hz, 1H), 3.87 (ddd, <i>J</i> = 11.0, 7.5, 3.2 Hz, 1H), 3.72 (dt, <i>J</i> = 9.5, 6.9 Hz, 1H), 3.67 (t, <i>J</i> = 6.4 Hz, 2H), 3.54–3.46 (m, 1H), 3.37 (dt, <i>J</i> = 9.5, 6.7 Hz, 1H), 2.23–2.16 (m, 2H), 2.16–2.09 (m, 2H), 1.88–1.76 (m, 1H), 1.76–1.63 (m, 3H), 1.63–1.40 (m, 10H), 1.40–1.23 (m, 10H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 98.79, 80.58, 79.78, 67.67, 62.29, 31.84, 30.74, 29.71, 29.46, 29.41, 29.10, 28.82, 26.21, 25.49, 25.43, 19.63, 18.72, 18.55. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>36</sub>O<sub>3</sub>Na 347.2557; Found 347.2567.</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> Synthesis of 15-(Tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5(<i>Z</i>)-en-1-ol</h5><div class="NLM_p last">NaBH<sub>4</sub> (141 mg, 3.70 mmol, 0.8 equiv) was added to a solution of Ni(OAc)<sub>2</sub> (690 mg, 2.77 mmol, 0.6 equiv) in anhydrous EtOH (10 mL) in a two-necked flask under a H<sub>2</sub> atmosphere (1 atm). After 25 min, ethylenediamine (EDA, 0.93 mL, 13.9 mmol, 3 equiv) was added to the flask, followed by the above 15-(tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5-yn-1-ol (1.5 g, 4.62 mmol) in anhydrous EtOH (10 mL). After completion as judged by TLC analysis (2 h), the reaction was filtered through a column of silica gel and eluted with ethyl acetate. The filtrate was concentrated <i>in vacuo</i> to give the crude product (1.48 g, 98%) as a colorless oil that was used directly in the next step. TLC: 20% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.35. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.43–5.28 (m, 2H), 4.61–4.53 (m, 1H), 3.87 (ddd, <i>J</i> = 11.0, 7.6, 3.2 Hz, 1H), 3.73 (dt, <i>J</i> = 9.6, 7.0 Hz, 1H), 3.65 (t, <i>J</i> = 6.6 Hz, 2H), 3.55–3.45 (m, 1H), 3.38 (dt, <i>J</i> = 9.6, 6.7 Hz, 1H), 2.06 (app q, <i>J</i> = 7.0 Hz, 2H), 2.01 (app q, <i>J</i> = 6.7 Hz, 2H), 1.83 (tdd, <i>J</i> = 11.9, 7.1, 3.6 Hz, 1H), 1.71 (ddt, <i>J</i> = 12.0, 8.5, 3.1 Hz, 1H), 1.63–1.48 (m, 8H), 1.46–1.38 (m, 2H), 1.38–1.24 (m, 12H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 130.24, 129.37, 98.78, 67.68, 62.55, 62.26, 32.34, 30.73, 29.70, 29.54, 29.46, 29.25, 27.20, 26.94, 26.21, 25.91, 25.48, 19.61. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>38</sub>O<sub>3</sub>Na 349.2713; Found 349.2711.</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Synthesis of 2-(15-Azidopentadec-10(<i>Z</i>)-enyloxy)tetrahydro-2<i>H</i>-pyran (<b>25</b>)</h5><div class="NLM_p last">Diisopropyl azodicarboxylate (DIAD, 1.04 g, 5.15 mmol, 1.2 equiv) was added dropwise to a solution of triphenylphosphine (TPP, 1.35 g, 5.15 mmol, 1.2 equiv) in anhydrous THF (20 mL) at −20 °C. After 10 min, the above crude 15-(tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5(<i>Z</i>)-en-1-ol dissolved in THF (2.8 mL) was added dropwise to the reaction, and the resultant yellow suspension was stirred for 30 min at −20 °C. The reaction was warmed to 0 °C, and diphenylphosphoryl azide (1.15 mL, 1.2 equiv) was added dropwise. The reaction was allowed to warm to rt overnight (16 h) and was quenched with H<sub>2</sub>O (11 mL). The organic layer was separated, and the aqueous phase was extracted with Et<sub>2</sub>O (4 × 20 mL). The combined organic fractions were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography using 2% EtOAc/hexanes to give a yellow oil (1.3 g, 86%). An analytical sample was purified by TLC to give <b>25</b> as a colorless oil. TLC: 10% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.4. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.43–5.28 (m, 2H), 4.59–4.56 (m, 1H), 3.91–3.84 (m, 1H), 3.77–3.69 (m, 1H), 3.54–3.46 (m, 1H), 3.41–3.35 (m, 1H), 3.27 (t, <i>J</i> = 6.8 Hz, 2H), 2.10–1.95 (m, 4H), 1.88–1.78 (m, 1H), 1.76–1.68 (m, 1H), 1.65–1.48 (m, 8H), 1.46–1.38 (m, 2H), 1.38–1.24 (m, 12H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 130.72, 128.83, 98.83, 67.67, 62.30, 51.39, 30.82, 29.80, 29.73, 29.60, 29.52, 29.32, 28.45, 27.28, 26.80, 26.67, 26.29, 25.57, 19.73. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>37</sub>N<sub>3</sub>O<sub>2</sub>Na 374.2778; Found 374.2776.</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Synthesis of <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(15-(tetrahydro-2<i>H</i>-pyran-2-yloxy)pentadec-5(<i>Z</i>)-enyl)oxalamide (<b>26</b>)</h5><div class="NLM_p">A mixture of <b>25</b> (1.1 g, 3.13 mmol) and TPP (1.07 g, 4.07 mmol, 1.3 equiv) in THF (23 mL) was stirred at rt. After 2 h, H<sub>2</sub>O (0.2 mL) was added and the reaction was continued overnight (20 h). The reaction was diluted with EtOAc, poured into brine (10 mL), and extracted with EtOAc (4 × 15 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. The crude product was carried on to the next reaction without further purification. TLC: 5% MeOH/DCM, <i>R</i><sub><i>f</i></sub> ∼ 0.1.</div><div class="NLM_p last">A mixture of the above crude amine (3.25 g, 10.0 mmol) and ethyl 2-(methylamino)-2-oxoacetate<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (1.57 g, 12.0 mmol, 1.2 equiv) in anhydrous EtOH (50 mL) was heated at reflux for 8 h. The reaction was cooled to rt and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 20–30% EtOAc/hexanes to give the title compound as a white solid (2.92 g, 71%), mp 69.9–70.2 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.65. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.50 (br s, 2H), 5.42–5.28 (m, 2H), 4.59–4.56 (m, 1H), 3.9 3.84 (m, 1H), 3.77–3.69 (m, 1H), 3.54–3.46 (m, 1H), 3.41–3.35 (m, 1H), 3.32 (q, <i>J</i> = 7.0 Hz, 2H), 2.91 (d, <i>J</i> = 5.5 Hz, 3H), 2.05 (app q, <i>J</i> = 7.0 Hz, 2H), 2.00 (app q, <i>J</i> = 7.0 Hz, 2H), 1.88–1.78 (m, 1H), 1.76–1.68 (m, 1H), 1.64–1.47 (m, 8H), 1.44–1.22 (m, 14H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 160.69, 159.80, 130.80, 128.94, 98.96, 67.82, 62.47, 39.69, 30.91, 29.88, 29.84, 29.69, 29.62, 29.61, 29.43, 28.93, 27.38, 26.98, 26.81, 26.36, 26.29, 25.63, 19.83. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>23</sub>H<sub>42</sub>N<sub>2</sub>O<sub>4</sub>Na 433.3037; Found 433.3029.</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Synthesis of <i>N</i><sup>1</sup>-(15-Hydroxypentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last"><i>p</i>-Toluenesulfonic acid monohydrate (PTSA, 71.4 mg, 0.375 mmol, 15 mol %) was added to a solution of <b>26</b> (1.0 g, 2.43 mmol) in anhydrous methanol (71.4 mL). The reaction was monitored by TLC every hour and was concentrated under vacuum after 2 h. The concentrate (white solid) was redissolved in EtOAc and passed through a pad of SiO<sub>2</sub> to give the title compound (0.777 g, 98%) as a white solid, mp 115.9–116.0 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.25. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.45 (br s, 2H), 5.42–5.28 (m, 2H), 3.64 (q, <i>J</i> = 6.5 Hz, 2H), 3.32 (q, <i>J</i> = 6.5 Hz, 2H), 2.91 (d, <i>J</i> = 5.0 Hz, 3H), 2.06 (app q, <i>J</i> = 7.0 Hz, 2H), 2.00 (app q, <i>J</i> = 7.0 Hz, 2H), 1.61–1.52 (m, 6H), 1.44–1.23 (m, 12H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 160.72, 159.83, 130.83, 129.01, 63.22, 39.73, 32.95, 29.78, 29.68, 29.53, 29.35, 28.97, 27.34, 27.01, 26.84, 26.32, 25.87. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>34</sub>N<sub>2</sub>O<sub>3</sub> 327.2642; Found 327.2627.</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Synthesis of <i>N</i><sup>1</sup>-(15-Iodopentadec-5(<i>Z</i>)-en-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>27</b>)</h5><div class="NLM_p last">Iodine crystals (I<sub>2</sub>, 1.75 g, 6.91 mmol, 1.2 equiv) were added to a solution of the above crude <i>N</i><sup>1</sup>-(15-hydroxypentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (1.80 g, 5.76 mmol), TPP (1.81 g, 1.2 equiv), and imidazole (0.784 g, 11.5 mmol, 2 equiv) in THF (180 mL) at 0 °C. The reaction was allowed to slowly warm to rt overnight. After the reaction was completed as judged by TLC analysis, the reaction was quenched with sat. aq. NaHSO<sub>3</sub> (10 mL) and concentrated <i>in vacuo</i>. The residue was diluted with water (70 mL) and extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through a funnel, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 20–25% EtOAc/hexanes to give <b>27</b> (1.76 g, 70%), mp 81.7 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.65. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.43 (br s, 2H), 5.42–5.27 (m, 2H), 3.31 (q, <i>J</i> = 6.9 Hz, 2H), 3.19 (t, <i>J</i> = 7.0 Hz, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.05 (app q, <i>J</i> = 7.2 Hz, 2H), 2.00 (app q, <i>J</i> = 7.0 Hz, 2H), 1.82 (p, <i>J</i> = 7.2 Hz, 2H), 1.61–1.52 (m, 2H) 1.44–1.33 (m, 4H), 1.28 (d, <i>J</i> = 4.8 Hz, 10H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 160.67, 159.80, 130.73, 128.98, 39.68, 33.66, 30.61, 29.79, 29.53, 29.49, 29.36, 28.92, 28.64, 27.34, 26.97, 26.81, 26.30, 26.4, 7.54. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>I 437.1660; Found 437.1676.</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Synthesis of <i>N</i><sup>1</sup>-(15-Bromopentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>28</b>)</h5><div class="NLM_p last">Carbon tetrabromide (CBr<sub>4</sub>, 0.942 g, 1.2 equiv) was added to a solution of TPP (0.745 g, 1.2 equiv) and <i>N</i><sup>1</sup>-(15-hydroxypentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (0.740 g, 2.37 mmol) in anhydrous DCM (120 mL), and the mixture was stirred at rt for 24 h. The reaction was concentrated <i>in vacuo</i>, and the crude product was purified via SiO<sub>2</sub> column chromatography with 20–25% EtOAc/hexanes to give <b>28</b> (0.596 g, 67%) as a white solid, mp 77.5–77.6 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.7. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45 (br s, 2H), 5.42–5.27 (m, 2H), 3.40 (t, <i>J</i> = 6.8 Hz, 2H), 3.31 (q, <i>J</i> = 6.8 Hz, 2H), 2.91 (d, <i>J</i> = 5.6 Hz, 3H), 2.09–1.96 (m, 4H), 1.85 (qn, <i>J</i> = 7.2 Hz, 2H), 1.62–1.52 (m, 2H), 1.47–1.37 (m, 4H), 1.37–1.23 (m, 10H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.70, 159.82, 130.78, 129.01, 39.71, 34.23, 32.98, 29.83, 29.56, 29.54, 29.40, 28.97, 28.90, 28.32, 27.38, 27.00, 26.84, 26.31. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>Br 389.1798; Found 389.1792.</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Synthesis of <i>N</i><sup>1</sup>-(15-Cyanopentadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>30</b>)</h5><div class="NLM_p last">Potassium cyanide (KCN, 0.480 g, 7.35 mmol, 5 equiv) was added to a solution of <b>28</b> (0.550 g, 1.47 mmol) in anhydrous DMSO (30 mL), and the mixture was stirred overnight at rt. After completion as judged by TLC analysis, the reaction was diluted with H<sub>2</sub>O (50 mL) and extracted with Et<sub>2</sub>O (3 × 25 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 × 10 mL) and brine (15 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered through a fritted funnel, and concentrated <i>in vacuo</i>. The crude product was purified via SiO<sub>2</sub> column chromatography with 20–25% EtOAc/hexanes to give <b>30</b> (0.467 g, 99%) as a white solid, mp 88.8–88.9 °C. TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.55. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43 (br s, 2H), 5.44–5.23 (m, 2H), 3.31 (q, <i>J</i> = 6.8 Hz, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.34 (t, <i>J</i> = 7.2 Hz, 2H), 2.09–1.96 (m, 4H), 1.71–1.60 (m, 2H), 1.61–1.49 (m, 5H), 1.49–1.36 (m, 3H), 1.36–1.22 (m, 8H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.67, 159.80, 130.62, 128.99, 119.95, 39.63, 29.72, 29.43, 29.33, 29.28, 28.88, 28.82, 28.72, 27.28, 26.94, 26.77, 26.24, 25.43, 17.20. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>19</sub>H<sub>33</sub>N<sub>3</sub>O<sub>2</sub> 336.2646; Found 336.2643.</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Synthesis of <i>N</i><sup>1</sup>-((5<i>Z</i>,16<i>Z</i>)-16-Amino-16-(hydroxyimino)hexadec-5(<i>Z</i>)-enyl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>31</b>)</h5><div class="NLM_p last">A mixture of <b>30</b> (100 mg, 0.311 mmol), NH<sub>2</sub>OH·HCl (108 mg, 1.56 mmol, 5 equiv), and Na<sub>2</sub>CO<sub>3</sub> (181 mg, 1.71 mmol, 5.5 equiv) in anhydrous methanol (2 mL) was refluxed in a sealed tube for 2 days. The reaction was filtered, and the residue was washed with MeOH. Concentration of the filtrate gave a solid that was sequentially washed with water (10 mL) and DCM (3 × 10 mL). The solid (white) residue (76.0 mg, 69%; mp: 118.1–118.5 °C) was used in the next reaction without further purification. An analytical sample was purified by TLC (5% MeOH/DCM, <i>R</i><sub><i>f</i></sub> ∼ 0.35). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.42–5.29 (m, 2H), 3.25 (t, <i>J</i> = 7.1 Hz, 2H), 2.82 (s, 3H), 2.12–1.98 (m, 4H), 1.90 (s, 1H), 1.56 (p, <i>J</i> = 7.3 Hz, 6H), 1.44–1.26 (m, 16H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 162.44, 161.57, 157.70, 131.31, 130.29, 40.38, 31.81, 30.82, 30.63, 30.58, 30.44, 30.32, 30.17, 29.87, 28.34, 28.13, 28.05, 27.77, 26.28. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>19</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub> 369.2860; Found 369.2859.</div></div><div id="sec5_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Synthesis of 2-(Hex-5-yn-1-yl)isoindoline-1,3-dione (<b>32</b>)</h5><div class="NLM_p last">Following literature precedent with slight modifications,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> a solution of 5-hexyn-1-ol (5.00 g, 50.9 mmol, 1 equiv) and diisopropyl azodicarboxylate (DIAD, 10.5 g, 52.0 mmol, 1.02 equiv) in anhydrous THF (30 mL) was slowly added via cannula to a 0 °C solution of phthalimide (7.50 g, 51.0 mmol) and triphenylphosphine (TPP, 13.4 g, 1 equiv) in anhydrous THF (50 mL). The flask and cannula were washed with an additional portion of dry THF (20 mL) to ensure complete addition. The reaction was allowed to gradually warm to room temperature overnight. After a total of 18 h, all volatiles were evaporated and the residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (80 g SiO<sub>2</sub> column eluted with hexanes, 2 min; 0–20% EtOAc/hexanes, 12 min; 20% EtOAc/hexanes, 6 min) to give <b>32</b> (8.30 g, 72%) as a white solid whose spectral values were similar to those reported.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.88–7.81 (m, 2H), 7.75–7.69 (m, 2H), 3.72 (t, <i>J</i> = 7.1 Hz, 2H), 2.25 (ddd, <i>J</i> = 7.0, 2.7, 1.0 Hz, 2H), 1.97–1.92 (m, 1H), 1.82 (app p, <i>J</i> = 7.4 Hz, 2H), 1.64–1.56 (m, 2H).</div></div><div id="sec5_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Synthesis of 2-(6-Iodohex-5-yn-1-yl)isoindoline-1,3-dione (<b>33</b>)</h5><div class="NLM_p last">Following literature precedent,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><i>N</i>-iodosuccinimide (NIS, 7.4 g, 1.5 equiv) was added in one portion to a rt solution of <b>32</b> (5.00 g, 22.0 mmol) and AgNO<sub>3</sub> (0.93 mg, 0.25 equiv) in anhydrous THF (120 mL). The reaction head space was flushed with argon, and the reaction mixture was protected from light with an aluminum foil wrap. After 4 h, the reaction mixture was poured into H<sub>2</sub>O (200 mL) and extracted with Et<sub>2</sub>O (2 × 50 mL). The ethereal extracts were washed with brine (3 × 60 mL) (note: the biphasic mixture turned brown). The combined aqueous phases were re-extracted with Et<sub>2</sub>O (2 × 50 mL). The combined ethereal extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated on a rotary evaporator. The residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (80 g SiO<sub>2</sub> column eluted with hexanes, 2 min; 0–40% EtOAc/hexanes, 8 min; 40% EtOAc/hexanes, 10 min; 40–100% EtOAc/hexanes, 5 min; 100%, EtOAc, 3 min) to give <b>33</b> (7.79 g, 97%) as a white solid, mp 132.5–132.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.87–7.82 (m, 2H), 7.75–7.67 (m, 2H), 3.71 (t, <i>J</i> = 7.1 Hz, 2H), 2.42 (t, <i>J</i> = 7.0 Hz, 2H), 1.83–1.73 (m, 2H), 1.61–1.51 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.53, 134.06, 132.22, 123.36, 93.96, 37.51, 27.82, 25.81, 20.52, −6.35. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>14</sub>H<sub>12</sub>NO<sub>2</sub>I 353.9986; Found 353.9976.</div></div><div id="sec5_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Synthesis of 2-(6-Iodohex-5(<i>Z</i>)-en-1-yl)isoindoline-1,3-dione</h5><div class="NLM_p last">Following literature precedent with slight modifications,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> neat 2-methyl-2-butene (4.20 mL, 2.80 equiv) was added over 5 min to a 0 °C solution of BH<sub>3</sub>·Me<sub>2</sub>S (2.0 M in THF, 9.20 mL, 1.3 equiv) in THF (3 mL). After 3 h at 0 °C, a solution of <b>33</b> (5.00 g, 1 equiv) in THF (30 mL) was added slowly over 5 min. Upon complete addition, the cold bath was removed and the reaction mixture was stirred at rt. After 10 h, the reaction was cooled again to 0 °C whereupon glacial AcOH (8.50 mL) was added slowly over 5 min (caution: gas evolution). After stirring overnight (14 h), the reaction mixture was diluted with H<sub>2</sub>O (20 mL) and then carefully poured into a stirring, saturated sodium bicarbonate solution (40 mL). The biphasic mixture was extracted with ether (2 × 40 mL), and the combined ethereal extracts were washed with water and brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (40 g SiO<sub>2</sub> column eluted with 0–20% EtOAc/hexanes, 8 min; 20% EtOAc/hexanes, 6 min) to give the crude title compound (4.52 g). A small portion was further purified by TLC to give the pure product. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.84 (dd, <i>J</i> = 5.4, 3.0 Hz, 2H), 7.71 (dd, <i>J</i> = 5.5, 3.0 Hz, 2H), 6.21 (dt, <i>J</i> = 7.3, 1.2 Hz, 1H), 6.18–6.11 (m, 1H), 3.71 (t, <i>J</i> = 7.2 Hz, 2H), 2.24–2.15 (m, 2H), 1.77–1.68 (m, 2H), 1.54–1.44 (m, 2H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.19, 140.49, 133.80, 131.96, 123.06, 82.98, 37.68, 34.11, 27.93, 25.14.</div></div><div id="sec5_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Synthesis of 6-Iodohex-5(<i>Z</i>)-en-1-amine (<b>34</b>)</h5><div class="NLM_p last">Following literature precedent,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> 40 wt % MeNH<sub>2</sub> in H<sub>2</sub>O (15 mL) was added to a rt solution of the above crude 2-(6-iodohex-5(<i>Z</i>)-en-1-yl)isoindoline-1,3-dione (4.52 g) in EtOH (20 mL). After stirring overnight (18 h), the reaction mixture was poured into ice water (100 mL) and extracted with Et<sub>2</sub>O (30 mL × 2). The combined ethereal extracts were washed with cold 1 N HCl solution (20 mL × 2). The combined aqueous washes were adjusted to pH 8 with dilute, aq. NaOH. The solution was extracted with Et<sub>2</sub>O (30 mL × 2), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to give the crude title product (1.12 g) as a brown oil that was used in the next step without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.29–6.08 (m, 2H), 2.76–2.65 (m, 2H), 2.16 (app q, <i>J</i> = 6.7 Hz, 2H), 1.78–1.52 (m, 2H).</div></div><div id="sec5_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Synthesis of 1-Ethyl-3-(6-iodohex-5(<i>Z</i>)-en-1-yl)urea (<b>35</b>)</h5><div class="NLM_p last">Ethyl isocyanate (0.198 g, 0.220 mL, 2.79 mmol, 1.10 equiv) was added dropwise to a solution of <b>34</b> (0.570 g, 2.53 mmol) in anhydrous THF (10 mL). After 20 h, the solution was concentrated <i>in vacuo</i>. Purification of the residue using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (24 g SiO<sub>2</sub> column eluted with 0–30% EtOAc/hexanes, 10 min; 30% EtOAc/hexanes, 10 min; 30–40% EtOAc/hexanes, 20 min; 40% EtOAc/hexanes, 60 min) gave <b>35</b> (0.710 g, 94%) as a white solid, mp 65.8–67.6 °C. TLC: 65% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.13. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.21–6.09 (m, 2H), 5.16 (br s, 2H), 5.12 (br s, 2H), 3.24–3.07 (m, 4H), 2.19–2.07 (m, 2H), 1.60–1.34 (m, 4H), 1.10 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 158.92, 140.95, 82.92, 40.23, 35.23, 34.48, 29.93, 25.40, 15.72. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>9</sub>H<sub>17</sub>N<sub>2</sub>OI 297.0458; Found 297.0467.</div></div><div id="sec5_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Synthesis of <i>N</i><sup>1</sup>-(6-Iodohex-5(<i>Z</i>)-en-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>36</b>)</h5><div class="NLM_p last">Following literature precedent,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> a solution of <b>34</b> (1.12 g, 4.98 mmol), ethyl 2-(methylamino)-2-oxoacetate<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (0.620 g, 1.2 equiv), and triethylamine (0.83 mL, 1.2 equiv) in anhydrous ethanol (10 mL) was heated at 60 °C. After 20 h, the brown solution was cooled to rt and concentrated <i>in vacuo</i>. Purification of the residue using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (25 g SiO<sub>2</sub> column eluted with 0–50% EtOAc/hexanes, 10 min; 50% EtOAc/hexanes, 10 min) gave <b>36</b> (0.930 g, 60%) as a white solid, mp 99.7–99.8 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.46 (br s, 2H), 6.32–6.02 (m, 2H), 3.34 (app q, <i>J</i> = 6.9 Hz, 2H), 2.91 (d, <i>J</i> = 5.3 Hz, 3H), 2.18 (dt, <i>J</i> = 7.2, 1.0 Hz, 2H), 1.68–1.59 (m, 2H), 1.54–1.42 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.65, 159.88, 140.61, 83.25, 39.58, 34.29, 28.78, 26.32, 25.29. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>9</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>I 311.0251; Found 311.0237.</div></div><div id="sec5_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Synthesis of Ethyl 2-(Oct-7-en-1-yloxy)acetate (<b>38</b>)</h5><div class="NLM_p last">Following literature precedent with slight modifications,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> commercial 6-hepten-1-ol (<b>37</b>, 1.92 g, 16.8 mmol, 1.2 equiv) was added neat to a rt suspension of In(OTf)<sub>3</sub> (1.57 g, 20 mol %) in anhydrous toluene (20 mL). Ethyl diazoacetate (1.60 g, 14 mmol) was added slowly under an argon atmosphere over 5 min (caution: exothermic) to give a yellow solution. After 2 days, the reaction mixture was concentrated <i>in vacuo</i> and the residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (25 g SiO<sub>2</sub> column eluted with 0–10% EtOAc/hexanes, 5 min; 10% EtOAc/hexanes, 8 min) to give <b>38</b> (1.96 g, 70%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.80 (ddt, <i>J</i> = 16.9, 10.2, 6.6 Hz, 1H), 5.08–4.84 (m, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 4.06 (s, 2H), 3.52 (t, <i>J</i> = 6.7 Hz, 2H), 2.13–1.96 (m, 2H), 1.72–1.52 (m, 2H), 1.48–1.33 (m, 4H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.68, 138.97, 114.43, 71.95, 68.44, 60.87, 33.78, 29.48, 28.78, 25.57, 14.31. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>11</sub>H<sub>20</sub>O<sub>3</sub>Na 223.1305; Found 223.1296.</div></div><div id="sec5_1_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Synthesis of Ethyl 2-((13-(3-Ethylureido)tridec-8(<i>Z</i>)-en-1-yl)oxy)acetate (<b>40</b>)</h5><div class="NLM_p last">To an oven-dried flask containing ethyl 2-(oct-7-en-1-yloxy)acetate (<b>38</b>, 82 mg, 0.409 mmol) was added a solution of 9-BBN (0.5 M in THF, 0.614 mmol, 1.50 equiv, 1.23 mL). After stirring at rt for 3 h, an aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (0.614 mL of 2 M solution prepared from argon sparged H<sub>2</sub>O) was added to the solution of 9-BBN adduct <b>39</b>. After 5 min, <b>35</b> (121 mg, 0.409 mmol) was added followed by Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (14.4 mg, 0.020 mmol, 5 mol %). The resulting red solution was continued overnight (16 h) at 50 °C. After cooling to rt, the reaction was diluted with EtOAc and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. TMEDA (61 μL, 0.409 mmol, metal chelating agent) was added, and the mixture was filtered and the filtrate concentrated <i>in vacuo</i>. The residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (12 g SiO<sub>2</sub> column eluted with 0–30% EtOAc/hexanes, 10 min; 30% EtOAc/hexanes, 15 min; 30–35% EtOAc/hexanes, 10 min; 35% EtOAc/hexanes, 50 min) to give <b>40</b> (107 mg, 70%) as a light red oil. TLC: 65% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.20. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.43–5.24 (m, 2H), 4.28 (s, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 4.06 (s, 2H), 3.52 (t, <i>J</i> = 6.7 Hz, 2H), 3.29–3.08 (m, 4H), 2.14–1.92 (m, 4H), 1.69–1.55 (m, 2H), 1.54–1.45 (m, 2H), 1.44–1.21 (m, 13H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.83, 158.40, 130.46, 129.45, 72.18, 68.43, 60.99, 40.61, 35.42, 30.09, 29.67, 29.62, 29.38, 29.19, 27.25, 27.12, 27.01, 26.08, 15.66, 14.35. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>38</sub>N<sub>2</sub>O<sub>4</sub> 371.2904; Found 371.2916.</div></div><div id="sec5_1_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Synthesis of Ethyl 2-((13-(2-(Methylamino)-2-oxoacetamido)tridec-8(<i>Z</i>)-en-1-yl)oxy)acetate (<b>41</b>)</h5><div class="NLM_p last">To an oven-dried flask containing ethyl 2-(oct-7-en-1-yloxy)acetate (<b>38</b>) (220 mg, 1.2 equiv) was added a solution of 9-BBN (0.5 M in THF, 2.4 equiv, 4.40 mL). After stirring at rt for 3 h, an aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (1.5 mL of 2 M solution prepared from argon sparged H<sub>2</sub>O) was added to the solution of 9-BBN adduct <b>39</b>. After 5 min, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (33 mg, 5 mol %) was added followed by <b>36</b> (284 mg, 0.92 mmol). The resulting red solution was protected from light while another portion of aq. Na<sub>2</sub>CO<sub>3</sub> (0.5 mL of 2 M solution) was added. The reaction was continued overnight (14 h) at rt and then at 50 °C for 4 h. After cooling to rt, the reaction mixture was concentrated <i>in vacuo</i> and the residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system (24 g SiO<sub>2</sub> column eluted with 0–40% EtOAc/hexanes, 6 min; 40% EtOAc/hexanes, 8 min; 40–100% EtOAc/hexanes, 4 min) to give ether <b>41</b> (330 mg, 90%) as an off-white solid. An analytical sample was purified by preparative TLC to give <b>41</b> as a white, low melting solid (paste). TLC: 50% EtOAc/hexanes, <i>R</i><sub><i>f</i></sub> ∼ 0.49. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.45 (br s, 2H), 5.42–5.26 (m, 2H), 4.22 (q, <i>J</i> = 7.2 Hz, 2H), 4.06 (s, 2H), 3.52 (t, <i>J</i> = 6.7 Hz, 2H), 3.32 (app q, <i>J</i> = 6.9 Hz, 2H), 2.91 (d, <i>J</i> = 5.1 Hz, 3H), 2.15–1.91 (m, 4H), 1.68–1.51 (m, 4H), 1.44–1.19 (m, 13H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.77, 160.70, 159.81, 130.73, 129.01, 72.11, 68.49, 60.92, 39.70, 29.76, 29.66, 29.45, 29.34, 28.95, 27.35, 26.98, 26.82, 26.30, 26.08, 14.36. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + Na]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>36</sub>N<sub>2</sub>O<sub>5</sub>Na 407.2516; Found 407.2518.</div></div><div id="sec5_1_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Synthesis of <i>N</i><sup>1</sup>-Methyl-<i>N</i><sup>2</sup>-(prop-2-yn-1-yl)oxalamide</h5><div class="NLM_p last">A solution of propargylamine (0.661 g, 0.769 mL, 12 mmol, 1.2 equiv) and methyl 2-(methylamino)-2-oxoacetatemethyl 2-(methylamino)-2-oxoacetate<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (1.17g, 10 mmol) in absolute EtOH (100 mL) was heated under reflux. After 12 h, the reaction mixture was cooled to rt and concentrated <i>in vacuo</i> to approximately 20% of the original volume when the title compound began to precipitate as an off-white solid. The solid was collected by filtration and used in the next step without further purification. TLC: EtOAc/hexanes (2:1), <i>R</i><sub><i>f</i></sub> ∼ 0.5. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.68 (br s, 1H), 7.44 (br s, 1H), 4.06–4.13 (m, 2H), 2.90 (d, <i>J</i> = 5.2 Hz, 3H), 2.26 (s, 1H).</div></div><div id="sec5_1_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Synthesis of 6-(2-Iodophenyl)hex-5-yn-1-ol</h5><div class="NLM_p last">To a solution of Pd(PPh<sub>3</sub>)<sub>4</sub> (3 mol %, 350 mg) and CuI (5 mol %, 100 mg) in Et<sub>3</sub>N (40 mL) under an argon atmosphere was added a solution of 1,2-diiodobenzene (3.30 g, 10 mmol) and 5-hexyne-1-ol (0.980 g, 10 mmol) in Et<sub>3</sub>N (10 mL). The reaction was heated to 60 °C for 12 h and then cooled to rt and filtered through a pad of Celite. The filtrate was concentrated <i>in vacuo</i>, and the residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system [40 g SiO<sub>2</sub> column eluted with EtOAc/hexanes (1:2)] to give the title compound (1.5 g, 50%) as a pale yellow oil. TLC: EtOAc/hexanes (1:2), <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 7.5 Hz, 1H), 7.29 (dd, <i>J</i> = 7.0, 8.0 Hz, 1H), 6.98 (dd, <i>J</i> = 7.0, 8.0 Hz, 1H), 3.76 (t, <i>J</i> = 7.0 Hz, 2H), 2.55 (t, <i>J</i> = 7.0 Hz, 2H), 1.82–1.88 (m, 2H), 1.73–1.81 (m, 2H).</div></div><div id="sec5_1_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Synthesis of <i>N</i><sup>1</sup>-(3-(2-(6-Hydroxyhex-1-yn-1-yl)phenyl)prop-2-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">Et<sub>3</sub>N (2.30 mL, 16.6 mmol) and 6-(2-iodophenyl)hex-5-yn-1-ol (0.500 g 1.66 mmol) were added sequentially to a solution of <i>N</i><sup>1</sup>-methyl-<i>N</i><sup>2</sup>-(prop-2-yn-1-yl)oxalamide (0.232 g, 1.66 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (3 mol %, 35 mg), and CuI (5 mol %, 16 mg) in dry CH<sub>3</sub>CN (15 mL) under an argon atmosphere. After heating at 50 °C for 12 h, the reaction mixture was cooled to rt and filtered through a Celite pad. The filtrate was concentrated <i>in vacuo</i>, and the residue was purified using a Teledyne Isco Combiflash RF chromatographic system [40 g SiO<sub>2</sub> column eluted with EtOAc/hexanes (2:1)] to afford the title compound (0.362 g, 70%) as a pale yellow oil. TLC: EtOAc/hexanes (2:1), <i>R</i><sub><i>f</i></sub> ∼ 0.15. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.24 (br s, 1H), 7.62 (br s, 1H), 7.36–7.44 (m, 2H), 7.18–7.28 (m, 2H), 4.40 (d, <i>J</i> = 6.0 Hz, 2H), 3.76 (t, <i>J</i> = 6.5 Hz, 2H), 2.92 (d, <i>J</i> = 5.0 Hz, 3H), 2.53 (t, <i>J</i> = 7.0 Hz, 2H), 1.80–1.88 (m, 2H),1.68–1.78 (m, 2H).</div></div><div id="sec5_1_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Synthesis of <i>N</i><sup>1</sup>-(3-(2-(6-Hydroxyhexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">A mixture of diyne <i>N</i><sup>1</sup>-(3-(2-(6-hydroxyhex-1-yn-1-yl)phenyl)prop-2-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (0.100 g, 0.320 mmol) and PtO<sub>2</sub> (10 mg) in dry MeOH (10 mL) was shaken in a Parr hydrogenation apparatus under a H<sub>2</sub> atmosphere (50 psi). After 12 h, the reaction mixture was filtered through a Celite pad and the filtrate was concentrated <i>in vacuo</i> to give the crude title compound as a white solid that was used in the next step without further purification.</div></div><div id="sec5_1_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Synthesis of <i>N</i><sup>1</sup>-(3-(2-(6-Bromohexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">PPh<sub>3</sub> (0.100 g, 0.380 mmol, 1.20 equiv) was added in one portion to a 0 °C solution of <i>N</i><sup>1</sup>-(3-(2-(6-hydroxyhexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide (0.100 g 0.320 mmol) and CBr<sub>4</sub> (0.160 g, 0.480 mmol, 1.50 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). After stirring at rt for 12 h, the solvent was evaporated <i>in vacuo</i> and the residue was purified using a Teledyne Isco Combiflash <i>R</i><sub><i>f</i></sub> chromatographic system [24 g SiO<sub>2</sub> column eluted with EtOAc/hexanes (2:1)] to give the title compound (98 mg, 80%) as a white solid. TLC: EtOAc/hexanes (4:1), <i>R</i><sub><i>f</i></sub> ∼ 0.7. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47 (br s, 1H), 7.42 (br s, 1H), 7.10–7.16 (m, 4H), 3.40 (<i>J</i> = 7.2, 7.2 Hz, 2H), 3.38 (dd, <i>J</i> = 7.2, 7.2 Hz, 2H), 2.91 (d, <i>J</i> = 5.2 Hz, 3H), 2.65 (dd, <i>J</i> = 8.0, 8.0 Hz, 2H), 2.58 (dd, <i>J</i> = 8.0, 8.0 Hz, 2H), 1.80–1.90 (m, 4H), 1.54–1.62 (m, 2H), 1.35–1.50 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.60, 159.92, 140.32, 138.72, 129.41, 129.16, 126.41, 126.18, 39.65, 34.08, 32.86, 32.62, 31.13, 30.68, 29.95, 28.92, 28.19, 26.32.</div></div><div id="sec5_1_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Synthesis of Dimethyl (6-(2-(3-(2-(Methylamino)-2-oxoacetamido)propyl)phenyl)hexyl)phosphonate</h5><div class="NLM_p last">A mixture of <i>N</i><sup>1</sup>-(3-(2-(6-bromohexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide (0.200 g, 0.540 mmol) and P(OMe)<sub>3</sub> (16.2 mmol, 1.9 mL) was heated under reflux in a sealed tube for 48 h and then cooled to rt, and the excess P(OMe)<sub>3</sub> was removed under vacuum. The residue was purified by TLC using EtOAc/hexanes/MeOH (2:1:0.3) to give the title compound (195 mg, 88%) as a white solid. TLC: EtOAc/hexanes/MeOH (2:1:0.3), <i>R</i><sub><i>f</i></sub> ∼ 0.3. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (br s, 2H), 7.08–7.12 (m, 4H), 3.71 (d, <i>J</i><sub>P–H</sub> = 10.4 Hz, 6H), 3.36 (dd, <i>J</i> = 6.8, 6.8 Hz, 2H), 2.89 (d, <i>J</i> = 5.2 Hz, 3H), 2.60–2.65 (m, 2H), 2.53–2.58 (m, 2H), 1.78–1.88 (m, 2H), 1.50–1.76 (m, 6H), 1.32–1.42 (m, 4H).</div></div><div id="sec5_1_1_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Synthesis of <i>N</i><sup>1</sup>-(4-(2-(9-Hydroxynon-1-yn-1-yl)phenyl)but-3-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">Following the procedure used above to prepare <i>N</i><sup>1</sup>-(3-(2-(6-hydroxyhex-1-yn-1-yl)phenyl)prop-2-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide, 9-(2-iodophenyl)non-8-yn-1-ol (prepared as described above for 6-(2-iodophenyl)hex-5-yn-1-ol) and <i>N</i><sup>1</sup>-(but-3-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide (prepared as described above for <i>N</i><sup>1</sup>-methyl-<i>N</i><sup>2</sup>-(prop-2-yn-1-yl)oxalamide) were transformed into the title compound, obtained as a pale yellow solid. TLC: EtOAc/hexanes (2:1), <i>R</i><sub><i>f</i></sub> ∼ 0.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90 (br s, 1H), 7.46 (br s, 1H), 7.34–7.40 (m, 2H), 7.15–7.22 (m, 2H), 3.64 (t, <i>J</i> = 6.4 Hz, 2 H), 3.58 (dd, <i>J</i> = 5.2, 13.2 Hz, 2 H), 2.90 (d, <i>J</i> = 5.2 Hz, 3 H), 2.72 (t, <i>J</i> = 6.8 Hz, 2 H), 2.46 (t, <i>J</i> = 6.8 Hz, 2 H), 1.46–1.66 (m, 6H), 1.32–1.42 (m, 4H).</div></div><div id="sec5_1_1_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Synthesis of <i>N</i><sup>1</sup>-(4-(2-(9-Hydroxynonyl)phenyl)butyl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">Following the procedure used above to prepare <i>N</i><sup>1</sup>-(3-(2-(6-hydroxyhexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide, diyne <i>N</i><sup>1</sup>-(4-(2-(9-hydroxynon-1-yn-1-yl)phenyl)but-3-yn-1-yl)-<i>N</i><sup>2</sup>-methyloxalamide was transformed into the title compound, obtained as a white solid. TLC: EtOAc/hexanes (2:1), <i>R</i><sub><i>f</i></sub> ∼ 0.15. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45 (br s, 2H), 7.08–7.14 (m, 4H), 3.60–3.68 (m, 2H), 3.30–3.38 (m, 2H), 2.90 (d, <i>J</i> = 5.2 Hz, 3 H), 2.60–2.65 (m, 2H), 2.54–2.59 (m, 2H), 1.50–1.65 (m, 8H), 1.25–1.40 (m, 10H).</div></div><div id="sec5_1_1_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Synthesis of <i>N</i><sup>1</sup>-(4-(2-(9-Bromononyl)phenyl)butyl)-<i>N</i><sup>2</sup>-methyloxalamide</h5><div class="NLM_p last">Following the procedure used above to prepare <i>N</i><sup>1</sup>-(3-(2-(6-bromohexyl)phenyl)propyl)-<i>N</i><sup>2</sup>-methyloxalamide, alcohol <i>N</i><sup>1</sup>-(4-(2-(9-hydroxynonyl)phenyl)butyl)-<i>N</i><sup>2</sup>-methyloxalamide was transformed into the title compound, obtained as a white solid. TLC: EtOAc/hexanes (2:1), <i>R</i><sub><i>f</i></sub> ∼ 0.75. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (br s, 2 H), 7.08–7.16 (m, 4H), 3.26–3.46 (m, 4H), 2.89 (d, <i>J</i> = 4.8 Hz, 3 H), 2.52–2.68 (m, 4H), 1.80–1.90 (m, 2H), 1.50–1.70 (m, 6H), 1.22–1.48 (m, 12 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.64, 159.83, 140.56, 139.55, 129.29, 129.19, 126.12, 125.94, 39.67, 34.18, 32.92, 32.77, 32.24, 31.39, 29.80, 29.55, 29.49, 29.38, 28.85, 28.46, 28.27, 26.28.</div></div><div id="sec5_1_1_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Synthesis of Dimethyl (9-(2-(4-(2-(Methylamino)-2-oxoacetamido)butyl)phenyl)nonyl)phosphonate</h5><div class="NLM_p last">Following the procedure used above to prepare dimethyl (6-(2-(3-(2-(methylamino)-2-oxoacetamido)propyl)phenyl)hexyl)phosphonate, bromide <i>N</i><sup>1</sup>-(4-(2-(9-bromononyl)phenyl)butyl)-<i>N</i><sup>2</sup>-methyloxalamide was transformed into the title compound, obtained as a white solid. TLC: EtOAc/hexanes/MeOH (1:1:0.2), <i>R</i><sub><i>f</i></sub> ∼ 0.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (br s, 2H), 7.08–7.18 (m, 4H), 3.76 (d, <i>J</i><sub>P–H</sub> = 10.0 Hz, 6H), 3.30–3.42 (m, 2H), 2.93 (s, 3H), 2.56–2.70 (m, 4H), 1.20–1.80 (m, 20H).</div></div><div id="sec5_1_1_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Measurement of Aqueous Solubility</h5><div class="NLM_p last">Each 17,18-EEQ analogue (2 mg) was weighed in a glass vial followed by the addition of deionized water and double-stoichiometric amounts of aq. NaOH (0.5 mL total volume). After stirring for 30 min at rt, potassium phosphate buffer (200 mM, 0.5 mL) was added to give a final pH of 7.4. Aliquots (100 μL) were taken after 1 and 24 h of stirring continuously at rt using a magnetic stirrer and centrifuged for 5 min at 15,000 rpm. The supernatant was then analyzed for the amount of dissolved compound via RP-HPLC using a Nucleosil 100-5 C18 HD column (250 × 4 mm; Macherey-Nagel) and a linear solvent gradient ranging from acetonitrile/water/acetic acid (50:50:0.1, v/v/v) to acetonitrile/water/acetic acid (75:25:0.1) over 15 min at a flow rate of 1 mL/min. The compounds were detected at 210 nm using a diode array detector connected to the HPLC system. Retention times were 6.8 min (<b>4</b>), 8.5 min (<b>16</b>), and 11.3 min (<b>2b</b>).</div></div><div id="sec5_1_1_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Determination of LogD Values</h5><div class="NLM_p last">Distribution coefficients (logD<sub>7.4</sub> values) of analogues <b>2b</b>, <b>4</b>, and <b>16</b> were determined by the Institute of Organic Synthesis (Riga, Latvia) using an <i>n-</i>octanol/water system. 80 mM Tris/phosphoric acid buffer (pH 7.4) was used as the aqueous phase. After dissolving the respective analogue in Tris-buffer-saturated <i>n</i>-octanol (3.75 mg/mL), an equal volume of <i>n</i>-octanol-saturated Tris buffer was added, followed by vigorous shaking for 30 min and equilibration for 24 h at 25 °C. Aliquots were taken from the resulting <i>n</i>-octanol and aqueous phases and analyzed by HPLC with UV-detection using an Apollo C18 column (5 μm, 4.6 × 150 mm; Hichrom) and a linear gradient from 40 to 95% acetonitrile in 0.1% H<sub>3</sub>PO<sub>4</sub> over 15 min, at a flow rate of 1 mL/min. The analogues were detected at 210 nm. LogD<sub>7.4</sub> values were calculated from the ratio of the peak areas of the analogues in the <i>n</i>-octanol versus aqueous phase chromatograms.</div></div><div id="sec5_1_1_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Calculation of p<i>K</i><sub>a</sub> Values</h5><div class="NLM_p last">The p<i>K</i><sub>a</sub> values of analogues <b>2b</b>, <b>4</b>, and <b>16</b> were predicted using Marvin Sketch, version 19.9 (<a href="https://docs.chemaxon.com/display/docs/pKa+Plugin" class="extLink">https://docs.chemaxon.com/display/docs/pKa+Plugin</a>). For calculations, the following parameters were chosen: static acid/base prefix, i.e., the submitted ionic forms are converted to their neutral forms (adding or removing protons) and their p<i>K</i><sub>a</sub> was then calculated; min basic p<i>K</i><sub>a</sub> = −2; max acidic p<i>K</i><sub>a</sub> = 16; and temperature = 298 K.</div></div><div id="sec5_1_1_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> NRCM Assay</h5><div class="NLM_p">The biological activities of natural metabolites and synthetic analogues were determined using a bioassay essentially as described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> NRCMs were isolated from the hearts of 1–4 day old Wistar rats using the Neonatal Heart Dissociation Kit (#130-098-373, Miltenyi Biotech, Germany) and the Gentle MACS Dissociator (#130-093-235, Miltenyi Biotech, Germany). After removing fibroblasts by preplating, the isolated cardiomyocytes were cultured on the bottom of Falcon flasks (12.5 cm<sup>2</sup>; 1.1 × 10<sup>6</sup> cells/flask) in 2.5 mL of SM 20-I medium (Biochrom, #F9005) supplemented with 10% heat-inactivated newborn calf serum, 2 μM fluorodeoxyuridine, 2 mM <span class="smallcaps smallerCapital">l</span>-alanyl-<span class="smallcaps smallerCapital">l</span>-glutamine, 0.5 μM hydrocortisone, 100 U/mL penicillin, 100 μg/mL streptomycin, and 5 μM <i>N</i>-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide (MS-PPOH; Cayman Chemicals). MS-PPOH served to inhibit endogenous CYP-epoxyeicosanoid formation and was washed out by medium replacement 4 h before testing the exogenous compounds. Spontaneously beating cell clusters occurred after 5–7 days (120–150 beats/min). Beating rates were recorded using an IonOptix Myocyte Contractility System equipped with an inverted microscope (Leica DM IRB) and a CCD camera (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative examples showing the spontaneous beating of cultured neonatal rat cardiomyocytes. Contractions were recorded under basal conditions and 7 min after adding vehicle (left panel; ethanol final concentration 0.025%) or compound <b>4</b> (right panel; final concentration 30 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Beating rates were determined for six to eight individual clusters before and 7 min after addition of the test substance. Based upon the difference between the basal and compound-modulated beating rate of the individual clusters, the chronotropic effects (changes in beats/min) were calculated and are given as means ± SEM values; <i>n</i> = 18–40 clusters originating from at least three independent NRCM cultures. All test compounds were prepared as stock solutions in ethanol and tested at a final concentration of 30 nM. An aq. ethanol solution (0.025%) served as the vehicle control.</div></div><div id="sec5_1_1_53" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Effect on sEH Activity</h5><div class="NLM_p last">Recombinant human sEH was purchased from Cayman Chemicals and diluted in incubation buffer containing 0.1% fatty-acid-free BSA. The hydrolase assays were performed at 30 °C in 300 μL of 50 mM Tris–HCl buffer (pH 7.5) containing 0.01% fatty-acid-free BSA and 14,15-EET (10 μM) as substrate. The compounds to be tested for inhibitory activity were added as ethanolic stock solutions to give a final concentration of 1 or 10 μM. Ethanol (0.01%) served as the vehicle control. Reactions were started by adding human sEH (0.01 μg) and stopped after 10 min with 15 μL of 400 mM citric acid. The remaining substrate and its product (14,15-DHET) were extracted and analyzed by reversed-phase HPLC as described previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec5_1_1_54" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> <i>In Vitro</i> ADME Properties</h5><div class="NLM_p last">Analogues <b>2b</b>, <b>4</b>, and <b>16</b> were analyzed for their stability in plasma, plasma protein binding, metabolic stability in hepatocytes, Caco-2 cell permeation, and CYP inhibition using the <i>in vitro</i> assays described below. These studies were performed by Pharmacelsus GmbH (Saarbrücken, Germany; Project 2019OMC002). If not indicated otherwise, liquid chromatography-electrospray-tandem mass spectrometry (LC-ESI-MS/MS) was used for quantitative analysis. Chromatographic separations were performed on a Kinetex Phenyl-Hexyl analytical column (Phenomenex) using acetonitrile/water/0.1% formic acid gradients ranging from 5 to 97% of acetonitrile. <b>2b</b>, <b>4</b>, and <b>16</b> as assay-specific reference compounds were detected and quantified in the selected reaction monitoring mode using the following [M + H]<sup>+</sup> to fragment ion transitions: <b>2b</b> (<i>m</i>/<i>z</i> 355–262), <b>4</b> (<i>m</i>/<i>z</i> 357–311), <b>16</b> (<i>m</i>/<i>z</i> 379–277), propantheline (<i>m</i>/<i>z</i> 368–181), warfarin (<i>m</i>/<i>z</i> 309–251), 7-ethoxycoumarin (<i>m</i>/<i>z</i> 191–163), testosterone (<i>m</i>/<i>z</i> 289–97), atenolol (<i>m</i>/<i>z</i> 267–145), and erythromycin (<i>m</i>/<i>z</i> 734–576). Diazepam (<i>m</i>/<i>z</i> 285–193) served as an internal standard. Calibration standards were prepared by spiking the respective assay matrix, after adding acetonitrile and the internal standard, with the corresponding test compound.</div></div><div id="sec5_1_1_55" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Plasma Stability</h5><div class="NLM_p last">Analogues <b>2b</b>, <b>4</b>, and <b>16</b> were incubated at a final concentration of 10 μM with human plasma at 37 °C over 0, 15, 60, 120, and 240 min. All incubations were run in triplicate. For each time point, the incubations were started by adding 3 μL of a 50-fold concentrated solution of the respective compound to 147 μL of human plasma (pool from five donors, with lithium heparin as anticoagulant, purchased from Sera Lab International). The final solvent (DMSO) concentration was 0.5%. Positive controls were run in parallel using an esterase-cleavable reference compound (propantheline, <i>N</i>-isopropyl-<i>N</i>-methyl-<i>N</i>-{2-[(9<i>H</i>-xanthen-9-ylcarbonyl)oxy]ethyl}propan-2-aminium bromide). The incubations were stopped by adding 300 μL of acetonitrile containing 1 μM diazepam as an internal standard. After centrifugation (2200 × <i>g</i>, 10 min), the supernatant was diluted with an equal volume of PBS buffer and analyzed by LC-ESI-MS/MS as described above to determine the percentage of parental compound remaining. Analysis of the incubations with propantheline showed that this reference compound was almost completely degraded within 60 min of incubation (2.6% remaining compound).</div></div><div id="sec5_1_1_56" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Plasma Protein Binding Assay</h5><div class="NLM_p last">Plasma protein binding of analogues <b>2b</b>, <b>4</b>, and <b>16</b> was analyzed using human plasma pooled from mixed gender with lithium heparin as anticoagulant (purchased from Sera Lab International). The assay was performed according to the modified ultrafiltration procedure, as described by Taylor and Harker.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The analogues and reference compounds were incubated with human plasma for 60 min at 37 °C in the dark at a final concentration of 10 μM in the presence of 0.5% DMSO. Warfarin (10 μM in the presence of 1% acetonitrile) served as a high binding positive control. All incubations were run in triplicate. After incubation, the samples were loaded onto ultrafiltration units (Ultracel-YM30, MWCO 30000 Da; Millipore, USA) and centrifuged at 6800 × <i>g</i> for 12 min. The obtained plasma retentates and filtrates were subjected to LC-ESI-MS/MS analysis as described above. For the reference compound warfarin, the calculated percentage of plasma protein binding was 99.2 ± 0.2%.</div></div><div id="sec5_1_1_57" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> Stability with Primary Hepatocytes</h5><div class="NLM_p last">Metabolic stabilities of <b>2b</b>, <b>4</b>, and <b>16</b> were tested using primary human hepatocytes (five-donor pool, mixed gender, Bioreclamation IVT (Westbury, NY), #X008052). The cryopreserved hepatocytes were thawed according to the instructions of the supplier, and the incubations were performed in Williams Medium E (PAN Biotech) supplemented with 25 mM HEPES and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. The incubation samples contained 0.2 × 10<sup>6</sup> cells and the test compound at an initial concentration of 1 μM in a total volume of 250 μL. The final solvent (DMSO) concentration was 0.5%. The incubations were stopped after 0, 15, 60, 90, and 180 min by withdrawing a 200 μL aliquot from the suspension cultures and adding an equal volume of acetonitrile containing 1 μM diazepam as internal standard. After centrifugation (4800 × <i>g</i>, 5 min), the supernatant was diluted with an equal volume of water and analyzed by LC-ESI-MS/MS as described above. The amount of compound in the samples was expressed as the percentage of remaining compound compared to time point zero. These percentages were plotted against the corresponding time points. <i>In vitro</i> intrinsic clearance (Cl<sub>int</sub>) and half-life (<i>t</i><sub>1/2</sub>) were calculated using established formulas.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Positive control incubations with 7-ethoxycoumarin (5 μM) showed that this reference substrate was rapidly degraded by the hepatocytes with a <i>t</i><sub>1/2</sub> value of 20.5 min and an <i>in vitro</i> Cl<sub>int</sub> value of 43.22 μL/min/10<sup>6</sup> cells. Negative controls showed that the compounds were stable in the incubation medium: 85.3 ± 4% of <b>2b</b>, 102 ± 2% of <b>4</b>, and 104 ± 5% of <b>16</b> remained after 180 min in incubations performed without hepatocytes.</div></div><div id="sec5_1_1_58" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> Metabolism by Human Liver Microsomes</h5><div class="NLM_p last">Human liver microsomes were purchased from Corning/BD Biosciences (mixed gender, pooled from 150 donors, lot 38292). Reactions were performed in 100 mM phosphate buffer pH 7.4 containing 2 mM MgCl<sub>2</sub>, 0.5 mg microsomal protein/mL, and the test compound at a concentration of 1 μM. The final solvent (DMSO) concentration was 0.5%. Reactions were started by adding NADPH (1 mM final concentration) and stopped after 0, 10, 30, or 60 min of incubation at 37 °C by adding an equal volume of acetonitrile. Subsequent LC-MS analysis was performed in single ion monitoring mode for detecting the molecular ions [M + H]<sup>+</sup> of the respective parental compound (<b>2b</b> at <i>m</i>/<i>z</i> 355.26; <b>4</b> at 357.24; <b>16</b> at 379.28; oleic acid at 281.25) and potential metabolites resulting from monooxygenation (molecular ion +16) and epoxidation followed by epoxide hydrolysis (molecular ion +34).</div></div><div id="sec5_1_1_59" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Caco-2 Permeation Assay</h5><div class="NLM_p last">A bidirectional transwell assay was used to determine the transport of <b>2b</b>, <b>4</b>, and <b>16</b> across Caco-2 cell monolayers. The cells were seeded on permeable membrane inserts with a surface of 1.1 cm<sup>2</sup> and grown to confluence over 21 days in DMEM supplemented with 10% fetal bovine serum and nonessential amino acids. After washing twice with Hanks balanced salt solution (HBSS), the cells were equilibrated for 20 min at 37 °C using HBSS containing 0.5 mM MgCl<sub>2</sub>, 1.25 mM CaCl<sub>2</sub>, and 25 mM glucose supplemented with 20 mM MES (pH 6.5) as apical buffer or with 20 mM HEPES (pH 7.4) as basolateral buffer. The assay was started by replacing the apical or basolateral buffer by the corresponding buffer containing the test compound at a final concentration of 10 μM in the presence of 0.5% DMSO. The Transwell plates were then incubated at 37 °C at 20 rpm in a shaking water bath, and samples were taken from the basolateral or apical side after 15, 45, and 90 min. The samples were mixed with a 0.5-fold volume of acetonitrile containing 1 μM diazepam as internal standard, cleared by centrifugation, and subjected to LC-ESI-MS/MS as described above. All assays were run in triplicate. Reference compounds analyzed in parallel showed apical to basolateral (a-b) and basolateral to apical (b-a) permeation rates as expected for a substrate with high (testosterone: 32.5 in a-b direction and 58.9 × 10<sup>6</sup> cm/s in b-a direction) and low (atenelol: 0.2 in a-b direction and 0.1 × 10<sup>6</sup> cm/s in b-a direction) permeability. A high efflux rate was observed with erythromycin (0.35 in a-b direction and 10.4 × 10<sup>6</sup> cm/s in b-a direction), confirming functional expression of P-glycoprotein in the cultured Caco-2 cells.</div></div><div id="sec5_1_1_60" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> CYP Inhibition Assay</h5><div class="NLM_p last">Human P450 inhibition screening kits were purchased from BD Gentest (Corning, NY) and used to test <b>2b</b>, <b>4</b>, and <b>16</b> for potential inhibition of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4A. The assays were performed in black 96-well plates according to the manufacturer’s instructions. To obtain concentration–response curves, <b>2b</b>, <b>4</b>, and <b>16</b> were tested at eight different final concentrations ranging from 0.023 to 50 μM. All reactions were performed in triplicate. The reactions were stopped by the addition of stop solution (75 μL/well) containing 60% acetonitrile and 40% 0.1 M Tris, pH 9.0. The fluorescence was measured using a Wallac Victor fluorescence plate reader. The wavelengths for excitation and emission of the individual fluorescent metabolites varied depending on the probe substrate for measuring individual CYP enzyme activities. Solvent controls (100% enzyme activity, no inhibition) and negative controls (blank values) were run in parallel. Positive controls with reference inhibitors yielded the following IC<sub>50</sub> values (in μM): CYP1A2/furafylline (5.7), CYP2B6/tranylcypromine (6.2), CYP2C8/quercetin (7.0), CYP2C9/sulphaphenazole (0.28), CYP2C19/tranylcypromine(2.8), CYP2D6/quinidine (0.01), and CYP3A4/ketoconazole (0.04).</div></div><div id="sec5_1_1_61" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Inhibition of CYP2J2 Catalyzed EPA Metabolism</h5><div class="NLM_p last">Supersomes containing recombinant human CYP2J2, NADPH-CYP reductase, and cytochrome b5 were purchased from Corning (product # 456264). Reactions were performed in 100 μL of 100 mM potassium phosphate buffer (pH 7.4) containing 10 pmol of CYP2J2 and EPA (10 μM) as substrate. CYP2J2 was preincubated with the substrate for 5 min at 37 °C in the presence of vehicle (0.5% DMSO) alone or the potential inhibitor to be tested (analogues <b>2b</b>, <b>4</b>, and <b>16</b> and the reference compounds amiodarone, dronedarone, and terfenadine) at final concentrations of 1, 10, or 50 μM. Reactions were started with NADPH (final concentration of 1 mM) and terminated after 15 min by adding 5 μL of 400 mM citric acid. Subsequent extraction and LC-MS/MS analysis of the reaction products were performed as described previously (Arnold et al. 2010). The EPA epoxygenase activity of recombinant CYP2J2 was calculated from the sum of regioisomeric epoxyeicosatetraenoic acids (8,9-, 11,12-, 14,15-, and 17,18-EEQ) and their corresponding vicinal diols (<i>vic</i>-dihydoxyeicosatetraenoic acids; DiHETEs) produced in the incubations. No product formation occurred if NADPH was omitted from the reaction mixtures.</div></div><div id="sec5_1_1_62" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Pharmacokinetics in Animal Models</h5><div class="NLM_p last">Pharmacokinetic studies were done at Pharmacelsus GmbH (Science Park 2, 66123 Saarbrücken, Germany, Project 2017OMC003). Briefly, adult male Sprague–Dawley rats (RjHan:SD) were purchased from Janvier Laboratories (France) and catheterized 3 days before test compound administration. All animals were fasted overnight before test compound administration and fed again 4 h post dose. Water was provided <i>ad libitum</i> throughout the study. Test compound formulations were administered intravenously via a vascular access harness [1 mg/kg bw in DMSO/PEG400 (1:4)] or by oral gavage (3 mg/kg bw in 0.5% methylcellulose), while the rats were manually restrained. Prior to the first blood sampling, animals were connected to a tether system that allows for blood sampling in the freely moving rat. At each of the designated time points, namely, 0.083 (only IV), 0.25, 0.5, 1, 2, 4, 8, 24, and 36 (only oral) h after application, 100 μL of blood was collected from the jugular catheter in tubes containing Li heparin, stored on ice, and subsequently centrifuged at 3000 × <i>g</i> for 10 min at 4 °C (Heraeus Biofuge fresco). The plasma was prepared within 45 min after sampling and was kept at −20 °C until assayed. All samples were stored at −20 °C until processing by LC-MS analysis.</div></div><div id="sec5_1_1_63" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> Rat Model of Ventricular Arrhythmia</h5><div class="NLM_p last">All animal procedures were approved by the Landesamt für Gesundheit and Soziales (LaGeSo, Berlin, Germany) for the use of laboratory animals (Approval number: G0283/12) and followed the “Principles of Laboratory Animal Care’’ (NIH publication No. 86-23, revised 1985) as well as the current version of German Law on the Protection of Animals. Male Wistar rats weighing 220–250 g were randomized to receive an i.v. bolus injection of analogue <b>5</b> (100 μg in 300 μL of 0.9% NaCl) or only 300 μL of 0.9% NaCl as the vehicle control 10 min before induction of myocardial infarction. Animals were anesthetized by i.p. injection of ketamin/xylazin (80 mg of ketamin/12 mg of xylazin, Sigma-Aldrich) and analogue <b>5</b> or vehicle control were injected into the vena subclavia. Continuous monitoring of surface ECG was started (EPTracer, Netherlands) and maintained until the end of the study (45 min after induction of myocardial infarction). After recording the basal ECG, myocardial infarction was induced by ligation of the left anterior descending artery (LAD). Forty-five min after LAD occlusion, the animals were sacrificed. Ventricular tachycardia (VT) burden was calculated as the sum of all sustained arrhythmic events (VT > 1.5 s) originating from the myocardium during the observational period of 45 min after LAD occlusion. To quantify the severity of ventricular arrhythmias, arrhythmic events were classified into premature ventricular contractions (PVC), couplet, triplet, VT < 1.5 s, and VT > 1.5 s. Each class was factorized by an increasing severity index of 1–5: PVC × 1, couplets × 2, triplets × 3, VT < 1.5 s × 4, VT > 1.5 s × 5).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00952" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00952" class="ext-link">10.1021/acs.jmedchem.9b00952</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C spectra of all new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_001.csv">jm9b00952_si_001.csv (1.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_002.pdf">jm9b00952_si_002.pdf (7.68 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00952" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolf-Hagen Schunck</span> - <span class="hlFld-Affiliation affiliation">Max
Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7965-7731" title="Orcid link">http://orcid.org/0000-0001-7965-7731</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#590a3a312c373a3219343d3a743b3c2b353037773d3c"><span class="__cf_email__" data-cfemail="8fdcece7fae1ece4cfe2ebeca2edeafde3e6e1a1ebea">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Falck</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9219-7845" title="Orcid link">http://orcid.org/0000-0002-9219-7845</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#440e6a022528272f041110172b31302c3321373021362a6a212031"><span class="__cf_email__" data-cfemail="7c36523a1d101f173c29282f130908140b190f08190e1252191809">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adeniyi Michael Adebesin</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2865-2532" title="Orcid link">http://orcid.org/0000-0002-2865-2532</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Wesser</span> - <span class="hlFld-Affiliation affiliation">OMEICOS
Therapeutics GmbH, Robert-Rössle-Straße
10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5076-7603" title="Orcid link">http://orcid.org/0000-0001-5076-7603</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonnalagadda Vijaykumar</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3570-2307" title="Orcid link">http://orcid.org/0000-0002-3570-2307</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Konkel</span> - <span class="hlFld-Affiliation affiliation">OMEICOS
Therapeutics GmbH, Robert-Rössle-Straße
10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4875-2204" title="Orcid link">http://orcid.org/0000-0003-4875-2204</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahesh P. Paudyal</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1025-395X" title="Orcid link">http://orcid.org/0000-0003-1025-395X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janine Lossie</span> - <span class="hlFld-Affiliation affiliation">OMEICOS
Therapeutics GmbH, Robert-Rössle-Straße
10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1210-4520" title="Orcid link">http://orcid.org/0000-0003-1210-4520</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen Zhu</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4548-047X" title="Orcid link">http://orcid.org/0000-0002-4548-047X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Westphal</span> - <span class="hlFld-Affiliation affiliation">Max
Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1480-2448" title="Orcid link">http://orcid.org/0000-0002-1480-2448</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narender Puli</span> - <span class="hlFld-Affiliation affiliation">Division
of Chemistry, Department of Biochemistry, University of Texas Southwestern, Dallas, Texas 75390, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8104-6008" title="Orcid link">http://orcid.org/0000-0001-8104-6008</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Fischer</span> - <span class="hlFld-Affiliation affiliation">OMEICOS
Therapeutics GmbH, Robert-Rössle-Straße
10, 13125 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4828-2882" title="Orcid link">http://orcid.org/0000-0002-4828-2882</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.M.A, J.V., M.P.P., C.Z., N.P., and J.R.F. designed and synthesized the analogues. Biological studies were conducted by T.W., A.K., J.L., C.W., R.F., and W.-H S. Manuscript preparation was conducted by A.M.A., A.K., R.F., W.-H S., and J.R.F. Patents describing the identification and biological activities of 17,18-EEQ analogues including those reported herein have been issued, assigned by A.K., R.F., W.-H.S., J.R.F., and N.P. to the Max Delbrück Center for Molecular Medicine and the University of Texas Southwestern Medical Center, and licensed to OMEICOS Therapeutics GmbH (Berlin).</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): T.W., A.K., J.L., and R.F. are current employees of OMEICOS Therapeutics GmbH, and W.H.S., J.R.F., and N.P. may receive compensation in stock and/or monetary payments.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support was provided by the Robert A. Welch Foundation (I-0011) and the Dr. Ralph and Marian Falk Medical Research Trust Bank of America, N.A., Trustee. This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG) to W.-H.S. (FOR 1054; SCHU 822/5 and FOR1368; SCHU822/7).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NRCM</td><td class="NLM_def"><p class="first last">neonatal rat cardiomyocyte</p></td></tr><tr><td class="NLM_term">EEQ</td><td class="NLM_def"><p class="first last">17,18-epoxyeicosatetraenoic acid</p></td></tr><tr><td class="NLM_term">EPA</td><td class="NLM_def"><p class="first last">eicosapentaenoic acid</p></td></tr><tr><td class="NLM_term">sEH</td><td class="NLM_def"><p class="first last">soluble epoxide hydrolase</p></td></tr><tr><td class="NLM_term">DiHETEs</td><td class="NLM_def"><p class="first last"><i>vic</i>-dihydoxyeicosatetraenoic acids</p></td></tr><tr><td class="NLM_term">PUFAs</td><td class="NLM_def"><p class="first last">polyunsaturated fatty acids</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenoic</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome</p></td></tr><tr><td class="NLM_term">Ang</td><td class="NLM_def"><p class="first last">angiotensin</p></td></tr><tr><td class="NLM_term">COXs</td><td class="NLM_def"><p class="first last">cyclooxygenases</p></td></tr><tr><td class="NLM_term">LOXs</td><td class="NLM_def"><p class="first last">lipoxygenases</p></td></tr><tr><td class="NLM_term">TEG</td><td class="NLM_def"><p class="first last">triethylene glycol</p></td></tr><tr><td class="NLM_term">EpOMEs</td><td class="NLM_def"><p class="first last">leukotoxins</p></td></tr><tr><td class="NLM_term">EETs</td><td class="NLM_def"><p class="first last">epoxyeicosatrienoic acids</p></td></tr><tr><td class="NLM_term">PL</td><td class="NLM_def"><p class="first last">phospholipase</p></td></tr><tr><td class="NLM_term">Piv</td><td class="NLM_def"><p class="first last">pivaloyl</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeation coefficient</p></td></tr><tr><td class="NLM_term">ECG</td><td class="NLM_def"><p class="first last">electrocardiogram</p></td></tr><tr><td class="NLM_term">MS-PPOH</td><td class="NLM_def"><p class="first last"><i>N</i>-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide</p></td></tr><tr><td class="NLM_term">ISTD</td><td class="NLM_def"><p class="first last">internal standard</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate hydrogen</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-F.</span></span> <span> </span><span class="NLM_article-title">Cardiac Arrhythmia and Heart Failure: From Bench to Bedside</span>. <i>J. Geriatr. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.3724/SP.J.1263.2011.00131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.3724%2FSP.J.1263.2011.00131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22783298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC38jptVCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=131-132&author=Y.-F.+Xiao&title=Cardiac+Arrhythmia+and+Heart+Failure%3A+From+Bench+to+Bedside&doi=10.3724%2FSP.J.1263.2011.00131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac arrhythmia and heart failure: From bench to bedside</span></div><div class="casAuthors">Xiao Yong-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of geriatric cardiology : JGC</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-2</span>
        ISSN:<span class="NLM_cas:issn">1671-5411</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7TLVUW1nGtyCEBeYuoi7AfW6udTcc2eZrZA9JhME4krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jptVCntw%253D%253D&md5=9be15e73824698fcad99b0df6256436b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3724%2FSP.J.1263.2011.00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3724%252FSP.J.1263.2011.00131%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.-F.%26atitle%3DCardiac%2520Arrhythmia%2520and%2520Heart%2520Failure%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DJ.%2520Geriatr.%2520Cardiol.%26date%3D2011%26volume%3D8%26spage%3D131%26epage%3D132%26doi%3D10.3724%2FSP.J.1263.2011.00131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">The Future of Cardiovascular Biomedicine: Arrhythmias and Electrophysiology</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">2687</span>– <span class="NLM_lpage">2696</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.116.023519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FCIRCULATIONAHA.116.023519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=27324363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC2s7itlCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2016&pages=2687-2696&author=C.+M.+Albertauthor=W.+G.+Stevenson&title=The+Future+of+Cardiovascular+Biomedicine%3A+Arrhythmias+and+Electrophysiology&doi=10.1161%2FCIRCULATIONAHA.116.023519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Future of Arrhythmias and Electrophysiology</span></div><div class="casAuthors">Albert Christine M; Stevenson William G</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2687-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbp8ONwNt92YkFb3mqPUYDfW6udTcc2eZrZA9JhME4krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7itlCqsw%253D%253D&md5=a6576f2991a52827ed7314fe7059c068</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.116.023519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.116.023519%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DC.%2BM.%26aulast%3DStevenson%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Future%2520of%2520Cardiovascular%2520Biomedicine%253A%2520Arrhythmias%2520and%2520Electrophysiology%26jtitle%3DCirculation%26date%3D2016%26volume%3D133%26spage%3D2687%26epage%3D2696%26doi%3D10.1161%2FCIRCULATIONAHA.116.023519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H.</span></span> <span> </span><span class="NLM_article-title">Current Approaches to the Treatment of Atrial Fibrillation</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-800167-7.00008-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FB978-0-12-800167-7.00008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOqtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=101-113&author=H.+Finlay&title=Current+Approaches+to+the+Treatment+of+Atrial+Fibrillation&doi=10.1016%2FB978-0-12-800167-7.00008-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to the treatment of atrial fibrillation</span></div><div class="casAuthors">Finlay, Heather</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A book.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8UWej9tvxG7Vg90H21EOLACvtfcHk0liPgBOWavzslw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOqtL7I&md5=2dff5eeebb6ec607642942f4cebf8279</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800167-7.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-800167-7.00008-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%26atitle%3DCurrent%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Atrial%2520Fibrillation%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2014%26volume%3D49%26spage%3D101%26epage%3D113%26doi%3D10.1016%2FB978-0-12-800167-7.00008-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katus, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D.</span></span> <span> </span><span class="NLM_article-title">The Pathology and Treatment of Cardiac Arrhythmias: Focus on Atrial Fibrillation</span>. <i>Vasc. Health Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.2147/VHRM.S10758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2147%2FVHRM.S10758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=21490945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC3MvjsVOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=193-202&author=C.+Schmidtauthor=J.+Kisselbachauthor=P.+A.+Schweizerauthor=H.+A.+Katusauthor=D.+Thomas&title=The+Pathology+and+Treatment+of+Cardiac+Arrhythmias%3A+Focus+on+Atrial+Fibrillation&doi=10.2147%2FVHRM.S10758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation</span></div><div class="casAuthors">Schmidt Constanze; Kisselbach Jana; Schweizer Patrick A; Katus Hugo A; Thomas Dierk</div><div class="citationInfo"><span class="NLM_cas:title">Vascular health and risk management</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">193-202</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Atrial fibrillation (AF) is the most frequently encountered sustained cardiac arrhythmia in clinical practice and a major cause of morbidity and mortality.  Effective treatment of AF still remains an unmet medical need.  Treatment of AF is based on drug therapy and ablative strategies.  Antiarrhythmic drug therapy is limited by a relatively high recurrence rate and proarrhythmic side effects.  Catheter ablation suppresses paroxysmal AF in the majority of patients without structural heart disease but is more difficult to achieve in patients with persistent AF or with concomitant cardiac disease.  Stroke is a potentially devastating complication of AF, requiring anticoagulation that harbors the risk of bleeding.  In search of novel treatment modalities, targeted pharmacological treatment and gene therapy offer the potential for greater selectivity than conventional small-molecule or interventional approaches.  This paper summarizes the current understanding of molecular mechanisms underlying AF.  Established drug therapy and interventional treatment of AF is reviewed, and emerging clinical and experimental therapeutic approaches are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpNFypI88-cQ20zIbnCCI3fW6udTcc2ebY-CJOcRMZlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvjsVOktg%253D%253D&md5=c22c32754f5673605e9bd6251f9777b4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2147%2FVHRM.S10758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FVHRM.S10758%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DKisselbach%26aufirst%3DJ.%26aulast%3DSchweizer%26aufirst%3DP.%2BA.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DThomas%26aufirst%3DD.%26atitle%3DThe%2520Pathology%2520and%2520Treatment%2520of%2520Cardiac%2520Arrhythmias%253A%2520Focus%2520on%2520Atrial%2520Fibrillation%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2011%26volume%3D7%26spage%3D193%26epage%3D202%26doi%3D10.2147%2FVHRM.S10758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libersa, C.</span></span> <span> </span><span class="NLM_article-title">Adverse Effects of Class I Antiarrhythmic Drugs</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2165/00002018-199717010-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2165%2F00002018-199717010-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=9258628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK2sXls1Wisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=8-36&author=J.+Caronauthor=C.+Libersa&title=Adverse+Effects+of+Class+I+Antiarrhythmic+Drugs&doi=10.2165%2F00002018-199717010-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse effects of class I antiarrhythmic drugs</span></div><div class="casAuthors">Caron, Jacques; Libersa, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-36</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">A review with 366 refs.  Class I antiarrhythmic drugs are characterized by their ability to block the fast inward sodium current in cardiac muscle tissue.  However, at the same time, they can be responsible for various effects involving other organs and systems.  Although some of these effects can be helpful in specific situations, most of them, such as their pro-arrhythmic propensity, are deleterious.  Some of the adverse effects of class I antiarrhythmic drugs are directly linked to sodium-channel blockade (conduction disorders, hemodynamic perturbations, and digestive and neurol. effects), while others are linked to other specific pharmacol. properties (e.g. atropinic, or α- or β-adrenergic blockade) or to nonspecific properties (idiosyncratic hypersensitivity, and hematol., dermatol. or hepatic reactions).  Other adverse effects are assocd. with complex interactions between class I antiarrhythmics and individual predisposing factors, trigger mechanisms and physiol. factors (including concomitant drug treatment).  These numerous variations and interactions within a specific environment and underlying disorder might be of pharmacol. or/and pharmacokinetic origin, making anal. of the true liability of the class I drugs very difficult when adverse effects occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHNVsgnLZVorVg90H21EOLACvtfcHk0ljiUbdbo0rbfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1Wisrw%253D&md5=079052760a33570f808af66268348e8a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2165%2F00002018-199717010-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199717010-00002%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DJ.%26aulast%3DLibersa%26aufirst%3DC.%26atitle%3DAdverse%2520Effects%2520of%2520Class%2520I%2520Antiarrhythmic%2520Drugs%26jtitle%3DDrug%2520Saf.%26date%3D1997%26volume%3D17%26spage%3D8%26epage%3D36%26doi%3D10.2165%2F00002018-199717010-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, D.-g.</span></span> <span> </span><span class="NLM_article-title">Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1007/s12013-015-0626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2Fs12013-015-0626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=25737133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslCqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2015&pages=291-296&author=D.-g.+Fu&title=Cardiac+Arrhythmias%3A+Diagnosis%2C+Symptoms%2C+and+Treatments&doi=10.1007%2Fs12013-015-0626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments</span></div><div class="casAuthors">Fu, Du-guan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-296</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The cardiac arrhythmia is characterized by irregular rhythm of heartbeat which could be either too slow (<60 beats/min) or too fast (>100 beats/min) and can happen at any age.  The use of pacemaker and defibrillators devices has been suggested for heart arrhythmias patients.  The antiarrhythmic medications have been reported for the treatment of cardiac arrhythmias or irregular heartbeats.  The diagnosis, symptoms, and treatments of cardiac arrhythmias as well as the radiofrequency ablation, tachycardia, Brugada syndrome, arterial fibrillation, and recent research on the genetics of cardiac arrhythmias have been described here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdfADPttQkRbVg90H21EOLACvtfcHk0ljiUbdbo0rbfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslCqtLY%253D&md5=15de948bdaab9c32c1c494be80211489</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs12013-015-0626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-015-0626-4%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DD.-g.%26atitle%3DCardiac%2520Arrhythmias%253A%2520Diagnosis%252C%2520Symptoms%252C%2520and%2520Treatments%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2015%26volume%3D73%26spage%3D291%26epage%3D296%26doi%3D10.1007%2Fs12013-015-0626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wagoner, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balk, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billman, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lands, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAnulty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathrop, D. A.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research. A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">e320</span>– <span class="NLM_lpage">e335</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.712984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FCIRCULATIONAHA.107.712984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=17768297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2isLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=e320-e335&author=B.+Londonauthor=C.+Albertauthor=M.+E.+Andersonauthor=W.+R.+Gilesauthor=D.+R.+Van+Wagonerauthor=E.+Balkauthor=G.+E.+Billmanauthor=M.+Chungauthor=W.+Landsauthor=A.+Leafauthor=J.+McAnultyauthor=J.+R.+Martensauthor=R.+B.+Costelloauthor=D.+A.+Lathrop&title=Omega-3+Fatty+Acids+and+Cardiac+Arrhythmias%3A+Prior+Studies+and+Recommendations+for+Future+Research.+A+Report+from+the+National+Heart%2C+Lung%2C+and+Blood+Institute+and+Office+of+Dietary+Supplements+Omega-3+Fatty+Acids+and+Their+Role+in+Cardiac+Arrhythmogenesis+Workshop&doi=10.1161%2FCIRCULATIONAHA.107.712984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their role in cardiac arrhythmogenesis workshop</span></div><div class="casAuthors">London, Barry; Albert, Christine; Anderson, Mark E.; Giles, Wayne R.; Van Wagoner, David R.; Balk, Ethan; Billman, George E.; Chung, Mei; Lands, William; Leaf, Alexander; McAnulty, John; Martens, Jeffrey R.; Costello, Rebecca B.; Lathrop, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e320-e335</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review discusses data from epidemiol. studies, randomized clin. trials, animal studies, and basic science mechanistic studies on the role of n-3 polyunsatd. fatty acids in arrhythmia prevention presented at the Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop sponsored by the National Heart, Lung, and Blood Institute and the Office of Dietary Supplements on August 29-30, 2005.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFaCzkQfgMFrVg90H21EOLACvtfcHk0lj-0_578Shozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2isLfF&md5=b3d64f218865f189893fbbf9dc0cecc1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.712984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.712984%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DB.%26aulast%3DAlbert%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DM.%2BE.%26aulast%3DGiles%26aufirst%3DW.%2BR.%26aulast%3DVan%2BWagoner%26aufirst%3DD.%2BR.%26aulast%3DBalk%26aufirst%3DE.%26aulast%3DBillman%26aufirst%3DG.%2BE.%26aulast%3DChung%26aufirst%3DM.%26aulast%3DLands%26aufirst%3DW.%26aulast%3DLeaf%26aufirst%3DA.%26aulast%3DMcAnulty%26aufirst%3DJ.%26aulast%3DMartens%26aufirst%3DJ.%2BR.%26aulast%3DCostello%26aufirst%3DR.%2BB.%26aulast%3DLathrop%26aufirst%3DD.%2BA.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Arrhythmias%253A%2520Prior%2520Studies%2520and%2520Recommendations%2520for%2520Future%2520Research.%2520A%2520Report%2520from%2520the%2520National%2520Heart%252C%2520Lung%252C%2520and%2520Blood%2520Institute%2520and%2520Office%2520of%2520Dietary%2520Supplements%2520Omega-3%2520Fatty%2520Acids%2520and%2520Their%2520Role%2520in%2520Cardiac%2520Arrhythmogenesis%2520Workshop%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3De320%26epage%3De335%26doi%3D10.1161%2FCIRCULATIONAHA.107.712984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kromhout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geleijnse, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Goede, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griep, L. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, B. J. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Boer, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckers, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boersma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zock, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giltay, E. J.</span></span> <span> </span><span class="NLM_article-title">n-3 Fatty Acids, Ventricular Arrhythmia-Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients with Diabetes</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2515</span>– <span class="NLM_lpage">2520</span>, <span class="refDoi"> DOI: 10.2337/dc11-0896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2337%2Fdc11-0896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22110169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=2515-2520&author=D.+Kromhoutauthor=J.+M.+Geleijnseauthor=J.+de+Goedeauthor=L.+M.+O.+Griepauthor=B.+J.+M+Mulderauthor=M.-J.+de%0ABoerauthor=J.+W.+Deckersauthor=E.+Boersmaauthor=P.+L.+Zockauthor=E.+J.+Giltay&title=n-3+Fatty+Acids%2C+Ventricular+Arrhythmia-Related+Events%2C+and+Fatal+Myocardial+Infarction+in+Postmyocardial+Infarction+Patients+with+Diabetes&doi=10.2337%2Fdc11-0896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes</span></div><div class="casAuthors">Kromhout, Daan; Geleijnse, Johanna M.; de Goede, Janette; Oude Griep, Linda M.; Mulder, Barbara J. M.; de Boer, Menko-Jan; Deckers, Jaap W.; Boersma, Eric; Zock, Peter L.; Giltay, Erik J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Care</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2515-2520</span>CODEN:
                <span class="NLM_cas:coden">DICAD2</span>;
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">OBJECTIVE-We carried out a secondary anal. in high-risk patients with a previous myocardial infarction (Ml) and diabetes in the Alpha Omega Trial.  We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and α-linolenic acid (ALA) will reduce the incidence of ventricular arrhythmias and fatal MI.  RESEARCH DESIGN AND METHODS-A subgroup of 1,014 post-MI patients with diabetes aged 60-80 years was randomly allocated to receive one of four trial margarines, three with an addnl. amt. of n-3 fatty acids and one placebo for 40 mo.  The end points were ventricular arrhythmia-related events and fatal Ml.  The data were analyzed according to the intention-to-treat principle, using multivariable Cox proportional hazards models.  RESULTS-The patients consumed on av. 18.6 g of margarine per day, which resulted in an addnl. intake of 223 mg EPA plus 149 mg DHA and/or 1.9 g ALA in the active treatment groups.  During follow-up, 29 patients developed a ventricular arrhythmia-related events and 27 had a fatal MI.  Compared with placebo patients, the EPA-DHA plus ALA group experienced less ventricular arrhythmia-related events (hazard ratio 0.16; 95% CI 0.04-0.69).  These n-3 fatty acids also reduced the combined end-point ventricular arrhythmia-related events and fatal MI (0.28; 0.11-0.71).  CONCLUSIONS-Our results suggest that low-dose supplementation of n-3 fatty acids exerts a protective effect against ventricular arrhythmia-related events in post-MI patients with diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm5ezmd00ALVg90H21EOLACvtfcHk0lj-0_578Shozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVaktQ%253D%253D&md5=bccc294f620a773007d4dcb0ce18ea6c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2Fdc11-0896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdc11-0896%26sid%3Dliteratum%253Aachs%26aulast%3DKromhout%26aufirst%3DD.%26aulast%3DGeleijnse%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BGoede%26aufirst%3DJ.%26aulast%3DGriep%26aufirst%3DL.%2BM.%2BO.%26aulast%3DMulder%26aufirst%3DB.%2BJ.%2BM%26aulast%3Dde%2BBoer%26aufirst%3DM.-J.%26aulast%3DDeckers%26aufirst%3DJ.%2BW.%26aulast%3DBoersma%26aufirst%3DE.%26aulast%3DZock%26aufirst%3DP.%2BL.%26aulast%3DGiltay%26aufirst%3DE.%2BJ.%26atitle%3Dn-3%2520Fatty%2520Acids%252C%2520Ventricular%2520Arrhythmia-Related%2520Events%252C%2520and%2520Fatal%2520Myocardial%2520Infarction%2520in%2520Postmyocardial%2520Infarction%2520Patients%2520with%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2011%26volume%3D34%26spage%3D2515%26epage%3D2520%26doi%3D10.2337%2Fdc11-0896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rix, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. B.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cardiac Arrhythmias</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e32835bf39b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1097%2FMCO.0b013e32835bf39b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=23196815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1egtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=168-173&author=T.+A.+Rixauthor=J.+H.+Christensenauthor=E.+B.+Schmidt&title=Omega-3+Fatty+Acids+and+Cardiac+Arrhythmias&doi=10.1097%2FMCO.0b013e32835bf39b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cardiac arrhythmias</span></div><div class="casAuthors">Rix, Thomas A.; Christensen, Jeppe H.; Schmidt, Erik B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-173</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: There are suggestions of effects of marine omega-3 polyunsatd. fatty acids (PUFAs) in relation to ventricular arrhythmia and sudden cardiac death and, more recently, also of possible effects related to atrial fibrillation.  Recent findings: On the basis of the recently published human studies, this article not only focusses primarily on recent developments and current knowledge on the effect of marine omega-3 PUFAs on atrial fibrillation, but also provides a status for their effects on ventricular arrhythmias.  Summary: Marine omega-3 PUFAs may protect against ventricular arrhythmias, and there is growing evidence for an effect of marine omega-3 PUFAs in the prevention and treatment of atrial fibrillation.  Further studies are needed to establish which patients are more likely to benefit from omega-3 PUFAs, the timing of treatment, and the dosages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-1_92NFr_1LVg90H21EOLACvtfcHk0lj-0_578Shozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1egtbs%253D&md5=87415324e5177808041c9c91e6640f98</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e32835bf39b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e32835bf39b%26sid%3Dliteratum%253Aachs%26aulast%3DRix%26aufirst%3DT.%2BA.%26aulast%3DChristensen%26aufirst%3DJ.%2BH.%26aulast%3DSchmidt%26aufirst%3DE.%2BB.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Arrhythmias%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2013%26volume%3D16%26spage%3D168%26epage%3D173%26doi%3D10.1097%2FMCO.0b013e32835bf39b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span> <span> </span><span class="NLM_article-title">Prevention of Fatal Cardiac Arrhythmias by Polyunsaturated Fatty Acids</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">202S</span>– <span class="NLM_lpage">207S</span>, <span class="refDoi"> DOI: 10.1093/ajcn/71.1.202S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1093%2Fajcn%2F71.1.202S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10617972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2000&pages=202S-207S&author=J.+X.+Kangauthor=A.+Leaf&title=Prevention+of+Fatal+Cardiac+Arrhythmias+by+Polyunsaturated+Fatty+Acids&doi=10.1093%2Fajcn%2F71.1.202S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids</span></div><div class="casAuthors">Kang, Jing X.; Leaf, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1, Suppl.</span>),
    <span class="NLM_cas:pages">202S-207S</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">A review with 33 refs.  In animal studies, and probably in humans, dietary n-3 polyunsatd. fatty acids (PUFA) can prevent fatal ischemia-induced cardiac arrhythmias.  The n-3 PUFA can also prevent heart arrhythmias in surgically prepd. conscious exercising dogs.  The mechanism of the antiarrhythmic action of n-3 PUFA has been studied by the authors in spontaneously contracting cultured cardiac myocytes of neonatal rats.  Adding arrhythmogenic toxins (ouabain, high Ca2+, lysophosphatidylcholine, β-adrenergic agonist, acylcarnitine, Ca ionophore) to the myocyte perfusate caused tachycardia, contracture, and fibrillation of the cultured myocytes.  Adding eicosapentaenoic acid (EPA; 5-15 μmol/L) to the superfusate before adding the toxins prevented the expected tachyarrhythmias.  When the arrhythmias were first induced, adding EPA to the superfusate terminated the arrhythmias.  This antiarrhythmic action occurred with dietary n-3 and n-6 PUFA; satd. fatty acids and the monounsatd. oleic acid had no such activity.  Arachidonic acid (AA; C20:4n-6) effects were anomalous because in 1/3 of the tests it provoked severe arrhythmias due to cyclooxygenase metabolites of AA.  When cyclooxygenase inhibitors were added with AA, the antiarrhythmic effect was like those of EPA and DHA.  The action of the n-3 and n-6 PUFA is to stabilize elec. every myocyte in the heart by increasing the elec. stimulus required to elicit an action potential by ∼50% and prolonging the relative refractory time by ∼150%.  These electrophysiol. effects result from an action of free PUFA to modulate sodium and calcium currents in the myocytes.  PUFA also modulate sodium and calcium channels and have anticonvulsant activity in brain cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4Y33dxq4aLVg90H21EOLACvtfcHk0ligv9RKtvvR8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFGruw%253D%253D&md5=7b715f46858c6d596bad48d4d8b8c377</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F71.1.202S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F71.1.202S%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BX.%26aulast%3DLeaf%26aufirst%3DA.%26atitle%3DPrevention%2520of%2520Fatal%2520Cardiac%2520Arrhythmias%2520by%2520Polyunsaturated%2520Fatty%2520Acids%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2000%26volume%3D71%26spage%3D202S%26epage%3D207S%26doi%3D10.1093%2Fajcn%2F71.1.202S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billman, G. E.</span></span> <span> </span><span class="NLM_article-title">Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2646</span>– <span class="NLM_lpage">2652</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000069566.78305.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2F01.CIR.0000069566.78305.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=12782616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ls1CgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=2646-2652&author=A.+Leafauthor=J.+X.+Kangauthor=Y.-F.+Xiaoauthor=G.+E.+Billman&title=Clinical+Prevention+of+Sudden+Cardiac+Death+by+n-3+Polyunsaturated+Fatty+Acids+and+Mechanism+of+Prevention+of+Arrhythmias+by+n-3+Fish+Oils&doi=10.1161%2F01.CIR.0000069566.78305.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils</span></div><div class="casAuthors">Leaf Alexander; Kang Jing X; Xiao Yong-Fu; Billman George E</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2646-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzbTltIGOu2kodMGTatQ7LfW6udTcc2ebZgdaa-Qurh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ls1CgsA%253D%253D&md5=5d86a4af26b47cf84c8a859a4e2ddb00</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000069566.78305.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000069566.78305.33%26sid%3Dliteratum%253Aachs%26aulast%3DLeaf%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DJ.%2BX.%26aulast%3DXiao%26aufirst%3DY.-F.%26aulast%3DBillman%26aufirst%3DG.%2BE.%26atitle%3DClinical%2520Prevention%2520of%2520Sudden%2520Cardiac%2520Death%2520by%2520n-3%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Mechanism%2520of%2520Prevention%2520of%2520Arrhythmias%2520by%2520n-3%2520Fish%2520Oils%26jtitle%3DCirculation%26date%3D2003%26volume%3D107%26spage%3D2646%26epage%3D2652%26doi%3D10.1161%2F01.CIR.0000069566.78305.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggioni, A. P.</span></span> <span> </span><span class="NLM_article-title">Upstream Treatment of Atrial Fibrillation with N-3 Polyunsaturated Fatty Acids: Myth or Reality?</span>. <i>Arrhythm. Electrophysiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.15420/aer.2015.4.3.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.15420%2Faer.2015.4.3.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26835119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC28nmvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=163-168&author=F.+Orsoauthor=G.+Fabbriauthor=A.+P.+Maggioni&title=Upstream+Treatment+of+Atrial+Fibrillation+with+N-3+Polyunsaturated+Fatty+Acids%3A+Myth+or+Reality%3F&doi=10.15420%2Faer.2015.4.3.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?</span></div><div class="casAuthors">Orso Francesco; Fabbri Gianna; Maggioni Aldo Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Arrhythmia & electrophysiology review</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-8</span>
        ISSN:<span class="NLM_cas:issn">2050-3369</span>.
    </div><div class="casAbstract">Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and is associated with an increased risk of fatal and non-fatal events.  Antiarrhythmic drugs provide limited protection against AF recurrence and have a poor safety profile.  Several mechanisms have been proven to be involved in AF, e.g. inflammation, oxidative stress, fibrosis and ischaemia.  Prevention of AF with interventions that target these mechanisms has emerged as a result of experimental studies suggesting the use of upstream therapies.  Long chain n-3 polyunsaturated fatty acids (n-3 PUFA) have multiple effects on cardiac electrophysiology, and epidemiological studies on fish oil suggest a possible use of n-3 PUFA in AF prevention.  Several randomised clinical trials have been designed to evaluate the efficacy of n-3 PUFA in preventing AF.  In this review, we report the conflicting results of these trials in two different clinical settings: recurrence in patients with history of AF and development of post-operative AF in patient undergoing cardiac surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAM8q032c8iIxhnOQkIHOxfW6udTcc2ebZgdaa-Qurh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmvVWquw%253D%253D&md5=51cc37fcd562e8cc620d7b33b3416e4e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.15420%2Faer.2015.4.3.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15420%252Faer.2015.4.3.163%26sid%3Dliteratum%253Aachs%26aulast%3DOrso%26aufirst%3DF.%26aulast%3DFabbri%26aufirst%3DG.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26atitle%3DUpstream%2520Treatment%2520of%2520Atrial%2520Fibrillation%2520with%2520N-3%2520Polyunsaturated%2520Fatty%2520Acids%253A%2520Myth%2520or%2520Reality%253F%26jtitle%3DArrhythm.%2520Electrophysiol.%2520Rev.%26date%3D2015%26volume%3D4%26spage%3D163%26epage%3D168%26doi%3D10.15420%2Faer.2015.4.3.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Schacky, C.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">88</span>, <span class="refDoi"> DOI: 10.3389/fphys.2012.00088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.3389%2Ffphys.2012.00088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22529815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC38rnt1yltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=88&author=C.+von%0ASchacky&title=Omega-3+Fatty+Acids%3A+Anti-Arrhythmic%2C+Pro-Arrhythmic%2C+or+Both%3F&doi=10.3389%2Ffphys.2012.00088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?</span></div><div class="casAuthors">von Schacky C</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This review focuses on developments after 2008, when the topic was last reviewed by the author.  Pertinent publications were found by medline searches and in the author's personal data base.  Prevention of atrial fibrillation (AF) was investigated in a number of trials, sparked by one positive report on the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), considerations of upstream therapy, data from electrophysiologic laboratories and animal experiments.  If EPA + DHA prevent postoperative AF, the effect is probably smaller than initially expected.  The same is probably true for maintenance of sinus rhythm after cardioversion and for new-onset AF.  Larger trials are currently ongoing.  Prevention of ventricular arrhythmias was studied in carriers of an implanted cardioverter-defibrillator, with no clear results.  This might have been due to a broad definition of the primary endpoint, including any ventricular arrhythmia and any action of the device.  Epidemiologic studies support the contention that high levels of EPA + DHA prevent sudden cardiac death (SCD).  However, since SCD is a rare occurrence, it is difficult to conduct an adequately powered trial.  In patients with congestive heart failure, EPA + DHA reduced total mortality and rehospitalizations, but not SCD or presumed arrhythmic death.  Of three trials in patients after a myocardial infarction, two were inadequately powered, and in one, the dose might have been too low.  Taken together, while epidemiologic studies support an inverse relation between EPA + DHA and occurrence of SCD or arrhythmic death, demonstrating this effect in intervention trials remained elusive so far.  A pro-arrhythmic effect of EPA + DHA has not been seen in intervention studies, and results of epidemiologic and animal studies also rather argue against such an effect.  A different, and probably more productive, perspective is provided by a standardized analytical assessment of a person's status in EPA + DHA by use of the omega-3 index, EPA + DHA in red cell fatty acids.  In populations with a high omega-3 index, SCD is rare.  Intervention trials can become more effective by including a low omega-3 index into the inclusion criteria, thus creating a study population more likely to demonstrate an effect of EPA + DHA.  This is especially relevant in case of rare endpoints, like new-onset AF or SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStpLp2g2-DHRBrI9DTGjC0fW6udTcc2ebZgdaa-Qurh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnt1yltg%253D%253D&md5=5c6ebd132678919e14379db83f23c2b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2012.00088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2012.00088%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26atitle%3DOmega-3%2520Fatty%2520Acids%253A%2520Anti-Arrhythmic%252C%2520Pro-Arrhythmic%252C%2520or%2520Both%253F%26jtitle%3DFront.%2520Physiol.%26date%3D2012%26volume%3D3%26spage%3D88%26doi%3D10.3389%2Ffphys.2012.00088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tota, C.</span></span> <span> </span><span class="NLM_article-title">The Anti-Arrhythmic Effects of <i>n</i>-3 PUFAs</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">S21</span>– <span class="NLM_lpage">S27</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2013.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.ijcard.2013.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24016540" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=S21-S27&author=L.+Cal%C3%B2author=A.+Martinoauthor=C.+Tota&title=The+Anti-Arrhythmic+Effects+of+n-3+PUFAs&doi=10.1016%2Fj.ijcard.2013.06.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2013.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2013.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DL.%26aulast%3DMartino%26aufirst%3DA.%26aulast%3DTota%26aufirst%3DC.%26atitle%3DThe%2520Anti-Arrhythmic%2520Effects%2520of%2520n-3%2520PUFAs%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D170%26spage%3DS21%26epage%3DS27%26doi%3D10.1016%2Fj.ijcard.2013.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">CYP-Eicosanoids-a New Link Between Omega-3 Fatty Acids and Cardiac Disease?</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2011.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.prostaglandins.2011.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOjurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=99-108&author=C.+Westphalauthor=A.+Konkelauthor=W.+H.+Schunck&title=CYP-Eicosanoids-a+New+Link+Between+Omega-3+Fatty+Acids+and+Cardiac+Disease%3F&doi=10.1016%2Fj.prostaglandins.2011.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CYP-eicosanoids-A new link between omega-3 fatty acids and cardiac disease?</span></div><div class="casAuthors">Westphal, Christina; Konkel, Anne; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">99-108</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Fish oil omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against arrhythmia and sudden cardiac death by largely unknown mechanisms.  Recent in vitro and in vivo studies demonstrate that arachidonic acid (AA) metabolizing cytochrome P 450-(CYP) enzymes accept EPA and DHA as efficient alternative substrates.  Dietary EPA/DHA supplementation causes a profound shift of the cardiac CYP-eicosanoid profile from AA- to EPA- and DHA-derived epoxy- and hydroxy-metabolites.  CYP2J2 and other CYP epoxygenases preferentially epoxidize the ω-3 double bond of EPA and DHA.  The corresponding metabolites, 17,18-epoxy-EPA and 19,20-epoxy-DHA, dominate the CYP-eicosanoid profile of the rat heart after EPA/DHA supplementation.  The (ω-3)-epoxyeicosanoids show highly potent antiarrhythmic properties in neonatal cardiomyocytes, suggesting that these metabolites may specifically contribute to the cardioprotective effects of omega-3 fatty acids.  This hypothesis is discussed in the context of recent findings that revealed CYP-eicosanoid mediated mechanisms in cardiac ischemia-reperfusion injury and maladaptive cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMUDV9LlYR7Vg90H21EOLACvtfcHk0lh32WhJTvTxiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOjurfF&md5=d8a8d82d16dd181493631c7eae4c623c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DCYP-Eicosanoids-a%2520New%2520Link%2520Between%2520Omega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Disease%253F%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2011%26volume%3D96%26spage%3D99%26epage%3D108%26doi%3D10.1016%2Fj.prostaglandins.2011.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weylandt, K. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Omega-3 Fatty Acid-Derived Epoxyeicosanoids in Cardiovascular and Inflammatory Diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.pharmthera.2017.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=29080699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=177-204&author=W.+H.+Schunckauthor=A.+Konkelauthor=R.+Fischerauthor=K.+H.+Weylandt&title=Therapeutic+Potential+of+Omega-3+Fatty+Acid-Derived+Epoxyeicosanoids+in+Cardiovascular+and+Inflammatory+Diseases&doi=10.1016%2Fj.pharmthera.2017.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases</span></div><div class="casAuthors">Schunck, Wolf-Hagen; Konkel, Anne; Fischer, Robert; Weylandt, Karsten-Henrich</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-204</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Numerous benefits have been attributed to dietary long-chain omega-3 polyunsatd. fatty acids (n-3 LC-PUFAs), including protection against cardiac arrhythmia, triglyceride-lowering, amelioration of inflammatory, and neurodegenerative disorders.  This review covers recent findings indicating that a variety of these beneficial effects are mediated by "omega-3 epoxyeicosanoids", a class of novel n-3 LC-PUFA-derived lipid mediators, which are generated via the cytochrome P 450 (CYP) epoxygenase pathway.  CYP enzymes, previously identified as arachidonic acid (20:4n-6; AA) epoxygenases, accept eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA), the major fish oil n-3 LC-PUFAs, as efficient alternative substrates.  In humans and rodents, dietary EPA/DHA supplementation causes a profound shift of the endogenous CYP-eicosanoid profile from AA- to EPA- and DHA-derived metabolites, increasing, in particular, the plasma and tissue levels of 17,18-epoxyeicosatetraenoic acid (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP).  Based on preclin. studies, these omega-3 epoxyeicosanoids display cardioprotective, vasodilatory, anti-inflammatory, and anti-allergic properties that contribute to the beneficial effects of n-3 LC-PUFAs in diverse disease conditions ranging from cardiac disease, bronchial disorders, and intraocular neovascularization, to allergic intestinal inflammation and inflammatory pain.  Increasing evidence also suggests that background nutrition as well as genetic and disease state-related factors could limit the response to EPA/DHA-supplementation by reducing the formation and/or enhancing the degrdn. of omega-3 epoxyeicosanoids.  Recently, metabolically robust synthetic analogs mimicking the biol. activities of 17,18-EEQ have been developed.  These drug candidates may overcome limitations of dietary EPA/DHA supplementation and provide novel options for the treatment of cardiovascular and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR4e6v0kblPLVg90H21EOLACvtfcHk0lh32WhJTvTxiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtr%252FI&md5=af1e271b25c13db6a521c20c2bec883f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DWeylandt%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520Potential%2520of%2520Omega-3%2520Fatty%2520Acid-Derived%2520Epoxyeicosanoids%2520in%2520Cardiovascular%2520and%2520Inflammatory%2520Diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D183%26spage%3D177%26epage%3D204%26doi%3D10.1016%2Fj.pharmthera.2017.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gapelyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharzowsky, U. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plehm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirdewan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span> <span> </span><span class="NLM_article-title">Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.103143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FHYPERTENSIONAHA.107.103143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=18158339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Krug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=540-546&author=R.+Fischerauthor=R.+Dechendauthor=F.+Qadriauthor=M.+Markovicauthor=S.+Feldtauthor=F.+Herseauthor=J.+K.+Parkauthor=A.+Gapelyukauthor=I.+Schwarzauthor=U.+B.+Zacharzowskyauthor=R.+Plehmauthor=E.+Safakauthor=A.+Heuserauthor=A.+Schirdewanauthor=F.+C.+Luftauthor=W.+H.+Schunckauthor=D.+N.+Muller&title=Dietary+n-3+Polyunsaturated+Fatty+Acids+and+Direct+Renin+Inhibition+Improve+Electrical+Remodeling+in+a+Model+of+High+Human+Renin+Hypertension&doi=10.1161%2FHYPERTENSIONAHA.107.103143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension</span></div><div class="casAuthors">Fischer, Robert; Dechend, Ralf; Qadri, Fatimunnisa; Markovic, Marija; Feldt, Sandra; Herse, Florian; Park, Joon-Keun; Gapelyuk, Andrej; Schwarz, Ines; Zacharzowsky, Udo B.; Plehm, Ralph; Safak, Erdal; Heuser, Arnd; Schirdewan, Alexander; Luft, Friedrich C.; Schunck, Wolf-Hagen; Muller, Dominik N.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We compared the effect n-3 polyunsatd. fatty acids (PUFAs) with direct renin inhibition on electrophysiol. remodeling in angiotensin II-induced cardiac injury.  We treated double-transgenic rats expressing the human renin and angiotensinogen genes (dTGRs) from week 4 to 7 with n-3 PUFA ethyl-esters (Omacor; 25-g/kg diet) or a direct renin inhibitor (aliskiren; 3 mg/kg per day).  Sprague-Dawley rats were controls.  We performed electrocardiog., magnetocardiog., and programmed elec. stimulation.  Dietary n-3 PUFAs increased the cardiac content of eicosapentaenoic and docosahexaenoic acid.  At week 7, mortality in dTGRs was 31%, whereas none of the n-3 PUFA- or aliskiren-treated dTGRs died.  Systolic blood pressure was modestly reduced in n-3 PUFA-treated (180 ± 3 mm Hg) compared with dTGRs (208 ± 5 mm Hg).  Aliskiren-treated dTGRs and Sprague-Dawley rats were normotensive (110 ± 3 and 119 ± 6 mm Hg, resp.).  Both n-3 PUFA-treated and untreated dTGRs showed cardiac hypertrophy and increased atrial natriuretic peptide levels.  Prolonged QRS and QTc intervals and increased T-wave dispersion in dTGRs were reduced by n-3 PUFAs or aliskiren.  Both treatments reduced arrhythmia induction from 75% in dTGRs to 17% vs. 0% in Sprague-Dawley rats.  Macrophage infiltration and fibrosis were reduced by n-3 PUFAs and aliskiren.  Connexin 43, a mediator of intermyocyte conduction, was redistributed to the lateral cell membranes in dTGRs. n-3 PUFAs and aliskiren restored normal localization to the intercalated disks.  Thus, n-3 PUFAs and aliskiren improved elec. remodeling, arrhythmia induction, and connexin 43 expression, despite a 70-mm Hg difference in blood pressure and the development of cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM9nmONMVTEbVg90H21EOLACvtfcHk0lgrduySVn83_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Krug%253D%253D&md5=078c8001995ff190d0b8f36570797b3f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.103143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.103143%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DQadri%26aufirst%3DF.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DHerse%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DGapelyuk%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DI.%26aulast%3DZacharzowsky%26aufirst%3DU.%2BB.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DSafak%26aufirst%3DE.%26aulast%3DHeuser%26aufirst%3DA.%26aulast%3DSchirdewan%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26atitle%3DDietary%2520n-3%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Direct%2520Renin%2520Inhibition%2520Improve%2520Electrical%2520Remodeling%2520in%2520a%2520Model%2520of%2520High%2520Human%2520Renin%2520Hypertension%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D540%26epage%3D546%26doi%3D10.1161%2FHYPERTENSIONAHA.107.103143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blossey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Schacky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Arachidonic Acid-Metabolizing Cytochrome P450 Enzymes are Targets of ω-3 Fatty Acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">32720</span>– <span class="NLM_lpage">32733</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1074%2Fjbc.M110.118406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=20732876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12nu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32720-32733&author=C.+Arnoldauthor=M.+Markovicauthor=K.+Blosseyauthor=G.+Wallukatauthor=R.+Fischerauthor=R.+Dechendauthor=A.+Konkelauthor=C.+von+Schackyauthor=F.+C.+Luftauthor=D.+N.+Mullerauthor=M.+Rotheauthor=W.-H.+Schunck&title=Arachidonic+Acid-Metabolizing+Cytochrome+P450+Enzymes+are+Targets+of+%CF%89-3+Fatty+Acids&doi=10.1074%2Fjbc.M110.118406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic Acid-metabolizing Cytochrome P450 Enzymes are Targets of ω-3 Fatty Acids</span></div><div class="casAuthors">Arnold, Cosima; Markovic, Marija; Blossey, Katrin; Wallukat, Gerd; Fischer, Robert; Dechend, Ralf; Konkel, Anne; von Schacky, Clemens; Luft, Friedrich C.; Muller, Dominik N.; Rothe, Michael; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">32720-32733</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against cardiovascular disease by largely unknown mechanisms.  We tested the hypothesis that EPA and DHA may compete with arachidonic acid (AA) for the conversion by cytochrome P 450 (CYP) enzymes, resulting in the formation of alternative, physiol. active, metabolites.  Renal and hepatic microsomes, as well as various CYP isoforms, displayed equal or elevated activities when metabolizing EPA or DHA instead of AA.  CYP2C/2J isoforms converting AA to epoxyeicosatrienoic acids (EETs) preferentially epoxidized the ω-3 double bond and thereby produced 17,18-epoxyeicosatetraenoic (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP) from EPA and DHA.  We found that these ω-3 epoxides are highly active as antiarrhythmic agents, suppressing the Ca2+-induced increased rate of spontaneous beating of neonatal rat cardiomyocytes, at low nanomolar concns.  CYP4A/4F isoforms ω-hydroxylating AA were less regioselective toward EPA and DHA, catalyzing predominantly ω- and ω minus 1 hydroxylation.  Rats given dietary EPA/DHA supplementation exhibited substantial replacement of AA by EPA and DHA in membrane phospholipids in plasma, heart, kidney, liver, lung, and pancreas, with less pronounced changes in the brain.  The changes in fatty acids were accompanied by concomitant changes in endogenous CYP metabolite profiles (e.g. altering the EET/EEQ/EDP ratio from 87:0:13 to 27:18:55 in the heart).  These results demonstrate that CYP enzymes efficiently convert EPA and DHA to novel epoxy and hydroxy metabolites that could mediate some of the beneficial cardiovascular effects of dietary ω-3 fatty acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqued4FkC5_sbVg90H21EOLACvtfcHk0lgrduySVn83_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12nu7%252FN&md5=117166ad5cb559d06093fd333f2826f8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118406%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DC.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DBlossey%26aufirst%3DK.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DArachidonic%2520Acid-Metabolizing%2520Cytochrome%2520P450%2520Enzymes%2520are%2520Targets%2520of%2520%25CF%2589-3%2520Fatty%2520Acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32720%26epage%3D32733%26doi%3D10.1074%2Fjbc.M110.118406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Molecular Properties of the Cytochrome P450 Arachidonic Acid Monooxygenases</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>68–69</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/S0090-6980(02)00038-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0090-6980%2802%2900038-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=12432927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvV2ntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68%E2%80%9369&publication_year=2002&pages=325-344&author=J.+H.+Capdevilaauthor=J.+R.+Falck&title=Biochemical+and+Molecular+Properties+of+the+Cytochrome+P450+Arachidonic+Acid+Monooxygenases&doi=10.1016%2FS0090-6980%2802%2900038-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases</span></div><div class="casAuthors">Capdevila, Jorge H.; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">68-69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">325-344</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 (P 450) arachidonic acid (AA) monooxygenase metabolizes the fatty acid to a series of epoxy- and hydroxy-acid derivs.  Catalytic turnover requires NADPH, and requires the redox-coupled activation and cleavage of diat. oxygen, and the delivery of an active form of at. oxygen to ground state carbon atoms.  Past and present advances in P 450 biochem. and mol. biol. are beginning to provide a description of the P 450 isoform specificity of AA bioactivation, and the mechanisms of action and physiol. relevance of the P 450 metabolites.  The demonstration of the endogenous biosynthesis of many of these metabolites has established the P 450 pathway as an important route for AA bioactivation, and has begun to uncover new and important functional roles for this enzyme system in cell and organ physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyom9LG8qo6LVg90H21EOLACvtfcHk0lgrduySVn83_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvV2ntr4%253D&md5=cd33dcaa2d905c204409f52f3c06e09c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2802%2900038-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252802%252900038-2%26sid%3Dliteratum%253Aachs%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DBiochemical%2520and%2520Molecular%2520Properties%2520of%2520the%2520Cytochrome%2520P450%2520Arachidonic%2520Acid%2520Monooxygenases%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2002%26volume%3D68%25E2%2580%259369%26spage%3D325%26epage%3D344%26doi%3D10.1016%2FS0090-6980%2802%2900038-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulitquer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marienhagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaneberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcos, L.</span></span> <span> </span><span class="NLM_article-title">Stereoselective Epoxidation of the Last Double Bond of Polyunsaturated Fatty Acids by Human Cytochromes P450</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1125</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1194/jlr.M003061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M003061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=19965576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1125-1133&author=D.+Lucasauthor=S.+Goulitquerauthor=J.+Marienhagenauthor=M.+Ferauthor=Y.+Dreanoauthor=U.+Schwanebergauthor=Y.+Ametauthor=L.+Corcos&title=Stereoselective+Epoxidation+of+the+Last+Double+Bond+of+Polyunsaturated+Fatty+Acids+by+Human+Cytochromes+P450&doi=10.1194%2Fjlr.M003061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450</span></div><div class="casAuthors">Lucas, Daniele; Goulitquer, Sophie; Marienhagen, Jan; Fer, Maude; Dreano, Yvonne; Schwaneberg, Ulrich; Amet, Yolande; Corcos, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1125-1133</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Cytochromes P 450 (CYPs) metabolize polyunsatd. long-chain fatty acids (PUFA-LC) to several classes of oxygenated metabolites.  Through use of human recombinant CYPs, we recently showed that CYP1A1, -2C19, -2D6, -2E1, and -3A4 are mainly hydroxylases, whereas CYP1A2, -2C8, -2C9, and -2J2 are mainly epoxygenases of arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), resp.  It is worth noting that the last double bond of these PUFAs, i.e., ω6 in AA or ω3 in EPA and DHA, resp., was preferentially epoxidized.  In this study, we have characterized the stereoselectivity of this epoxidn. reaction by comparison with the PUFA-LC epoxide stereoisomers obtained from the enantioselective bacterial CYP102A1 F87V.  The stereoselectivity of the epoxidn. of the last olefin of AA (ω6), EPA (ω3), or DHA (ω3) differed between the CYP isoforms but was similar for EPA and DHA.  These data give addnl. insight into the PUFA-LC epoxide enantiomers generated by the hepatic CYPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPXrDlI8zcyLVg90H21EOLACvtfcHk0lhXdkIBjWf1fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWktL0%253D&md5=c847aab0e38064a3f9cb64702c758c0f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M003061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M003061%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DD.%26aulast%3DGoulitquer%26aufirst%3DS.%26aulast%3DMarienhagen%26aufirst%3DJ.%26aulast%3DFer%26aufirst%3DM.%26aulast%3DDreano%26aufirst%3DY.%26aulast%3DSchwaneberg%26aufirst%3DU.%26aulast%3DAmet%26aufirst%3DY.%26aulast%3DCorcos%26aufirst%3DL.%26atitle%3DStereoselective%2520Epoxidation%2520of%2520the%2520Last%2520Double%2520Bond%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520by%2520Human%2520Cytochromes%2520P450%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2010%26volume%3D51%26spage%3D1125%26epage%3D1133%26doi%3D10.1194%2Fjlr.M003061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">Eicosapentaenoic Acid Metabolism by Cytochrome P450 Enzymes of the CYP2C Subfamily</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.02.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bbrc.2005.02.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=15766564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1eqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=1275-1281&author=E.+Barbosa-Sicardauthor=M.+Markovicauthor=H.+Honeckauthor=B.+Christauthor=D.+N.+M%C3%BCllerauthor=W.+H.+Schunck&title=Eicosapentaenoic+Acid+Metabolism+by+Cytochrome+P450+Enzymes+of+the+CYP2C+Subfamily&doi=10.1016%2Fj.bbrc.2005.02.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily</span></div><div class="casAuthors">Barbosa-Sicard, Eduardo; Markovic, Marija; Honeck, Horst; Christ, Baghat; Muller, Dominik N.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1275-1281</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">CYP2C enzymes epoxidize arachidonic acid (AA) to metabolites involved in the regulation of vascular and renal function.  We tested the hypothesis that eicosapentaenoic acid (EPA), a n-3 polyunsatd. fatty acid, may serve as an alternative substrate.  Human CYP2C8 and CYP2C9, as well as rat CYP2C11 and CYP2C23, were co-expressed with NADPH-CYP reductase in a baculovirus/insect cell system.  The recombinant enzymes showed high EPA and AA epoxygenase activities and the catalytic efficiencies were almost equal comparing the two substrates.  The 17,18-double bond was the preferred site of EPA epoxidn. by CYPs 2C8, 2C11, and 2C23.  17(R),18(S)-Epoxyeicosatetraenoic acid was produced with an optical purity of about 70% by CYPs 2C9, 2C11, and 2C23 whereas CYP2C8 showed the opposite enantioselectivity.  These results demonstrate that EPA is an efficient substrate of CYP2C enzymes and suggest that n-3 PUFA-rich diets may shift the CYP2C-dependent generation of physiol. active eicosanoids from AA- to EPA-derived metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVWXmn1Hld2LVg90H21EOLACvtfcHk0lhXdkIBjWf1fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1eqt7o%253D&md5=8ea4eea71f4350eaad26ae0dd76ab02e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.02.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.02.103%26sid%3Dliteratum%253Aachs%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DHoneck%26aufirst%3DH.%26aulast%3DChrist%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DEicosapentaenoic%2520Acid%2520Metabolism%2520by%2520Cytochrome%2520P450%2520Enzymes%2520of%2520the%2520CYP2C%2520Subfamily%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D1275%26epage%3D1281%26doi%3D10.1016%2Fj.bbrc.2005.02.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hercule, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Mouse Cyp4a Isoforms: Enzymatic Properties, Gender- and Strain-Specific Expression, and Role in Renal 20-Hydroxyeicosatetraenoic Acid Formation</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1042/BJ20061328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1042%2FBJ20061328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=17112342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFOksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2007&pages=109-118&author=D.+N.+M%C3%BCllerauthor=C.+Schmidtauthor=E.+Barbosa-Sicardauthor=N.+Wellnerauthor=V.+Grossauthor=H.+Herculeauthor=M.+Markovicauthor=H.+Honeckauthor=F.+C.+Luftauthor=W.-H.+Schunck&title=Mouse+Cyp4a+Isoforms%3A+Enzymatic+Properties%2C+Gender-+and+Strain-Specific+Expression%2C+and+Role+in+Renal+20-Hydroxyeicosatetraenoic+Acid+Formation&doi=10.1042%2FBJ20061328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation</span></div><div class="casAuthors">Muller, Dominik N.; Schmidt, Cosima; Barbosa-Sicard, Eduardo; Wellner, Maren; Gross, Volkmar; Hercule, Hantz; Markovic, Marija; Honeck, Horst; Luft, Friedrich C.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-118</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">AA (arachidonic acid) hydroxylation to 20-HETE (20-hydroxyeicosatetraenoic acid) influences renal vascular and tubular function.  To identify the CYP (cytochrome P 450) isoforms catalyzing this reaction in the mouse kidney, we analyzed the substrate specificity of Cyp4a10, 4a12a, 4a12b and 4a14 and detd. sex- and strain-specific expressions.  All recombinant enzymes showed high lauric acid hydroxylase activities.  Cyp4a12a and Cyp4a12b efficiently hydroxylated AA to 20-HETE with Vmax values of approx. 10 nmol nmol-1 min-1 and Km values of 20-40 μM.  20-Carboxyeicosatetraenoic acid occurred as a secondary metabolite.  AA hydroxylase activities were approx. 25-75-fold lower with Cyp4a10 and not detectable with Cyp4a14.  Cyp4a12a and Cyp4a12b also efficiently converted EPA (eicosapentaenoic acid) into 19/20-OH- and 17,18-epoxy-EPA.  In male mice, renal microsomal AA hydroxylase activities ranged between approx. 100 (NMRI), 45-55 (FVB/N, 129 Sv/J and Balb/c) and 25 pmol min-1 mg-1 (C57BL/6).  The activities correlated with differences in Cyp4a12a protein and mRNA levels.  Treatment with 5α-dihydrotestosterone induced both 20-HETE prodn. and Cyp4a12a expression more than 4-fold in male C57BL/6 mice.  All female mice showed low AA hydroxylase activities (15-25 pmol min-1 mg-1) and very low Cyp4a12a mRNA and protein levels, but high Cyp4a10 and Cyp4a14 expression.  Renal Cyp4a12b mRNA expression was almost undetectable in both sexes of all strains.  Thus Cyp4a12a is the predominant 20-HETE synthase in the mouse kidney.  Cyp4a12a expression dets. the sex- and strain-specific differences in 20-HETE generation and may explain sex and strain differences in the susceptibility to hypertension and target organ damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTniS7Waz28bVg90H21EOLACvtfcHk0lhXdkIBjWf1fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFOksLw%253D&md5=2b8d39a33e21e2b099a1dfb0c69e8a29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1042%2FBJ20061328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061328%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DWellner%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DV.%26aulast%3DHercule%26aufirst%3DH.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DHoneck%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DMouse%2520Cyp4a%2520Isoforms%253A%2520Enzymatic%2520Properties%252C%2520Gender-%2520and%2520Strain-Specific%2520Expression%252C%2520and%2520Role%2520in%2520Renal%252020-Hydroxyeicosatetraenoic%2520Acid%2520Formation%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D403%26spage%3D109%26epage%3D118%26doi%3D10.1042%2FBJ20061328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regitz-Zagrosek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span> <span> </span><span class="NLM_article-title">CYP2J2 Overexpression Protects Against Arrhythmia Susceptibility in Cardiac Hypertrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73490</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1371%2Fjournal.pone.0073490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24023684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=C.+Westphalauthor=B.+Spallekauthor=A.+Konkelauthor=L.+Markoauthor=F.+Qadriauthor=L.+M.+DeGraffauthor=C.+Schubertauthor=J.+A.+Bradburyauthor=V.+Regitz-Zagrosekauthor=J.+R.+Falckauthor=D.+C.+Zeldinauthor=D.+N.+M%C3%BCllerauthor=W.+H.+Schunckauthor=R.+Fischer&title=CYP2J2+Overexpression+Protects+Against+Arrhythmia+Susceptibility+in+Cardiac+Hypertrophy&doi=10.1371%2Fjournal.pone.0073490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy</span></div><div class="casAuthors">Westphal, Christina; Spallek, Bastian; Konkel, Anne; Marko, Lajos; Qadri, Fatimunnisa; DeGraff, Laura M.; Schubert, Carola; Bradbury, J. Alyce; Regitz-Zagrosek, Vera; Falck, John R.; Zeldin, Darryl C.; Mueller, Dominik N.; Schunck, Wolf-Hagen; Fischer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e73490</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Maladaptive cardiac hypertrophy predisposes one to arrhythmia and sudden death.  Cytochrome P 450 (CYP)-derived epoxyeicosatrienoic acids (EETs) promote anti-inflammatory and antiapoptotic mechanisms, and are involved in the regulation of cardiac Ca2+-, K+- and Na+-channels.  To test the hypothesis that enhanced cardiac EET biosynthesis counteracts hypertrophy-induced elec. remodeling, male transgenic mice with cardiomyocyte-specific overexpression of the human epoxygenase CYP2J2 (CYP2J2-TG) and wildtype littermates (WT) were subjected to chronic pressure overload (transverse aortic constriction, TAC) or β-adrenergic stimulation (isoproterenol infusion, ISO).  TAC caused progressive mortality that was higher in WT (42% over 8 wk after TAC), compared to CYP2J2-TG mice (6%).  In vivo electrophysiol. studies, 4 wk after TAC, revealed high ventricular tachyarrhythmia inducibility in WT (47% of the stimulation protocols), but not in CYP2J2-TG mice (0%).  CYP2J2 overexpression also enhanced ventricular refractoriness and protected against TAC-induced QRS prolongation and delocalization of left ventricular connexin-43.  ISO for 14 days induced high vulnerability for atrial fibrillation in WT mice (54%) that was reduced in CYP-TG mice (17%).  CYP2J2 overexpression also protected against ISO-induced redn. of atrial refractoriness and development of atrial fibrosis.  In contrast to these profound effects on elec. remodeling, CYP2J2 overexpression only moderately reduced TAC-induced cardiac hypertrophy and did not affect the hypertrophic response to β-adrenergic stimulation.  These results demonstrate that enhanced cardiac EET biosynthesis protects against elec. remodeling, ventricular tachyarrhythmia, and atrial fibrillation susceptibility during maladaptive cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKgdkbfAMwrVg90H21EOLACvtfcHk0ljv6PbgLD99fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLbP&md5=6b548c2ad340e860ca9f997897a3347e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073490%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DSpallek%26aufirst%3DB.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DMarko%26aufirst%3DL.%26aulast%3DQadri%26aufirst%3DF.%26aulast%3DDeGraff%26aufirst%3DL.%2BM.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DRegitz-Zagrosek%26aufirst%3DV.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DCYP2J2%2520Overexpression%2520Protects%2520Against%2520Arrhythmia%2520Susceptibility%2520in%2520Cardiac%2520Hypertrophy%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. A.</span></span> <span> </span><span class="NLM_article-title">Urinary Excretion of Diols Derived from Eicosapentaenoic Acid During N-3 Fatty Acid Ingestion by Man</span>. <i>Prostaglandins</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/0090-6980(91)90093-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2F0090-6980%2891%2990093-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1771239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK3MXkslSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1991&pages=47-54&author=H.+R.+Knappauthor=A.+J.+Millerauthor=J.+A.+Lawson&title=Urinary+Excretion+of+Diols+Derived+from+Eicosapentaenoic+Acid+During+N-3+Fatty+Acid+Ingestion+by+Man&doi=10.1016%2F0090-6980%2891%2990093-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man</span></div><div class="casAuthors">Knapp, H. R.; Miller, A. J.; Lawson, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">PRGLBA</span>;
        ISSN:<span class="NLM_cas:issn">0090-6980</span>.
    </div><div class="casAbstract">Utilizing gas chromatog./neg. chem. ionization mass spectrometry, it was found that humans ingesting n-3 fatty acids (eicosapentaenoic acid) excrete vicinal diols of eicosapentaenoic acid in substantial quantities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYl2cD42WCNbVg90H21EOLACvtfcHk0ljv6PbgLD99fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslSgsrs%253D&md5=a2dc62bfbd359c5a1431414d43ec377f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0090-6980%2891%2990093-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0090-6980%252891%252990093-U%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DH.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26atitle%3DUrinary%2520Excretion%2520of%2520Diols%2520Derived%2520from%2520Eicosapentaenoic%2520Acid%2520During%2520N-3%2520Fatty%2520Acid%2520Ingestion%2520by%2520Man%26jtitle%3DProstaglandins%26date%3D1991%26volume%3D42%26spage%3D47%26epage%3D54%26doi%3D10.1016%2F0090-6980%2891%2990093-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span> <span> </span><span class="NLM_article-title">Detection of Omega-3 Oxylipins in Human Plasma and Response to Treatment with Omega-3 Acid Ethyl Esters</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2074</span>– <span class="NLM_lpage">2081</span>, <span class="refDoi"> DOI: 10.1194/jlr.M900193-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M900193-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=19671931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2074-2081&author=G.+C.+Shearerauthor=W.+S.+Harrisauthor=T.+L.+Pedersenauthor=J.+W.+Newman&title=Detection+of+Omega-3+Oxylipins+in+Human+Plasma+and+Response+to+Treatment+with+Omega-3+Acid+Ethyl+Esters&doi=10.1194%2Fjlr.M900193-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters</span></div><div class="casAuthors">Shearer, Gregory C.; Harris, William S.; Pedersen, Theresa L.; Newman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2074-2081</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">The long-chain omega-3 fatty acids (n-3 FA) eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) have beneficial health effects, but the mol. mediators of these effects are not well characterized.  Oxygenated n-3 FAs (oxylipins) may be an important class of mediators.  Members of this chem. class include epoxides, alcs., diols, and ketones, many of which have bioactivity in vitro.  Neither the presence of n-3 oxylipins in human plasma nor the effect of n-3 FA ingestion on their levels has been documented.  We measured plasma oxylipins derived from both the n-3 and n-6 FA classes in healthy volunteers (n = 10) before and after 4 wk of treatment with prescription n-3 FA Et esters (4 g/day).  At baseline, EPA and DHA oxylipins were detected in low (1-50 nM) range, with alcs. > epoxides ≥ diols.  Treatment increased n-3 oxylipin levels 2- to 5-fold and reduced selected n-6 oxylipins by ∼20%.  This is the first documentation that endogenous n-3 oxylipin levels can be modulated by n-3 FA treatment in humans.  The extent to which the beneficial cardiovascular effects of n-3 FAs are mediated by increased n-3 and/or reduced n-6 oxylipin levels remains to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZanjDqRKVB7Vg90H21EOLACvtfcHk0ljv6PbgLD99fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOlurs%253D&md5=904590c4ca718c863dd1286995584d4f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M900193-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M900193-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DShearer%26aufirst%3DG.%2BC.%26aulast%3DHarris%26aufirst%3DW.%2BS.%26aulast%3DPedersen%26aufirst%3DT.%2BL.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26atitle%3DDetection%2520of%2520Omega-3%2520Oxylipins%2520in%2520Human%2520Plasma%2520and%2520Response%2520to%2520Treatment%2520with%2520Omega-3%2520Acid%2520Ethyl%2520Esters%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2010%26volume%3D51%26spage%3D2074%26epage%3D2081%26doi%3D10.1194%2Fjlr.M900193-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blossey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gapelyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Schacky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weylandt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Dietary Omega-3 Fatty Acids Modulate the Eicosanoid Profile in Man Primarily via the CYP-Epoxygenase Pathway</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1194/jlr.M047357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M047357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24634501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1entr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1150-1164&author=R.+Fischerauthor=A.+Konkelauthor=H.+Mehlingauthor=K.+Blosseyauthor=A.+Gapelyukauthor=N.+Wesselauthor=C.+von+Schackyauthor=R.+Dechendauthor=D.+N.+Mullerauthor=M.+Rotheauthor=F.+C.+Luftauthor=K.+Weylandtauthor=W.-H.+Schunck&title=Dietary+Omega-3+Fatty+Acids+Modulate+the+Eicosanoid+Profile+in+Man+Primarily+via+the+CYP-Epoxygenase+Pathway&doi=10.1194%2Fjlr.M047357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway</span></div><div class="casAuthors">Fischer, Robert; Konkel, Anne; Mehling, Heidrun; Blossey, Katrin; Gapelyuk, Andrej; Wessel, Niels; von Schacky, Clemens; Dechend, Ralf; Muller, Dominik N.; Rothe, Michael; Luft, Friedrich C.; Weylandt, Karsten; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1150-1164</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP)-dependent metabolites of arachidonic acid (AA) contribute to the regulation of cardiovascular function.  CYP enzymes also accept EPA and DHA to yield more potent vasodilatory and potentially anti-arrhythmic metabolites, suggesting that the endogenous CYP-eicosanoid profile can be favorably shifted by dietary omega-3 fatty acids.  To test this hypothesis, 20 healthy volunteers were treated with an EPA/DHA supplement and analyzed for concomitant changes in the circulatory and urinary levels of AA-, EPA-, and DHA-derived metabolites produced by the cyclooxygenase-, lipoxygenase (LOX)-, and CYP-dependent pathways.  Raising the Omega-3 Index from about four to eight primarily resulted in a large increase of EPA-derived CYP-dependent epoxy-metabolites followed by increases of EPA- and DHA-derived LOX-dependent monohydroxy-metabolites including the precursors of the resolvin E and D families; resolvins themselves were not detected.  The metabolite/precursor fatty acid ratios indicated that CYP epoxygenases metabolized EPA with an 8.6-fold higher efficiency and DHA with a 2.2-fold higher efficiency than AA.  Effects on leukotriene, prostaglandin E, prostacyclin, and thromboxane formation remained rather weak.  We propose that CYP-dependent epoxy-metabolites of EPA and DHA may function as mediators of the vasodilatory and cardioprotective effects of omega-3 fatty acids and could serve as biomarkers in clin. studies investigating the cardiovascular effects of EPA/DHA supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OGaWewI_M7Vg90H21EOLACvtfcHk0licssgyuEN-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1entr0%253D&md5=ae098dedbcb2583468819a93ff3a54ef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M047357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M047357%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DMehling%26aufirst%3DH.%26aulast%3DBlossey%26aufirst%3DK.%26aulast%3DGapelyuk%26aufirst%3DA.%26aulast%3DWessel%26aufirst%3DN.%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DWeylandt%26aufirst%3DK.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DDietary%2520Omega-3%2520Fatty%2520Acids%2520Modulate%2520the%2520Eicosanoid%2520Profile%2520in%2520Man%2520Primarily%2520via%2520the%2520CYP-Epoxygenase%2520Pathway%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1150%26epage%3D1164%26doi%3D10.1194%2Fjlr.M047357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">ω-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Angiogenesis, Inflammation and Cancer</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113–115</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.prostaglandins.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113%E2%80%93115&publication_year=2014&pages=13-20&author=W.+Wangauthor=J.+Zhuauthor=F.+Lyuauthor=D.+Panigrahyauthor=K.+W.+Ferraraauthor=B.+Hammockauthor=G.+Zhang&title=%CF%89-3+Polyunsaturated+Fatty+Acids-Derived+Lipid+Metabolites+on+Angiogenesis%2C+Inflammation+and+Cancer&doi=10.1016%2Fj.prostaglandins.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer</span></div><div class="casAuthors">Wang, Weicang; Zhu, Julia; Lyu, Fei; Panigrahy, Dipak; Ferrara, Katherine W.; Hammock, Bruce; Zhang, Guodong</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113-115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Epidemiol. and pre-clin. studies support the anti-tumor effects of ω-3 PUFAs; however, the results from human trials are mixed, making it difficult to provide dietary guidelines or recommendations of ω-3 PUFAs for disease prevention or treatment.  Understanding the mol. mechanisms by which ω-3 PUFAs inhibit cancer could lead to better nutritional paradigms and human trials to clarify their health effects.  The ω-3 PUFAs exert their biol. activities mainly through the formation of bioactive lipid metabolites.  Here we discuss the biol. of cyclooxygenase, lipoxygenase and cytochrome P 450 enzymes-derived ω-3-series lipid metabolites on angiogenesis, inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptNk-fcb-1zLVg90H21EOLACvtfcHk0licssgyuEN-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSqt7jE&md5=24bef3cb944a6f0eea6aa4b370f6dd30</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLyu%26aufirst%3DF.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3D%25CF%2589-3%2520Polyunsaturated%2520Fatty%2520Acids-Derived%2520Lipid%2520Metabolites%2520on%2520Angiogenesis%252C%2520Inflammation%2520and%2520Cancer%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2014%26volume%3D113%25E2%2580%2593115%26spage%3D13%26epage%3D20%26doi%3D10.1016%2Fj.prostaglandins.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">17(<i>R</i>),18(<i>S</i>)-Epoxyeicosatetraenoic Acid, a Potent Eicosapentaenoic Acid (EPA) Derived Regulator of Cardiomyocyte Contraction: Structure-Activity Relationships and Stable Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4109</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1021/jm200132q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200132q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4109-4118&author=J.+R.+Falckauthor=G.+Wallukatauthor=N.+Puliauthor=M.+Goliauthor=C.+Arnoldauthor=A.+Konkelauthor=M.+Rotheauthor=R.+Fischerauthor=D.+N.+M%C3%BCllerauthor=W.-H.+Schunck&title=17%28R%29%2C18%28S%29-Epoxyeicosatetraenoic+Acid%2C+a+Potent+Eicosapentaenoic+Acid+%28EPA%29+Derived+Regulator+of+Cardiomyocyte+Contraction%3A+Structure-Activity+Relationships+and+Stable+Analogues&doi=10.1021%2Fjm200132q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">17(R),18(S)-Epoxyeicosatetraenoic Acid, a Potent Eicosapentaenoic Acid (EPA) Derived Regulator of Cardiomyocyte Contraction: Structure-Activity Relationships and Stable Analogues</span></div><div class="casAuthors">Falck, John R.; Wallukat, Gerd; Puli, Narender; Goli, Mohan; Arnold, Cosima; Konkel, Anne; Rothe, Michael; Fischer, Robert; Muller, Dominik N.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4109-4118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">17(R),18(S)-Epoxyeicosatetraenoic acid [17(R),18(S)-EETeTr], a cytochrome P 450 epoxygenase metabolite of eicosapentaenoic acid (EPA), exerts neg. chronotropic effects and protects neonatal rat cardiomyocytes against Ca2+-overload with EC50 ≈ 1-2 nM.  Structure-activity studies revealed that a cis-Δ11,12- or Δ14,15-olefin and a 17(R),18(S)-epoxide are minimal structural elements for antiarrhythmic activity whereas antagonist activity was often assocd. with the combination of a Δ14,15-olefin and a 17(S),18(R)-epoxide.  Compared with natural material, the agonist and antagonist analogs are chem. and metabolically more robust and several show promise as templates for future development of clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7lHjKyC-4rVg90H21EOLACvtfcHk0lh6yyivS95t3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChs7o%253D&md5=6a3c4a295b59353101c51f14daa093e5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200132q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200132q%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DPuli%26aufirst%3DN.%26aulast%3DGoli%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3D17%2528R%2529%252C18%2528S%2529-Epoxyeicosatetraenoic%2520Acid%252C%2520a%2520Potent%2520Eicosapentaenoic%2520Acid%2520%2528EPA%2529%2520Derived%2520Regulator%2520of%2520Cardiomyocyte%2520Contraction%253A%2520Structure-Activity%2520Relationships%2520and%2520Stable%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4109%26epage%3D4118%26doi%3D10.1021%2Fjm200132q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondlela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">11,12-Epoxyeicosatrienoic Acid (11,12-EET): Structural Determinants for Inhibition of TNF-α-Induced VCAM-1 Expression</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmcl.2003.08.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=14592496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4011-4014&author=J.+R.+Falckauthor=L.+M.+Reddyauthor=Y.+K.+Reddyauthor=M.+Bondlelaauthor=U.+M.+Krishnaauthor=Y.+Jiauthor=J.+Sunauthor=J.+K.+Liao&title=11%2C12-Epoxyeicosatrienoic+Acid+%2811%2C12-EET%29%3A+Structural+Determinants+for+Inhibition+of+TNF-%CE%B1-Induced+VCAM-1+Expression&doi=10.1016%2Fj.bmcl.2003.08.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">11,12-Epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-α-Induced VCAM-1 expression</span></div><div class="casAuthors">Falck, J. R.; Reddy, L. Manmohan; Reddy, Y. Krishna; Bondlela, Muralidhar; Krishna, U. Murali; Ji, Yu; Sun, Jianxin; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4011-4014</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of 11,12-EET analogs (e.g. I) were synthesized and compared using a human endothelial cell based TNF-α-induced VCAM-1 expression assay.  The resulting data were used to map a putative recognition/binding domain for 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7A5oYyhuPVLVg90H21EOLACvtfcHk0lh6yyivS95t3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVWrsLc%253D&md5=9b7638650afa22437074d4815a6c8afc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.060%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DReddy%26aufirst%3DL.%2BM.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DBondlela%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DU.%2BM.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3D11%252C12-Epoxyeicosatrienoic%2520Acid%2520%252811%252C12-EET%2529%253A%2520Structural%2520Determinants%2520for%2520Inhibition%2520of%2520TNF-%25CE%25B1-Induced%2520VCAM-1%2520Expression%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4011%26epage%3D4014%26doi%3D10.1016%2Fj.bmcl.2003.08.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atcha, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubasi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthati, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5069</span>– <span class="NLM_lpage">5075</span>, <span class="refDoi"> DOI: 10.1021/jm900634w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900634w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlGgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5069-5075&author=J.+R.+Falckauthor=R.+Kodelaauthor=R.+Manneauthor=K.+R.+Atchaauthor=N.+Puliauthor=N.+Dubasiauthor=V.+L.+Manthatiauthor=J.+H.+Capdevilaauthor=X.-Y.+Yiauthor=D.+H.+Goldmanauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=W.+B.+Campbell&title=14%2C15-Epoxyeicosa-5%2C8%2C11-trienoic+Acid+%2814%2C15-EET%29+Surrogates+Containing+Epoxide+Bioisosteres%3A+Influence+upon+Vascular+Relaxation+and+Soluble+Epoxide+Hydrolase+Inhibition&doi=10.1021%2Fjm900634w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition</span></div><div class="casAuthors">Falck, J. R.; Kodela, Ravinder; Manne, Rajkumar; Atcha, Krishnam Raju; Puli, Narender; Dubasi, Narsimhaswamy; Manthati, Vijay L.; Capdevila, Jorge H.; Yi, Xiu-Yu; Goldman, Daniel H.; Morisseau, Christophe; Hammock, Bruce D.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5069-5075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">All-cis-14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) is a labile, vasodilatory eicosanoid generated from arachidonic acid by cytochrome P 450 epoxygenases.  A series of robust, partially satd. analogs contg. epoxide bioisosteres were synthesized and evaluated for relaxation of precontracted bovine coronary artery rings and for in vitro inhibition of sol. epoxide hydrolase (sEH).  Depending upon the bioisostere and its position along the carbon chain, varying levels of vascular relaxation and/or sEH inhibition were obsd.  For example, oxamide I and N-iPr-amide II were comparable (ED50 1.7 μM) to 14,15-EET as vasorelaxants but were approx. 10-35 times less potent as sEH inhibitors (IC50 59 and 19 μM, resp.); unsubstituted urea III showed useful activity in both assays (ED50 3.5 μM, IC50 16 nM).  These data reveal differential structural parameters for the two pharmacophores that could assist the development of potent and specific in vivo drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxqh4zQjLsbVg90H21EOLACvtfcHk0lh6yyivS95t3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlGgurc%253D&md5=0204001138e8b6ee2298d9278bbef75b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900634w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900634w%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DManne%26aufirst%3DR.%26aulast%3DAtcha%26aufirst%3DK.%2BR.%26aulast%3DPuli%26aufirst%3DN.%26aulast%3DDubasi%26aufirst%3DN.%26aulast%3DManthati%26aufirst%3DV.%2BL.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DYi%26aufirst%3DX.-Y.%26aulast%3DGoldman%26aufirst%3DD.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D14%252C15-Epoxyeicosa-5%252C8%252C11-trienoic%2520Acid%2520%252814%252C15-EET%2529%2520Surrogates%2520Containing%2520Epoxide%2520Bioisosteres%253A%2520Influence%2520upon%2520Vascular%2520Relaxation%2520and%2520Soluble%2520Epoxide%2520Hydrolase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5069%26epage%3D5075%26doi%3D10.1021%2Fjm900634w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 Enzymes in the Bioactivation of Polyunsaturated Fatty Acids and Their Role in Cardiovascular Disease</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>851</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-16009-2_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2F978-3-319-16009-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26002735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslGht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=851&publication_year=2015&pages=151-187&author=C.+Westphalauthor=A.+Konkelauthor=W.-H.+Schunck&title=Cytochrome+P450+Enzymes+in+the+Bioactivation+of+Polyunsaturated+Fatty+Acids+and+Their+Role+in+Cardiovascular+Disease&doi=10.1007%2F978-3-319-16009-2_6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids and their role in cardiovascular disease</span></div><div class="casAuthors">Westphal, Christina; Konkel, Anne; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">851</span>
        (<span class="NLM_cas:issue">Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450</span>),
    <span class="NLM_cas:pages">151-187</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Various members of the cytochrome P 450 (CYP) superfamily have the capacity of metabolizing omega-6 and omega-3 polyunsatd. fatty acids (n-6 and n-3 PUFAs).  In most mammalian tissues, CYP2C and CYP2J enzymes are the major PUFA epoxygenases, whereas CYP4A and CYP4F subfamily members function as PUFA hydroxylases.  The individual CYP enzymes differ in their substrate specificities as well as regio- and stereoselectivities and thus produce distinct sets of epoxy and/or hydroxy metabolites, collectively termed CYP eicosanoids.  Nutrition has a major impact on the endogenous CYP-eicosanoid profile. "Western diets" rich in n-6 PUFAs result in a predominance of arachidonic acid-derived metabolites, whereas marine foodstuffs rich in n-3 PUFAs shift the profile to eicosapentaenoic and docosahexaenoic acid-derived metabolites.  In general, CYP eicosanoids are formed as second messengers of numerous hormones, growth factors and cytokines regulating cardiovascular and renal function, and a variety of other physiol. processes.  Imbalances in the formation of individual CYP eicosanoids are linked to the development of hypertension, myocardial infarction, maladaptive cardiac hypertrophy, acute kidney injury, stroke and inflammatory disorders.  The underlying mechanisms are increasingly understood and may provide novel targets for the prevention and treatment of these disease states.  Suitable pharmacol. agents are underdevelopment and first proofs of concept have been obtained in animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFGHW3BxTN17Vg90H21EOLACvtfcHk0lhb7i-Jo3zCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslGht7c%253D&md5=e86595302c413b11cffb857f2342b7d8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-16009-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-16009-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DCytochrome%2520P450%2520Enzymes%2520in%2520the%2520Bioactivation%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Their%2520Role%2520in%2520Cardiovascular%2520Disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2015%26volume%3D851%26spage%3D151%26epage%3D187%26doi%3D10.1007%2F978-3-319-16009-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chechetkin, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grechkin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de León, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castresana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannenberg, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-Oxalinolenic Acid and β-Oxidation-Resistant 3-Oxa-Oxylipins</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1007/s11745-006-5123-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2Fs11745-006-5123-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16933794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1WmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=499-506&author=M.+Hambergauthor=I.+R.+Chechetkinauthor=A.+N.+Grechkinauthor=I.+P.+de+Le%C3%B3nauthor=C.+Castresanaauthor=G.+Bannenberg&title=Synthesis+of+3-Oxalinolenic+Acid+and+%CE%B2-Oxidation-Resistant+3-Oxa-Oxylipins&doi=10.1007%2Fs11745-006-5123-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-oxalinolenic acid and β-oxidation-resistant 3-oxa-oxylipins</span></div><div class="casAuthors">Hamberg, Mats; Chechetkin, Ivan R.; Grechkin, Alexander N.; Ponce de Leon, Ines; Castresana, Carmen; Bannenberg, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">499-506</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">AOCS Press</span>)
        </div><div class="casAbstract">3-Oxalinolenic acid (3-oxa-9(Z),12(Z),15(Z)-octadecatrienoic acid or (6(Z),9(Z),12(Z)-pentadecatrienyloxy)acetic acid) was synthesized from 5(Z),8(Z),11(Z),14(Z),17(Z)-eicosapentaenoic acid by a sequence involving the C15 aldehyde 3(Z),6(Z),9(Z),12(Z)-pentadecatetraenal as a key intermediate.  Conversion of the aldehyde by isomerization and two steps of redn. afforded 6(Z),9(Z),12(Z)-pentadecatrienol, which was coupled to bromoacetate to afford after purifn. by HPLC >99%-pure 3-oxalinolenic acid in 10-15% overall yield.  3-Oxalinolenic acid was efficiently oxygenated by soybean lipoxygenase-1 into 3-oxa-13(S)-hydroperoxy-9(Z),11(E),15(Z)-octadecatrienoic acid, and this hydroperoxide could be further converted chem. into 3-oxa-13(S)-hydroxy-9(Z),11(E),15(Z)-octadecatrienoic acid and 3-oxa-13-oxo-9(Z),11(E),15(Z)-octadecatrienoic acid.  The 3-oxa-hydroperoxide also served as the substrate for the plant enzymes allene oxide synthase, divinyl ether synthase, and hydroperoxide lyase to produce 3-oxa-12-oxo-10,15(Z)-phytodienoic acid and other 3-oxa-oxylipins that were characterized by MS.  3-Oxalinolenic acid was not oxygenated by 9-lipoxygenase from tomato but was converted at a slow rate into 3-oxa-9(S)-hydroperoxy-10(E),12(Z),15(Z)-octadecatrienoic acid by recombinant maize 9-lipoxygenase.  Recombinant α-dioxygenase-1 from Arabidopsis thaliana catalyzed the conversion of 3-oxalinolenic acid into a 2-hydroperoxide, which underwent spontaneous degrdn. into a mixt. of 6,9,12-pentadecatrienol and 6,9,12-pentadecatrienyl formate.  A novel α-dioxygenase from the moss Physcomitrella patens was cloned and expressed and was found to display the same activity with 3-oxalinolenic acid as Arabidopsis thaliana α-dioxygenase-1.  Lipoxygenase-generated 3-oxa-oxylipins are resistant toward β-oxidn. and have the potential for displaying enhanced biol. activity in situations where activity is limited by metabolic degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpiZ14vmWuAbVg90H21EOLACvtfcHk0lhb7i-Jo3zCHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1WmsA%253D%253D&md5=d0639a5b98389f1ce55029ea2f70fb4a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11745-006-5123-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11745-006-5123-5%26sid%3Dliteratum%253Aachs%26aulast%3DHamberg%26aufirst%3DM.%26aulast%3DChechetkin%26aufirst%3DI.%2BR.%26aulast%3DGrechkin%26aufirst%3DA.%2BN.%26aulast%3Dde%2BLe%25C3%25B3n%26aufirst%3DI.%2BP.%26aulast%3DCastresana%26aufirst%3DC.%26aulast%3DBannenberg%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25203-Oxalinolenic%2520Acid%2520and%2520%25CE%25B2-Oxidation-Resistant%25203-Oxa-Oxylipins%26jtitle%3DLipids%26date%3D2006%26volume%3D41%26spage%3D499%26epage%3D506%26doi%3D10.1007%2Fs11745-006-5123-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skuballa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkelsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schottelius, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J. F.</span></span> <span> </span><span class="NLM_article-title">Novel 3-Oxa Lipoxin A<sub>4</sub>Analogues with Enhanced Chemical and Metabolic Stability have Anti-Inflammatory Activity in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2165</span>, <span class="refDoi"> DOI: 10.1021/jm030569l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030569l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFKnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2157-2165&author=W.+J.+Guilfordauthor=J.+G.+Baumanauthor=W.+Skuballaauthor=S.+Bauerauthor=G.+P.+Weiauthor=D.+Daveyauthor=C.+Schaeferauthor=C.+Mallariauthor=J.+Terkelsenauthor=J.-L.+Tsengauthor=J.+Shenauthor=B.+Subramanyamauthor=A.+J.+Schotteliusauthor=J.+F.+Parkinson&title=Novel+3-Oxa+Lipoxin+A4Analogues+with+Enhanced+Chemical+and+Metabolic+Stability+have+Anti-Inflammatory+Activity+in+Vivo&doi=10.1021%2Fjm030569l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo</span></div><div class="casAuthors">Guilford, William J.; Bauman, John G.; Skuballa, Werner; Bauer, Shawn; Wei, Guo Ping; Davey, David; Schaefer, Caralee; Mallari, Cornell; Terkelsen, Jennifer; Tseng, Jih-Lie; Shen, Jun; Subramanyam, Babu; Schottelius, Arndt J.; Parkinson, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2157-2165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoxin A4 (LXA4) is a structurally and functionally distinct natural product called an eicosanoid, which displays immunomodulatory and anti-inflammatory activity but is rapidly metabolized to inactive catabolites in vivo.  A previously described analog of LXA4, Me 16-(4-fluorophenoxy)-5,6,15-trihydroxy-7,9,11,13-hexadecatetraenoate (2, ATLa), was shown to have a poor pharmacokinetic profile after both oral and i.v. administration, as well as sensitivity to acid and light.  The chem. stability of the corresponding E,E,E-trien-11-yne analog, 3, was improved over 2 without loss of efficacy in the mouse air pouch model of inflammation.  Careful anal. of the plasma samples from the pharmacokinetic assays for both 2 and 3 identified a previously undetected metabolite, which is consistent with metab. by β-oxidn.  The formation of the oxidative metabolites was eliminated with the corresponding 3-oxatetraene, 4, and the 3-oxatrien-11-yne, 5, analogs of 2.  Evaluation of 3-oxa analogs 4 and 5 in calcium ionophore-induced acute skin inflammation model demonstrated similar topical potency and efficacy compared to 2.  The 3-oxatrien-11-yne analog, 5, is equipotent to 2 in an animal model of inflammation but has enhanced metabolic and chem. stability and a greatly improved pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNo1Ql1Puz7Vg90H21EOLACvtfcHk0lhKDG74kA3UMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFKnurs%253D&md5=b2e9a2c1bd828974c02efdc801ef23f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm030569l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030569l%26sid%3Dliteratum%253Aachs%26aulast%3DGuilford%26aufirst%3DW.%2BJ.%26aulast%3DBauman%26aufirst%3DJ.%2BG.%26aulast%3DSkuballa%26aufirst%3DW.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DG.%2BP.%26aulast%3DDavey%26aufirst%3DD.%26aulast%3DSchaefer%26aufirst%3DC.%26aulast%3DMallari%26aufirst%3DC.%26aulast%3DTerkelsen%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.-L.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DSchottelius%26aufirst%3DA.%2BJ.%26aulast%3DParkinson%26aufirst%3DJ.%2BF.%26atitle%3DNovel%25203-Oxa%2520Lipoxin%2520A4Analogues%2520with%2520Enhanced%2520Chemical%2520and%2520Metabolic%2520Stability%2520have%2520Anti-Inflammatory%2520Activity%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2157%26epage%3D2165%26doi%3D10.1021%2Fjm030569l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hørvik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, H. I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, J.</span></span> <span> </span><span class="NLM_article-title">Polyunsaturated Thia- and Oxa-Fatty Acids: Incorporation into Cell-Lipids and Their Effects on Arachidonic Acid and Eicosanoid Synthesis</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1348</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(97)00075-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0005-2760%2897%2900075-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=9366251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFKgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1348&publication_year=1997&pages=346-354&author=L.+N.+Larsenauthor=K.+H%C3%B8rvikauthor=H.+I.+N.+S%C3%B8rensenauthor=J.+Bremer&title=Polyunsaturated+Thia-+and+Oxa-Fatty+Acids%3A+Incorporation+into+Cell-Lipids+and+Their+Effects+on+Arachidonic+Acid+and+Eicosanoid+Synthesis&doi=10.1016%2FS0005-2760%2897%2900075-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Polyunsaturated thia- and oxa-fatty acids: incorporation into cell-lipids and their effects on arachidonic acid- and eicosanoid synthesis</span></div><div class="casAuthors">Larsen, L. N.; Horvik, K.; Sorensen, H. I. N.; Bremer, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-354</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">EPA, DHA, C15SCH2COOH (n-3), C15SCH2COOH (n-6) and C18SCH2COOH (n-3) are extensively incorporated into phospholipids and triacylglycerol in rat hepatocytes after 24 h incubation with 80 μM fatty acid/deriv.  Only traces of polyunsatd. 3-oxa fatty acids (C15OCH2COOH, C18OCH2COOH) were incorporated.  C15-S-butyric acid (n-3) is a stronger inhibitor of Δ6-desaturase in rat liver-microsomes than C15SCH2COOH (n-3), C15-S-propionic acid (n-3), EPA and DHA.  It inhibits Δ5-desaturase in a similar manner to EPA and DHA.  Arachidonic acid and C15SCH2COOH, (n-6) are better substrates for PGH-synthase than EPA and C15SCH2COOH, (n-3), showing the inhibitory effect of the n-3 bond.  The n-3 polyunsatd. fatty acids, including the sulfur-substituted fatty acid derivs., are poor substrates for PGH-synthase.  However, they inactivate the PGH-synthase activity at least as efficiently as arachidonic acid.  C15SCH2COOH (n-3), C15S(CH2)2COOH (n-3) and C18SCH2COOH (n-3) induce peroxisomal β-oxidn. more than EPA and DHA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCTYV6_eNqB7Vg90H21EOLACvtfcHk0lhKDG74kA3UMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFKgsrs%253D&md5=3331942ec6740cf172a3616a5a5f9ad1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2897%2900075-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252897%252900075-1%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DL.%2BN.%26aulast%3DH%25C3%25B8rvik%26aufirst%3DK.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DH.%2BI.%2BN.%26aulast%3DBremer%26aufirst%3DJ.%26atitle%3DPolyunsaturated%2520Thia-%2520and%2520Oxa-Fatty%2520Acids%253A%2520Incorporation%2520into%2520Cell-Lipids%2520and%2520Their%2520Effects%2520on%2520Arachidonic%2520Acid%2520and%2520Eicosanoid%2520Synthesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1997%26volume%3D1348%26spage%3D346%26epage%3D354%26doi%3D10.1016%2FS0005-2760%2897%2900075-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphates and Phosphonates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm701260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2328-2345&author=S.+J.+Heckerauthor=M.+D.+Erion&title=Prodrugs+of+Phosphates+and+Phosphonates&doi=10.1021%2Fjm701260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of Phosphates and Phosphonates</span></div><div class="casAuthors">Hecker, Scott J.; Erion, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of prodrugs for phosph(on)ates has evolved considerably in the past decade.  There are now several approaches available to the researcher who finds that a phosphonate moiety achieves the right balance of properties in the lead series, yet needs a prodrug for oral delivery.  The overall best choice in this situation, taking into account stability, byproduct toxicity, avoidance of stereoisomers, and validation in humans, appears to be the diamide class.  Given its relatively recent appearance, there are few examples to date, but it is expected that phosphonic diamides will play an increasingly important role as phosphonate prodrugs going forward.  For drugs given at low to moderate doses, where risks assocd. with the byproduct formaldehyde are low, acyloxyalkyl prodrugs will continue to find application.  If selective targeting to the liver is desired, HepDirect prodrugs are the clear choice, whereas aryl amidates (and possibly diamides) offer the potential for targeting to lymphatic tissue.  The increasing availability of prodrug options should encourage the practicing medicinal chemist to explore phosphonic acids in the course of lead development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrooUagDflp3rVg90H21EOLACvtfcHk0lhKDG74kA3UMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D&md5=62699075f111d09d2ba3f19f089cb7c2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701260b%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DProdrugs%2520of%2520Phosphates%2520and%2520Phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2328%26epage%3D2345%26doi%3D10.1021%2Fjm701260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhKDG74kA3UMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkhanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojodjojo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. C.</span></span> <span> </span><span class="NLM_article-title">Multiple Modes of Inhibition of Human Cytochrome P450 2J2 by Dronedarone, Amiodarone and their Active Metabolites</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bcp.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26972388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=67-80&author=A.+Karkhanisauthor=H.+Y.+Lamauthor=G.+Venkatesanauthor=S.+K.+Kohauthor=C.+L.+Chaiauthor=L.+Zhouauthor=Y.+Hongauthor=P.+Kojodjojoauthor=E.+C.+Chan&title=Multiple+Modes+of+Inhibition+of+Human+Cytochrome+P450+2J2+by+Dronedarone%2C+Amiodarone+and+their+Active+Metabolites&doi=10.1016%2Fj.bcp.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites</span></div><div class="casAuthors">Karkhanis, Aneesh; Lam, Hui Yuan; Venkatesan, Gopalakrishnan; Koh, Siew Kwan; Chai, Christina Li Lin; Zhou, Lei; Hong, Yanjun; Kojodjojo, Pipin; Chan, Eric Chun Yong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dronedarone, a multiple ion channel blocker is prescribed for the treatment of paroxysmal and persistent atrial fibrillation.  While dronedarone does not ppt. toxicities like its predecessor amiodarone, its clin. use has been assocd. with idiosyncratic hepatic and cardiac adverse effects and drug-drug interactions (DDIs).  As dronedarone is a potent mechanism-based inactivator of CYP3A4 and CYP3A5, a question arose if it exerts a similar inhibitory effect on CYP2J2, a prominent cardiac CYP 450 enzyme.  In this study, the authors demonstrated that CYP2J2 is reversibly inhibited by dronedarone (Ki = 0.034 μM), amiodarone (Ki = 4.8 μM) and their resp. pharmacol. active metabolites namely N-desbutyldronedarone (NDBD) (Ki = 0.55 μM) and N-desethylamiodarone (NDEA) (Ki = 7.4 μM).  Moreover, time-, concn.- and NADPH-dependent irreversible inactivation of CYP2J2 was investigated where inactivation kinetic parameters (KI, kinact) and partition ratio (r) of dronedarone (0.05 μM, 0.034 min-1, 3.3), amiodarone (0.21 μM, 0.015 min-1, 20.7) and NDBD (0.48 μM, 0.024 min-1, 21.7) were obsd. except for NDEA.  The absence of the characteristic Soret peak, lack of recovery of CYP2J2 activity upon dialysis, and biotransformation of dronedarone and NDBD to quinone-oxime reactive metabolites further confirmed the irreversible inactivation of CYP2J2 by dronedarone and NDBD is via the covalent adduction of CYP2J2.  The authors' novel findings illuminate the possible mechanisms of DDIs and cardiac adverse effects due to both reversible inhibition and irreversible inactivation of CYP2J2 by dronedarone, amiodarone and their active metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5EqJHXycRBLVg90H21EOLACvtfcHk0li0f9LDlBlAyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgtb4%253D&md5=19d7d62ac7c1671bbe1bf4505d99cda8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DKarkhanis%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%2BY.%26aulast%3DVenkatesan%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DS.%2BK.%26aulast%3DChai%26aufirst%3DC.%2BL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DKojodjojo%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%2BC.%26atitle%3DMultiple%2520Modes%2520of%2520Inhibition%2520of%2520Human%2520Cytochrome%2520P450%25202J2%2520by%2520Dronedarone%252C%2520Amiodarone%2520and%2520their%2520Active%2520Metabolites%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D107%26spage%3D67%26epage%3D80%26doi%3D10.1016%2Fj.bcp.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkhanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. C. Y.</span></span> <span> </span><span class="NLM_article-title">Dronedarone-Induced Cardiac Mitochondrial Dysfunction and Its Mitigation by Epoxyeicosatrienoic Acids</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfy011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1093%2Ftoxsci%2Fkfy011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=29385569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGlu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2018&pages=79-91&author=A.+Karkhanisauthor=J.+W.+H.+Leowauthor=T.+Hagenauthor=E.+C.+Y.+Chan&title=Dronedarone-Induced+Cardiac+Mitochondrial+Dysfunction+and+Its+Mitigation+by+Epoxyeicosatrienoic+Acids&doi=10.1093%2Ftoxsci%2Fkfy011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dronedarone-induced cardiac mitochondrial dysfunction and its mitigation by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Karkhanis, Aneesh; Leow, Jacqueline Wen Hui; Hagen, Thilo; Chan, Eric Chun Yong</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-91</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dronedarone and amiodarone are structurally similar antiarrhythmic drugs.  Dronedarone worsens cardiac adverse effects with unknown causes while amiodarone has no cardiac adversity.  Dronedarone induces preclin. mitochondrial toxicity in rat liver and exhibits clin. hepatotoxicity.  Here, the authors further investigated the relative potential of the antiarrhythmic drugs in causing mitochondrial injury in cardiomyocytes.  Differentiated rat H9c2 cardiomyocytes were treated with dronedarone, amiodarone, and their resp. metabolites namely N-desbutyldronedarone (NDBD) and N-desethylamiodarone (NDEA).  Intracellular ATP content, mitochondrial membrane potential (Δ ψm), and inhibition of carnitine palmitoyltransferase I (CPT1) activity and arachidonic acid (AA) metab. were measured in H9c2 cells.  Inhibition of electron transport chain (ETC) activities and uncoupling of ETC were further studied in isolated rat heart mitochondria.  Dronedarone, amiodarone, NDBD and NDEA decreased intracellular ATP content significantly (IC50 = 0.49, 1.84, 1.07, and 0.63 μM, resp.) and dissipated Δ ψm potently (IC50 = 0.5, 2.94, 12.8, and 7.38 ψM, resp.).  Dronedarone, NDBD, and NDEA weakly inhibited CPT1 activity while amiodarone (IC50 >100 ψM) yielded negligible inhibition.  Only dronedarone inhibited AA metab. to its regioisomeric epoxyeicosatrienoic acids (EETs) consistently and potently.  NADH-supplemented ETC activity was inhibited by dronedarone, amiodarone, NDBD and NDEA (IC50 = 3.07, 5.24, 11.94, and 16.16 ψM, resp.).  Cytotoxicity, ATP decrease and Δ ψm disruption were ameliorated via exogenous pre-treatment of H9c2 cells with 11,12-EET and 14,15-EET.  The authors' study confirmed that dronedarone causes mitochondrial injury in cardiomyocytes by perturbing Δ ψm, inhibiting mitochondrial complex I, uncoupling ETC and dysregulating AA-EET metab.  The authors postulate that cardiac mitochondrial injury is one potential contributing factor to dronedarone-induced cardiac failure exacerbation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbotMD1WAckLVg90H21EOLACvtfcHk0li0f9LDlBlAyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGlu7zP&md5=525d8191d320b2865081f018c9db1687</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfy011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfy011%26sid%3Dliteratum%253Aachs%26aulast%3DKarkhanis%26aufirst%3DA.%26aulast%3DLeow%26aufirst%3DJ.%2BW.%2BH.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%2BC.%2BY.%26atitle%3DDronedarone-Induced%2520Cardiac%2520Mitochondrial%2520Dysfunction%2520and%2520Its%2520Mitigation%2520by%2520Epoxyeicosatrienoic%2520Acids%26jtitle%3DToxicol.%2520Sci.%26date%3D2018%26volume%3D163%26spage%3D79%26epage%3D91%26doi%3D10.1093%2Ftoxsci%2Fkfy011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">Chiral Lipidomics of Monoepoxy and Monohydroxy Metabolites Derived from Long-Chain Polyunsaturated Fatty Acids</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1194/jlr.M089755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M089755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=30409844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2isw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=135-148&author=M.+Blumauthor=I.+Doganauthor=M.+Karberauthor=M.+Rotheauthor=W.+H.+Schunck&title=Chiral+Lipidomics+of+Monoepoxy+and+Monohydroxy+Metabolites+Derived+from+Long-Chain+Polyunsaturated+Fatty+Acids&doi=10.1194%2Fjlr.M089755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral lipidomics of monoepoxy and monohydroxy metabolites derived from long-chain polyunsaturated fatty acids</span></div><div class="casAuthors">Blum, Maximilian; Dogan, Inci; Karber, Mirjam; Rothe, Michael; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-148</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A chiral lipidomics approach was established for comprehensive profiling of regio- and stereoisomeric monoepoxy and monohydroxy metabolites of long-chain PUFAs as generated enzymically by cytochromes P 450 (CYPs), lipoxygenases (LOXs), and cyclooxygenases (COXs) and, in part, also unspecific oxidns.  The method relies on reversed-phase chiral-LC coupled with ESI/MS/MS.  Applications revealed partially opposing enantioselectivities of sol. and microsomal epoxide hydrolases (mEHs).  Ablation of the sol. epoxide hydrolase (sEH) gene resulted in specific alterations in the enantiomeric compn. of endogenous monoepoxy metabolites.  For example, the (R,S)/(S,R)-ratio of circulating 14,15-EET changed from 2.1:1 in WT to 9.7:1 in the sEH-KO mice.  Studies with liver microsomes suggested that CYP/mEH interactions play a primary role in detg. the enantiomeric compn. of monoepoxy metabolites during their generation and release from the ER.  Anal. of human plasma showed significant enantiomeric excess with several monoepoxy metabolites.  Monohydroxy metabolites were generally present as racemates; however, Ca2+-ionophore stimulation of whole blood samples resulted in enantioselective increases of LOX-derived metabolites (12S-HETE and 17S-hydroxydocosahexaenoic acid) and COX-derived metabolites (11R-HETE).  Our chiral approach may provide novel opportunities for investigating the role of bioactive lipid mediators that generally exert their physiol. functions in a highly regio- and stereospecific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhoZP9ZYewbVg90H21EOLACvtfcHk0li0f9LDlBlAyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2isw%253D%253D&md5=635fda95a18393275fd4594a7af5629a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M089755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M089755%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DM.%26aulast%3DDogan%26aufirst%3DI.%26aulast%3DKarber%26aufirst%3DM.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DChiral%2520Lipidomics%2520of%2520Monoepoxy%2520and%2520Monohydroxy%2520Metabolites%2520Derived%2520from%2520Long-Chain%2520Polyunsaturated%2520Fatty%2520Acids%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2019%26volume%3D60%26spage%3D135%26epage%3D148%26doi%3D10.1194%2Fjlr.M089755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective Synthesis of (10<i>S</i>)- and (10<i>R</i>)-Methyl-Anandamides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6329</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.tet.2012.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=6329-6337&author=S.+P.+Nikasauthor=M.+D%E2%80%99Souzaauthor=A.+Makriyannis&title=Enantioselective+Synthesis+of+%2810S%29-+and+%2810R%29-Methyl-Anandamides&doi=10.1016%2Fj.tet.2012.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of (10S)- and (10R)-methyl-anandamides</span></div><div class="casAuthors">Nikas, Spyros P.; D'Souza, Marsha; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6329-6337</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">For the development of novel endocannabinoid templates with potential resistance to hydrolytic and oxidative metab., we are targeting the bis-allylic carbons of the arachidonoyl skeleton.  Toward this end, we recently disclosed the synthesis and preliminary biol. data for the (13S)-methyl-anandamide.  We report now the total synthesis of the (10S)- and (10R)-methyl-counterparts.  Our synthetic approach is stereospecific, efficient, and provides the analogs without the need for resoln.  Peptide coupling, P-2 nickel partial hydrogenation, and cis-selective Wittig olefination are the key steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqP9D7GXbeSbVg90H21EOLACvtfcHk0lhqki7EtnVvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWntr4%253D&md5=ff1b239139e231e168e6a7851453c5bc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520%252810S%2529-%2520and%2520%252810R%2529-Methyl-Anandamides%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D6329%26epage%3D6337%26doi%3D10.1016%2Fj.tet.2012.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grube, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kock, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Mass Spectrometric Analysis of Cyclostellettamines H, I, K and L</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200500208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fejoc.200500208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1285-1295&author=A.+Grubeauthor=C.+Timmauthor=M.+Kock&title=Synthesis+and+Mass+Spectrometric+Analysis+of+Cyclostellettamines+H%2C+I%2C+K+and+L&doi=10.1002%2Fejoc.200500208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200500208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200500208%26sid%3Dliteratum%253Aachs%26aulast%3DGrube%26aufirst%3DA.%26aulast%3DTimm%26aufirst%3DC.%26aulast%3DKock%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Mass%2520Spectrometric%2520Analysis%2520of%2520Cyclostellettamines%2520H%252C%2520I%252C%2520K%2520and%2520L%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2006%26volume%3D2006%26spage%3D1285%26epage%3D1295%26doi%3D10.1002%2Fejoc.200500208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yavari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayat, M.</span></span> <span> </span><span class="NLM_article-title">New Synthesis of Highly Functionalized 3-Pyrrolin-2-ones</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2527</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1081/SCC-120005935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1081%2FSCC-120005935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2rur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=2527-2534&author=I.+Yavariauthor=M.+Bayat&title=New+Synthesis+of+Highly+Functionalized+3-Pyrrolin-2-ones&doi=10.1081%2FSCC-120005935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New synthesis of highly functionalized 3-pyrrolin-2-ones</span></div><div class="casAuthors">Yavari, Issa; Bayat, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2527-2534</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Et N-aryl-(or N-alkyl)-oxamate undergo a smooth reaction with triphenylphosphine and di-Me acetylenedicarboxylate to produce di-Me N-aryl-(or N-alkyl)-3-ethoxy-3-pyrrolin-2-one-4,5-dicarboxylates in fairly high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0qOJ_mw2hWLVg90H21EOLACvtfcHk0lhqki7EtnVvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2rur8%253D&md5=54d0fdfa82a6cdc52567f48fb3aab216</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1081%2FSCC-120005935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-120005935%26sid%3Dliteratum%253Aachs%26aulast%3DYavari%26aufirst%3DI.%26aulast%3DBayat%26aufirst%3DM.%26atitle%3DNew%2520Synthesis%2520of%2520Highly%2520Functionalized%25203-Pyrrolin-2-ones%26jtitle%3DSynth.%2520Commun.%26date%3D2002%26volume%3D32%26spage%3D2527%26epage%3D2534%26doi%3D10.1081%2FSCC-120005935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, R.</span></span> <span> </span><span class="NLM_article-title">Tertiary Phosphane/Tetrachloromethane, a Versatile Reagent for Chlorination, Dehydration, and P-N Linkage</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1002/anie.197508011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fanie.197508011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=801-811&author=R.+Appel&title=Tertiary+Phosphane%2FTetrachloromethane%2C+a+Versatile+Reagent+for+Chlorination%2C+Dehydration%2C+and+P-N+Linkage&doi=10.1002%2Fanie.197508011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.197508011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197508011%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26atitle%3DTertiary%2520Phosphane%252FTetrachloromethane%252C%2520a%2520Versatile%2520Reagent%2520for%2520Chlorination%252C%2520Dehydration%252C%2520and%2520P-N%2520Linkage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1975%26volume%3D14%26spage%3D801%26epage%3D811%26doi%3D10.1002%2Fanie.197508011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannon, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavva, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J. J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span> <span> </span><span class="NLM_article-title">Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3528</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1021/jm070191h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070191h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslyrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3528-3539&author=H.-L.+Wangauthor=J.+Katonauthor=C.+Balanauthor=A.+W.+Bannonauthor=C.+Bernardauthor=E.+M.+Dohertyauthor=C.+Dominguezauthor=N.+R.+Gavvaauthor=V.+Goreauthor=V.+Maauthor=N.+Nishimuraauthor=S.+Surapaneniauthor=P.+Tangauthor=R.+Tamirauthor=O.+Thielauthor=J.+J.+S.+Treanorauthor=M.+H.+Norman&title=Novel+Vanilloid+Receptor-1+Antagonists%3A+3.+The+Identification+of+a+Second-Generation+Clinical+Candidate+with+Improved+Physicochemical+and+Pharmacokinetic+Properties&doi=10.1021%2Fjm070191h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties</span></div><div class="casAuthors">Wang, Hui-Ling; Katon, Jodie; Balan, Chenera; Bannon, Anthony W.; Bernard, Charles; Doherty, Elizabeth M.; Dominguez, Celia; Gavva, Narender R.; Gore, Vijay; Ma, Vu; Nishimura, Nobuko; Surapaneni, Sekhar; Tang, Phi; Tamir, Rami; Thiel, Oliver; Treanor, James J. S.; Norman, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3528-3539</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on the previously reported clin. candidate, AMG 517 (compd. 1), a series of related piperazinylpyrimidine analogs were synthesized and evaluated as antagonists of the vanilloid 1 receptor (VR1 or TRPV1).  Optimization of in vitro potency and physicochem. and pharmacokinetic properties led to the discovery of (R)-N-(4-(6-(4-(1-(4-fluorophenyl)ethyl)piperazin-1-yl)pyrimidin-4-yloxy)benzo[d]thiazol-2-yl)acetamide (16p, I), a potent TRPV1 antagonist [rTRPV1(CAP) IC50 = 3.7 nM] with excellent aq. soly. (≥200 μg/mL in 0.01 N HCl) and a reduced half-life (rat t1/2 = 3.8 h, dog t1/2 = 2.7 h, monkey t1/2 = 3.2 h) as compared to AMG 517.  In addn., compd. 16p was shown to be efficacious at blocking a TRPV1-mediated physiol. response in vivo (ED50 = 1.9 mg/kg, p.o. in the capsaicin-induced flinch model in rats) and was also effective at reducing thermal hyperalgesia induced by complete Freund's adjuvant in rats (MED = 1 mg/kg, p.o).  Based on its improved overall profile, compd. 16p (AMG 628) was selected as a second-generation candidate for further evaluation in human clin. trials as a potential new treatment for chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrINDCYTN9z2rVg90H21EOLACvtfcHk0lg_rgjuAB34KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslyrsbc%253D&md5=5eea82130b3293a6ab0b583730eeda4f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070191h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070191h%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DKaton%26aufirst%3DJ.%26aulast%3DBalan%26aufirst%3DC.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBernard%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DE.%2BM.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DGavva%26aufirst%3DN.%2BR.%26aulast%3DGore%26aufirst%3DV.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DSurapaneni%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DP.%26aulast%3DTamir%26aufirst%3DR.%26aulast%3DThiel%26aufirst%3DO.%26aulast%3DTreanor%26aufirst%3DJ.%2BJ.%2BS.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26atitle%3DNovel%2520Vanilloid%2520Receptor-1%2520Antagonists%253A%25203.%2520The%2520Identification%2520of%2520a%2520Second-Generation%2520Clinical%2520Candidate%2520with%2520Improved%2520Physicochemical%2520and%2520Pharmacokinetic%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3528%26epage%3D3539%26doi%3D10.1021%2Fjm070191h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shchepin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarathna, D. H. M. L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumitru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, P. H.</span></span> <span> </span><span class="NLM_article-title">Influence of Heterocyclic and Oxime-Containing Farnesol Analogs on Quorum Sensing and Pathogenicity in <i>Candida albicans</i></span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1848</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmc.2007.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=18037299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1842-1848&author=R.+Shchepinauthor=D.+H.+M.+L.+P.+Navarathnaauthor=R.+Dumitruauthor=S.+Lippoldauthor=K.+W.+Nickersonauthor=P.+H.+Dussault&title=Influence+of+Heterocyclic+and+Oxime-Containing+Farnesol+Analogs+on+Quorum+Sensing+and+Pathogenicity+in+Candida+albicans&doi=10.1016%2Fj.bmc.2007.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of heterocyclic and oxime-containing farnesol analogs on quorum sensing and pathogenicity in Candida albicans</span></div><div class="casAuthors">Shchepin, Roman; Navarathna, Dhammika H. M. L. P.; Dumitru, Raluca; Lippold, Shane; Nickerson, Kenneth W.; Dussault, Patrick H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of synthetic mols. combining a geranyl backbone with a heterocyclic or oxime head group are quorum-sensing mols. that block the yeast to mycelium transition in the dimorphic fungus Candida albicans.  A no. of the analogs have an IC50 ≤ 10 μM, a level of potency essentially identical to the natural quorum sensing signal, the sesquiterpene farnesol.  Two of the most potent analogs, neither toxic toward healthy mice, display remarkably different effects when co-administered with C. albicans.  While neither offers protection from candidiasis, one analog mimics farnesol in acting as a virulence factor, whereas the other has no effect.  The results offer the first example of highly potent synthetic fungal quorum-sensing mols., and provide the first evidence for the ability to decouple quorum sensing and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAxd048-Vy07Vg90H21EOLACvtfcHk0lg_rgjuAB34KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOisrs%253D&md5=1a7697a599ebfdf7fbdd1962138f6faa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DShchepin%26aufirst%3DR.%26aulast%3DNavarathna%26aufirst%3DD.%2BH.%2BM.%2BL.%2BP.%26aulast%3DDumitru%26aufirst%3DR.%26aulast%3DLippold%26aufirst%3DS.%26aulast%3DNickerson%26aufirst%3DK.%2BW.%26aulast%3DDussault%26aufirst%3DP.%2BH.%26atitle%3DInfluence%2520of%2520Heterocyclic%2520and%2520Oxime-Containing%2520Farnesol%2520Analogs%2520on%2520Quorum%2520Sensing%2520and%2520Pathogenicity%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmc.2007.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muthusamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunanathan, C.</span></span> <span> </span><span class="NLM_article-title">Indium Triflate: a Mild and Efficient Lewis Acid Catalyst for O-H Insertion Reactions of α-Diazo Ketones</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3136</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)00489-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0040-4039%2802%2900489-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVOksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=3133-3136&author=S.+Muthusamyauthor=S.+A.+Babuauthor=C.+Gunanathan&title=Indium+Triflate%3A+a+Mild+and+Efficient+Lewis+Acid+Catalyst+for+O-H+Insertion+Reactions+of+%CE%B1-Diazo+Ketones&doi=10.1016%2FS0040-4039%2802%2900489-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Indium triflate: a mild and efficient Lewis acid catalyst for O-H insertion reactions of α-diazo ketones</span></div><div class="casAuthors">Muthusamy, Sengodagounder; Babu, Srinivasarao Arulananda; Gunanathan, Chidambaram</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3133-3136</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Facile O-H insertion reactions of α-diazo ketones with aliph./arom. alcs. or benzenethiol have been developed in the presence of indium triflate as catalyst.  These reactions provided good yields of α-alkoxy ketones.  A comparative study with other Lewis acids establishes the reactivity of indium triflate in O-H insertion reactions of α-diazo ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0h2g56XsMzLVg90H21EOLACvtfcHk0lg_rgjuAB34KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVOksLs%253D&md5=10a6000c348dd58c5d24365ddfa18600</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900489-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900489-6%26sid%3Dliteratum%253Aachs%26aulast%3DMuthusamy%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DS.%2BA.%26aulast%3DGunanathan%26aufirst%3DC.%26atitle%3DIndium%2520Triflate%253A%2520a%2520Mild%2520and%2520Efficient%2520Lewis%2520Acid%2520Catalyst%2520for%2520O-H%2520Insertion%2520Reactions%2520of%2520%25CE%25B1-Diazo%2520Ketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D3133%26epage%3D3136%26doi%3D10.1016%2FS0040-4039%2802%2900489-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rozkiewicz, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janczewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verboom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravoo, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhoudt, N. D.</span></span> <span> </span><span class="NLM_article-title">Click” Chemistry by Microcontact Printing</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1002/anie.200601090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fanie.200601090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5292-5296&author=I.+D.+Rozkiewiczauthor=D.+Janczewskiauthor=W.+Verboomauthor=J.+B.+Ravooauthor=N.+D.+Reinhoudt&title=Click%E2%80%9D+Chemistry+by+Microcontact+Printing&doi=10.1002%2Fanie.200601090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">"Click" chemistry by microcontact printing</span></div><div class="casAuthors">Rozkiewicz, Dorata I.; Janczewski, Dominik; Verboom, Willem; Ravoo, Bart Jan; Reinhoudt, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5292-5296</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Click chem. can be efficiently combined with microcontact printing.  Synthesis in the nanoscale confinement between an elastomeric stamp and a reactive substrate leads to the desired product within a short time, without a catalyst, and under ambient conditions.  As a result, 1-octadecyne could be printed onto an azido-terminated, self-assembled monolayer on a silicon oxide substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgdS_grtZFfrVg90H21EOLACvtfcHk0li-bf3IS5AKRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslegtbs%253D&md5=e989dcf1927eeb2867b841c7852fdbf1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200601090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200601090%26sid%3Dliteratum%253Aachs%26aulast%3DRozkiewicz%26aufirst%3DI.%2BD.%26aulast%3DJanczewski%26aufirst%3DD.%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DRavoo%26aufirst%3DJ.%2BB.%26aulast%3DReinhoudt%26aufirst%3DN.%2BD.%26atitle%3DClick%25E2%2580%259D%2520Chemistry%2520by%2520Microcontact%2520Printing%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D5292%26epage%3D5296%26doi%3D10.1002%2Fanie.200601090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read de Alaniz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taupin, V.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of (+)-Nankakurines A and B and (±)-5-<i>epi</i>-Nankakurine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">7519</span>– <span class="NLM_lpage">7534</span>, <span class="refDoi"> DOI: 10.1021/jo101619d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101619d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=7519-7534&author=A.+R.+Altmanauthor=L.+B.+Nilssonauthor=E.+L.+Overmanauthor=J.+Read+de+Alanizauthor=M.+J.+Rohdeauthor=V.+Taupin&title=Total+Synthesis+of+%28%2B%29-Nankakurines+A+and+B+and+%28%C2%B1%29-5-epi-Nankakurine&doi=10.1021%2Fjo101619d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of (+)-Nankakurines A and B and (±)-5-epi-Nankakurine A</span></div><div class="casAuthors">Altman, Ryan A.; Nilsson, Bradley L.; Overman, Larry E.; Read de Alaniz, Javier; Rohde, Jason M.; Taupin, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7519-7534</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first total syntheses of the Lycopodium alkaloids (+)-nankakurine A I (R = H), (+)-nankakurine B I (R = Me) and (±)-5-epi-nankakurine A (II) with the originally purported relative configuration of nankakurine A were accomplished.  The syntheses of I (R = H and R = Me) featured a demanding intramol. azomethine imine cycloaddn. as the key step for generating the octahydro-3,5-ethanoquinoline moiety and installing the correct relative configuration at the spiropiperidine ring juncture.  The cyclization precursor was prepd. from octahydronaphthalene ketone III, which was assembled from enone (R)-5-methyl-2-cyclohexen-1-one and diene H2C:CHC(:CH2)(CH2)4OCH2Ph by a cationic Diels-Alder reaction.  The Diels-Alder reactants were synthesized from 5-hexyn-1-ol and (+)-pulegone, resp.  The tetracyclic ring system of (±)-5-epi-nankakurine A was generated using an unprecedented nitrogen-terminated aza-Prins cyclization cascade.  The enantioselective total syntheses of (+)-nankakurine A and (+)-nankakurine B establish the relative and abs. configuration of these alkaloids and were sufficiently concise that substantial quantities were prepd. for biol. studies.  (+)-Nankakurine A and (+)-nankakurine B showed no effect on neurite outgrowth in rat hippocampal H-19 cells over a concn. range of 0.3-10 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYT24TlqHqbrVg90H21EOLACvtfcHk0li-bf3IS5AKRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbvI&md5=35a1c3aace27ec49f301414730b7a85c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo101619d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101619d%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DA.%2BR.%26aulast%3DNilsson%26aufirst%3DL.%2BB.%26aulast%3DOverman%26aufirst%3DE.%2BL.%26aulast%3DRead%2Bde%2BAlaniz%26aufirst%3DJ.%26aulast%3DRohde%26aufirst%3DM.%2BJ.%26aulast%3DTaupin%26aufirst%3DV.%26atitle%3DTotal%2520Synthesis%2520of%2520%2528%252B%2529-Nankakurines%2520A%2520and%2520B%2520and%2520%2528%25C2%25B1%2529-5-epi-Nankakurine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D7519%26epage%3D7534%26doi%3D10.1021%2Fjo101619d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webb, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klijn, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goroff, S. N.</span></span> <span> </span><span class="NLM_article-title">Experimental Studies of the <sup>13</sup>C NMR of Iodoalkynes in Lewis-Basic Solvents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1021/jo035584c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo035584c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVKr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=660-664&author=A.+J.+Webbauthor=E.+J.+Klijnauthor=A.+P.+Hillauthor=L.+J.+Bennettauthor=S.+N.+Goroff&title=Experimental+Studies+of+the+13C+NMR+of+Iodoalkynes+in+Lewis-Basic+Solvents&doi=10.1021%2Fjo035584c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental Studies of the 13C NMR of Iodoalkynes in Lewis-Basic Solvents</span></div><div class="casAuthors">Webb, Jeffrey A.; Klijn, Jaap E.; Hill, Philip Aru; Bennett, Jordan L.; Goroff, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">660-664</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 13C NMR spectra of two different iodoalkynes, 1-iodo-1-hexyne (1) and diiodoethyne (2), exhibit a strong solvent dependence.  Comparisons of the data with several common empirical models, including Gutmann's Donor nos., Reichardt's ENT, and Taft and Kamlet's β and π*, demonstrate that this solvent effect arises from a specific acid-base interaction.  Solvent basicity measures such as Donor nos. and β values correlate well with the α-C chem. shift of 1, but polarity measures such as ENT and π* do not correlate.  The similarity of the solvent effect for 1 and 2 suggests that C-C bond polarization may not play a role in the change in chem. shift, as previously hypothesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI-DwvrzeDO7Vg90H21EOLACvtfcHk0li-bf3IS5AKRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVKr&md5=913fc29d1b303c679731390632880ea3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo035584c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035584c%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DA.%2BJ.%26aulast%3DKlijn%26aufirst%3DE.%2BJ.%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DBennett%26aufirst%3DL.%2BJ.%26aulast%3DGoroff%26aufirst%3DS.%2BN.%26atitle%3DExperimental%2520Studies%2520of%2520the%252013C%2520NMR%2520of%2520Iodoalkynes%2520in%2520Lewis-Basic%2520Solvents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D660%26epage%3D664%26doi%3D10.1021%2Fjo035584c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vranken, D. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Carbene Insertion and Trapping with Carbon Nucleophiles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1909</span>– <span class="NLM_lpage">1911</span>, <span class="refDoi"> DOI: 10.1021/ol800431w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800431w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFakurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1909-1911&author=S.+K.+J.+Devineauthor=D.+L.+Van+Vranken&title=Palladium-Catalyzed+Carbene+Insertion+and+Trapping+with+Carbon+Nucleophiles&doi=10.1021%2Fol800431w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed carbene insertion and trapping with carbon nucleophiles</span></div><div class="casAuthors">Devine, Sean K. J.; Van Vranken, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1909-1911</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three-component coupling of vinyl halides RCH:CHX (X = Br, I), stabilized carbon nucleophiles (Nu) and diazomethyl silane N2CHSiMe3, catalyzed by Pd(0) complexes, gave vinylsilanes RCH(Nu)CH:CHSiMe3 with high yields.  Reaction of R1R2C:CHX with sodium di-Et malonate and N2CHSiMe3 gave vinylsilanes (E)-R1CR2[CH(CO2Et)2]CH:CHSiMe3 (X = I, Br, R1 = PhCH2CH2, NCCH2CH2CH2, TBSOCH2CH2CH2; R2 = H, Me).  The reaction is believed to proceed through a palladium-carbene intermediate LX(R)Pd:CHSiMe3 that undergoes migration of the vinyl substituent to the electrophilic carbene center to generate an η3-allylpalladium intermediate.  The allylpalladium intermediate is attacked by the carbon nucleophile to generate a vinylsilane product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSd2qD5vqsrVg90H21EOLACvtfcHk0lgqhdfSlN5YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFakurw%253D&md5=8f85bae783e5d75c2e8f0d0f426a27ee</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fol800431w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800431w%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BK.%2BJ.%26aulast%3DVan%2BVranken%26aufirst%3DD.%2BL.%26atitle%3DPalladium-Catalyzed%2520Carbene%2520Insertion%2520and%2520Trapping%2520with%2520Carbon%2520Nucleophiles%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D1909%26epage%3D1911%26doi%3D10.1021%2Fol800431w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trybulski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. I.</span></span> <span> </span><span class="NLM_article-title">2-Benzazepines.1. Synthesis of 2-Benzazepin-4-ones and 5-ones via 2-Acetylenic Benzophenones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2441</span>– <span class="NLM_lpage">2447</span>, <span class="refDoi"> DOI: 10.1021/jo00133a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00133a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaL38XitFOltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=2441-2447&author=J.+E.+Trybulskiauthor=E.+Reederauthor=F.+J.+Blountauthor=A.+Walserauthor=R.+I.+Fryer&title=2-Benzazepines.1.+Synthesis+of+2-Benzazepin-4-ones+and+5-ones+via+2-Acetylenic+Benzophenones&doi=10.1021%2Fjo00133a040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">2-Benzazepines.  I.  Synthesis of 2-benzazepin-4-ones and -5-ones via 2-acetylenic benzophenones</span></div><div class="casAuthors">Trybulski, Eugene J.; Reeder, Earl; Blount, John F.; Walser, Armin; Fryer, R. Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2441-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">1-Phenyl-2-benzazepin-4-ones and -5-ones were prepd.  The palladium-catalyzed coupling of iodobenzophenones to monosubstituted acetylenes assembled the necessary atoms required for the benzazepine rings.  Transformation of the acetylene group into a ketone group with concomitant cyclization of the resulting β-amino ketone completed the synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk6CwZrSeKebVg90H21EOLACvtfcHk0lgqhdfSlN5YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XitFOltbg%253D&md5=5f78f378efdcccc7e0f93a34ec69d425</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo00133a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00133a040%26sid%3Dliteratum%253Aachs%26aulast%3DTrybulski%26aufirst%3DJ.%2BE.%26aulast%3DReeder%26aufirst%3DE.%26aulast%3DBlount%26aufirst%3DF.%2BJ.%26aulast%3DWalser%26aufirst%3DA.%26aulast%3DFryer%26aufirst%3DR.%2BI.%26atitle%3D2-Benzazepines.1.%2520Synthesis%2520of%25202-Benzazepin-4-ones%2520and%25205-ones%2520via%25202-Acetylenic%2520Benzophenones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1982%26volume%3D47%26spage%3D2441%26epage%3D2447%26doi%3D10.1021%2Fjo00133a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meddad-Belhabich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djimdé, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redeuilh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massicot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymans, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamouri, A.</span></span> <span> </span><span class="NLM_article-title">Design of New Potent and Selective Secretory Phospholipase A<sub>2</sub>Inhibitors. 6-Synthesis, Structure-Activity Relationships and Molecular Modeling of 1-Substituted-4-[4,5-dihydro-1,2,4-(4<i>H</i>)-oxadiazol-5-one-3-yl(methyl)]-Functionalizedaryl Piperazin/one/dione Derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3588</span>– <span class="NLM_lpage">3600</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmc.2010.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=20417107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3588-3600&author=N.+Meddad-Belhabichauthor=D.+Aounauthor=A.+Djimd%C3%A9author=C.+Redeuilhauthor=G.+Diveauthor=F.+Massicotauthor=F.+Chauauthor=F.+Heymansauthor=A.+Lamouri&title=Design+of+New+Potent+and+Selective+Secretory+Phospholipase+A2Inhibitors.+6-Synthesis%2C+Structure-Activity+Relationships+and+Molecular+Modeling+of+1-Substituted-4-%5B4%2C5-dihydro-1%2C2%2C4-%284H%29-oxadiazol-5-one-3-yl%28methyl%29%5D-Functionalizedaryl+Piperazin%2Fone%2Fdione+Derivatives&doi=10.1016%2Fj.bmc.2010.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design of new potent and selective secretory phospholipase A2 inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives</span></div><div class="casAuthors">Meddad-Belhabich, Nadia; Aoun, Darina; Djimde, Atime; Redeuilh, Catherine; Dive, Georges; Massicot, France; Chau, Francois; Heymans, Francoise; Lamouri, Aazdine</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3588-3600</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The group IIA human non-pancreatic secretory phospholipase A2 (hnp-sPLA2) is one of the enzymes implied in the inflammatory process.  In the course of our work on inhibitors of this enzyme we investigated the influence of rigidity of the piperazine region on the biol. activity.  Several modifications were explored.  Various linkers, such as amide, urea, carbamate, or alkoxyphenyl were inserted between the piperazine and the lipophilic chain.  Also, modification of the piperazine core to incorporate carbonyl groups was studied.  In an in vitro fluorimetric assay using the human GIIA (HPLA2) and porcine pancreatic GIB enzymes, compd. 60a (I) had the optimal activity with an IC50 = 30 nM on HPLA2.  By means of mol. modeling we attempted to get informations towards comprehension of differences in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBQ29O1kSTbVg90H21EOLACvtfcHk0lgqhdfSlN5YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGrur4%253D&md5=365ebce7ec6462af7f06c26c00f5a4ba</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DMeddad-Belhabich%26aufirst%3DN.%26aulast%3DAoun%26aufirst%3DD.%26aulast%3DDjimd%25C3%25A9%26aufirst%3DA.%26aulast%3DRedeuilh%26aufirst%3DC.%26aulast%3DDive%26aufirst%3DG.%26aulast%3DMassicot%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DHeymans%26aufirst%3DF.%26aulast%3DLamouri%26aufirst%3DA.%26atitle%3DDesign%2520of%2520New%2520Potent%2520and%2520Selective%2520Secretory%2520Phospholipase%2520A2Inhibitors.%25206-Synthesis%252C%2520Structure-Activity%2520Relationships%2520and%2520Molecular%2520Modeling%2520of%25201-Substituted-4-%255B4%252C5-dihydro-1%252C2%252C4-%25284H%2529-oxadiazol-5-one-3-yl%2528methyl%2529%255D-Functionalizedaryl%2520Piperazin%252Fone%252Fdione%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3588%26epage%3D3600%26doi%3D10.1016%2Fj.bmc.2010.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matyja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daldrup, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbah, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of Oxalic Acid Derivatives as New Metabolites of Metamizol (Dipyrone) in Incubated Hen’s Egg and Human</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2005.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.ejps.2005.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16417995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=15-25&author=J.+C.+Wesselauthor=M.+Matyjaauthor=M.+Neugebauerauthor=H.+Kieferauthor=T.+Daldrupauthor=F.+A.+Tarbahauthor=H.+Weber&title=Characterization+of+Oxalic+Acid+Derivatives+as+New+Metabolites+of+Metamizol+%28Dipyrone%29+in+Incubated+Hen%E2%80%99s+Egg+and+Human&doi=10.1016%2Fj.ejps.2005.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen's egg and human</span></div><div class="casAuthors">Wessel, Julia C.; Matyja, Magdalena; Neugebauer, Michael; Kiefer, Heiko; Daldrup, Thomas; Tarbah, Fuad A.; Weber, Horst</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">15-25</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Metamizol (1), a widely used drug with effective analgesic and antispasmodic properties, shows severe side effects like agranulocytosis and anaphylactic shock reactions, the reasons of which are not known until today.  After oral administration 1 is completely metabolized.  All hitherto known metabolites have an intact pyrazolinone ring structure like the parent compd. and are completely extractable from urine with polar org. solvents.  However, only a fractional amt. of the applied dosage can be recovered by this procedure.  To clarify the reason of this deficit of unknown metabolites the authors followed the hypothesis of oxidative rupture of the heterocyclic ring during metab. of 1.  On the basis of former in vitro results the authors now were able to identify in quality three oxalic acid derivs. and one acetic acid phenylhydrazide as new metabolites of metamizol in the allantoic fluid (AF) of incubated hen's eggs as well as in human urine by means of GC-MS anal. and comparison with unequivocally synthesized authentic ref. compds.  Whereas the oxamazide 7, the phenylhydrazide 8 and N-methyloxamic acid 9 are only present in trace concns. and therefore cannot account for the deficit in the balance of metabolites, the oxalic acid monohydrazide 11 seems to be excreted in higher amt.  Quant. detn. of this new metabolite would be required to answer the open questions concerning the biotransformation of metamizol and thereby to detect new facts about mode of action and side effects of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptP1O6MjcPRLVg90H21EOLACvtfcHk0lgqhdfSlN5YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLk%253D&md5=21340914a56998c154bd124f4b32d481</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DWessel%26aufirst%3DJ.%2BC.%26aulast%3DMatyja%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DH.%26aulast%3DDaldrup%26aufirst%3DT.%26aulast%3DTarbah%26aufirst%3DF.%2BA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520Oxalic%2520Acid%2520Derivatives%2520as%2520New%2520Metabolites%2520of%2520Metamizol%2520%2528Dipyrone%2529%2520in%2520Incubated%2520Hen%25E2%2580%2599s%2520Egg%2520and%2520Human%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D28%26spage%3D15%26epage%3D25%26doi%3D10.1016%2Fj.ejps.2005.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harker, A.</span></span> <span> </span><span class="NLM_article-title">Modification of The Ultrafiltration Technique to Overcome Solubility and Non-Specific Binding Challenges Associated with the Measurement of Plasma Protein Binding of Corticosteroids</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2005.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.jpba.2005.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16314065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1enur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=299-303&author=S.+Taylorauthor=A.+Harker&title=Modification+of+The+Ultrafiltration+Technique+to+Overcome+Solubility+and+Non-Specific+Binding+Challenges+Associated+with+the+Measurement+of+Plasma+Protein+Binding+of+Corticosteroids&doi=10.1016%2Fj.jpba.2005.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids</span></div><div class="casAuthors">Taylor, Simon; Harker, Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma protein binding (PPB) methodol. suitable for application in the lead optimization of a corticosteroid series known to demonstrate non-specific binding (NSB) and poor soly. has been established.  The method involved a modification to std. ultrafiltration (UF) techniques.  In parallel with each exptl. plasma sample, a control plasma sample was also processed by ultrafiltration.  The retentate from exptl. and control plasma samples were mixed back into the filtrate of the partner sample.  The resulting regenerated plasma samples, one representing the exptl. filtrate and one representing the exptl. retentate, were then analyzed by LC/MS/MS.  Varying degrees of NSB were demonstrated with a no. of corticosteroids, and this effect was eliminated using the modified method.  Validation using a panel of established corticosteroids showed good agreement with published PPB figures.  The published PPB figure for fluticasone propionate (FP) was, however, found to be an underestimate, and this was subsequently confirmed, at clin. relevant plasma concns., to be 99.3%.  The modified method was particularly suited to lead optimization because it provided samples in a consistent matrix compatible with std. high throughput LC/MS/MS anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyxrIbNE9yorVg90H21EOLACvtfcHk0lhbyqJNTLptaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1enur8%253D&md5=b4d0b6a6a358a8c4e6e393987a275605</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2005.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2005.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DHarker%26aufirst%3DA.%26atitle%3DModification%2520of%2520The%2520Ultrafiltration%2520Technique%2520to%2520Overcome%2520Solubility%2520and%2520Non-Specific%2520Binding%2520Challenges%2520Associated%2520with%2520the%2520Measurement%2520of%2520Plasma%2520Protein%2520Binding%2520of%2520Corticosteroids%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D41%26spage%3D299%26epage%3D303%26doi%3D10.1016%2Fj.jpba.2005.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of Human Clearance of Twenty-Nine Drugs from Hepaticmicrosomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+Human+Clearance+of+Twenty-Nine+Drugs+from+Hepaticmicrosomal+Intrinsic+Clearance+Data%3A+An+Examination+of+In+Vitro+Half-Life+Approach+and+Nonspecific+Binding+to+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lhbyqJNTLptaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520Human%2520Clearance%2520of%2520Twenty-Nine%2520Drugs%2520from%2520Hepaticmicrosomal%2520Intrinsic%2520Clearance%2520Data%253A%2520An%2520Examination%2520of%2520In%2520Vitro%2520Half-Life%2520Approach%2520and%2520Nonspecific%2520Binding%2520to%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Szeiffova Bacova</span>, <span class="hlFld-ContribAuthor ">Jana  Radosinska</span>, <span class="hlFld-ContribAuthor ">Gerd  Wallukat</span>, <span class="hlFld-ContribAuthor ">Miroslav  Barancik</span>, <span class="hlFld-ContribAuthor ">Anne  Wallukat</span>, <span class="hlFld-ContribAuthor ">Vladimir  Knezl</span>, <span class="hlFld-ContribAuthor ">Matus  Sykora</span>, <span class="hlFld-ContribAuthor ">Ludovit  Paulis</span>, <span class="hlFld-ContribAuthor ">Narcis  Tribulova</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of β1-Adrenoceptor Autoantibodies is Involved in the Antiarrhythmic Effects of Omega-3 Fatty Acids in Male and Female Hypertensive Rats. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (2)
                                     , 526. <a href="https://doi.org/10.3390/ijms21020526" title="DOI URL">https://doi.org/10.3390/ijms21020526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21020526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21020526%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSuppression%252Bof%252B%2525CE%2525B21-Adrenoceptor%252BAutoantibodies%252Bis%252BInvolved%252Bin%252Bthe%252BAntiarrhythmic%252BEffects%252Bof%252BOmega-3%252BFatty%252BAcids%252Bin%252BMale%252Band%252BFemale%252BHypertensive%252BRats%26aulast%3DSzeiffova%2BBacova%26aufirst%3DBarbara%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and properties of eicosapentaenoic acid (EPA), 17,18-EEQ, and analogues. Negative chronotropic effects on NRCM beating rate at 30 nM.<a onclick="showRef(event, 'ref18 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref28">(18,28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–response curves for (±)-17,18-EEQ, <b>2b</b>, <b>4</b>, and <b>16</b> using NRCMs. Data points are means ± SEM (<i>n</i> = 24, each concentration). Curves were fitted using the standard slope model in GraphPad Prism. The basal beating rates of the spontaneously contracting cardiomyocyte clusters ranged between 120 and 150 beats/min.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>2b</b>, <b>4</b>, <b>16</b>, amiodarone, dronedarone, and terfenadine on CYP2J2-catalyzed EPA epoxidation. Epoxygenase activities were calculated from the sum of EEQs and <i>vic</i>-dihydoxyeicosatetraenoic acids (DiHETEs) formed by the recombinant enzyme in incubations containing 10 μM EPA as substrate and 1 mM NADPH as electron donor. All reactions were performed in triplicate, as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. The inhibitory effects of amiodarone, dronedarone, and terfenadine on CYP2J2-catalyzed EPA epoxidation were analyzed in parallel incubations. Data are means ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NADPH-dependent metabolism of oleic acid (reference compound) and analogues <b>2b</b>, <b>4</b>, and <b>16</b> by human liver microsomes. The incubations contained 0.5 mg/mL of human liver microsomes and the test compound at a final concentration of 1 μM, as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. LC-MS in single ion monitoring mode was used to follow the time-dependent loss of the respective parental compound and the formation of primary metabolites resulting from monooxygenation (hydroxylation or epoxidation; [+O] metabolites) as well as secondary metabolites originating from epoxidation and addition of the elements of water, presumably from epoxide hydrolysis; ([+O + H<sub>2</sub>O] metabolites). Data are mean values from reactions run in duplicate for each time point and represent the peak areas of the molecular ions as detected by LC-MS. No product formation occurred when NADPH was omitted from the incubations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma concentration–time curves of <b>2b</b>, <b>4</b>, and <b>16</b> in rats. (A) Time course of uptake, distribution, and elimination after a single oral dose of 3 mg/kg. (B) Time course of distribution and elimination after a single intravenous dose of 1 mg/kg. Data are means ± SEM; <i>n</i> = 4 per group; n.d. = not detectable (below LOQ).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma half-life of <b>4</b> in different animal species and predicted value for human. Data are based on PK studies following single dose oral administration of <b>4</b> to mouse (<i>n</i> = 3, 8 mg/kg bw), rat (<i>n</i> = 4, 3 mg/kg bw), and dog (<i>n</i> = 4, 3 mg/kg bw).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>5</b>, the triethylene glycol (TEG)-prodrug of <b>4</b>, on the development of ventricular tachycardia in a rat model of acute myocardial infarction. The animals received single i.v. bolus injections of <b>5</b> (<i>n</i> = 10) or vehicle (<i>n</i> = 9) 10 min before inducing ventricular arrhythmia by coronary artery ligation. Continuous ECG monitoring was performed over the whole observational period of 45 min. The severity score was calculated as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Data are means ± SD; *(<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>11</b>, <b>19</b>, and <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi (1.1 equiv), THF/HMPA (5:1), −78 to −20 °C, 1 h; Br(CH<sub>2</sub>)<sub>9</sub>OTHP, −78 °C to rt, 14 h, 88%. (b) <i>n</i>-Bu<sub>4</sub>NF, THF, rt, 12 h, 80%. (c) P-2 Ni/(H<sub>2</sub>NCH<sub>2</sub>)<sub>2</sub>, H<sub>2</sub> (1 atm), EtOH, rt, 98%. (d) DIAD, Ph<sub>3</sub>P, THF, −20 °C, 30 min; (PhO)<sub>2</sub>P(O)N<sub>3</sub>, 0 °C to rt, 10 h, 86%. (e) Ph<sub>3</sub>P, THF/H<sub>2</sub>O, rt, 14 h. (f) EtO(CO)(CO)NHCH<sub>3</sub>, EtOH, 85 °C, 10 h, 71% (over two steps). (g) 10 mol % <i>p</i>-TSA, MeOH, rt, 10 h, 98%. (h) Ph<sub>3</sub>P, imidazole, I<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 70%. (i) Ph<sub>3</sub>P, CBr<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 67%. (j) Na<sub>2</sub>SO<sub>3</sub>, cyclohexene, rt, 27%. (k) <b>29</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h, 29%. (l) KHCO<sub>3</sub>, <i>o</i>-thiophenol, DMF, rt, 79%.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of <b>12</b>, <b>13</b>, <b>14</b>, and <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (MeO)<sub>3</sub>P, reflux, 48 h, 54%. (b) TMSBr, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; Na<sub>2</sub>CO<sub>3</sub>, 1 h, SM-2 Biobeads, 30%. (c) POM-I (5 equiv), MeCN/CH<sub>2</sub>Cl<sub>2</sub> (5:1), rt, 48 h: <b>14</b> (3.8%) and <b>15</b> (3.3%).</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of <b>16</b>, <b>17</b>, and <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KCN, DMSO, rt, 20 h, 99%. (b) NaN<sub>3</sub>, Et<sub>3</sub>N·HCl, dioxane, 120 °C, 24 h, 37%. (c) NH<sub>2</sub>OH·HCl, Na<sub>2</sub>CO<sub>3</sub>, MeOH, rt, 10 h, 69%. (d) SOCl<sub>2</sub>, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 14 h, 63%. (e) (Imidazole)<sub>2</sub>CO, CH<sub>2</sub>Cl<sub>2</sub>, rt, 14 h, 18%.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Iodosuccinimide, AgNO<sub>3</sub>, THF, rt, 14 h, 97%. (b) Disiamylborane, THF, 0 °C to rt, 4 h. (c) 40% aq. MeNH<sub>2</sub>, EtOH, rt, 35% (two steps). (d) EtNCO, THF, rt, 20 h, 94%. (e) EtO(CO)(CO)NHCH<sub>3</sub>, EtOH, 85 °C, 10 h, 60%. (f) 20 mol % In(OTf)<sub>3</sub>, ethyl diazoacetate, toluene, rt, 3 h, 70%. (g) 9-BBN, THF, 0 °C to rt, 2 h. (h) <b>35</b>, 10 mol % Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, THF, 50 °C, 14–16 h, <b>40</b> (70%); <b>36</b>, same conditions, <b>41</b> (90%). (i) LiOH, THF, H<sub>2</sub>O, 0 °C to rt, 18–20 h; 1 M oxalic acid, <b>3</b> (82%) and <b>4</b> (67%).</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of <b>5</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Triethylene glycol (TEG), EDCI, CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 53%. (b) TEG, EDCI, DMF, rt, 14 h, 85%. (c) Methyl glycinate, EDCI, MeCN/CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 18 h, 71%. (d) NaOH, THF/MeOH/H<sub>2</sub>O, 0 °C to rt, 48 h; SM-2 Bio-Beads, 79%. (e) Methyl sarcosinate, EDCI, MeCN/CH<sub>2</sub>Cl<sub>2</sub>, rt, 48 h, 74%. (f) NaOH, THF/H<sub>2</sub>O, 0 °C to rt, 48 h; SM-2 Bio-Beads, 84%. (g) NHS, DCC, cat. DMAP, EtOAc, 40 °C, 24 h. (h) <span class="smallcaps smallerCapital"><i>L</i></span>-Alanine, DMAP, MeCN/DMF/H<sub>2</sub>O, 48 h; 1 N HCl; NaHCO<sub>3</sub>, 37% (two steps). (i) Benzenesulfonamide, EDCI, cat. DMAP, DMF, rt, 24 h, 84%.</p></p></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/medium/jm9b00952_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative examples showing the spontaneous beating of cultured neonatal rat cardiomyocytes. Contractions were recorded under basal conditions and 7 min after adding vehicle (left panel; ethanol final concentration 0.025%) or compound <b>4</b> (right panel; final concentration 30 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00952/20191122/images/large/jm9b00952_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00952&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-F.</span></span> <span> </span><span class="NLM_article-title">Cardiac Arrhythmia and Heart Failure: From Bench to Bedside</span>. <i>J. Geriatr. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.3724/SP.J.1263.2011.00131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.3724%2FSP.J.1263.2011.00131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22783298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC38jptVCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=131-132&author=Y.-F.+Xiao&title=Cardiac+Arrhythmia+and+Heart+Failure%3A+From+Bench+to+Bedside&doi=10.3724%2FSP.J.1263.2011.00131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac arrhythmia and heart failure: From bench to bedside</span></div><div class="casAuthors">Xiao Yong-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of geriatric cardiology : JGC</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-2</span>
        ISSN:<span class="NLM_cas:issn">1671-5411</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7TLVUW1nGtyCEBeYuoi7AfW6udTcc2eYOpVJesxrNCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jptVCntw%253D%253D&md5=9be15e73824698fcad99b0df6256436b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3724%2FSP.J.1263.2011.00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3724%252FSP.J.1263.2011.00131%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.-F.%26atitle%3DCardiac%2520Arrhythmia%2520and%2520Heart%2520Failure%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DJ.%2520Geriatr.%2520Cardiol.%26date%3D2011%26volume%3D8%26spage%3D131%26epage%3D132%26doi%3D10.3724%2FSP.J.1263.2011.00131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, W. G.</span></span> <span> </span><span class="NLM_article-title">The Future of Cardiovascular Biomedicine: Arrhythmias and Electrophysiology</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">2687</span>– <span class="NLM_lpage">2696</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.116.023519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FCIRCULATIONAHA.116.023519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=27324363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC2s7itlCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2016&pages=2687-2696&author=C.+M.+Albertauthor=W.+G.+Stevenson&title=The+Future+of+Cardiovascular+Biomedicine%3A+Arrhythmias+and+Electrophysiology&doi=10.1161%2FCIRCULATIONAHA.116.023519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Future of Arrhythmias and Electrophysiology</span></div><div class="casAuthors">Albert Christine M; Stevenson William G</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2687-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbp8ONwNt92YkFb3mqPUYDfW6udTcc2eZHfg2UfYoi5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7itlCqsw%253D%253D&md5=a6576f2991a52827ed7314fe7059c068</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.116.023519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.116.023519%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DC.%2BM.%26aulast%3DStevenson%26aufirst%3DW.%2BG.%26atitle%3DThe%2520Future%2520of%2520Cardiovascular%2520Biomedicine%253A%2520Arrhythmias%2520and%2520Electrophysiology%26jtitle%3DCirculation%26date%3D2016%26volume%3D133%26spage%3D2687%26epage%3D2696%26doi%3D10.1161%2FCIRCULATIONAHA.116.023519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H.</span></span> <span> </span><span class="NLM_article-title">Current Approaches to the Treatment of Atrial Fibrillation</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-800167-7.00008-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FB978-0-12-800167-7.00008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOqtL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=101-113&author=H.+Finlay&title=Current+Approaches+to+the+Treatment+of+Atrial+Fibrillation&doi=10.1016%2FB978-0-12-800167-7.00008-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to the treatment of atrial fibrillation</span></div><div class="casAuthors">Finlay, Heather</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A book.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8UWej9tvxG7Vg90H21EOLACvtfcHk0lhySFtP1GQLZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOqtL7I&md5=2dff5eeebb6ec607642942f4cebf8279</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800167-7.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-800167-7.00008-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%26atitle%3DCurrent%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Atrial%2520Fibrillation%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2014%26volume%3D49%26spage%3D101%26epage%3D113%26doi%3D10.1016%2FB978-0-12-800167-7.00008-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katus, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D.</span></span> <span> </span><span class="NLM_article-title">The Pathology and Treatment of Cardiac Arrhythmias: Focus on Atrial Fibrillation</span>. <i>Vasc. Health Risk Manage.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.2147/VHRM.S10758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2147%2FVHRM.S10758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=21490945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC3MvjsVOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=193-202&author=C.+Schmidtauthor=J.+Kisselbachauthor=P.+A.+Schweizerauthor=H.+A.+Katusauthor=D.+Thomas&title=The+Pathology+and+Treatment+of+Cardiac+Arrhythmias%3A+Focus+on+Atrial+Fibrillation&doi=10.2147%2FVHRM.S10758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation</span></div><div class="casAuthors">Schmidt Constanze; Kisselbach Jana; Schweizer Patrick A; Katus Hugo A; Thomas Dierk</div><div class="citationInfo"><span class="NLM_cas:title">Vascular health and risk management</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">193-202</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Atrial fibrillation (AF) is the most frequently encountered sustained cardiac arrhythmia in clinical practice and a major cause of morbidity and mortality.  Effective treatment of AF still remains an unmet medical need.  Treatment of AF is based on drug therapy and ablative strategies.  Antiarrhythmic drug therapy is limited by a relatively high recurrence rate and proarrhythmic side effects.  Catheter ablation suppresses paroxysmal AF in the majority of patients without structural heart disease but is more difficult to achieve in patients with persistent AF or with concomitant cardiac disease.  Stroke is a potentially devastating complication of AF, requiring anticoagulation that harbors the risk of bleeding.  In search of novel treatment modalities, targeted pharmacological treatment and gene therapy offer the potential for greater selectivity than conventional small-molecule or interventional approaches.  This paper summarizes the current understanding of molecular mechanisms underlying AF.  Established drug therapy and interventional treatment of AF is reviewed, and emerging clinical and experimental therapeutic approaches are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpNFypI88-cQ20zIbnCCI3fW6udTcc2eZHfg2UfYoi5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvjsVOktg%253D%253D&md5=c22c32754f5673605e9bd6251f9777b4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2147%2FVHRM.S10758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FVHRM.S10758%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DKisselbach%26aufirst%3DJ.%26aulast%3DSchweizer%26aufirst%3DP.%2BA.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DThomas%26aufirst%3DD.%26atitle%3DThe%2520Pathology%2520and%2520Treatment%2520of%2520Cardiac%2520Arrhythmias%253A%2520Focus%2520on%2520Atrial%2520Fibrillation%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2011%26volume%3D7%26spage%3D193%26epage%3D202%26doi%3D10.2147%2FVHRM.S10758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libersa, C.</span></span> <span> </span><span class="NLM_article-title">Adverse Effects of Class I Antiarrhythmic Drugs</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2165/00002018-199717010-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2165%2F00002018-199717010-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=9258628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK2sXls1Wisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=8-36&author=J.+Caronauthor=C.+Libersa&title=Adverse+Effects+of+Class+I+Antiarrhythmic+Drugs&doi=10.2165%2F00002018-199717010-00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse effects of class I antiarrhythmic drugs</span></div><div class="casAuthors">Caron, Jacques; Libersa, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-36</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis</span>)
        </div><div class="casAbstract">A review with 366 refs.  Class I antiarrhythmic drugs are characterized by their ability to block the fast inward sodium current in cardiac muscle tissue.  However, at the same time, they can be responsible for various effects involving other organs and systems.  Although some of these effects can be helpful in specific situations, most of them, such as their pro-arrhythmic propensity, are deleterious.  Some of the adverse effects of class I antiarrhythmic drugs are directly linked to sodium-channel blockade (conduction disorders, hemodynamic perturbations, and digestive and neurol. effects), while others are linked to other specific pharmacol. properties (e.g. atropinic, or α- or β-adrenergic blockade) or to nonspecific properties (idiosyncratic hypersensitivity, and hematol., dermatol. or hepatic reactions).  Other adverse effects are assocd. with complex interactions between class I antiarrhythmics and individual predisposing factors, trigger mechanisms and physiol. factors (including concomitant drug treatment).  These numerous variations and interactions within a specific environment and underlying disorder might be of pharmacol. or/and pharmacokinetic origin, making anal. of the true liability of the class I drugs very difficult when adverse effects occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHNVsgnLZVorVg90H21EOLACvtfcHk0liQ506ItPg0XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXls1Wisrw%253D&md5=079052760a33570f808af66268348e8a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2165%2F00002018-199717010-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199717010-00002%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DJ.%26aulast%3DLibersa%26aufirst%3DC.%26atitle%3DAdverse%2520Effects%2520of%2520Class%2520I%2520Antiarrhythmic%2520Drugs%26jtitle%3DDrug%2520Saf.%26date%3D1997%26volume%3D17%26spage%3D8%26epage%3D36%26doi%3D10.2165%2F00002018-199717010-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, D.-g.</span></span> <span> </span><span class="NLM_article-title">Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1007/s12013-015-0626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2Fs12013-015-0626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=25737133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslCqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2015&pages=291-296&author=D.-g.+Fu&title=Cardiac+Arrhythmias%3A+Diagnosis%2C+Symptoms%2C+and+Treatments&doi=10.1007%2Fs12013-015-0626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments</span></div><div class="casAuthors">Fu, Du-guan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-296</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The cardiac arrhythmia is characterized by irregular rhythm of heartbeat which could be either too slow (<60 beats/min) or too fast (>100 beats/min) and can happen at any age.  The use of pacemaker and defibrillators devices has been suggested for heart arrhythmias patients.  The antiarrhythmic medications have been reported for the treatment of cardiac arrhythmias or irregular heartbeats.  The diagnosis, symptoms, and treatments of cardiac arrhythmias as well as the radiofrequency ablation, tachycardia, Brugada syndrome, arterial fibrillation, and recent research on the genetics of cardiac arrhythmias have been described here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdfADPttQkRbVg90H21EOLACvtfcHk0liyhtV5T2hUhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslCqtLY%253D&md5=15de948bdaab9c32c1c494be80211489</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs12013-015-0626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-015-0626-4%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DD.-g.%26atitle%3DCardiac%2520Arrhythmias%253A%2520Diagnosis%252C%2520Symptoms%252C%2520and%2520Treatments%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2015%26volume%3D73%26spage%3D291%26epage%3D296%26doi%3D10.1007%2Fs12013-015-0626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">London, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wagoner, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balk, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billman, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lands, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAnulty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathrop, D. A.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research. A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">e320</span>– <span class="NLM_lpage">e335</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.712984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FCIRCULATIONAHA.107.712984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=17768297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2isLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=e320-e335&author=B.+Londonauthor=C.+Albertauthor=M.+E.+Andersonauthor=W.+R.+Gilesauthor=D.+R.+Van+Wagonerauthor=E.+Balkauthor=G.+E.+Billmanauthor=M.+Chungauthor=W.+Landsauthor=A.+Leafauthor=J.+McAnultyauthor=J.+R.+Martensauthor=R.+B.+Costelloauthor=D.+A.+Lathrop&title=Omega-3+Fatty+Acids+and+Cardiac+Arrhythmias%3A+Prior+Studies+and+Recommendations+for+Future+Research.+A+Report+from+the+National+Heart%2C+Lung%2C+and+Blood+Institute+and+Office+of+Dietary+Supplements+Omega-3+Fatty+Acids+and+Their+Role+in+Cardiac+Arrhythmogenesis+Workshop&doi=10.1161%2FCIRCULATIONAHA.107.712984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their role in cardiac arrhythmogenesis workshop</span></div><div class="casAuthors">London, Barry; Albert, Christine; Anderson, Mark E.; Giles, Wayne R.; Van Wagoner, David R.; Balk, Ethan; Billman, George E.; Chung, Mei; Lands, William; Leaf, Alexander; McAnulty, John; Martens, Jeffrey R.; Costello, Rebecca B.; Lathrop, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e320-e335</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review discusses data from epidemiol. studies, randomized clin. trials, animal studies, and basic science mechanistic studies on the role of n-3 polyunsatd. fatty acids in arrhythmia prevention presented at the Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop sponsored by the National Heart, Lung, and Blood Institute and the Office of Dietary Supplements on August 29-30, 2005.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFaCzkQfgMFrVg90H21EOLACvtfcHk0liyhtV5T2hUhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2isLfF&md5=b3d64f218865f189893fbbf9dc0cecc1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.712984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.712984%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DB.%26aulast%3DAlbert%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DM.%2BE.%26aulast%3DGiles%26aufirst%3DW.%2BR.%26aulast%3DVan%2BWagoner%26aufirst%3DD.%2BR.%26aulast%3DBalk%26aufirst%3DE.%26aulast%3DBillman%26aufirst%3DG.%2BE.%26aulast%3DChung%26aufirst%3DM.%26aulast%3DLands%26aufirst%3DW.%26aulast%3DLeaf%26aufirst%3DA.%26aulast%3DMcAnulty%26aufirst%3DJ.%26aulast%3DMartens%26aufirst%3DJ.%2BR.%26aulast%3DCostello%26aufirst%3DR.%2BB.%26aulast%3DLathrop%26aufirst%3DD.%2BA.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Arrhythmias%253A%2520Prior%2520Studies%2520and%2520Recommendations%2520for%2520Future%2520Research.%2520A%2520Report%2520from%2520the%2520National%2520Heart%252C%2520Lung%252C%2520and%2520Blood%2520Institute%2520and%2520Office%2520of%2520Dietary%2520Supplements%2520Omega-3%2520Fatty%2520Acids%2520and%2520Their%2520Role%2520in%2520Cardiac%2520Arrhythmogenesis%2520Workshop%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3De320%26epage%3De335%26doi%3D10.1161%2FCIRCULATIONAHA.107.712984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kromhout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geleijnse, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Goede, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griep, L. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, B. J. M</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Boer, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckers, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boersma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zock, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giltay, E. J.</span></span> <span> </span><span class="NLM_article-title">n-3 Fatty Acids, Ventricular Arrhythmia-Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients with Diabetes</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2515</span>– <span class="NLM_lpage">2520</span>, <span class="refDoi"> DOI: 10.2337/dc11-0896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.2337%2Fdc11-0896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22110169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=2515-2520&author=D.+Kromhoutauthor=J.+M.+Geleijnseauthor=J.+de+Goedeauthor=L.+M.+O.+Griepauthor=B.+J.+M+Mulderauthor=M.-J.+de%0ABoerauthor=J.+W.+Deckersauthor=E.+Boersmaauthor=P.+L.+Zockauthor=E.+J.+Giltay&title=n-3+Fatty+Acids%2C+Ventricular+Arrhythmia-Related+Events%2C+and+Fatal+Myocardial+Infarction+in+Postmyocardial+Infarction+Patients+with+Diabetes&doi=10.2337%2Fdc11-0896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes</span></div><div class="casAuthors">Kromhout, Daan; Geleijnse, Johanna M.; de Goede, Janette; Oude Griep, Linda M.; Mulder, Barbara J. M.; de Boer, Menko-Jan; Deckers, Jaap W.; Boersma, Eric; Zock, Peter L.; Giltay, Erik J.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Care</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2515-2520</span>CODEN:
                <span class="NLM_cas:coden">DICAD2</span>;
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">OBJECTIVE-We carried out a secondary anal. in high-risk patients with a previous myocardial infarction (Ml) and diabetes in the Alpha Omega Trial.  We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and α-linolenic acid (ALA) will reduce the incidence of ventricular arrhythmias and fatal MI.  RESEARCH DESIGN AND METHODS-A subgroup of 1,014 post-MI patients with diabetes aged 60-80 years was randomly allocated to receive one of four trial margarines, three with an addnl. amt. of n-3 fatty acids and one placebo for 40 mo.  The end points were ventricular arrhythmia-related events and fatal Ml.  The data were analyzed according to the intention-to-treat principle, using multivariable Cox proportional hazards models.  RESULTS-The patients consumed on av. 18.6 g of margarine per day, which resulted in an addnl. intake of 223 mg EPA plus 149 mg DHA and/or 1.9 g ALA in the active treatment groups.  During follow-up, 29 patients developed a ventricular arrhythmia-related events and 27 had a fatal MI.  Compared with placebo patients, the EPA-DHA plus ALA group experienced less ventricular arrhythmia-related events (hazard ratio 0.16; 95% CI 0.04-0.69).  These n-3 fatty acids also reduced the combined end-point ventricular arrhythmia-related events and fatal MI (0.28; 0.11-0.71).  CONCLUSIONS-Our results suggest that low-dose supplementation of n-3 fatty acids exerts a protective effect against ventricular arrhythmia-related events in post-MI patients with diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm5ezmd00ALVg90H21EOLACvtfcHk0lidDoTjRXpauQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVaktQ%253D%253D&md5=bccc294f620a773007d4dcb0ce18ea6c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2Fdc11-0896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdc11-0896%26sid%3Dliteratum%253Aachs%26aulast%3DKromhout%26aufirst%3DD.%26aulast%3DGeleijnse%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BGoede%26aufirst%3DJ.%26aulast%3DGriep%26aufirst%3DL.%2BM.%2BO.%26aulast%3DMulder%26aufirst%3DB.%2BJ.%2BM%26aulast%3Dde%2BBoer%26aufirst%3DM.-J.%26aulast%3DDeckers%26aufirst%3DJ.%2BW.%26aulast%3DBoersma%26aufirst%3DE.%26aulast%3DZock%26aufirst%3DP.%2BL.%26aulast%3DGiltay%26aufirst%3DE.%2BJ.%26atitle%3Dn-3%2520Fatty%2520Acids%252C%2520Ventricular%2520Arrhythmia-Related%2520Events%252C%2520and%2520Fatal%2520Myocardial%2520Infarction%2520in%2520Postmyocardial%2520Infarction%2520Patients%2520with%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2011%26volume%3D34%26spage%3D2515%26epage%3D2520%26doi%3D10.2337%2Fdc11-0896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rix, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E. B.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids and Cardiac Arrhythmias</span>. <i>Curr. Opin. Clin. Nutr. Metab. Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1097/MCO.0b013e32835bf39b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1097%2FMCO.0b013e32835bf39b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=23196815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1egtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=168-173&author=T.+A.+Rixauthor=J.+H.+Christensenauthor=E.+B.+Schmidt&title=Omega-3+Fatty+Acids+and+Cardiac+Arrhythmias&doi=10.1097%2FMCO.0b013e32835bf39b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 fatty acids and cardiac arrhythmias</span></div><div class="casAuthors">Rix, Thomas A.; Christensen, Jeppe H.; Schmidt, Erik B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-173</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: There are suggestions of effects of marine omega-3 polyunsatd. fatty acids (PUFAs) in relation to ventricular arrhythmia and sudden cardiac death and, more recently, also of possible effects related to atrial fibrillation.  Recent findings: On the basis of the recently published human studies, this article not only focusses primarily on recent developments and current knowledge on the effect of marine omega-3 PUFAs on atrial fibrillation, but also provides a status for their effects on ventricular arrhythmias.  Summary: Marine omega-3 PUFAs may protect against ventricular arrhythmias, and there is growing evidence for an effect of marine omega-3 PUFAs in the prevention and treatment of atrial fibrillation.  Further studies are needed to establish which patients are more likely to benefit from omega-3 PUFAs, the timing of treatment, and the dosages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-1_92NFr_1LVg90H21EOLACvtfcHk0lidDoTjRXpauQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1egtbs%253D&md5=87415324e5177808041c9c91e6640f98</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e32835bf39b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e32835bf39b%26sid%3Dliteratum%253Aachs%26aulast%3DRix%26aufirst%3DT.%2BA.%26aulast%3DChristensen%26aufirst%3DJ.%2BH.%26aulast%3DSchmidt%26aufirst%3DE.%2BB.%26atitle%3DOmega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Arrhythmias%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2013%26volume%3D16%26spage%3D168%26epage%3D173%26doi%3D10.1097%2FMCO.0b013e32835bf39b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span> <span> </span><span class="NLM_article-title">Prevention of Fatal Cardiac Arrhythmias by Polyunsaturated Fatty Acids</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">202S</span>– <span class="NLM_lpage">207S</span>, <span class="refDoi"> DOI: 10.1093/ajcn/71.1.202S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1093%2Fajcn%2F71.1.202S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10617972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2000&pages=202S-207S&author=J.+X.+Kangauthor=A.+Leaf&title=Prevention+of+Fatal+Cardiac+Arrhythmias+by+Polyunsaturated+Fatty+Acids&doi=10.1093%2Fajcn%2F71.1.202S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids</span></div><div class="casAuthors">Kang, Jing X.; Leaf, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Nutrition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1, Suppl.</span>),
    <span class="NLM_cas:pages">202S-207S</span>CODEN:
                <span class="NLM_cas:coden">AJCNAC</span>;
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Nutrition</span>)
        </div><div class="casAbstract">A review with 33 refs.  In animal studies, and probably in humans, dietary n-3 polyunsatd. fatty acids (PUFA) can prevent fatal ischemia-induced cardiac arrhythmias.  The n-3 PUFA can also prevent heart arrhythmias in surgically prepd. conscious exercising dogs.  The mechanism of the antiarrhythmic action of n-3 PUFA has been studied by the authors in spontaneously contracting cultured cardiac myocytes of neonatal rats.  Adding arrhythmogenic toxins (ouabain, high Ca2+, lysophosphatidylcholine, β-adrenergic agonist, acylcarnitine, Ca ionophore) to the myocyte perfusate caused tachycardia, contracture, and fibrillation of the cultured myocytes.  Adding eicosapentaenoic acid (EPA; 5-15 μmol/L) to the superfusate before adding the toxins prevented the expected tachyarrhythmias.  When the arrhythmias were first induced, adding EPA to the superfusate terminated the arrhythmias.  This antiarrhythmic action occurred with dietary n-3 and n-6 PUFA; satd. fatty acids and the monounsatd. oleic acid had no such activity.  Arachidonic acid (AA; C20:4n-6) effects were anomalous because in 1/3 of the tests it provoked severe arrhythmias due to cyclooxygenase metabolites of AA.  When cyclooxygenase inhibitors were added with AA, the antiarrhythmic effect was like those of EPA and DHA.  The action of the n-3 and n-6 PUFA is to stabilize elec. every myocyte in the heart by increasing the elec. stimulus required to elicit an action potential by ∼50% and prolonging the relative refractory time by ∼150%.  These electrophysiol. effects result from an action of free PUFA to modulate sodium and calcium currents in the myocytes.  PUFA also modulate sodium and calcium channels and have anticonvulsant activity in brain cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4Y33dxq4aLVg90H21EOLACvtfcHk0lidDoTjRXpauQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFGruw%253D%253D&md5=7b715f46858c6d596bad48d4d8b8c377</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F71.1.202S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F71.1.202S%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BX.%26aulast%3DLeaf%26aufirst%3DA.%26atitle%3DPrevention%2520of%2520Fatal%2520Cardiac%2520Arrhythmias%2520by%2520Polyunsaturated%2520Fatty%2520Acids%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D2000%26volume%3D71%26spage%3D202S%26epage%3D207S%26doi%3D10.1093%2Fajcn%2F71.1.202S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leaf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billman, G. E.</span></span> <span> </span><span class="NLM_article-title">Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">2646</span>– <span class="NLM_lpage">2652</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000069566.78305.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2F01.CIR.0000069566.78305.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=12782616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ls1CgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2003&pages=2646-2652&author=A.+Leafauthor=J.+X.+Kangauthor=Y.-F.+Xiaoauthor=G.+E.+Billman&title=Clinical+Prevention+of+Sudden+Cardiac+Death+by+n-3+Polyunsaturated+Fatty+Acids+and+Mechanism+of+Prevention+of+Arrhythmias+by+n-3+Fish+Oils&doi=10.1161%2F01.CIR.0000069566.78305.33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils</span></div><div class="casAuthors">Leaf Alexander; Kang Jing X; Xiao Yong-Fu; Billman George E</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2646-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzbTltIGOu2kodMGTatQ7LfW6udTcc2eZsC_I7-U8xN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ls1CgsA%253D%253D&md5=5d86a4af26b47cf84c8a859a4e2ddb00</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000069566.78305.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000069566.78305.33%26sid%3Dliteratum%253Aachs%26aulast%3DLeaf%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DJ.%2BX.%26aulast%3DXiao%26aufirst%3DY.-F.%26aulast%3DBillman%26aufirst%3DG.%2BE.%26atitle%3DClinical%2520Prevention%2520of%2520Sudden%2520Cardiac%2520Death%2520by%2520n-3%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Mechanism%2520of%2520Prevention%2520of%2520Arrhythmias%2520by%2520n-3%2520Fish%2520Oils%26jtitle%3DCirculation%26date%3D2003%26volume%3D107%26spage%3D2646%26epage%3D2652%26doi%3D10.1161%2F01.CIR.0000069566.78305.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggioni, A. P.</span></span> <span> </span><span class="NLM_article-title">Upstream Treatment of Atrial Fibrillation with N-3 Polyunsaturated Fatty Acids: Myth or Reality?</span>. <i>Arrhythm. Electrophysiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.15420/aer.2015.4.3.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.15420%2Faer.2015.4.3.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26835119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC28nmvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=163-168&author=F.+Orsoauthor=G.+Fabbriauthor=A.+P.+Maggioni&title=Upstream+Treatment+of+Atrial+Fibrillation+with+N-3+Polyunsaturated+Fatty+Acids%3A+Myth+or+Reality%3F&doi=10.15420%2Faer.2015.4.3.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?</span></div><div class="casAuthors">Orso Francesco; Fabbri Gianna; Maggioni Aldo Pietro</div><div class="citationInfo"><span class="NLM_cas:title">Arrhythmia & electrophysiology review</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-8</span>
        ISSN:<span class="NLM_cas:issn">2050-3369</span>.
    </div><div class="casAbstract">Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and is associated with an increased risk of fatal and non-fatal events.  Antiarrhythmic drugs provide limited protection against AF recurrence and have a poor safety profile.  Several mechanisms have been proven to be involved in AF, e.g. inflammation, oxidative stress, fibrosis and ischaemia.  Prevention of AF with interventions that target these mechanisms has emerged as a result of experimental studies suggesting the use of upstream therapies.  Long chain n-3 polyunsaturated fatty acids (n-3 PUFA) have multiple effects on cardiac electrophysiology, and epidemiological studies on fish oil suggest a possible use of n-3 PUFA in AF prevention.  Several randomised clinical trials have been designed to evaluate the efficacy of n-3 PUFA in preventing AF.  In this review, we report the conflicting results of these trials in two different clinical settings: recurrence in patients with history of AF and development of post-operative AF in patient undergoing cardiac surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAM8q032c8iIxhnOQkIHOxfW6udTcc2eYuHh0p4llXDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmvVWquw%253D%253D&md5=51cc37fcd562e8cc620d7b33b3416e4e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.15420%2Faer.2015.4.3.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15420%252Faer.2015.4.3.163%26sid%3Dliteratum%253Aachs%26aulast%3DOrso%26aufirst%3DF.%26aulast%3DFabbri%26aufirst%3DG.%26aulast%3DMaggioni%26aufirst%3DA.%2BP.%26atitle%3DUpstream%2520Treatment%2520of%2520Atrial%2520Fibrillation%2520with%2520N-3%2520Polyunsaturated%2520Fatty%2520Acids%253A%2520Myth%2520or%2520Reality%253F%26jtitle%3DArrhythm.%2520Electrophysiol.%2520Rev.%26date%3D2015%26volume%3D4%26spage%3D163%26epage%3D168%26doi%3D10.15420%2Faer.2015.4.3.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Schacky, C.</span></span> <span> </span><span class="NLM_article-title">Omega-3 Fatty Acids: Anti-Arrhythmic, Pro-Arrhythmic, or Both?</span>. <i>Front. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">88</span>, <span class="refDoi"> DOI: 10.3389/fphys.2012.00088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.3389%2Ffphys.2012.00088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=22529815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A280%3ADC%252BC38rnt1yltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=88&author=C.+von%0ASchacky&title=Omega-3+Fatty+Acids%3A+Anti-Arrhythmic%2C+Pro-Arrhythmic%2C+or+Both%3F&doi=10.3389%2Ffphys.2012.00088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?</span></div><div class="casAuthors">von Schacky C</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This review focuses on developments after 2008, when the topic was last reviewed by the author.  Pertinent publications were found by medline searches and in the author's personal data base.  Prevention of atrial fibrillation (AF) was investigated in a number of trials, sparked by one positive report on the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), considerations of upstream therapy, data from electrophysiologic laboratories and animal experiments.  If EPA + DHA prevent postoperative AF, the effect is probably smaller than initially expected.  The same is probably true for maintenance of sinus rhythm after cardioversion and for new-onset AF.  Larger trials are currently ongoing.  Prevention of ventricular arrhythmias was studied in carriers of an implanted cardioverter-defibrillator, with no clear results.  This might have been due to a broad definition of the primary endpoint, including any ventricular arrhythmia and any action of the device.  Epidemiologic studies support the contention that high levels of EPA + DHA prevent sudden cardiac death (SCD).  However, since SCD is a rare occurrence, it is difficult to conduct an adequately powered trial.  In patients with congestive heart failure, EPA + DHA reduced total mortality and rehospitalizations, but not SCD or presumed arrhythmic death.  Of three trials in patients after a myocardial infarction, two were inadequately powered, and in one, the dose might have been too low.  Taken together, while epidemiologic studies support an inverse relation between EPA + DHA and occurrence of SCD or arrhythmic death, demonstrating this effect in intervention trials remained elusive so far.  A pro-arrhythmic effect of EPA + DHA has not been seen in intervention studies, and results of epidemiologic and animal studies also rather argue against such an effect.  A different, and probably more productive, perspective is provided by a standardized analytical assessment of a person's status in EPA + DHA by use of the omega-3 index, EPA + DHA in red cell fatty acids.  In populations with a high omega-3 index, SCD is rare.  Intervention trials can become more effective by including a low omega-3 index into the inclusion criteria, thus creating a study population more likely to demonstrate an effect of EPA + DHA.  This is especially relevant in case of rare endpoints, like new-onset AF or SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStpLp2g2-DHRBrI9DTGjC0fW6udTcc2eYuHh0p4llXDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnt1yltg%253D%253D&md5=5c6ebd132678919e14379db83f23c2b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3389%2Ffphys.2012.00088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphys.2012.00088%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26atitle%3DOmega-3%2520Fatty%2520Acids%253A%2520Anti-Arrhythmic%252C%2520Pro-Arrhythmic%252C%2520or%2520Both%253F%26jtitle%3DFront.%2520Physiol.%26date%3D2012%26volume%3D3%26spage%3D88%26doi%3D10.3389%2Ffphys.2012.00088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tota, C.</span></span> <span> </span><span class="NLM_article-title">The Anti-Arrhythmic Effects of <i>n</i>-3 PUFAs</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">S21</span>– <span class="NLM_lpage">S27</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2013.06.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.ijcard.2013.06.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24016540" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=S21-S27&author=L.+Cal%C3%B2author=A.+Martinoauthor=C.+Tota&title=The+Anti-Arrhythmic+Effects+of+n-3+PUFAs&doi=10.1016%2Fj.ijcard.2013.06.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2013.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2013.06.043%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DL.%26aulast%3DMartino%26aufirst%3DA.%26aulast%3DTota%26aufirst%3DC.%26atitle%3DThe%2520Anti-Arrhythmic%2520Effects%2520of%2520n-3%2520PUFAs%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D170%26spage%3DS21%26epage%3DS27%26doi%3D10.1016%2Fj.ijcard.2013.06.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">CYP-Eicosanoids-a New Link Between Omega-3 Fatty Acids and Cardiac Disease?</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2011.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.prostaglandins.2011.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOjurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2011&pages=99-108&author=C.+Westphalauthor=A.+Konkelauthor=W.+H.+Schunck&title=CYP-Eicosanoids-a+New+Link+Between+Omega-3+Fatty+Acids+and+Cardiac+Disease%3F&doi=10.1016%2Fj.prostaglandins.2011.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CYP-eicosanoids-A new link between omega-3 fatty acids and cardiac disease?</span></div><div class="casAuthors">Westphal, Christina; Konkel, Anne; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">99-108</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Fish oil omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against arrhythmia and sudden cardiac death by largely unknown mechanisms.  Recent in vitro and in vivo studies demonstrate that arachidonic acid (AA) metabolizing cytochrome P 450-(CYP) enzymes accept EPA and DHA as efficient alternative substrates.  Dietary EPA/DHA supplementation causes a profound shift of the cardiac CYP-eicosanoid profile from AA- to EPA- and DHA-derived epoxy- and hydroxy-metabolites.  CYP2J2 and other CYP epoxygenases preferentially epoxidize the ω-3 double bond of EPA and DHA.  The corresponding metabolites, 17,18-epoxy-EPA and 19,20-epoxy-DHA, dominate the CYP-eicosanoid profile of the rat heart after EPA/DHA supplementation.  The (ω-3)-epoxyeicosanoids show highly potent antiarrhythmic properties in neonatal cardiomyocytes, suggesting that these metabolites may specifically contribute to the cardioprotective effects of omega-3 fatty acids.  This hypothesis is discussed in the context of recent findings that revealed CYP-eicosanoid mediated mechanisms in cardiac ischemia-reperfusion injury and maladaptive cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMUDV9LlYR7Vg90H21EOLACvtfcHk0lh1NxHGpv1aKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOjurfF&md5=d8a8d82d16dd181493631c7eae4c623c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DCYP-Eicosanoids-a%2520New%2520Link%2520Between%2520Omega-3%2520Fatty%2520Acids%2520and%2520Cardiac%2520Disease%253F%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2011%26volume%3D96%26spage%3D99%26epage%3D108%26doi%3D10.1016%2Fj.prostaglandins.2011.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weylandt, K. H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Potential of Omega-3 Fatty Acid-Derived Epoxyeicosanoids in Cardiovascular and Inflammatory Diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.pharmthera.2017.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=29080699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslygtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=177-204&author=W.+H.+Schunckauthor=A.+Konkelauthor=R.+Fischerauthor=K.+H.+Weylandt&title=Therapeutic+Potential+of+Omega-3+Fatty+Acid-Derived+Epoxyeicosanoids+in+Cardiovascular+and+Inflammatory+Diseases&doi=10.1016%2Fj.pharmthera.2017.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases</span></div><div class="casAuthors">Schunck, Wolf-Hagen; Konkel, Anne; Fischer, Robert; Weylandt, Karsten-Henrich</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-204</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Numerous benefits have been attributed to dietary long-chain omega-3 polyunsatd. fatty acids (n-3 LC-PUFAs), including protection against cardiac arrhythmia, triglyceride-lowering, amelioration of inflammatory, and neurodegenerative disorders.  This review covers recent findings indicating that a variety of these beneficial effects are mediated by "omega-3 epoxyeicosanoids", a class of novel n-3 LC-PUFA-derived lipid mediators, which are generated via the cytochrome P 450 (CYP) epoxygenase pathway.  CYP enzymes, previously identified as arachidonic acid (20:4n-6; AA) epoxygenases, accept eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA), the major fish oil n-3 LC-PUFAs, as efficient alternative substrates.  In humans and rodents, dietary EPA/DHA supplementation causes a profound shift of the endogenous CYP-eicosanoid profile from AA- to EPA- and DHA-derived metabolites, increasing, in particular, the plasma and tissue levels of 17,18-epoxyeicosatetraenoic acid (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP).  Based on preclin. studies, these omega-3 epoxyeicosanoids display cardioprotective, vasodilatory, anti-inflammatory, and anti-allergic properties that contribute to the beneficial effects of n-3 LC-PUFAs in diverse disease conditions ranging from cardiac disease, bronchial disorders, and intraocular neovascularization, to allergic intestinal inflammation and inflammatory pain.  Increasing evidence also suggests that background nutrition as well as genetic and disease state-related factors could limit the response to EPA/DHA-supplementation by reducing the formation and/or enhancing the degrdn. of omega-3 epoxyeicosanoids.  Recently, metabolically robust synthetic analogs mimicking the biol. activities of 17,18-EEQ have been developed.  These drug candidates may overcome limitations of dietary EPA/DHA supplementation and provide novel options for the treatment of cardiovascular and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR4e6v0kblPLVg90H21EOLACvtfcHk0lgwU1oCp5NzEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslygtr%252FI&md5=af1e271b25c13db6a521c20c2bec883f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DWeylandt%26aufirst%3DK.%2BH.%26atitle%3DTherapeutic%2520Potential%2520of%2520Omega-3%2520Fatty%2520Acid-Derived%2520Epoxyeicosanoids%2520in%2520Cardiovascular%2520and%2520Inflammatory%2520Diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D183%26spage%3D177%26epage%3D204%26doi%3D10.1016%2Fj.pharmthera.2017.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gapelyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharzowsky, U. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plehm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirdewan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span> <span> </span><span class="NLM_article-title">Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.107.103143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1161%2FHYPERTENSIONAHA.107.103143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=18158339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Krug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=540-546&author=R.+Fischerauthor=R.+Dechendauthor=F.+Qadriauthor=M.+Markovicauthor=S.+Feldtauthor=F.+Herseauthor=J.+K.+Parkauthor=A.+Gapelyukauthor=I.+Schwarzauthor=U.+B.+Zacharzowskyauthor=R.+Plehmauthor=E.+Safakauthor=A.+Heuserauthor=A.+Schirdewanauthor=F.+C.+Luftauthor=W.+H.+Schunckauthor=D.+N.+Muller&title=Dietary+n-3+Polyunsaturated+Fatty+Acids+and+Direct+Renin+Inhibition+Improve+Electrical+Remodeling+in+a+Model+of+High+Human+Renin+Hypertension&doi=10.1161%2FHYPERTENSIONAHA.107.103143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension</span></div><div class="casAuthors">Fischer, Robert; Dechend, Ralf; Qadri, Fatimunnisa; Markovic, Marija; Feldt, Sandra; Herse, Florian; Park, Joon-Keun; Gapelyuk, Andrej; Schwarz, Ines; Zacharzowsky, Udo B.; Plehm, Ralph; Safak, Erdal; Heuser, Arnd; Schirdewan, Alexander; Luft, Friedrich C.; Schunck, Wolf-Hagen; Muller, Dominik N.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2, Pt. 2</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We compared the effect n-3 polyunsatd. fatty acids (PUFAs) with direct renin inhibition on electrophysiol. remodeling in angiotensin II-induced cardiac injury.  We treated double-transgenic rats expressing the human renin and angiotensinogen genes (dTGRs) from week 4 to 7 with n-3 PUFA ethyl-esters (Omacor; 25-g/kg diet) or a direct renin inhibitor (aliskiren; 3 mg/kg per day).  Sprague-Dawley rats were controls.  We performed electrocardiog., magnetocardiog., and programmed elec. stimulation.  Dietary n-3 PUFAs increased the cardiac content of eicosapentaenoic and docosahexaenoic acid.  At week 7, mortality in dTGRs was 31%, whereas none of the n-3 PUFA- or aliskiren-treated dTGRs died.  Systolic blood pressure was modestly reduced in n-3 PUFA-treated (180 ± 3 mm Hg) compared with dTGRs (208 ± 5 mm Hg).  Aliskiren-treated dTGRs and Sprague-Dawley rats were normotensive (110 ± 3 and 119 ± 6 mm Hg, resp.).  Both n-3 PUFA-treated and untreated dTGRs showed cardiac hypertrophy and increased atrial natriuretic peptide levels.  Prolonged QRS and QTc intervals and increased T-wave dispersion in dTGRs were reduced by n-3 PUFAs or aliskiren.  Both treatments reduced arrhythmia induction from 75% in dTGRs to 17% vs. 0% in Sprague-Dawley rats.  Macrophage infiltration and fibrosis were reduced by n-3 PUFAs and aliskiren.  Connexin 43, a mediator of intermyocyte conduction, was redistributed to the lateral cell membranes in dTGRs. n-3 PUFAs and aliskiren restored normal localization to the intercalated disks.  Thus, n-3 PUFAs and aliskiren improved elec. remodeling, arrhythmia induction, and connexin 43 expression, despite a 70-mm Hg difference in blood pressure and the development of cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM9nmONMVTEbVg90H21EOLACvtfcHk0lgwU1oCp5NzEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Krug%253D%253D&md5=078c8001995ff190d0b8f36570797b3f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.107.103143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.107.103143%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DQadri%26aufirst%3DF.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DFeldt%26aufirst%3DS.%26aulast%3DHerse%26aufirst%3DF.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DGapelyuk%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DI.%26aulast%3DZacharzowsky%26aufirst%3DU.%2BB.%26aulast%3DPlehm%26aufirst%3DR.%26aulast%3DSafak%26aufirst%3DE.%26aulast%3DHeuser%26aufirst%3DA.%26aulast%3DSchirdewan%26aufirst%3DA.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26atitle%3DDietary%2520n-3%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Direct%2520Renin%2520Inhibition%2520Improve%2520Electrical%2520Remodeling%2520in%2520a%2520Model%2520of%2520High%2520Human%2520Renin%2520Hypertension%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D540%26epage%3D546%26doi%3D10.1161%2FHYPERTENSIONAHA.107.103143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blossey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Schacky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Arachidonic Acid-Metabolizing Cytochrome P450 Enzymes are Targets of ω-3 Fatty Acids</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">32720</span>– <span class="NLM_lpage">32733</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.118406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1074%2Fjbc.M110.118406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=20732876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12nu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32720-32733&author=C.+Arnoldauthor=M.+Markovicauthor=K.+Blosseyauthor=G.+Wallukatauthor=R.+Fischerauthor=R.+Dechendauthor=A.+Konkelauthor=C.+von+Schackyauthor=F.+C.+Luftauthor=D.+N.+Mullerauthor=M.+Rotheauthor=W.-H.+Schunck&title=Arachidonic+Acid-Metabolizing+Cytochrome+P450+Enzymes+are+Targets+of+%CF%89-3+Fatty+Acids&doi=10.1074%2Fjbc.M110.118406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonic Acid-metabolizing Cytochrome P450 Enzymes are Targets of ω-3 Fatty Acids</span></div><div class="casAuthors">Arnold, Cosima; Markovic, Marija; Blossey, Katrin; Wallukat, Gerd; Fischer, Robert; Dechend, Ralf; Konkel, Anne; von Schacky, Clemens; Luft, Friedrich C.; Muller, Dominik N.; Rothe, Michael; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">32720-32733</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against cardiovascular disease by largely unknown mechanisms.  We tested the hypothesis that EPA and DHA may compete with arachidonic acid (AA) for the conversion by cytochrome P 450 (CYP) enzymes, resulting in the formation of alternative, physiol. active, metabolites.  Renal and hepatic microsomes, as well as various CYP isoforms, displayed equal or elevated activities when metabolizing EPA or DHA instead of AA.  CYP2C/2J isoforms converting AA to epoxyeicosatrienoic acids (EETs) preferentially epoxidized the ω-3 double bond and thereby produced 17,18-epoxyeicosatetraenoic (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP) from EPA and DHA.  We found that these ω-3 epoxides are highly active as antiarrhythmic agents, suppressing the Ca2+-induced increased rate of spontaneous beating of neonatal rat cardiomyocytes, at low nanomolar concns.  CYP4A/4F isoforms ω-hydroxylating AA were less regioselective toward EPA and DHA, catalyzing predominantly ω- and ω minus 1 hydroxylation.  Rats given dietary EPA/DHA supplementation exhibited substantial replacement of AA by EPA and DHA in membrane phospholipids in plasma, heart, kidney, liver, lung, and pancreas, with less pronounced changes in the brain.  The changes in fatty acids were accompanied by concomitant changes in endogenous CYP metabolite profiles (e.g. altering the EET/EEQ/EDP ratio from 87:0:13 to 27:18:55 in the heart).  These results demonstrate that CYP enzymes efficiently convert EPA and DHA to novel epoxy and hydroxy metabolites that could mediate some of the beneficial cardiovascular effects of dietary ω-3 fatty acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqued4FkC5_sbVg90H21EOLACvtfcHk0lh-XqrtGVxxGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12nu7%252FN&md5=117166ad5cb559d06093fd333f2826f8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.118406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.118406%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DC.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DBlossey%26aufirst%3DK.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DArachidonic%2520Acid-Metabolizing%2520Cytochrome%2520P450%2520Enzymes%2520are%2520Targets%2520of%2520%25CF%2589-3%2520Fatty%2520Acids%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32720%26epage%3D32733%26doi%3D10.1074%2Fjbc.M110.118406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Molecular Properties of the Cytochrome P450 Arachidonic Acid Monooxygenases</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>68–69</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/S0090-6980(02)00038-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0090-6980%2802%2900038-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=12432927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvV2ntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68%E2%80%9369&publication_year=2002&pages=325-344&author=J.+H.+Capdevilaauthor=J.+R.+Falck&title=Biochemical+and+Molecular+Properties+of+the+Cytochrome+P450+Arachidonic+Acid+Monooxygenases&doi=10.1016%2FS0090-6980%2802%2900038-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases</span></div><div class="casAuthors">Capdevila, Jorge H.; Falck, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">68-69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">325-344</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The cytochrome P 450 (P 450) arachidonic acid (AA) monooxygenase metabolizes the fatty acid to a series of epoxy- and hydroxy-acid derivs.  Catalytic turnover requires NADPH, and requires the redox-coupled activation and cleavage of diat. oxygen, and the delivery of an active form of at. oxygen to ground state carbon atoms.  Past and present advances in P 450 biochem. and mol. biol. are beginning to provide a description of the P 450 isoform specificity of AA bioactivation, and the mechanisms of action and physiol. relevance of the P 450 metabolites.  The demonstration of the endogenous biosynthesis of many of these metabolites has established the P 450 pathway as an important route for AA bioactivation, and has begun to uncover new and important functional roles for this enzyme system in cell and organ physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyom9LG8qo6LVg90H21EOLACvtfcHk0lh-XqrtGVxxGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvV2ntr4%253D&md5=cd33dcaa2d905c204409f52f3c06e09c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0090-6980%2802%2900038-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-6980%252802%252900038-2%26sid%3Dliteratum%253Aachs%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26atitle%3DBiochemical%2520and%2520Molecular%2520Properties%2520of%2520the%2520Cytochrome%2520P450%2520Arachidonic%2520Acid%2520Monooxygenases%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2002%26volume%3D68%25E2%2580%259369%26spage%3D325%26epage%3D344%26doi%3D10.1016%2FS0090-6980%2802%2900038-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulitquer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marienhagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaneberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcos, L.</span></span> <span> </span><span class="NLM_article-title">Stereoselective Epoxidation of the Last Double Bond of Polyunsaturated Fatty Acids by Human Cytochromes P450</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1125</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1194/jlr.M003061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M003061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=19965576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1125-1133&author=D.+Lucasauthor=S.+Goulitquerauthor=J.+Marienhagenauthor=M.+Ferauthor=Y.+Dreanoauthor=U.+Schwanebergauthor=Y.+Ametauthor=L.+Corcos&title=Stereoselective+Epoxidation+of+the+Last+Double+Bond+of+Polyunsaturated+Fatty+Acids+by+Human+Cytochromes+P450&doi=10.1194%2Fjlr.M003061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450</span></div><div class="casAuthors">Lucas, Daniele; Goulitquer, Sophie; Marienhagen, Jan; Fer, Maude; Dreano, Yvonne; Schwaneberg, Ulrich; Amet, Yolande; Corcos, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1125-1133</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Cytochromes P 450 (CYPs) metabolize polyunsatd. long-chain fatty acids (PUFA-LC) to several classes of oxygenated metabolites.  Through use of human recombinant CYPs, we recently showed that CYP1A1, -2C19, -2D6, -2E1, and -3A4 are mainly hydroxylases, whereas CYP1A2, -2C8, -2C9, and -2J2 are mainly epoxygenases of arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), resp.  It is worth noting that the last double bond of these PUFAs, i.e., ω6 in AA or ω3 in EPA and DHA, resp., was preferentially epoxidized.  In this study, we have characterized the stereoselectivity of this epoxidn. reaction by comparison with the PUFA-LC epoxide stereoisomers obtained from the enantioselective bacterial CYP102A1 F87V.  The stereoselectivity of the epoxidn. of the last olefin of AA (ω6), EPA (ω3), or DHA (ω3) differed between the CYP isoforms but was similar for EPA and DHA.  These data give addnl. insight into the PUFA-LC epoxide enantiomers generated by the hepatic CYPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPXrDlI8zcyLVg90H21EOLACvtfcHk0lh-XqrtGVxxGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWktL0%253D&md5=c847aab0e38064a3f9cb64702c758c0f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M003061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M003061%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DD.%26aulast%3DGoulitquer%26aufirst%3DS.%26aulast%3DMarienhagen%26aufirst%3DJ.%26aulast%3DFer%26aufirst%3DM.%26aulast%3DDreano%26aufirst%3DY.%26aulast%3DSchwaneberg%26aufirst%3DU.%26aulast%3DAmet%26aufirst%3DY.%26aulast%3DCorcos%26aufirst%3DL.%26atitle%3DStereoselective%2520Epoxidation%2520of%2520the%2520Last%2520Double%2520Bond%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520by%2520Human%2520Cytochromes%2520P450%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2010%26volume%3D51%26spage%3D1125%26epage%3D1133%26doi%3D10.1194%2Fjlr.M003061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">Eicosapentaenoic Acid Metabolism by Cytochrome P450 Enzymes of the CYP2C Subfamily</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.02.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bbrc.2005.02.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=15766564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1eqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=1275-1281&author=E.+Barbosa-Sicardauthor=M.+Markovicauthor=H.+Honeckauthor=B.+Christauthor=D.+N.+M%C3%BCllerauthor=W.+H.+Schunck&title=Eicosapentaenoic+Acid+Metabolism+by+Cytochrome+P450+Enzymes+of+the+CYP2C+Subfamily&doi=10.1016%2Fj.bbrc.2005.02.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily</span></div><div class="casAuthors">Barbosa-Sicard, Eduardo; Markovic, Marija; Honeck, Horst; Christ, Baghat; Muller, Dominik N.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1275-1281</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">CYP2C enzymes epoxidize arachidonic acid (AA) to metabolites involved in the regulation of vascular and renal function.  We tested the hypothesis that eicosapentaenoic acid (EPA), a n-3 polyunsatd. fatty acid, may serve as an alternative substrate.  Human CYP2C8 and CYP2C9, as well as rat CYP2C11 and CYP2C23, were co-expressed with NADPH-CYP reductase in a baculovirus/insect cell system.  The recombinant enzymes showed high EPA and AA epoxygenase activities and the catalytic efficiencies were almost equal comparing the two substrates.  The 17,18-double bond was the preferred site of EPA epoxidn. by CYPs 2C8, 2C11, and 2C23.  17(R),18(S)-Epoxyeicosatetraenoic acid was produced with an optical purity of about 70% by CYPs 2C9, 2C11, and 2C23 whereas CYP2C8 showed the opposite enantioselectivity.  These results demonstrate that EPA is an efficient substrate of CYP2C enzymes and suggest that n-3 PUFA-rich diets may shift the CYP2C-dependent generation of physiol. active eicosanoids from AA- to EPA-derived metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVWXmn1Hld2LVg90H21EOLACvtfcHk0lg2HdEmYHHNng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1eqt7o%253D&md5=8ea4eea71f4350eaad26ae0dd76ab02e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.02.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.02.103%26sid%3Dliteratum%253Aachs%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DHoneck%26aufirst%3DH.%26aulast%3DChrist%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DEicosapentaenoic%2520Acid%2520Metabolism%2520by%2520Cytochrome%2520P450%2520Enzymes%2520of%2520the%2520CYP2C%2520Subfamily%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D1275%26epage%3D1281%26doi%3D10.1016%2Fj.bbrc.2005.02.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa-Sicard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hercule, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Mouse Cyp4a Isoforms: Enzymatic Properties, Gender- and Strain-Specific Expression, and Role in Renal 20-Hydroxyeicosatetraenoic Acid Formation</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1042/BJ20061328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1042%2FBJ20061328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=17112342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFOksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2007&pages=109-118&author=D.+N.+M%C3%BCllerauthor=C.+Schmidtauthor=E.+Barbosa-Sicardauthor=N.+Wellnerauthor=V.+Grossauthor=H.+Herculeauthor=M.+Markovicauthor=H.+Honeckauthor=F.+C.+Luftauthor=W.-H.+Schunck&title=Mouse+Cyp4a+Isoforms%3A+Enzymatic+Properties%2C+Gender-+and+Strain-Specific+Expression%2C+and+Role+in+Renal+20-Hydroxyeicosatetraenoic+Acid+Formation&doi=10.1042%2FBJ20061328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation</span></div><div class="casAuthors">Muller, Dominik N.; Schmidt, Cosima; Barbosa-Sicard, Eduardo; Wellner, Maren; Gross, Volkmar; Hercule, Hantz; Markovic, Marija; Honeck, Horst; Luft, Friedrich C.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-118</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">AA (arachidonic acid) hydroxylation to 20-HETE (20-hydroxyeicosatetraenoic acid) influences renal vascular and tubular function.  To identify the CYP (cytochrome P 450) isoforms catalyzing this reaction in the mouse kidney, we analyzed the substrate specificity of Cyp4a10, 4a12a, 4a12b and 4a14 and detd. sex- and strain-specific expressions.  All recombinant enzymes showed high lauric acid hydroxylase activities.  Cyp4a12a and Cyp4a12b efficiently hydroxylated AA to 20-HETE with Vmax values of approx. 10 nmol nmol-1 min-1 and Km values of 20-40 μM.  20-Carboxyeicosatetraenoic acid occurred as a secondary metabolite.  AA hydroxylase activities were approx. 25-75-fold lower with Cyp4a10 and not detectable with Cyp4a14.  Cyp4a12a and Cyp4a12b also efficiently converted EPA (eicosapentaenoic acid) into 19/20-OH- and 17,18-epoxy-EPA.  In male mice, renal microsomal AA hydroxylase activities ranged between approx. 100 (NMRI), 45-55 (FVB/N, 129 Sv/J and Balb/c) and 25 pmol min-1 mg-1 (C57BL/6).  The activities correlated with differences in Cyp4a12a protein and mRNA levels.  Treatment with 5α-dihydrotestosterone induced both 20-HETE prodn. and Cyp4a12a expression more than 4-fold in male C57BL/6 mice.  All female mice showed low AA hydroxylase activities (15-25 pmol min-1 mg-1) and very low Cyp4a12a mRNA and protein levels, but high Cyp4a10 and Cyp4a14 expression.  Renal Cyp4a12b mRNA expression was almost undetectable in both sexes of all strains.  Thus Cyp4a12a is the predominant 20-HETE synthase in the mouse kidney.  Cyp4a12a expression dets. the sex- and strain-specific differences in 20-HETE generation and may explain sex and strain differences in the susceptibility to hypertension and target organ damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTniS7Waz28bVg90H21EOLACvtfcHk0lg2HdEmYHHNng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFOksLw%253D&md5=2b8d39a33e21e2b099a1dfb0c69e8a29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1042%2FBJ20061328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061328%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchmidt%26aufirst%3DC.%26aulast%3DBarbosa-Sicard%26aufirst%3DE.%26aulast%3DWellner%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DV.%26aulast%3DHercule%26aufirst%3DH.%26aulast%3DMarkovic%26aufirst%3DM.%26aulast%3DHoneck%26aufirst%3DH.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DMouse%2520Cyp4a%2520Isoforms%253A%2520Enzymatic%2520Properties%252C%2520Gender-%2520and%2520Strain-Specific%2520Expression%252C%2520and%2520Role%2520in%2520Renal%252020-Hydroxyeicosatetraenoic%2520Acid%2520Formation%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D403%26spage%3D109%26epage%3D118%26doi%3D10.1042%2FBJ20061328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallek, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeGraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regitz-Zagrosek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span> <span> </span><span class="NLM_article-title">CYP2J2 Overexpression Protects Against Arrhythmia Susceptibility in Cardiac Hypertrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e73490</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0073490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1371%2Fjournal.pone.0073490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24023684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=C.+Westphalauthor=B.+Spallekauthor=A.+Konkelauthor=L.+Markoauthor=F.+Qadriauthor=L.+M.+DeGraffauthor=C.+Schubertauthor=J.+A.+Bradburyauthor=V.+Regitz-Zagrosekauthor=J.+R.+Falckauthor=D.+C.+Zeldinauthor=D.+N.+M%C3%BCllerauthor=W.+H.+Schunckauthor=R.+Fischer&title=CYP2J2+Overexpression+Protects+Against+Arrhythmia+Susceptibility+in+Cardiac+Hypertrophy&doi=10.1371%2Fjournal.pone.0073490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy</span></div><div class="casAuthors">Westphal, Christina; Spallek, Bastian; Konkel, Anne; Marko, Lajos; Qadri, Fatimunnisa; DeGraff, Laura M.; Schubert, Carola; Bradbury, J. Alyce; Regitz-Zagrosek, Vera; Falck, John R.; Zeldin, Darryl C.; Mueller, Dominik N.; Schunck, Wolf-Hagen; Fischer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e73490</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Maladaptive cardiac hypertrophy predisposes one to arrhythmia and sudden death.  Cytochrome P 450 (CYP)-derived epoxyeicosatrienoic acids (EETs) promote anti-inflammatory and antiapoptotic mechanisms, and are involved in the regulation of cardiac Ca2+-, K+- and Na+-channels.  To test the hypothesis that enhanced cardiac EET biosynthesis counteracts hypertrophy-induced elec. remodeling, male transgenic mice with cardiomyocyte-specific overexpression of the human epoxygenase CYP2J2 (CYP2J2-TG) and wildtype littermates (WT) were subjected to chronic pressure overload (transverse aortic constriction, TAC) or β-adrenergic stimulation (isoproterenol infusion, ISO).  TAC caused progressive mortality that was higher in WT (42% over 8 wk after TAC), compared to CYP2J2-TG mice (6%).  In vivo electrophysiol. studies, 4 wk after TAC, revealed high ventricular tachyarrhythmia inducibility in WT (47% of the stimulation protocols), but not in CYP2J2-TG mice (0%).  CYP2J2 overexpression also enhanced ventricular refractoriness and protected against TAC-induced QRS prolongation and delocalization of left ventricular connexin-43.  ISO for 14 days induced high vulnerability for atrial fibrillation in WT mice (54%) that was reduced in CYP-TG mice (17%).  CYP2J2 overexpression also protected against ISO-induced redn. of atrial refractoriness and development of atrial fibrosis.  In contrast to these profound effects on elec. remodeling, CYP2J2 overexpression only moderately reduced TAC-induced cardiac hypertrophy and did not affect the hypertrophic response to β-adrenergic stimulation.  These results demonstrate that enhanced cardiac EET biosynthesis protects against elec. remodeling, ventricular tachyarrhythmia, and atrial fibrillation susceptibility during maladaptive cardiac hypertrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCKgdkbfAMwrVg90H21EOLACvtfcHk0lg2HdEmYHHNng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChsLbP&md5=6b548c2ad340e860ca9f997897a3347e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073490%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DSpallek%26aufirst%3DB.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DMarko%26aufirst%3DL.%26aulast%3DQadri%26aufirst%3DF.%26aulast%3DDeGraff%26aufirst%3DL.%2BM.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DRegitz-Zagrosek%26aufirst%3DV.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DCYP2J2%2520Overexpression%2520Protects%2520Against%2520Arrhythmia%2520Susceptibility%2520in%2520Cardiac%2520Hypertrophy%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0073490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. A.</span></span> <span> </span><span class="NLM_article-title">Urinary Excretion of Diols Derived from Eicosapentaenoic Acid During N-3 Fatty Acid Ingestion by Man</span>. <i>Prostaglandins</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/0090-6980(91)90093-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2F0090-6980%2891%2990093-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1771239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK3MXkslSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1991&pages=47-54&author=H.+R.+Knappauthor=A.+J.+Millerauthor=J.+A.+Lawson&title=Urinary+Excretion+of+Diols+Derived+from+Eicosapentaenoic+Acid+During+N-3+Fatty+Acid+Ingestion+by+Man&doi=10.1016%2F0090-6980%2891%2990093-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man</span></div><div class="casAuthors">Knapp, H. R.; Miller, A. J.; Lawson, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">PRGLBA</span>;
        ISSN:<span class="NLM_cas:issn">0090-6980</span>.
    </div><div class="casAbstract">Utilizing gas chromatog./neg. chem. ionization mass spectrometry, it was found that humans ingesting n-3 fatty acids (eicosapentaenoic acid) excrete vicinal diols of eicosapentaenoic acid in substantial quantities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYl2cD42WCNbVg90H21EOLACvtfcHk0lhmop_K76PXfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslSgsrs%253D&md5=a2dc62bfbd359c5a1431414d43ec377f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0090-6980%2891%2990093-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0090-6980%252891%252990093-U%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DH.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26atitle%3DUrinary%2520Excretion%2520of%2520Diols%2520Derived%2520from%2520Eicosapentaenoic%2520Acid%2520During%2520N-3%2520Fatty%2520Acid%2520Ingestion%2520by%2520Man%26jtitle%3DProstaglandins%26date%3D1991%26volume%3D42%26spage%3D47%26epage%3D54%26doi%3D10.1016%2F0090-6980%2891%2990093-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span> <span> </span><span class="NLM_article-title">Detection of Omega-3 Oxylipins in Human Plasma and Response to Treatment with Omega-3 Acid Ethyl Esters</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2074</span>– <span class="NLM_lpage">2081</span>, <span class="refDoi"> DOI: 10.1194/jlr.M900193-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M900193-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=19671931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2074-2081&author=G.+C.+Shearerauthor=W.+S.+Harrisauthor=T.+L.+Pedersenauthor=J.+W.+Newman&title=Detection+of+Omega-3+Oxylipins+in+Human+Plasma+and+Response+to+Treatment+with+Omega-3+Acid+Ethyl+Esters&doi=10.1194%2Fjlr.M900193-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters</span></div><div class="casAuthors">Shearer, Gregory C.; Harris, William S.; Pedersen, Theresa L.; Newman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2074-2081</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">The long-chain omega-3 fatty acids (n-3 FA) eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) have beneficial health effects, but the mol. mediators of these effects are not well characterized.  Oxygenated n-3 FAs (oxylipins) may be an important class of mediators.  Members of this chem. class include epoxides, alcs., diols, and ketones, many of which have bioactivity in vitro.  Neither the presence of n-3 oxylipins in human plasma nor the effect of n-3 FA ingestion on their levels has been documented.  We measured plasma oxylipins derived from both the n-3 and n-6 FA classes in healthy volunteers (n = 10) before and after 4 wk of treatment with prescription n-3 FA Et esters (4 g/day).  At baseline, EPA and DHA oxylipins were detected in low (1-50 nM) range, with alcs. > epoxides ≥ diols.  Treatment increased n-3 oxylipin levels 2- to 5-fold and reduced selected n-6 oxylipins by ∼20%.  This is the first documentation that endogenous n-3 oxylipin levels can be modulated by n-3 FA treatment in humans.  The extent to which the beneficial cardiovascular effects of n-3 FAs are mediated by increased n-3 and/or reduced n-6 oxylipin levels remains to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZanjDqRKVB7Vg90H21EOLACvtfcHk0lhmop_K76PXfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOlurs%253D&md5=904590c4ca718c863dd1286995584d4f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M900193-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M900193-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DShearer%26aufirst%3DG.%2BC.%26aulast%3DHarris%26aufirst%3DW.%2BS.%26aulast%3DPedersen%26aufirst%3DT.%2BL.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26atitle%3DDetection%2520of%2520Omega-3%2520Oxylipins%2520in%2520Human%2520Plasma%2520and%2520Response%2520to%2520Treatment%2520with%2520Omega-3%2520Acid%2520Ethyl%2520Esters%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2010%26volume%3D51%26spage%3D2074%26epage%3D2081%26doi%3D10.1194%2Fjlr.M900193-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blossey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gapelyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Schacky, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechend, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weylandt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Dietary Omega-3 Fatty Acids Modulate the Eicosanoid Profile in Man Primarily via the CYP-Epoxygenase Pathway</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1194/jlr.M047357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M047357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=24634501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1entr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1150-1164&author=R.+Fischerauthor=A.+Konkelauthor=H.+Mehlingauthor=K.+Blosseyauthor=A.+Gapelyukauthor=N.+Wesselauthor=C.+von+Schackyauthor=R.+Dechendauthor=D.+N.+Mullerauthor=M.+Rotheauthor=F.+C.+Luftauthor=K.+Weylandtauthor=W.-H.+Schunck&title=Dietary+Omega-3+Fatty+Acids+Modulate+the+Eicosanoid+Profile+in+Man+Primarily+via+the+CYP-Epoxygenase+Pathway&doi=10.1194%2Fjlr.M047357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway</span></div><div class="casAuthors">Fischer, Robert; Konkel, Anne; Mehling, Heidrun; Blossey, Katrin; Gapelyuk, Andrej; Wessel, Niels; von Schacky, Clemens; Dechend, Ralf; Muller, Dominik N.; Rothe, Michael; Luft, Friedrich C.; Weylandt, Karsten; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1150-1164</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Cytochrome P 450 (CYP)-dependent metabolites of arachidonic acid (AA) contribute to the regulation of cardiovascular function.  CYP enzymes also accept EPA and DHA to yield more potent vasodilatory and potentially anti-arrhythmic metabolites, suggesting that the endogenous CYP-eicosanoid profile can be favorably shifted by dietary omega-3 fatty acids.  To test this hypothesis, 20 healthy volunteers were treated with an EPA/DHA supplement and analyzed for concomitant changes in the circulatory and urinary levels of AA-, EPA-, and DHA-derived metabolites produced by the cyclooxygenase-, lipoxygenase (LOX)-, and CYP-dependent pathways.  Raising the Omega-3 Index from about four to eight primarily resulted in a large increase of EPA-derived CYP-dependent epoxy-metabolites followed by increases of EPA- and DHA-derived LOX-dependent monohydroxy-metabolites including the precursors of the resolvin E and D families; resolvins themselves were not detected.  The metabolite/precursor fatty acid ratios indicated that CYP epoxygenases metabolized EPA with an 8.6-fold higher efficiency and DHA with a 2.2-fold higher efficiency than AA.  Effects on leukotriene, prostaglandin E, prostacyclin, and thromboxane formation remained rather weak.  We propose that CYP-dependent epoxy-metabolites of EPA and DHA may function as mediators of the vasodilatory and cardioprotective effects of omega-3 fatty acids and could serve as biomarkers in clin. studies investigating the cardiovascular effects of EPA/DHA supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OGaWewI_M7Vg90H21EOLACvtfcHk0lhmop_K76PXfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1entr0%253D&md5=ae098dedbcb2583468819a93ff3a54ef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M047357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M047357%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DMehling%26aufirst%3DH.%26aulast%3DBlossey%26aufirst%3DK.%26aulast%3DGapelyuk%26aufirst%3DA.%26aulast%3DWessel%26aufirst%3DN.%26aulast%3Dvon%2BSchacky%26aufirst%3DC.%26aulast%3DDechend%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DD.%2BN.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DWeylandt%26aufirst%3DK.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DDietary%2520Omega-3%2520Fatty%2520Acids%2520Modulate%2520the%2520Eicosanoid%2520Profile%2520in%2520Man%2520Primarily%2520via%2520the%2520CYP-Epoxygenase%2520Pathway%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1150%26epage%3D1164%26doi%3D10.1194%2Fjlr.M047357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">ω-3 Polyunsaturated Fatty Acids-Derived Lipid Metabolites on Angiogenesis, Inflammation and Cancer</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>113–115</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.prostaglandins.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113%E2%80%93115&publication_year=2014&pages=13-20&author=W.+Wangauthor=J.+Zhuauthor=F.+Lyuauthor=D.+Panigrahyauthor=K.+W.+Ferraraauthor=B.+Hammockauthor=G.+Zhang&title=%CF%89-3+Polyunsaturated+Fatty+Acids-Derived+Lipid+Metabolites+on+Angiogenesis%2C+Inflammation+and+Cancer&doi=10.1016%2Fj.prostaglandins.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer</span></div><div class="casAuthors">Wang, Weicang; Zhu, Julia; Lyu, Fei; Panigrahy, Dipak; Ferrara, Katherine W.; Hammock, Bruce; Zhang, Guodong</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">113-115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Epidemiol. and pre-clin. studies support the anti-tumor effects of ω-3 PUFAs; however, the results from human trials are mixed, making it difficult to provide dietary guidelines or recommendations of ω-3 PUFAs for disease prevention or treatment.  Understanding the mol. mechanisms by which ω-3 PUFAs inhibit cancer could lead to better nutritional paradigms and human trials to clarify their health effects.  The ω-3 PUFAs exert their biol. activities mainly through the formation of bioactive lipid metabolites.  Here we discuss the biol. of cyclooxygenase, lipoxygenase and cytochrome P 450 enzymes-derived ω-3-series lipid metabolites on angiogenesis, inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptNk-fcb-1zLVg90H21EOLACvtfcHk0liLc9JIfNwXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSqt7jE&md5=24bef3cb944a6f0eea6aa4b370f6dd30</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLyu%26aufirst%3DF.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DFerrara%26aufirst%3DK.%2BW.%26aulast%3DHammock%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3D%25CF%2589-3%2520Polyunsaturated%2520Fatty%2520Acids-Derived%2520Lipid%2520Metabolites%2520on%2520Angiogenesis%252C%2520Inflammation%2520and%2520Cancer%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2014%26volume%3D113%25E2%2580%2593115%26spage%3D13%26epage%3D20%26doi%3D10.1016%2Fj.prostaglandins.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">17(<i>R</i>),18(<i>S</i>)-Epoxyeicosatetraenoic Acid, a Potent Eicosapentaenoic Acid (EPA) Derived Regulator of Cardiomyocyte Contraction: Structure-Activity Relationships and Stable Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4109</span>– <span class="NLM_lpage">4118</span>, <span class="refDoi"> DOI: 10.1021/jm200132q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200132q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4109-4118&author=J.+R.+Falckauthor=G.+Wallukatauthor=N.+Puliauthor=M.+Goliauthor=C.+Arnoldauthor=A.+Konkelauthor=M.+Rotheauthor=R.+Fischerauthor=D.+N.+M%C3%BCllerauthor=W.-H.+Schunck&title=17%28R%29%2C18%28S%29-Epoxyeicosatetraenoic+Acid%2C+a+Potent+Eicosapentaenoic+Acid+%28EPA%29+Derived+Regulator+of+Cardiomyocyte+Contraction%3A+Structure-Activity+Relationships+and+Stable+Analogues&doi=10.1021%2Fjm200132q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">17(R),18(S)-Epoxyeicosatetraenoic Acid, a Potent Eicosapentaenoic Acid (EPA) Derived Regulator of Cardiomyocyte Contraction: Structure-Activity Relationships and Stable Analogues</span></div><div class="casAuthors">Falck, John R.; Wallukat, Gerd; Puli, Narender; Goli, Mohan; Arnold, Cosima; Konkel, Anne; Rothe, Michael; Fischer, Robert; Muller, Dominik N.; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4109-4118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">17(R),18(S)-Epoxyeicosatetraenoic acid [17(R),18(S)-EETeTr], a cytochrome P 450 epoxygenase metabolite of eicosapentaenoic acid (EPA), exerts neg. chronotropic effects and protects neonatal rat cardiomyocytes against Ca2+-overload with EC50 ≈ 1-2 nM.  Structure-activity studies revealed that a cis-Δ11,12- or Δ14,15-olefin and a 17(R),18(S)-epoxide are minimal structural elements for antiarrhythmic activity whereas antagonist activity was often assocd. with the combination of a Δ14,15-olefin and a 17(S),18(R)-epoxide.  Compared with natural material, the agonist and antagonist analogs are chem. and metabolically more robust and several show promise as templates for future development of clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7lHjKyC-4rVg90H21EOLACvtfcHk0liLc9JIfNwXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChs7o%253D&md5=6a3c4a295b59353101c51f14daa093e5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm200132q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200132q%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DPuli%26aufirst%3DN.%26aulast%3DGoli%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3D17%2528R%2529%252C18%2528S%2529-Epoxyeicosatetraenoic%2520Acid%252C%2520a%2520Potent%2520Eicosapentaenoic%2520Acid%2520%2528EPA%2529%2520Derived%2520Regulator%2520of%2520Cardiomyocyte%2520Contraction%253A%2520Structure-Activity%2520Relationships%2520and%2520Stable%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4109%26epage%3D4118%26doi%3D10.1021%2Fjm200132q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondlela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J. K.</span></span> <span> </span><span class="NLM_article-title">11,12-Epoxyeicosatrienoic Acid (11,12-EET): Structural Determinants for Inhibition of TNF-α-Induced VCAM-1 Expression</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmcl.2003.08.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=14592496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4011-4014&author=J.+R.+Falckauthor=L.+M.+Reddyauthor=Y.+K.+Reddyauthor=M.+Bondlelaauthor=U.+M.+Krishnaauthor=Y.+Jiauthor=J.+Sunauthor=J.+K.+Liao&title=11%2C12-Epoxyeicosatrienoic+Acid+%2811%2C12-EET%29%3A+Structural+Determinants+for+Inhibition+of+TNF-%CE%B1-Induced+VCAM-1+Expression&doi=10.1016%2Fj.bmcl.2003.08.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">11,12-Epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-α-Induced VCAM-1 expression</span></div><div class="casAuthors">Falck, J. R.; Reddy, L. Manmohan; Reddy, Y. Krishna; Bondlela, Muralidhar; Krishna, U. Murali; Ji, Yu; Sun, Jianxin; Liao, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4011-4014</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of 11,12-EET analogs (e.g. I) were synthesized and compared using a human endothelial cell based TNF-α-induced VCAM-1 expression assay.  The resulting data were used to map a putative recognition/binding domain for 11,12-EET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7A5oYyhuPVLVg90H21EOLACvtfcHk0liLc9JIfNwXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVWrsLc%253D&md5=9b7638650afa22437074d4815a6c8afc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.060%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DReddy%26aufirst%3DL.%2BM.%26aulast%3DReddy%26aufirst%3DY.%2BK.%26aulast%3DBondlela%26aufirst%3DM.%26aulast%3DKrishna%26aufirst%3DU.%2BM.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DJ.%2BK.%26atitle%3D11%252C12-Epoxyeicosatrienoic%2520Acid%2520%252811%252C12-EET%2529%253A%2520Structural%2520Determinants%2520for%2520Inhibition%2520of%2520TNF-%25CE%25B1-Induced%2520VCAM-1%2520Expression%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4011%26epage%3D4014%26doi%3D10.1016%2Fj.bmcl.2003.08.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atcha, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubasi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthati, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldman, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5069</span>– <span class="NLM_lpage">5075</span>, <span class="refDoi"> DOI: 10.1021/jm900634w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900634w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlGgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5069-5075&author=J.+R.+Falckauthor=R.+Kodelaauthor=R.+Manneauthor=K.+R.+Atchaauthor=N.+Puliauthor=N.+Dubasiauthor=V.+L.+Manthatiauthor=J.+H.+Capdevilaauthor=X.-Y.+Yiauthor=D.+H.+Goldmanauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=W.+B.+Campbell&title=14%2C15-Epoxyeicosa-5%2C8%2C11-trienoic+Acid+%2814%2C15-EET%29+Surrogates+Containing+Epoxide+Bioisosteres%3A+Influence+upon+Vascular+Relaxation+and+Soluble+Epoxide+Hydrolase+Inhibition&doi=10.1021%2Fjm900634w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition</span></div><div class="casAuthors">Falck, J. R.; Kodela, Ravinder; Manne, Rajkumar; Atcha, Krishnam Raju; Puli, Narender; Dubasi, Narsimhaswamy; Manthati, Vijay L.; Capdevila, Jorge H.; Yi, Xiu-Yu; Goldman, Daniel H.; Morisseau, Christophe; Hammock, Bruce D.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5069-5075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">All-cis-14,15-epoxyeicosa-5,8,11-trienoic acid (14,15-EET) is a labile, vasodilatory eicosanoid generated from arachidonic acid by cytochrome P 450 epoxygenases.  A series of robust, partially satd. analogs contg. epoxide bioisosteres were synthesized and evaluated for relaxation of precontracted bovine coronary artery rings and for in vitro inhibition of sol. epoxide hydrolase (sEH).  Depending upon the bioisostere and its position along the carbon chain, varying levels of vascular relaxation and/or sEH inhibition were obsd.  For example, oxamide I and N-iPr-amide II were comparable (ED50 1.7 μM) to 14,15-EET as vasorelaxants but were approx. 10-35 times less potent as sEH inhibitors (IC50 59 and 19 μM, resp.); unsubstituted urea III showed useful activity in both assays (ED50 3.5 μM, IC50 16 nM).  These data reveal differential structural parameters for the two pharmacophores that could assist the development of potent and specific in vivo drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxqh4zQjLsbVg90H21EOLACvtfcHk0ljMqUakMGOIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlGgurc%253D&md5=0204001138e8b6ee2298d9278bbef75b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900634w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900634w%26sid%3Dliteratum%253Aachs%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DKodela%26aufirst%3DR.%26aulast%3DManne%26aufirst%3DR.%26aulast%3DAtcha%26aufirst%3DK.%2BR.%26aulast%3DPuli%26aufirst%3DN.%26aulast%3DDubasi%26aufirst%3DN.%26aulast%3DManthati%26aufirst%3DV.%2BL.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DYi%26aufirst%3DX.-Y.%26aulast%3DGoldman%26aufirst%3DD.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3D14%252C15-Epoxyeicosa-5%252C8%252C11-trienoic%2520Acid%2520%252814%252C15-EET%2529%2520Surrogates%2520Containing%2520Epoxide%2520Bioisosteres%253A%2520Influence%2520upon%2520Vascular%2520Relaxation%2520and%2520Soluble%2520Epoxide%2520Hydrolase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5069%26epage%3D5075%26doi%3D10.1021%2Fjm900634w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westphal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W.-H.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 Enzymes in the Bioactivation of Polyunsaturated Fatty Acids and Their Role in Cardiovascular Disease</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>851</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-16009-2_6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2F978-3-319-16009-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26002735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslGht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=851&publication_year=2015&pages=151-187&author=C.+Westphalauthor=A.+Konkelauthor=W.-H.+Schunck&title=Cytochrome+P450+Enzymes+in+the+Bioactivation+of+Polyunsaturated+Fatty+Acids+and+Their+Role+in+Cardiovascular+Disease&doi=10.1007%2F978-3-319-16009-2_6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids and their role in cardiovascular disease</span></div><div class="casAuthors">Westphal, Christina; Konkel, Anne; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">851</span>
        (<span class="NLM_cas:issue">Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450</span>),
    <span class="NLM_cas:pages">151-187</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Various members of the cytochrome P 450 (CYP) superfamily have the capacity of metabolizing omega-6 and omega-3 polyunsatd. fatty acids (n-6 and n-3 PUFAs).  In most mammalian tissues, CYP2C and CYP2J enzymes are the major PUFA epoxygenases, whereas CYP4A and CYP4F subfamily members function as PUFA hydroxylases.  The individual CYP enzymes differ in their substrate specificities as well as regio- and stereoselectivities and thus produce distinct sets of epoxy and/or hydroxy metabolites, collectively termed CYP eicosanoids.  Nutrition has a major impact on the endogenous CYP-eicosanoid profile. "Western diets" rich in n-6 PUFAs result in a predominance of arachidonic acid-derived metabolites, whereas marine foodstuffs rich in n-3 PUFAs shift the profile to eicosapentaenoic and docosahexaenoic acid-derived metabolites.  In general, CYP eicosanoids are formed as second messengers of numerous hormones, growth factors and cytokines regulating cardiovascular and renal function, and a variety of other physiol. processes.  Imbalances in the formation of individual CYP eicosanoids are linked to the development of hypertension, myocardial infarction, maladaptive cardiac hypertrophy, acute kidney injury, stroke and inflammatory disorders.  The underlying mechanisms are increasingly understood and may provide novel targets for the prevention and treatment of these disease states.  Suitable pharmacol. agents are underdevelopment and first proofs of concept have been obtained in animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFGHW3BxTN17Vg90H21EOLACvtfcHk0ljMqUakMGOIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslGht7c%253D&md5=e86595302c413b11cffb857f2342b7d8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-16009-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-16009-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DC.%26aulast%3DKonkel%26aufirst%3DA.%26aulast%3DSchunck%26aufirst%3DW.-H.%26atitle%3DCytochrome%2520P450%2520Enzymes%2520in%2520the%2520Bioactivation%2520of%2520Polyunsaturated%2520Fatty%2520Acids%2520and%2520Their%2520Role%2520in%2520Cardiovascular%2520Disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2015%26volume%3D851%26spage%3D151%26epage%3D187%26doi%3D10.1007%2F978-3-319-16009-2_6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chechetkin, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grechkin, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de León, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castresana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannenberg, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 3-Oxalinolenic Acid and β-Oxidation-Resistant 3-Oxa-Oxylipins</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1007/s11745-006-5123-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1007%2Fs11745-006-5123-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16933794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1WmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=499-506&author=M.+Hambergauthor=I.+R.+Chechetkinauthor=A.+N.+Grechkinauthor=I.+P.+de+Le%C3%B3nauthor=C.+Castresanaauthor=G.+Bannenberg&title=Synthesis+of+3-Oxalinolenic+Acid+and+%CE%B2-Oxidation-Resistant+3-Oxa-Oxylipins&doi=10.1007%2Fs11745-006-5123-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3-oxalinolenic acid and β-oxidation-resistant 3-oxa-oxylipins</span></div><div class="casAuthors">Hamberg, Mats; Chechetkin, Ivan R.; Grechkin, Alexander N.; Ponce de Leon, Ines; Castresana, Carmen; Bannenberg, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">499-506</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">AOCS Press</span>)
        </div><div class="casAbstract">3-Oxalinolenic acid (3-oxa-9(Z),12(Z),15(Z)-octadecatrienoic acid or (6(Z),9(Z),12(Z)-pentadecatrienyloxy)acetic acid) was synthesized from 5(Z),8(Z),11(Z),14(Z),17(Z)-eicosapentaenoic acid by a sequence involving the C15 aldehyde 3(Z),6(Z),9(Z),12(Z)-pentadecatetraenal as a key intermediate.  Conversion of the aldehyde by isomerization and two steps of redn. afforded 6(Z),9(Z),12(Z)-pentadecatrienol, which was coupled to bromoacetate to afford after purifn. by HPLC >99%-pure 3-oxalinolenic acid in 10-15% overall yield.  3-Oxalinolenic acid was efficiently oxygenated by soybean lipoxygenase-1 into 3-oxa-13(S)-hydroperoxy-9(Z),11(E),15(Z)-octadecatrienoic acid, and this hydroperoxide could be further converted chem. into 3-oxa-13(S)-hydroxy-9(Z),11(E),15(Z)-octadecatrienoic acid and 3-oxa-13-oxo-9(Z),11(E),15(Z)-octadecatrienoic acid.  The 3-oxa-hydroperoxide also served as the substrate for the plant enzymes allene oxide synthase, divinyl ether synthase, and hydroperoxide lyase to produce 3-oxa-12-oxo-10,15(Z)-phytodienoic acid and other 3-oxa-oxylipins that were characterized by MS.  3-Oxalinolenic acid was not oxygenated by 9-lipoxygenase from tomato but was converted at a slow rate into 3-oxa-9(S)-hydroperoxy-10(E),12(Z),15(Z)-octadecatrienoic acid by recombinant maize 9-lipoxygenase.  Recombinant α-dioxygenase-1 from Arabidopsis thaliana catalyzed the conversion of 3-oxalinolenic acid into a 2-hydroperoxide, which underwent spontaneous degrdn. into a mixt. of 6,9,12-pentadecatrienol and 6,9,12-pentadecatrienyl formate.  A novel α-dioxygenase from the moss Physcomitrella patens was cloned and expressed and was found to display the same activity with 3-oxalinolenic acid as Arabidopsis thaliana α-dioxygenase-1.  Lipoxygenase-generated 3-oxa-oxylipins are resistant toward β-oxidn. and have the potential for displaying enhanced biol. activity in situations where activity is limited by metabolic degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpiZ14vmWuAbVg90H21EOLACvtfcHk0ljMqUakMGOIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1WmsA%253D%253D&md5=d0639a5b98389f1ce55029ea2f70fb4a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs11745-006-5123-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11745-006-5123-5%26sid%3Dliteratum%253Aachs%26aulast%3DHamberg%26aufirst%3DM.%26aulast%3DChechetkin%26aufirst%3DI.%2BR.%26aulast%3DGrechkin%26aufirst%3DA.%2BN.%26aulast%3Dde%2BLe%25C3%25B3n%26aufirst%3DI.%2BP.%26aulast%3DCastresana%26aufirst%3DC.%26aulast%3DBannenberg%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25203-Oxalinolenic%2520Acid%2520and%2520%25CE%25B2-Oxidation-Resistant%25203-Oxa-Oxylipins%26jtitle%3DLipids%26date%3D2006%26volume%3D41%26spage%3D499%26epage%3D506%26doi%3D10.1007%2Fs11745-006-5123-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guilford, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skuballa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terkelsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schottelius, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J. F.</span></span> <span> </span><span class="NLM_article-title">Novel 3-Oxa Lipoxin A<sub>4</sub>Analogues with Enhanced Chemical and Metabolic Stability have Anti-Inflammatory Activity in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2165</span>, <span class="refDoi"> DOI: 10.1021/jm030569l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030569l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFKnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2157-2165&author=W.+J.+Guilfordauthor=J.+G.+Baumanauthor=W.+Skuballaauthor=S.+Bauerauthor=G.+P.+Weiauthor=D.+Daveyauthor=C.+Schaeferauthor=C.+Mallariauthor=J.+Terkelsenauthor=J.-L.+Tsengauthor=J.+Shenauthor=B.+Subramanyamauthor=A.+J.+Schotteliusauthor=J.+F.+Parkinson&title=Novel+3-Oxa+Lipoxin+A4Analogues+with+Enhanced+Chemical+and+Metabolic+Stability+have+Anti-Inflammatory+Activity+in+Vivo&doi=10.1021%2Fjm030569l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo</span></div><div class="casAuthors">Guilford, William J.; Bauman, John G.; Skuballa, Werner; Bauer, Shawn; Wei, Guo Ping; Davey, David; Schaefer, Caralee; Mallari, Cornell; Terkelsen, Jennifer; Tseng, Jih-Lie; Shen, Jun; Subramanyam, Babu; Schottelius, Arndt J.; Parkinson, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2157-2165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoxin A4 (LXA4) is a structurally and functionally distinct natural product called an eicosanoid, which displays immunomodulatory and anti-inflammatory activity but is rapidly metabolized to inactive catabolites in vivo.  A previously described analog of LXA4, Me 16-(4-fluorophenoxy)-5,6,15-trihydroxy-7,9,11,13-hexadecatetraenoate (2, ATLa), was shown to have a poor pharmacokinetic profile after both oral and i.v. administration, as well as sensitivity to acid and light.  The chem. stability of the corresponding E,E,E-trien-11-yne analog, 3, was improved over 2 without loss of efficacy in the mouse air pouch model of inflammation.  Careful anal. of the plasma samples from the pharmacokinetic assays for both 2 and 3 identified a previously undetected metabolite, which is consistent with metab. by β-oxidn.  The formation of the oxidative metabolites was eliminated with the corresponding 3-oxatetraene, 4, and the 3-oxatrien-11-yne, 5, analogs of 2.  Evaluation of 3-oxa analogs 4 and 5 in calcium ionophore-induced acute skin inflammation model demonstrated similar topical potency and efficacy compared to 2.  The 3-oxatrien-11-yne analog, 5, is equipotent to 2 in an animal model of inflammation but has enhanced metabolic and chem. stability and a greatly improved pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNo1Ql1Puz7Vg90H21EOLACvtfcHk0liTv7uSsBq6UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFKnurs%253D&md5=b2e9a2c1bd828974c02efdc801ef23f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm030569l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030569l%26sid%3Dliteratum%253Aachs%26aulast%3DGuilford%26aufirst%3DW.%2BJ.%26aulast%3DBauman%26aufirst%3DJ.%2BG.%26aulast%3DSkuballa%26aufirst%3DW.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DG.%2BP.%26aulast%3DDavey%26aufirst%3DD.%26aulast%3DSchaefer%26aufirst%3DC.%26aulast%3DMallari%26aufirst%3DC.%26aulast%3DTerkelsen%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.-L.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DSchottelius%26aufirst%3DA.%2BJ.%26aulast%3DParkinson%26aufirst%3DJ.%2BF.%26atitle%3DNovel%25203-Oxa%2520Lipoxin%2520A4Analogues%2520with%2520Enhanced%2520Chemical%2520and%2520Metabolic%2520Stability%2520have%2520Anti-Inflammatory%2520Activity%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2157%26epage%3D2165%26doi%3D10.1021%2Fjm030569l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hørvik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, H. I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, J.</span></span> <span> </span><span class="NLM_article-title">Polyunsaturated Thia- and Oxa-Fatty Acids: Incorporation into Cell-Lipids and Their Effects on Arachidonic Acid and Eicosanoid Synthesis</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1348</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(97)00075-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0005-2760%2897%2900075-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=9366251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFKgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1348&publication_year=1997&pages=346-354&author=L.+N.+Larsenauthor=K.+H%C3%B8rvikauthor=H.+I.+N.+S%C3%B8rensenauthor=J.+Bremer&title=Polyunsaturated+Thia-+and+Oxa-Fatty+Acids%3A+Incorporation+into+Cell-Lipids+and+Their+Effects+on+Arachidonic+Acid+and+Eicosanoid+Synthesis&doi=10.1016%2FS0005-2760%2897%2900075-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Polyunsaturated thia- and oxa-fatty acids: incorporation into cell-lipids and their effects on arachidonic acid- and eicosanoid synthesis</span></div><div class="casAuthors">Larsen, L. N.; Horvik, K.; Sorensen, H. I. N.; Bremer, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">346-354</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">EPA, DHA, C15SCH2COOH (n-3), C15SCH2COOH (n-6) and C18SCH2COOH (n-3) are extensively incorporated into phospholipids and triacylglycerol in rat hepatocytes after 24 h incubation with 80 μM fatty acid/deriv.  Only traces of polyunsatd. 3-oxa fatty acids (C15OCH2COOH, C18OCH2COOH) were incorporated.  C15-S-butyric acid (n-3) is a stronger inhibitor of Δ6-desaturase in rat liver-microsomes than C15SCH2COOH (n-3), C15-S-propionic acid (n-3), EPA and DHA.  It inhibits Δ5-desaturase in a similar manner to EPA and DHA.  Arachidonic acid and C15SCH2COOH, (n-6) are better substrates for PGH-synthase than EPA and C15SCH2COOH, (n-3), showing the inhibitory effect of the n-3 bond.  The n-3 polyunsatd. fatty acids, including the sulfur-substituted fatty acid derivs., are poor substrates for PGH-synthase.  However, they inactivate the PGH-synthase activity at least as efficiently as arachidonic acid.  C15SCH2COOH (n-3), C15S(CH2)2COOH (n-3) and C18SCH2COOH (n-3) induce peroxisomal β-oxidn. more than EPA and DHA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCTYV6_eNqB7Vg90H21EOLACvtfcHk0liTv7uSsBq6UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFKgsrs%253D&md5=3331942ec6740cf172a3616a5a5f9ad1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2897%2900075-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252897%252900075-1%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DL.%2BN.%26aulast%3DH%25C3%25B8rvik%26aufirst%3DK.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DH.%2BI.%2BN.%26aulast%3DBremer%26aufirst%3DJ.%26atitle%3DPolyunsaturated%2520Thia-%2520and%2520Oxa-Fatty%2520Acids%253A%2520Incorporation%2520into%2520Cell-Lipids%2520and%2520Their%2520Effects%2520on%2520Arachidonic%2520Acid%2520and%2520Eicosanoid%2520Synthesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1997%26volume%3D1348%26spage%3D346%26epage%3D354%26doi%3D10.1016%2FS0005-2760%2897%2900075-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphates and Phosphonates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1021/jm701260b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2328-2345&author=S.+J.+Heckerauthor=M.+D.+Erion&title=Prodrugs+of+Phosphates+and+Phosphonates&doi=10.1021%2Fjm701260b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of Phosphates and Phosphonates</span></div><div class="casAuthors">Hecker, Scott J.; Erion, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of prodrugs for phosph(on)ates has evolved considerably in the past decade.  There are now several approaches available to the researcher who finds that a phosphonate moiety achieves the right balance of properties in the lead series, yet needs a prodrug for oral delivery.  The overall best choice in this situation, taking into account stability, byproduct toxicity, avoidance of stereoisomers, and validation in humans, appears to be the diamide class.  Given its relatively recent appearance, there are few examples to date, but it is expected that phosphonic diamides will play an increasingly important role as phosphonate prodrugs going forward.  For drugs given at low to moderate doses, where risks assocd. with the byproduct formaldehyde are low, acyloxyalkyl prodrugs will continue to find application.  If selective targeting to the liver is desired, HepDirect prodrugs are the clear choice, whereas aryl amidates (and possibly diamides) offer the potential for targeting to lymphatic tissue.  The increasing availability of prodrug options should encourage the practicing medicinal chemist to explore phosphonic acids in the course of lead development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrooUagDflp3rVg90H21EOLACvtfcHk0liTv7uSsBq6UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D&md5=62699075f111d09d2ba3f19f089cb7c2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701260b%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DProdrugs%2520of%2520Phosphates%2520and%2520Phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2328%26epage%3D2345%26doi%3D10.1021%2Fjm701260b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhj6Soi9eyU2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkhanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojodjojo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. C.</span></span> <span> </span><span class="NLM_article-title">Multiple Modes of Inhibition of Human Cytochrome P450 2J2 by Dronedarone, Amiodarone and their Active Metabolites</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bcp.2016.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=26972388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=67-80&author=A.+Karkhanisauthor=H.+Y.+Lamauthor=G.+Venkatesanauthor=S.+K.+Kohauthor=C.+L.+Chaiauthor=L.+Zhouauthor=Y.+Hongauthor=P.+Kojodjojoauthor=E.+C.+Chan&title=Multiple+Modes+of+Inhibition+of+Human+Cytochrome+P450+2J2+by+Dronedarone%2C+Amiodarone+and+their+Active+Metabolites&doi=10.1016%2Fj.bcp.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites</span></div><div class="casAuthors">Karkhanis, Aneesh; Lam, Hui Yuan; Venkatesan, Gopalakrishnan; Koh, Siew Kwan; Chai, Christina Li Lin; Zhou, Lei; Hong, Yanjun; Kojodjojo, Pipin; Chan, Eric Chun Yong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dronedarone, a multiple ion channel blocker is prescribed for the treatment of paroxysmal and persistent atrial fibrillation.  While dronedarone does not ppt. toxicities like its predecessor amiodarone, its clin. use has been assocd. with idiosyncratic hepatic and cardiac adverse effects and drug-drug interactions (DDIs).  As dronedarone is a potent mechanism-based inactivator of CYP3A4 and CYP3A5, a question arose if it exerts a similar inhibitory effect on CYP2J2, a prominent cardiac CYP 450 enzyme.  In this study, the authors demonstrated that CYP2J2 is reversibly inhibited by dronedarone (Ki = 0.034 μM), amiodarone (Ki = 4.8 μM) and their resp. pharmacol. active metabolites namely N-desbutyldronedarone (NDBD) (Ki = 0.55 μM) and N-desethylamiodarone (NDEA) (Ki = 7.4 μM).  Moreover, time-, concn.- and NADPH-dependent irreversible inactivation of CYP2J2 was investigated where inactivation kinetic parameters (KI, kinact) and partition ratio (r) of dronedarone (0.05 μM, 0.034 min-1, 3.3), amiodarone (0.21 μM, 0.015 min-1, 20.7) and NDBD (0.48 μM, 0.024 min-1, 21.7) were obsd. except for NDEA.  The absence of the characteristic Soret peak, lack of recovery of CYP2J2 activity upon dialysis, and biotransformation of dronedarone and NDBD to quinone-oxime reactive metabolites further confirmed the irreversible inactivation of CYP2J2 by dronedarone and NDBD is via the covalent adduction of CYP2J2.  The authors' novel findings illuminate the possible mechanisms of DDIs and cardiac adverse effects due to both reversible inhibition and irreversible inactivation of CYP2J2 by dronedarone, amiodarone and their active metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5EqJHXycRBLVg90H21EOLACvtfcHk0lhj6Soi9eyU2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgtb4%253D&md5=19d7d62ac7c1671bbe1bf4505d99cda8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DKarkhanis%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%2BY.%26aulast%3DVenkatesan%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DS.%2BK.%26aulast%3DChai%26aufirst%3DC.%2BL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DKojodjojo%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%2BC.%26atitle%3DMultiple%2520Modes%2520of%2520Inhibition%2520of%2520Human%2520Cytochrome%2520P450%25202J2%2520by%2520Dronedarone%252C%2520Amiodarone%2520and%2520their%2520Active%2520Metabolites%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D107%26spage%3D67%26epage%3D80%26doi%3D10.1016%2Fj.bcp.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karkhanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leow, J. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. C. Y.</span></span> <span> </span><span class="NLM_article-title">Dronedarone-Induced Cardiac Mitochondrial Dysfunction and Its Mitigation by Epoxyeicosatrienoic Acids</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfy011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1093%2Ftoxsci%2Fkfy011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=29385569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGlu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2018&pages=79-91&author=A.+Karkhanisauthor=J.+W.+H.+Leowauthor=T.+Hagenauthor=E.+C.+Y.+Chan&title=Dronedarone-Induced+Cardiac+Mitochondrial+Dysfunction+and+Its+Mitigation+by+Epoxyeicosatrienoic+Acids&doi=10.1093%2Ftoxsci%2Fkfy011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dronedarone-induced cardiac mitochondrial dysfunction and its mitigation by epoxyeicosatrienoic acids</span></div><div class="casAuthors">Karkhanis, Aneesh; Leow, Jacqueline Wen Hui; Hagen, Thilo; Chan, Eric Chun Yong</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-91</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-0929</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dronedarone and amiodarone are structurally similar antiarrhythmic drugs.  Dronedarone worsens cardiac adverse effects with unknown causes while amiodarone has no cardiac adversity.  Dronedarone induces preclin. mitochondrial toxicity in rat liver and exhibits clin. hepatotoxicity.  Here, the authors further investigated the relative potential of the antiarrhythmic drugs in causing mitochondrial injury in cardiomyocytes.  Differentiated rat H9c2 cardiomyocytes were treated with dronedarone, amiodarone, and their resp. metabolites namely N-desbutyldronedarone (NDBD) and N-desethylamiodarone (NDEA).  Intracellular ATP content, mitochondrial membrane potential (Δ ψm), and inhibition of carnitine palmitoyltransferase I (CPT1) activity and arachidonic acid (AA) metab. were measured in H9c2 cells.  Inhibition of electron transport chain (ETC) activities and uncoupling of ETC were further studied in isolated rat heart mitochondria.  Dronedarone, amiodarone, NDBD and NDEA decreased intracellular ATP content significantly (IC50 = 0.49, 1.84, 1.07, and 0.63 μM, resp.) and dissipated Δ ψm potently (IC50 = 0.5, 2.94, 12.8, and 7.38 ψM, resp.).  Dronedarone, NDBD, and NDEA weakly inhibited CPT1 activity while amiodarone (IC50 >100 ψM) yielded negligible inhibition.  Only dronedarone inhibited AA metab. to its regioisomeric epoxyeicosatrienoic acids (EETs) consistently and potently.  NADH-supplemented ETC activity was inhibited by dronedarone, amiodarone, NDBD and NDEA (IC50 = 3.07, 5.24, 11.94, and 16.16 ψM, resp.).  Cytotoxicity, ATP decrease and Δ ψm disruption were ameliorated via exogenous pre-treatment of H9c2 cells with 11,12-EET and 14,15-EET.  The authors' study confirmed that dronedarone causes mitochondrial injury in cardiomyocytes by perturbing Δ ψm, inhibiting mitochondrial complex I, uncoupling ETC and dysregulating AA-EET metab.  The authors postulate that cardiac mitochondrial injury is one potential contributing factor to dronedarone-induced cardiac failure exacerbation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbotMD1WAckLVg90H21EOLACvtfcHk0lhj6Soi9eyU2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGlu7zP&md5=525d8191d320b2865081f018c9db1687</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfy011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfy011%26sid%3Dliteratum%253Aachs%26aulast%3DKarkhanis%26aufirst%3DA.%26aulast%3DLeow%26aufirst%3DJ.%2BW.%2BH.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%2BC.%2BY.%26atitle%3DDronedarone-Induced%2520Cardiac%2520Mitochondrial%2520Dysfunction%2520and%2520Its%2520Mitigation%2520by%2520Epoxyeicosatrienoic%2520Acids%26jtitle%3DToxicol.%2520Sci.%26date%3D2018%26volume%3D163%26spage%3D79%26epage%3D91%26doi%3D10.1093%2Ftoxsci%2Fkfy011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunck, W. H.</span></span> <span> </span><span class="NLM_article-title">Chiral Lipidomics of Monoepoxy and Monohydroxy Metabolites Derived from Long-Chain Polyunsaturated Fatty Acids</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1194/jlr.M089755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1194%2Fjlr.M089755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=30409844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2isw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=135-148&author=M.+Blumauthor=I.+Doganauthor=M.+Karberauthor=M.+Rotheauthor=W.+H.+Schunck&title=Chiral+Lipidomics+of+Monoepoxy+and+Monohydroxy+Metabolites+Derived+from+Long-Chain+Polyunsaturated+Fatty+Acids&doi=10.1194%2Fjlr.M089755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral lipidomics of monoepoxy and monohydroxy metabolites derived from long-chain polyunsaturated fatty acids</span></div><div class="casAuthors">Blum, Maximilian; Dogan, Inci; Karber, Mirjam; Rothe, Michael; Schunck, Wolf-Hagen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">135-148</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A chiral lipidomics approach was established for comprehensive profiling of regio- and stereoisomeric monoepoxy and monohydroxy metabolites of long-chain PUFAs as generated enzymically by cytochromes P 450 (CYPs), lipoxygenases (LOXs), and cyclooxygenases (COXs) and, in part, also unspecific oxidns.  The method relies on reversed-phase chiral-LC coupled with ESI/MS/MS.  Applications revealed partially opposing enantioselectivities of sol. and microsomal epoxide hydrolases (mEHs).  Ablation of the sol. epoxide hydrolase (sEH) gene resulted in specific alterations in the enantiomeric compn. of endogenous monoepoxy metabolites.  For example, the (R,S)/(S,R)-ratio of circulating 14,15-EET changed from 2.1:1 in WT to 9.7:1 in the sEH-KO mice.  Studies with liver microsomes suggested that CYP/mEH interactions play a primary role in detg. the enantiomeric compn. of monoepoxy metabolites during their generation and release from the ER.  Anal. of human plasma showed significant enantiomeric excess with several monoepoxy metabolites.  Monohydroxy metabolites were generally present as racemates; however, Ca2+-ionophore stimulation of whole blood samples resulted in enantioselective increases of LOX-derived metabolites (12S-HETE and 17S-hydroxydocosahexaenoic acid) and COX-derived metabolites (11R-HETE).  Our chiral approach may provide novel opportunities for investigating the role of bioactive lipid mediators that generally exert their physiol. functions in a highly regio- and stereospecific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhoZP9ZYewbVg90H21EOLACvtfcHk0liaS7qprYU_xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2isw%253D%253D&md5=635fda95a18393275fd4594a7af5629a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M089755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M089755%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DM.%26aulast%3DDogan%26aufirst%3DI.%26aulast%3DKarber%26aufirst%3DM.%26aulast%3DRothe%26aufirst%3DM.%26aulast%3DSchunck%26aufirst%3DW.%2BH.%26atitle%3DChiral%2520Lipidomics%2520of%2520Monoepoxy%2520and%2520Monohydroxy%2520Metabolites%2520Derived%2520from%2520Long-Chain%2520Polyunsaturated%2520Fatty%2520Acids%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2019%26volume%3D60%26spage%3D135%26epage%3D148%26doi%3D10.1194%2Fjlr.M089755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective Synthesis of (10<i>S</i>)- and (10<i>R</i>)-Methyl-Anandamides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6329</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.tet.2012.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=6329-6337&author=S.+P.+Nikasauthor=M.+D%E2%80%99Souzaauthor=A.+Makriyannis&title=Enantioselective+Synthesis+of+%2810S%29-+and+%2810R%29-Methyl-Anandamides&doi=10.1016%2Fj.tet.2012.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective synthesis of (10S)- and (10R)-methyl-anandamides</span></div><div class="casAuthors">Nikas, Spyros P.; D'Souza, Marsha; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6329-6337</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">For the development of novel endocannabinoid templates with potential resistance to hydrolytic and oxidative metab., we are targeting the bis-allylic carbons of the arachidonoyl skeleton.  Toward this end, we recently disclosed the synthesis and preliminary biol. data for the (13S)-methyl-anandamide.  We report now the total synthesis of the (10S)- and (10R)-methyl-counterparts.  Our synthetic approach is stereospecific, efficient, and provides the analogs without the need for resoln.  Peptide coupling, P-2 nickel partial hydrogenation, and cis-selective Wittig olefination are the key steps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqP9D7GXbeSbVg90H21EOLACvtfcHk0liaS7qprYU_xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWntr4%253D&md5=ff1b239139e231e168e6a7851453c5bc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520%252810S%2529-%2520and%2520%252810R%2529-Methyl-Anandamides%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D6329%26epage%3D6337%26doi%3D10.1016%2Fj.tet.2012.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grube, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kock, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Mass Spectrometric Analysis of Cyclostellettamines H, I, K and L</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200500208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fejoc.200500208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1285-1295&author=A.+Grubeauthor=C.+Timmauthor=M.+Kock&title=Synthesis+and+Mass+Spectrometric+Analysis+of+Cyclostellettamines+H%2C+I%2C+K+and+L&doi=10.1002%2Fejoc.200500208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200500208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200500208%26sid%3Dliteratum%253Aachs%26aulast%3DGrube%26aufirst%3DA.%26aulast%3DTimm%26aufirst%3DC.%26aulast%3DKock%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Mass%2520Spectrometric%2520Analysis%2520of%2520Cyclostellettamines%2520H%252C%2520I%252C%2520K%2520and%2520L%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2006%26volume%3D2006%26spage%3D1285%26epage%3D1295%26doi%3D10.1002%2Fejoc.200500208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yavari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayat, M.</span></span> <span> </span><span class="NLM_article-title">New Synthesis of Highly Functionalized 3-Pyrrolin-2-ones</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2527</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1081/SCC-120005935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1081%2FSCC-120005935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2rur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=2527-2534&author=I.+Yavariauthor=M.+Bayat&title=New+Synthesis+of+Highly+Functionalized+3-Pyrrolin-2-ones&doi=10.1081%2FSCC-120005935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">New synthesis of highly functionalized 3-pyrrolin-2-ones</span></div><div class="casAuthors">Yavari, Issa; Bayat, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2527-2534</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Et N-aryl-(or N-alkyl)-oxamate undergo a smooth reaction with triphenylphosphine and di-Me acetylenedicarboxylate to produce di-Me N-aryl-(or N-alkyl)-3-ethoxy-3-pyrrolin-2-one-4,5-dicarboxylates in fairly high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0qOJ_mw2hWLVg90H21EOLACvtfcHk0liaS7qprYU_xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2rur8%253D&md5=54d0fdfa82a6cdc52567f48fb3aab216</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1081%2FSCC-120005935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-120005935%26sid%3Dliteratum%253Aachs%26aulast%3DYavari%26aufirst%3DI.%26aulast%3DBayat%26aufirst%3DM.%26atitle%3DNew%2520Synthesis%2520of%2520Highly%2520Functionalized%25203-Pyrrolin-2-ones%26jtitle%3DSynth.%2520Commun.%26date%3D2002%26volume%3D32%26spage%3D2527%26epage%3D2534%26doi%3D10.1081%2FSCC-120005935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, R.</span></span> <span> </span><span class="NLM_article-title">Tertiary Phosphane/Tetrachloromethane, a Versatile Reagent for Chlorination, Dehydration, and P-N Linkage</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1002/anie.197508011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fanie.197508011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=801-811&author=R.+Appel&title=Tertiary+Phosphane%2FTetrachloromethane%2C+a+Versatile+Reagent+for+Chlorination%2C+Dehydration%2C+and+P-N+Linkage&doi=10.1002%2Fanie.197508011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.197508011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197508011%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26atitle%3DTertiary%2520Phosphane%252FTetrachloromethane%252C%2520a%2520Versatile%2520Reagent%2520for%2520Chlorination%252C%2520Dehydration%252C%2520and%2520P-N%2520Linkage%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1975%26volume%3D14%26spage%3D801%26epage%3D811%26doi%3D10.1002%2Fanie.197508011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannon, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavva, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gore, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surapaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J. J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M. H.</span></span> <span> </span><span class="NLM_article-title">Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3528</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1021/jm070191h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070191h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmslyrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3528-3539&author=H.-L.+Wangauthor=J.+Katonauthor=C.+Balanauthor=A.+W.+Bannonauthor=C.+Bernardauthor=E.+M.+Dohertyauthor=C.+Dominguezauthor=N.+R.+Gavvaauthor=V.+Goreauthor=V.+Maauthor=N.+Nishimuraauthor=S.+Surapaneniauthor=P.+Tangauthor=R.+Tamirauthor=O.+Thielauthor=J.+J.+S.+Treanorauthor=M.+H.+Norman&title=Novel+Vanilloid+Receptor-1+Antagonists%3A+3.+The+Identification+of+a+Second-Generation+Clinical+Candidate+with+Improved+Physicochemical+and+Pharmacokinetic+Properties&doi=10.1021%2Fjm070191h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties</span></div><div class="casAuthors">Wang, Hui-Ling; Katon, Jodie; Balan, Chenera; Bannon, Anthony W.; Bernard, Charles; Doherty, Elizabeth M.; Dominguez, Celia; Gavva, Narender R.; Gore, Vijay; Ma, Vu; Nishimura, Nobuko; Surapaneni, Sekhar; Tang, Phi; Tamir, Rami; Thiel, Oliver; Treanor, James J. S.; Norman, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3528-3539</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on the previously reported clin. candidate, AMG 517 (compd. 1), a series of related piperazinylpyrimidine analogs were synthesized and evaluated as antagonists of the vanilloid 1 receptor (VR1 or TRPV1).  Optimization of in vitro potency and physicochem. and pharmacokinetic properties led to the discovery of (R)-N-(4-(6-(4-(1-(4-fluorophenyl)ethyl)piperazin-1-yl)pyrimidin-4-yloxy)benzo[d]thiazol-2-yl)acetamide (16p, I), a potent TRPV1 antagonist [rTRPV1(CAP) IC50 = 3.7 nM] with excellent aq. soly. (≥200 μg/mL in 0.01 N HCl) and a reduced half-life (rat t1/2 = 3.8 h, dog t1/2 = 2.7 h, monkey t1/2 = 3.2 h) as compared to AMG 517.  In addn., compd. 16p was shown to be efficacious at blocking a TRPV1-mediated physiol. response in vivo (ED50 = 1.9 mg/kg, p.o. in the capsaicin-induced flinch model in rats) and was also effective at reducing thermal hyperalgesia induced by complete Freund's adjuvant in rats (MED = 1 mg/kg, p.o).  Based on its improved overall profile, compd. 16p (AMG 628) was selected as a second-generation candidate for further evaluation in human clin. trials as a potential new treatment for chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrINDCYTN9z2rVg90H21EOLACvtfcHk0ljKY98vL5etAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmslyrsbc%253D&md5=5eea82130b3293a6ab0b583730eeda4f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070191h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070191h%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.-L.%26aulast%3DKaton%26aufirst%3DJ.%26aulast%3DBalan%26aufirst%3DC.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBernard%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DE.%2BM.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DGavva%26aufirst%3DN.%2BR.%26aulast%3DGore%26aufirst%3DV.%26aulast%3DMa%26aufirst%3DV.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DSurapaneni%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DP.%26aulast%3DTamir%26aufirst%3DR.%26aulast%3DThiel%26aufirst%3DO.%26aulast%3DTreanor%26aufirst%3DJ.%2BJ.%2BS.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26atitle%3DNovel%2520Vanilloid%2520Receptor-1%2520Antagonists%253A%25203.%2520The%2520Identification%2520of%2520a%2520Second-Generation%2520Clinical%2520Candidate%2520with%2520Improved%2520Physicochemical%2520and%2520Pharmacokinetic%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3528%26epage%3D3539%26doi%3D10.1021%2Fjm070191h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shchepin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarathna, D. H. M. L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumitru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickerson, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, P. H.</span></span> <span> </span><span class="NLM_article-title">Influence of Heterocyclic and Oxime-Containing Farnesol Analogs on Quorum Sensing and Pathogenicity in <i>Candida albicans</i></span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1842</span>– <span class="NLM_lpage">1848</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmc.2007.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=18037299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1842-1848&author=R.+Shchepinauthor=D.+H.+M.+L.+P.+Navarathnaauthor=R.+Dumitruauthor=S.+Lippoldauthor=K.+W.+Nickersonauthor=P.+H.+Dussault&title=Influence+of+Heterocyclic+and+Oxime-Containing+Farnesol+Analogs+on+Quorum+Sensing+and+Pathogenicity+in+Candida+albicans&doi=10.1016%2Fj.bmc.2007.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of heterocyclic and oxime-containing farnesol analogs on quorum sensing and pathogenicity in Candida albicans</span></div><div class="casAuthors">Shchepin, Roman; Navarathna, Dhammika H. M. L. P.; Dumitru, Raluca; Lippold, Shane; Nickerson, Kenneth W.; Dussault, Patrick H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of synthetic mols. combining a geranyl backbone with a heterocyclic or oxime head group are quorum-sensing mols. that block the yeast to mycelium transition in the dimorphic fungus Candida albicans.  A no. of the analogs have an IC50 ≤ 10 μM, a level of potency essentially identical to the natural quorum sensing signal, the sesquiterpene farnesol.  Two of the most potent analogs, neither toxic toward healthy mice, display remarkably different effects when co-administered with C. albicans.  While neither offers protection from candidiasis, one analog mimics farnesol in acting as a virulence factor, whereas the other has no effect.  The results offer the first example of highly potent synthetic fungal quorum-sensing mols., and provide the first evidence for the ability to decouple quorum sensing and virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAxd048-Vy07Vg90H21EOLACvtfcHk0ljKY98vL5etAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOisrs%253D&md5=1a7697a599ebfdf7fbdd1962138f6faa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DShchepin%26aufirst%3DR.%26aulast%3DNavarathna%26aufirst%3DD.%2BH.%2BM.%2BL.%2BP.%26aulast%3DDumitru%26aufirst%3DR.%26aulast%3DLippold%26aufirst%3DS.%26aulast%3DNickerson%26aufirst%3DK.%2BW.%26aulast%3DDussault%26aufirst%3DP.%2BH.%26atitle%3DInfluence%2520of%2520Heterocyclic%2520and%2520Oxime-Containing%2520Farnesol%2520Analogs%2520on%2520Quorum%2520Sensing%2520and%2520Pathogenicity%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmc.2007.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muthusamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunanathan, C.</span></span> <span> </span><span class="NLM_article-title">Indium Triflate: a Mild and Efficient Lewis Acid Catalyst for O-H Insertion Reactions of α-Diazo Ketones</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3136</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)00489-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2FS0040-4039%2802%2900489-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVOksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=3133-3136&author=S.+Muthusamyauthor=S.+A.+Babuauthor=C.+Gunanathan&title=Indium+Triflate%3A+a+Mild+and+Efficient+Lewis+Acid+Catalyst+for+O-H+Insertion+Reactions+of+%CE%B1-Diazo+Ketones&doi=10.1016%2FS0040-4039%2802%2900489-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Indium triflate: a mild and efficient Lewis acid catalyst for O-H insertion reactions of α-diazo ketones</span></div><div class="casAuthors">Muthusamy, Sengodagounder; Babu, Srinivasarao Arulananda; Gunanathan, Chidambaram</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3133-3136</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Facile O-H insertion reactions of α-diazo ketones with aliph./arom. alcs. or benzenethiol have been developed in the presence of indium triflate as catalyst.  These reactions provided good yields of α-alkoxy ketones.  A comparative study with other Lewis acids establishes the reactivity of indium triflate in O-H insertion reactions of α-diazo ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0h2g56XsMzLVg90H21EOLACvtfcHk0ljKY98vL5etAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVOksLs%253D&md5=10a6000c348dd58c5d24365ddfa18600</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900489-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900489-6%26sid%3Dliteratum%253Aachs%26aulast%3DMuthusamy%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DS.%2BA.%26aulast%3DGunanathan%26aufirst%3DC.%26atitle%3DIndium%2520Triflate%253A%2520a%2520Mild%2520and%2520Efficient%2520Lewis%2520Acid%2520Catalyst%2520for%2520O-H%2520Insertion%2520Reactions%2520of%2520%25CE%25B1-Diazo%2520Ketones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D3133%26epage%3D3136%26doi%3D10.1016%2FS0040-4039%2802%2900489-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rozkiewicz, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janczewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verboom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravoo, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhoudt, N. D.</span></span> <span> </span><span class="NLM_article-title">Click” Chemistry by Microcontact Printing</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5292</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1002/anie.200601090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1002%2Fanie.200601090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xoslegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5292-5296&author=I.+D.+Rozkiewiczauthor=D.+Janczewskiauthor=W.+Verboomauthor=J.+B.+Ravooauthor=N.+D.+Reinhoudt&title=Click%E2%80%9D+Chemistry+by+Microcontact+Printing&doi=10.1002%2Fanie.200601090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">"Click" chemistry by microcontact printing</span></div><div class="casAuthors">Rozkiewicz, Dorata I.; Janczewski, Dominik; Verboom, Willem; Ravoo, Bart Jan; Reinhoudt, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">5292-5296</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Click chem. can be efficiently combined with microcontact printing.  Synthesis in the nanoscale confinement between an elastomeric stamp and a reactive substrate leads to the desired product within a short time, without a catalyst, and under ambient conditions.  As a result, 1-octadecyne could be printed onto an azido-terminated, self-assembled monolayer on a silicon oxide substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgdS_grtZFfrVg90H21EOLACvtfcHk0lgH0mYJKD82tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xoslegtbs%253D&md5=e989dcf1927eeb2867b841c7852fdbf1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200601090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200601090%26sid%3Dliteratum%253Aachs%26aulast%3DRozkiewicz%26aufirst%3DI.%2BD.%26aulast%3DJanczewski%26aufirst%3DD.%26aulast%3DVerboom%26aufirst%3DW.%26aulast%3DRavoo%26aufirst%3DJ.%2BB.%26aulast%3DReinhoudt%26aufirst%3DN.%2BD.%26atitle%3DClick%25E2%2580%259D%2520Chemistry%2520by%2520Microcontact%2520Printing%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D5292%26epage%3D5296%26doi%3D10.1002%2Fanie.200601090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read de Alaniz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taupin, V.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of (+)-Nankakurines A and B and (±)-5-<i>epi</i>-Nankakurine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">7519</span>– <span class="NLM_lpage">7534</span>, <span class="refDoi"> DOI: 10.1021/jo101619d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101619d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=7519-7534&author=A.+R.+Altmanauthor=L.+B.+Nilssonauthor=E.+L.+Overmanauthor=J.+Read+de+Alanizauthor=M.+J.+Rohdeauthor=V.+Taupin&title=Total+Synthesis+of+%28%2B%29-Nankakurines+A+and+B+and+%28%C2%B1%29-5-epi-Nankakurine&doi=10.1021%2Fjo101619d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of (+)-Nankakurines A and B and (±)-5-epi-Nankakurine A</span></div><div class="casAuthors">Altman, Ryan A.; Nilsson, Bradley L.; Overman, Larry E.; Read de Alaniz, Javier; Rohde, Jason M.; Taupin, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7519-7534</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first total syntheses of the Lycopodium alkaloids (+)-nankakurine A I (R = H), (+)-nankakurine B I (R = Me) and (±)-5-epi-nankakurine A (II) with the originally purported relative configuration of nankakurine A were accomplished.  The syntheses of I (R = H and R = Me) featured a demanding intramol. azomethine imine cycloaddn. as the key step for generating the octahydro-3,5-ethanoquinoline moiety and installing the correct relative configuration at the spiropiperidine ring juncture.  The cyclization precursor was prepd. from octahydronaphthalene ketone III, which was assembled from enone (R)-5-methyl-2-cyclohexen-1-one and diene H2C:CHC(:CH2)(CH2)4OCH2Ph by a cationic Diels-Alder reaction.  The Diels-Alder reactants were synthesized from 5-hexyn-1-ol and (+)-pulegone, resp.  The tetracyclic ring system of (±)-5-epi-nankakurine A was generated using an unprecedented nitrogen-terminated aza-Prins cyclization cascade.  The enantioselective total syntheses of (+)-nankakurine A and (+)-nankakurine B establish the relative and abs. configuration of these alkaloids and were sufficiently concise that substantial quantities were prepd. for biol. studies.  (+)-Nankakurine A and (+)-nankakurine B showed no effect on neurite outgrowth in rat hippocampal H-19 cells over a concn. range of 0.3-10 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYT24TlqHqbrVg90H21EOLACvtfcHk0lgH0mYJKD82tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbvI&md5=35a1c3aace27ec49f301414730b7a85c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo101619d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101619d%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DA.%2BR.%26aulast%3DNilsson%26aufirst%3DL.%2BB.%26aulast%3DOverman%26aufirst%3DE.%2BL.%26aulast%3DRead%2Bde%2BAlaniz%26aufirst%3DJ.%26aulast%3DRohde%26aufirst%3DM.%2BJ.%26aulast%3DTaupin%26aufirst%3DV.%26atitle%3DTotal%2520Synthesis%2520of%2520%2528%252B%2529-Nankakurines%2520A%2520and%2520B%2520and%2520%2528%25C2%25B1%2529-5-epi-Nankakurine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D7519%26epage%3D7534%26doi%3D10.1021%2Fjo101619d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Webb, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klijn, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goroff, S. N.</span></span> <span> </span><span class="NLM_article-title">Experimental Studies of the <sup>13</sup>C NMR of Iodoalkynes in Lewis-Basic Solvents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1021/jo035584c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo035584c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVKr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=660-664&author=A.+J.+Webbauthor=E.+J.+Klijnauthor=A.+P.+Hillauthor=L.+J.+Bennettauthor=S.+N.+Goroff&title=Experimental+Studies+of+the+13C+NMR+of+Iodoalkynes+in+Lewis-Basic+Solvents&doi=10.1021%2Fjo035584c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental Studies of the 13C NMR of Iodoalkynes in Lewis-Basic Solvents</span></div><div class="casAuthors">Webb, Jeffrey A.; Klijn, Jaap E.; Hill, Philip Aru; Bennett, Jordan L.; Goroff, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">660-664</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 13C NMR spectra of two different iodoalkynes, 1-iodo-1-hexyne (1) and diiodoethyne (2), exhibit a strong solvent dependence.  Comparisons of the data with several common empirical models, including Gutmann's Donor nos., Reichardt's ENT, and Taft and Kamlet's β and π*, demonstrate that this solvent effect arises from a specific acid-base interaction.  Solvent basicity measures such as Donor nos. and β values correlate well with the α-C chem. shift of 1, but polarity measures such as ENT and π* do not correlate.  The similarity of the solvent effect for 1 and 2 suggests that C-C bond polarization may not play a role in the change in chem. shift, as previously hypothesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI-DwvrzeDO7Vg90H21EOLACvtfcHk0lgH0mYJKD82tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVKr&md5=913fc29d1b303c679731390632880ea3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo035584c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035584c%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DA.%2BJ.%26aulast%3DKlijn%26aufirst%3DE.%2BJ.%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DBennett%26aufirst%3DL.%2BJ.%26aulast%3DGoroff%26aufirst%3DS.%2BN.%26atitle%3DExperimental%2520Studies%2520of%2520the%252013C%2520NMR%2520of%2520Iodoalkynes%2520in%2520Lewis-Basic%2520Solvents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D660%26epage%3D664%26doi%3D10.1021%2Fjo035584c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vranken, D. L.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Carbene Insertion and Trapping with Carbon Nucleophiles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1909</span>– <span class="NLM_lpage">1911</span>, <span class="refDoi"> DOI: 10.1021/ol800431w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800431w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksFakurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1909-1911&author=S.+K.+J.+Devineauthor=D.+L.+Van+Vranken&title=Palladium-Catalyzed+Carbene+Insertion+and+Trapping+with+Carbon+Nucleophiles&doi=10.1021%2Fol800431w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed carbene insertion and trapping with carbon nucleophiles</span></div><div class="casAuthors">Devine, Sean K. J.; Van Vranken, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1909-1911</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three-component coupling of vinyl halides RCH:CHX (X = Br, I), stabilized carbon nucleophiles (Nu) and diazomethyl silane N2CHSiMe3, catalyzed by Pd(0) complexes, gave vinylsilanes RCH(Nu)CH:CHSiMe3 with high yields.  Reaction of R1R2C:CHX with sodium di-Et malonate and N2CHSiMe3 gave vinylsilanes (E)-R1CR2[CH(CO2Et)2]CH:CHSiMe3 (X = I, Br, R1 = PhCH2CH2, NCCH2CH2CH2, TBSOCH2CH2CH2; R2 = H, Me).  The reaction is believed to proceed through a palladium-carbene intermediate LX(R)Pd:CHSiMe3 that undergoes migration of the vinyl substituent to the electrophilic carbene center to generate an η3-allylpalladium intermediate.  The allylpalladium intermediate is attacked by the carbon nucleophile to generate a vinylsilane product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSd2qD5vqsrVg90H21EOLACvtfcHk0lh6uoMCMkwlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksFakurw%253D&md5=8f85bae783e5d75c2e8f0d0f426a27ee</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fol800431w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800431w%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DS.%2BK.%2BJ.%26aulast%3DVan%2BVranken%26aufirst%3DD.%2BL.%26atitle%3DPalladium-Catalyzed%2520Carbene%2520Insertion%2520and%2520Trapping%2520with%2520Carbon%2520Nucleophiles%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D1909%26epage%3D1911%26doi%3D10.1021%2Fol800431w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trybulski, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. I.</span></span> <span> </span><span class="NLM_article-title">2-Benzazepines.1. Synthesis of 2-Benzazepin-4-ones and 5-ones via 2-Acetylenic Benzophenones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2441</span>– <span class="NLM_lpage">2447</span>, <span class="refDoi"> DOI: 10.1021/jo00133a040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00133a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaL38XitFOltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=2441-2447&author=J.+E.+Trybulskiauthor=E.+Reederauthor=F.+J.+Blountauthor=A.+Walserauthor=R.+I.+Fryer&title=2-Benzazepines.1.+Synthesis+of+2-Benzazepin-4-ones+and+5-ones+via+2-Acetylenic+Benzophenones&doi=10.1021%2Fjo00133a040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">2-Benzazepines.  I.  Synthesis of 2-benzazepin-4-ones and -5-ones via 2-acetylenic benzophenones</span></div><div class="casAuthors">Trybulski, Eugene J.; Reeder, Earl; Blount, John F.; Walser, Armin; Fryer, R. Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2441-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">1-Phenyl-2-benzazepin-4-ones and -5-ones were prepd.  The palladium-catalyzed coupling of iodobenzophenones to monosubstituted acetylenes assembled the necessary atoms required for the benzazepine rings.  Transformation of the acetylene group into a ketone group with concomitant cyclization of the resulting β-amino ketone completed the synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk6CwZrSeKebVg90H21EOLACvtfcHk0lh6uoMCMkwlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XitFOltbg%253D&md5=5f78f378efdcccc7e0f93a34ec69d425</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo00133a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00133a040%26sid%3Dliteratum%253Aachs%26aulast%3DTrybulski%26aufirst%3DJ.%2BE.%26aulast%3DReeder%26aufirst%3DE.%26aulast%3DBlount%26aufirst%3DF.%2BJ.%26aulast%3DWalser%26aufirst%3DA.%26aulast%3DFryer%26aufirst%3DR.%2BI.%26atitle%3D2-Benzazepines.1.%2520Synthesis%2520of%25202-Benzazepin-4-ones%2520and%25205-ones%2520via%25202-Acetylenic%2520Benzophenones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1982%26volume%3D47%26spage%3D2441%26epage%3D2447%26doi%3D10.1021%2Fjo00133a040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meddad-Belhabich, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djimdé, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redeuilh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massicot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymans, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamouri, A.</span></span> <span> </span><span class="NLM_article-title">Design of New Potent and Selective Secretory Phospholipase A<sub>2</sub>Inhibitors. 6-Synthesis, Structure-Activity Relationships and Molecular Modeling of 1-Substituted-4-[4,5-dihydro-1,2,4-(4<i>H</i>)-oxadiazol-5-one-3-yl(methyl)]-Functionalizedaryl Piperazin/one/dione Derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3588</span>– <span class="NLM_lpage">3600</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.bmc.2010.03.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=20417107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVGrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3588-3600&author=N.+Meddad-Belhabichauthor=D.+Aounauthor=A.+Djimd%C3%A9author=C.+Redeuilhauthor=G.+Diveauthor=F.+Massicotauthor=F.+Chauauthor=F.+Heymansauthor=A.+Lamouri&title=Design+of+New+Potent+and+Selective+Secretory+Phospholipase+A2Inhibitors.+6-Synthesis%2C+Structure-Activity+Relationships+and+Molecular+Modeling+of+1-Substituted-4-%5B4%2C5-dihydro-1%2C2%2C4-%284H%29-oxadiazol-5-one-3-yl%28methyl%29%5D-Functionalizedaryl+Piperazin%2Fone%2Fdione+Derivatives&doi=10.1016%2Fj.bmc.2010.03.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design of new potent and selective secretory phospholipase A2 inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives</span></div><div class="casAuthors">Meddad-Belhabich, Nadia; Aoun, Darina; Djimde, Atime; Redeuilh, Catherine; Dive, Georges; Massicot, France; Chau, Francois; Heymans, Francoise; Lamouri, Aazdine</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3588-3600</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The group IIA human non-pancreatic secretory phospholipase A2 (hnp-sPLA2) is one of the enzymes implied in the inflammatory process.  In the course of our work on inhibitors of this enzyme we investigated the influence of rigidity of the piperazine region on the biol. activity.  Several modifications were explored.  Various linkers, such as amide, urea, carbamate, or alkoxyphenyl were inserted between the piperazine and the lipophilic chain.  Also, modification of the piperazine core to incorporate carbonyl groups was studied.  In an in vitro fluorimetric assay using the human GIIA (HPLA2) and porcine pancreatic GIB enzymes, compd. 60a (I) had the optimal activity with an IC50 = 30 nM on HPLA2.  By means of mol. modeling we attempted to get informations towards comprehension of differences in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPBQ29O1kSTbVg90H21EOLACvtfcHk0lh6uoMCMkwlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVGrur4%253D&md5=365ebce7ec6462af7f06c26c00f5a4ba</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DMeddad-Belhabich%26aufirst%3DN.%26aulast%3DAoun%26aufirst%3DD.%26aulast%3DDjimd%25C3%25A9%26aufirst%3DA.%26aulast%3DRedeuilh%26aufirst%3DC.%26aulast%3DDive%26aufirst%3DG.%26aulast%3DMassicot%26aufirst%3DF.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DHeymans%26aufirst%3DF.%26aulast%3DLamouri%26aufirst%3DA.%26atitle%3DDesign%2520of%2520New%2520Potent%2520and%2520Selective%2520Secretory%2520Phospholipase%2520A2Inhibitors.%25206-Synthesis%252C%2520Structure-Activity%2520Relationships%2520and%2520Molecular%2520Modeling%2520of%25201-Substituted-4-%255B4%252C5-dihydro-1%252C2%252C4-%25284H%2529-oxadiazol-5-one-3-yl%2528methyl%2529%255D-Functionalizedaryl%2520Piperazin%252Fone%252Fdione%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3588%26epage%3D3600%26doi%3D10.1016%2Fj.bmc.2010.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matyja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daldrup, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbah, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of Oxalic Acid Derivatives as New Metabolites of Metamizol (Dipyrone) in Incubated Hen’s Egg and Human</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2005.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.ejps.2005.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16417995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=15-25&author=J.+C.+Wesselauthor=M.+Matyjaauthor=M.+Neugebauerauthor=H.+Kieferauthor=T.+Daldrupauthor=F.+A.+Tarbahauthor=H.+Weber&title=Characterization+of+Oxalic+Acid+Derivatives+as+New+Metabolites+of+Metamizol+%28Dipyrone%29+in+Incubated+Hen%E2%80%99s+Egg+and+Human&doi=10.1016%2Fj.ejps.2005.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen's egg and human</span></div><div class="casAuthors">Wessel, Julia C.; Matyja, Magdalena; Neugebauer, Michael; Kiefer, Heiko; Daldrup, Thomas; Tarbah, Fuad A.; Weber, Horst</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">15-25</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Metamizol (1), a widely used drug with effective analgesic and antispasmodic properties, shows severe side effects like agranulocytosis and anaphylactic shock reactions, the reasons of which are not known until today.  After oral administration 1 is completely metabolized.  All hitherto known metabolites have an intact pyrazolinone ring structure like the parent compd. and are completely extractable from urine with polar org. solvents.  However, only a fractional amt. of the applied dosage can be recovered by this procedure.  To clarify the reason of this deficit of unknown metabolites the authors followed the hypothesis of oxidative rupture of the heterocyclic ring during metab. of 1.  On the basis of former in vitro results the authors now were able to identify in quality three oxalic acid derivs. and one acetic acid phenylhydrazide as new metabolites of metamizol in the allantoic fluid (AF) of incubated hen's eggs as well as in human urine by means of GC-MS anal. and comparison with unequivocally synthesized authentic ref. compds.  Whereas the oxamazide 7, the phenylhydrazide 8 and N-methyloxamic acid 9 are only present in trace concns. and therefore cannot account for the deficit in the balance of metabolites, the oxalic acid monohydrazide 11 seems to be excreted in higher amt.  Quant. detn. of this new metabolite would be required to answer the open questions concerning the biotransformation of metamizol and thereby to detect new facts about mode of action and side effects of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptP1O6MjcPRLVg90H21EOLACvtfcHk0ljq4xJNDLr-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ChtLk%253D&md5=21340914a56998c154bd124f4b32d481</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2005.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2005.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DWessel%26aufirst%3DJ.%2BC.%26aulast%3DMatyja%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DH.%26aulast%3DDaldrup%26aufirst%3DT.%26aulast%3DTarbah%26aufirst%3DF.%2BA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520Oxalic%2520Acid%2520Derivatives%2520as%2520New%2520Metabolites%2520of%2520Metamizol%2520%2528Dipyrone%2529%2520in%2520Incubated%2520Hen%25E2%2580%2599s%2520Egg%2520and%2520Human%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D28%26spage%3D15%26epage%3D25%26doi%3D10.1016%2Fj.ejps.2005.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harker, A.</span></span> <span> </span><span class="NLM_article-title">Modification of The Ultrafiltration Technique to Overcome Solubility and Non-Specific Binding Challenges Associated with the Measurement of Plasma Protein Binding of Corticosteroids</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2005.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10.1016%2Fj.jpba.2005.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=16314065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1enur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=299-303&author=S.+Taylorauthor=A.+Harker&title=Modification+of+The+Ultrafiltration+Technique+to+Overcome+Solubility+and+Non-Specific+Binding+Challenges+Associated+with+the+Measurement+of+Plasma+Protein+Binding+of+Corticosteroids&doi=10.1016%2Fj.jpba.2005.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids</span></div><div class="casAuthors">Taylor, Simon; Harker, Andy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma protein binding (PPB) methodol. suitable for application in the lead optimization of a corticosteroid series known to demonstrate non-specific binding (NSB) and poor soly. has been established.  The method involved a modification to std. ultrafiltration (UF) techniques.  In parallel with each exptl. plasma sample, a control plasma sample was also processed by ultrafiltration.  The retentate from exptl. and control plasma samples were mixed back into the filtrate of the partner sample.  The resulting regenerated plasma samples, one representing the exptl. filtrate and one representing the exptl. retentate, were then analyzed by LC/MS/MS.  Varying degrees of NSB were demonstrated with a no. of corticosteroids, and this effect was eliminated using the modified method.  Validation using a panel of established corticosteroids showed good agreement with published PPB figures.  The published PPB figure for fluticasone propionate (FP) was, however, found to be an underestimate, and this was subsequently confirmed, at clin. relevant plasma concns., to be 99.3%.  The modified method was particularly suited to lead optimization because it provided samples in a consistent matrix compatible with std. high throughput LC/MS/MS anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyxrIbNE9yorVg90H21EOLACvtfcHk0ljq4xJNDLr-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1enur8%253D&md5=b4d0b6a6a358a8c4e6e393987a275605</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2005.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2005.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DHarker%26aufirst%3DA.%26atitle%3DModification%2520of%2520The%2520Ultrafiltration%2520Technique%2520to%2520Overcome%2520Solubility%2520and%2520Non-Specific%2520Binding%2520Challenges%2520Associated%2520with%2520the%2520Measurement%2520of%2520Plasma%2520Protein%2520Binding%2520of%2520Corticosteroids%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D41%26spage%3D299%26epage%3D303%26doi%3D10.1016%2Fj.jpba.2005.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of Human Clearance of Twenty-Nine Drugs from Hepaticmicrosomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+Human+Clearance+of+Twenty-Nine+Drugs+from+Hepaticmicrosomal+Intrinsic+Clearance+Data%3A+An+Examination+of+In+Vitro+Half-Life+Approach+and+Nonspecific+Binding+to+Microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0ljq4xJNDLr-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520Human%2520Clearance%2520of%2520Twenty-Nine%2520Drugs%2520from%2520Hepaticmicrosomal%2520Intrinsic%2520Clearance%2520Data%253A%2520An%2520Examination%2520of%2520In%2520Vitro%2520Half-Life%2520Approach%2520and%2520Nonspecific%2520Binding%2520to%2520Microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00952">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77528"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00952">10.1021/acs.jmedchem.9b00952</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C spectra of all new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_001.csv">jm9b00952_si_001.csv (1.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00952/suppl_file/jm9b00952_si_002.pdf">jm9b00952_si_002.pdf (7.68 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00952&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00952%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00952" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679923493d2e24bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
